<HTML><HEAD><TITLE>Gene Ontology Results</TITLE></HEAD><BODY>
<H1>Gene Ontology Enrichment Results</H1>
<A HREF="homerResults.html">Homer <i>de novo</i> Motif Enrichment Results</A><BR/>
<A HREF="knownResults.html">Known Motif Enrichment Results</A><BR/>
<H4>Text file version of complete results (i.e. open with Excel)
<UL>
<LI><A HREF="biological_process.txt">biological process</A>: Functional groupings of proteins (<A HREF="http://www.geneontology.org">Gene Ontology</A>)</LI>
<LI><A HREF="molecular_function.txt">molecular function</A>: Mechanistic actions of proteins (<A HREF="http://www.geneontology.org">Gene Ontology</A>)</LI>
<LI><A HREF="cellular_component.txt">cellular component</A>: Protein localization (<A HREF="http://www.geneontology.org">Gene Ontology</A>)</LI>
<LI><A HREF="chromosome.txt">chromosome location</A>: Genes with similar chromosome localization (<A HREF="http://www.ncbi.nlm.nih.gov/gene">NCBI Gene</A>)</LI>
<LI><A HREF="kegg.txt">KEGG pathways</A>: Groups of proteins in the same pathways (<A HREF="http://www.genome.jp/kegg/pathway.html">KEGG</A>)</LI>
<LI><A HREF="interactions.txt">protein interactions</A>: "Proteins interacting with a common protein (BIND, EcoCyc, HPRD)" (<A HREF="http://www.ncbi.nlm.nih.gov/gene">NCBI Gene</A>)</LI>
<LI><A HREF="interpro.txt">interpro domains</A>: Proteins with similar domains and features (<A HREF="http://www.ebi.ac.uk/interpro/">Interpro</A>)</LI>
<LI><A HREF="pfam.txt">pfam domains</A>: Proteins with similar domains and features (<A HREF="http://www.sanger.ac.uk/Software/Pfam/">Pfam</A>)</LI>
<LI><A HREF="smart.txt">smart domains</A>: Proteins with similar domains and features (<A HREF="http://smart.embl-heidelberg.de/">SMART</A>)</LI>
<LI><A HREF="gene3d.txt">gene3d domains</A>: Proteins with similar domains and features (<A HREF="http://cathwww.biochem.ucl.ac.uk:8080/Gene3D">Gene3D</A>)</LI>
<LI><A HREF="prosite.txt">prosite domains</A>: Proteins with similar domains and features (<A HREF="http://ca.expasy.org/prosite/">Prosite</A>)</LI>
<LI><A HREF="prints.txt">prints domains</A>: Proteins with similar domains and features (<A HREF="http://www.bioinf.manchester.ac.uk/dbbrowser/PRINTS/">PRINTS</A>)</LI>
<LI><A HREF="msigdb.txt">MSigDB lists</A>: "Genes sets for pathways, factor/miRNA target predictions, expression patterns, etc." (<A HREF="http://www.broadinstitute.org/gsea/msigdb/index.jsp">MSigDB</A>)</LI>
<LI><A HREF="biocyc.txt">BIOCYC pathways</A>: Groups of proteins in the same pathways (<A HREF="http://biocyc.org/">BIOCYC</A>)</LI>
<LI><A HREF="cosmic.txt">COSMIC cancer mutations</A>: Genes mutated in similar cancers (<A HREF="http://cancer.sanger.ac.uk/cancergenome/projects/cosmic/">COSMIC</A>)</LI>
<LI><A HREF="gwas.txt">GWAS genes</A>: Genes mutated in similar diseases (<A HREF="http://www.genome.gov/26525384">GWAS Catalog</A>)</LI>
<LI><A HREF="lipidmaps.txt">Lipid Maps pathways</A>: Groups of proteins in the same lipid pathways (<A HREF="http://www.ncbi.nlm.nih.gov/biosystems/">Lipid Maps/Biosystems</A>)</LI>
<LI><A HREF="pathwayInteractionDB.txt">Pathway Interaction DB</A>: Groups of proteins in the same pathways (<A HREF="http://pid.nci.nih.gov/">Pathway Interaction Database</A>)</LI>
<LI><A HREF="reactome.txt">REACTOME pathways</A>: Groups of proteins in the same pathways (<A HREF="http://www.reactome.org/PathwayBrowser/">REACTOME</A>)</LI>
<LI><A HREF="smpdb.txt">SMPDB pathways</A>: Groups of proteins in the same pathways (<A HREF="http://www.smpdb.ca/">SMPDB</A>)</LI>
<LI><A HREF="wikipathways.txt">WikiPathways</A>: Groups of proteins in the same pathways (<A HREF="http://www.wikipathways.org/index.php/Special:BrowsePathwaysPage">Wikipathways</A>)</LI>
</UL>
<H2>Enriched Categories</H2>
<TABLE border="1" cellpading="0" cellspacing="0">
<TR><TH>P-value</TH><TD>ln(P)</TD><TD>Term</TD><TD>GO Tree</TD><TD>GO ID</TD><TD># of Genes in Term</TD><TD># of Target Genes in Term</TD><TD># of Total Genes</TD><TD># of Target Genes</TD><TD>Common Genes</TD></TR>
<TR><TD>1.054e-17</TD><TD>-39.09</TD><TD>ZHANG_INTERFERON_RESPONSE</TD><TD>MSigDB lists</TD><TD>ZHANG_INTERFERON_RESPONSE</TD><TD>23</TD><TD>8</TD><TD>17275</TD><TD>29</TD>
<TD>IFI27,ISG15,IFIT2,IFI44,OAS3,OAS1,OASL,OAS2</TD></TR>
<TR><TD>1.446e-16</TD><TD>-36.47</TD><TD>HECKER_IFNB1_TARGETS</TD><TD>MSigDB lists</TD><TD>HECKER_IFNB1_TARGETS</TD><TD>89</TD><TD>10</TD><TD>17275</TD><TD>29</TD>
<TD>RSAD2,ISG15,IFIT2,IFI44L,IFI44,OAS3,OAS1,OAS2,OASL,IFI27</TD></TR>
<TR><TD>9.270e-16</TD><TD>-34.61</TD><TD>BROWNE_INTERFERON_RESPONSIVE_GENES</TD><TD>MSigDB lists</TD><TD>BROWNE_INTERFERON_RESPONSIVE_GENES</TD><TD>66</TD><TD>9</TD><TD>17275</TD><TD>29</TD>
<TD>IFI27,OASL,OAS1,OAS2,IFI44L,IFI44,RSAD2,IFIT2,ISG15</TD></TR>
<TR><TD>1.300e-15</TD><TD>-34.28</TD><TD>FARMER_BREAST_CANCER_CLUSTER_1</TD><TD>MSigDB lists</TD><TD>FARMER_BREAST_CANCER_CLUSTER_1</TD><TD>39</TD><TD>8</TD><TD>17275</TD><TD>29</TD>
<TD>OAS1,OASL,OAS2,OAS3,IFI44,IFI44L,ISG15,RSAD2</TD></TR>
<TR><TD>3.613e-15</TD><TD>-33.25</TD><TD>GSE42021_CD24INT_VS_CD24LOW_TCONV_THYMUS_DN</TD><TD>MSigDB lists</TD><TD>GSE42021_CD24INT_VS_CD24LOW_TCONV_THYMUS_DN</TD><TD>181</TD><TD>11</TD><TD>17275</TD><TD>29</TD>
<TD>OAS3,OAS1,OAS2,OASL,IFIT2,ISG15,RSAD2,IFI44,IFI44L,MGAT3,IFI27</TD></TR>
<TR><TD>4.392e-14</TD><TD>-30.76</TD><TD>MOSERLE_IFNA_RESPONSE</TD><TD>MSigDB lists</TD><TD>MOSERLE_IFNA_RESPONSE</TD><TD>31</TD><TD>7</TD><TD>17275</TD><TD>29</TD>
<TD>IFIT2,RSAD2,IFI44,IFI44L,OAS1,OASL,OAS2</TD></TR>
<TR><TD>8.742e-14</TD><TD>-30.07</TD><TD>TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_3D_UP</TD><TD>MSigDB lists</TD><TD>TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_3D_UP</TD><TD>166</TD><TD>10</TD><TD>17275</TD><TD>29</TD>
<TD>IFI44L,IFI44,RSAD2,IFIT2,ISG15,OAS1,OAS2,OASL,OAS3,IFI27</TD></TR>
<TR><TD>9.422e-14</TD><TD>-29.99</TD><TD>type I interferon signaling pathway</TD><TD>biological process</TD><TD>GO:0060337</TD><TD>67</TD><TD>8</TD><TD>18054</TD><TD>29</TD>
<TD>ISG15,OASL,OAS2,OAS3,IFI27,RSAD2,OAS1,IFIT2</TD></TR>
<TR><TD>9.422e-14</TD><TD>-29.99</TD><TD>cellular response to type I interferon</TD><TD>biological process</TD><TD>GO:0071357</TD><TD>67</TD><TD>8</TD><TD>18054</TD><TD>29</TD>
<TD>IFIT2,OAS1,RSAD2,IFI27,OAS2,OAS3,OASL,ISG15</TD></TR>
<TR><TD>1.119e-13</TD><TD>-29.82</TD><TD>Interferon alpha/beta signaling</TD><TD>REACTOME pathways</TD><TD>R-HSA-909733</TD><TD>69</TD><TD>8</TD><TD>10287</TD><TD>18</TD>
<TD>RSAD2,IFI27,OAS3,OASL,IFIT2,OAS2,ISG15,OAS1</TD></TR>
<TR><TD>1.179e-13</TD><TD>-29.77</TD><TD>GO_RESPONSE_TO_TYPE_I_INTERFERON</TD><TD>MSigDB lists</TD><TD>GO_RESPONSE_TO_TYPE_I_INTERFERON</TD><TD>66</TD><TD>8</TD><TD>17275</TD><TD>29</TD>
<TD>IFI27,OAS3,OASL,OAS2,OAS1,ISG15,IFIT2,RSAD2</TD></TR>
<TR><TD>1.578e-13</TD><TD>-29.48</TD><TD>TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_10D_UP</TD><TD>MSigDB lists</TD><TD>TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_10D_UP</TD><TD>176</TD><TD>10</TD><TD>17275</TD><TD>29</TD>
<TD>IFIT2,ISG15,RSAD2,IFI44,IFI44L,OAS3,OASL,OAS2,OAS1,IFI27</TD></TR>
<TR><TD>1.578e-13</TD><TD>-29.48</TD><TD>GSE21546_WT_VS_SAP1A_KO_DP_THYMOCYTES_UP</TD><TD>MSigDB lists</TD><TD>GSE21546_WT_VS_SAP1A_KO_DP_THYMOCYTES_UP</TD><TD>176</TD><TD>10</TD><TD>17275</TD><TD>29</TD>
<TD>IFI27,OAS3,OAS1,OASL,OAS2,RSAD2,ISG15,IFIT2,IFI44L,IFI44</TD></TR>
<TR><TD>1.671e-13</TD><TD>-29.42</TD><TD>GSE42724_NAIVE_BCELL_VS_PLASMABLAST_UP</TD><TD>MSigDB lists</TD><TD>GSE42724_NAIVE_BCELL_VS_PLASMABLAST_UP</TD><TD>177</TD><TD>10</TD><TD>17275</TD><TD>29</TD>
<TD>IFI27,IFI44L,IFI44,RSAD2,ISG15,IFIT2,OAS2,OASL,OAS1,OAS3</TD></TR>
<TR><TD>1.711e-13</TD><TD>-29.40</TD><TD>SEITZ_NEOPLASTIC_TRANSFORMATION_BY_8P_DELETION_UP</TD><TD>MSigDB lists</TD><TD>SEITZ_NEOPLASTIC_TRANSFORMATION_BY_8P_DELETION_UP</TD><TD>69</TD><TD>8</TD><TD>17275</TD><TD>29</TD>
<TD>IFI27,IFI44,IFI44L,IFIT2,ISG15,OAS1,OAS2,OASL</TD></TR>
<TR><TD>1.720e-13</TD><TD>-29.39</TD><TD>response to type I interferon</TD><TD>biological process</TD><TD>GO:0034340</TD><TD>72</TD><TD>8</TD><TD>18054</TD><TD>29</TD>
<TD>ISG15,OASL,OAS2,OAS3,IFI27,OAS1,IFIT2,RSAD2</TD></TR>
<TR><TD>1.980e-13</TD><TD>-29.25</TD><TD>GSE42021_CD24INT_VS_CD24LOW_TREG_THYMUS_DN</TD><TD>MSigDB lists</TD><TD>GSE42021_CD24INT_VS_CD24LOW_TREG_THYMUS_DN</TD><TD>180</TD><TD>10</TD><TD>17275</TD><TD>29</TD>
<TD>ISG15,IFIT2,RSAD2,IFI44,IFI44L,OAS3,OAS2,OAS1,OASL,IFI27</TD></TR>
<TR><TD>2.094e-13</TD><TD>-29.19</TD><TD>GSE42021_CD24HI_VS_CD24LOW_TREG_THYMUS_DN</TD><TD>MSigDB lists</TD><TD>GSE42021_CD24HI_VS_CD24LOW_TREG_THYMUS_DN</TD><TD>181</TD><TD>10</TD><TD>17275</TD><TD>29</TD>
<TD>IFI44,IFI44L,IFIT2,ISG15,RSAD2,OAS1,OAS2,OASL,OAS3,IFI27</TD></TR>
<TR><TD>2.094e-13</TD><TD>-29.19</TD><TD>GSE13485_DAY3_VS_DAY7_YF17D_VACCINE_PBMC_DN</TD><TD>MSigDB lists</TD><TD>GSE13485_DAY3_VS_DAY7_YF17D_VACCINE_PBMC_DN</TD><TD>181</TD><TD>10</TD><TD>17275</TD><TD>29</TD>
<TD>OAS2,OAS1,OASL,OAS3,IFI44,IFI44L,IFIT2,ISG15,RSAD2,IFI27</TD></TR>
<TR><TD>2.094e-13</TD><TD>-29.19</TD><TD>GSE26890_CXCR1_NEG_VS_POS_EFFECTOR_CD8_TCELL_UP</TD><TD>MSigDB lists</TD><TD>GSE26890_CXCR1_NEG_VS_POS_EFFECTOR_CD8_TCELL_UP</TD><TD>181</TD><TD>10</TD><TD>17275</TD><TD>29</TD>
<TD>CAMKK2,OAS3,OASL,OAS1,OAS2,RSAD2,ISG15,IFIT2,IFI44L,IFI44</TD></TR>
<TR><TD>2.471e-13</TD><TD>-29.03</TD><TD>GSE13485_DAY1_VS_DAY7_YF17D_VACCINE_PBMC_DN</TD><TD>MSigDB lists</TD><TD>GSE13485_DAY1_VS_DAY7_YF17D_VACCINE_PBMC_DN</TD><TD>184</TD><TD>10</TD><TD>17275</TD><TD>29</TD>
<TD>IFIT2,ISG15,RSAD2,IFI44,IFI44L,OAS3,OASL,OAS2,OAS1,IFI27</TD></TR>
<TR><TD>2.609e-13</TD><TD>-28.97</TD><TD>GSE13485_CTRL_VS_DAY3_YF17D_VACCINE_PBMC_DN</TD><TD>MSigDB lists</TD><TD>GSE13485_CTRL_VS_DAY3_YF17D_VACCINE_PBMC_DN</TD><TD>185</TD><TD>10</TD><TD>17275</TD><TD>29</TD>
<TD>IFI27,IFI44,IFI44L,IFIT2,ISG15,RSAD2,OASL,OAS2,OAS1,OAS3</TD></TR>
<TR><TD>2.755e-13</TD><TD>-28.92</TD><TD>GSE13485_PRE_VS_POST_YF17D_VACCINATION_PBMC_DN</TD><TD>MSigDB lists</TD><TD>GSE13485_PRE_VS_POST_YF17D_VACCINATION_PBMC_DN</TD><TD>186</TD><TD>10</TD><TD>17275</TD><TD>29</TD>
<TD>OAS3,OASL,OAS2,OAS1,RSAD2,IFIT2,ISG15,IFI44L,IFI44,IFI27</TD></TR>
<TR><TD>2.907e-13</TD><TD>-28.87</TD><TD>GSE21360_NAIVE_VS_QUATERNARY_MEMORY_CD8_TCELL_DN</TD><TD>MSigDB lists</TD><TD>GSE21360_NAIVE_VS_QUATERNARY_MEMORY_CD8_TCELL_DN</TD><TD>187</TD><TD>10</TD><TD>17275</TD><TD>29</TD>
<TD>IFI27,IFIT2,ISG15,RSAD2,IFI44,IFI44L,OAS3,OAS1,OASL,OAS2</TD></TR>
<TR><TD>2.907e-13</TD><TD>-28.87</TD><TD>GSE42021_TREG_VS_TCONV_PLN_UP</TD><TD>MSigDB lists</TD><TD>GSE42021_TREG_VS_TCONV_PLN_UP</TD><TD>187</TD><TD>10</TD><TD>17275</TD><TD>29</TD>
<TD>OAS2,OASL,OAS1,OAS3,IFI44L,IFI44,RSAD2,IFIT2,ISG15,IFI27</TD></TR>
<TR><TD>3.067e-13</TD><TD>-28.81</TD><TD>GSE37533_PPARG1_FOXP3_VS_FOXP3_TRANSDUCED_CD4_TCELL_DN</TD><TD>MSigDB lists</TD><TD>GSE37533_PPARG1_FOXP3_VS_FOXP3_TRANSDUCED_CD4_TCELL_DN</TD><TD>188</TD><TD>10</TD><TD>17275</TD><TD>29</TD>
<TD>ISG15,IFIT2,RSAD2,IFI44,IFI44L,OAS3,OASL,OAS1,OAS2,IFI27</TD></TR>
<TR><TD>3.236e-13</TD><TD>-28.76</TD><TD>GSE37534_UNTREATED_VS_PIOGLITAZONE_TREATED_CD4_TCELL_PPARG1_AND_FOXP3_TRASDUCED_DN</TD><TD>MSigDB lists</TD><TD>GSE37534_UNTREATED_VS_PIOGLITAZONE_TREATED_CD4_TCELL_PPARG1_AND_FOXP3_TRASDUCED_DN</TD><TD>189</TD><TD>10</TD><TD>17275</TD><TD>29</TD>
<TD>IFI44L,IFI44,RSAD2,IFIT2,ISG15,OAS1,OASL,OAS2,OAS3,IFI27</TD></TR>
<TR><TD>3.236e-13</TD><TD>-28.76</TD><TD>GSE42021_TREG_PLN_VS_TREG_PRECURSORS_THYMUS_DN</TD><TD>MSigDB lists</TD><TD>GSE42021_TREG_PLN_VS_TREG_PRECURSORS_THYMUS_DN</TD><TD>189</TD><TD>10</TD><TD>17275</TD><TD>29</TD>
<TD>IFI27,OAS3,OAS2,OASL,OAS1,IFIT2,ISG15,RSAD2,IFI44,IFI44L</TD></TR>
<TR><TD>3.597e-13</TD><TD>-28.65</TD><TD>GSE37533_PPARG1_FOXP3_VS_FOXP3_TRANSDUCED_CD4_TCELL_PIOGLITAZONE_TREATED_UP</TD><TD>MSigDB lists</TD><TD>GSE37533_PPARG1_FOXP3_VS_FOXP3_TRANSDUCED_CD4_TCELL_PIOGLITAZONE_TREATED_UP</TD><TD>191</TD><TD>10</TD><TD>17275</TD><TD>29</TD>
<TD>ISG15,IFIT2,RSAD2,IFI44,IFI44L,OAS3,OAS1,OAS2,OASL,IFI27</TD></TR>
<TR><TD>3.597e-13</TD><TD>-28.65</TD><TD>GSE13485_CTRL_VS_DAY7_YF17D_VACCINE_PBMC_DN</TD><TD>MSigDB lists</TD><TD>GSE13485_CTRL_VS_DAY7_YF17D_VACCINE_PBMC_DN</TD><TD>191</TD><TD>10</TD><TD>17275</TD><TD>29</TD>
<TD>IFI27,IFI44L,IFI44,RSAD2,IFIT2,ISG15,OAS2,OAS1,OASL,OAS3</TD></TR>
<TR><TD>3.791e-13</TD><TD>-28.60</TD><TD>GSE21360_NAIVE_VS_QUATERNARY_MEMORY_CD8_TCELL_UP</TD><TD>MSigDB lists</TD><TD>GSE21360_NAIVE_VS_QUATERNARY_MEMORY_CD8_TCELL_UP</TD><TD>192</TD><TD>10</TD><TD>17275</TD><TD>29</TD>
<TD>IFI44,IFI44L,ISG15,IFIT2,RSAD2,OAS1,OAS2,OASL,OAS3,IFI27</TD></TR>
<TR><TD>1.397e-12</TD><TD>-27.30</TD><TD>TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_8D_UP</TD><TD>MSigDB lists</TD><TD>TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_8D_UP</TD><TD>145</TD><TD>9</TD><TD>17275</TD><TD>29</TD>
<TD>IFI44,IFI44L,ISG15,IFIT2,RSAD2,OAS2,OAS1,OAS3,IFI27</TD></TR>
<TR><TD>1.406e-12</TD><TD>-27.29</TD><TD>DAUER_STAT3_TARGETS_DN</TD><TD>MSigDB lists</TD><TD>DAUER_STAT3_TARGETS_DN</TD><TD>49</TD><TD>7</TD><TD>17275</TD><TD>29</TD>
<TD>OAS2,OAS1,OASL,OAS3,IFI44,IFI27,ISG15</TD></TR>
<TR><TD>2.030e-12</TD><TD>-26.92</TD><TD>HALLMARK_INTERFERON_ALPHA_RESPONSE</TD><TD>MSigDB lists</TD><TD>HALLMARK_INTERFERON_ALPHA_RESPONSE</TD><TD>93</TD><TD>8</TD><TD>17275</TD><TD>29</TD>
<TD>IFI44,IFI44L,IFIT2,ISG15,RSAD2,OASL,OAS1,IFI27</TD></TR>
<TR><TD>2.183e-12</TD><TD>-26.85</TD><TD>RADAEVA_RESPONSE_TO_IFNA1_UP</TD><TD>MSigDB lists</TD><TD>RADAEVA_RESPONSE_TO_IFNA1_UP</TD><TD>52</TD><TD>7</TD><TD>17275</TD><TD>29</TD>
<TD>OAS1,IFI44,IFI44L,IFI27,ISG15,IFIT2,RSAD2</TD></TR>
<TR><TD>2.563e-12</TD><TD>-26.69</TD><TD>GSE6269_HEALTHY_VS_FLU_INF_PBMC_DN</TD><TD>MSigDB lists</TD><TD>GSE6269_HEALTHY_VS_FLU_INF_PBMC_DN</TD><TD>155</TD><TD>9</TD><TD>17275</TD><TD>29</TD>
<TD>IFI27,RSAD2,ISG15,IFI44L,IFI44,OAS3,OASL,OAS1,OAS2</TD></TR>
<TR><TD>3.616e-12</TD><TD>-26.35</TD><TD>TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_16D_UP</TD><TD>MSigDB lists</TD><TD>TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_16D_UP</TD><TD>161</TD><TD>9</TD><TD>17275</TD><TD>29</TD>
<TD>OAS2,OASL,OAS3,IFI44,IFI44L,IFIT2,ISG15,RSAD2,IFI27</TD></TR>
<TR><TD>4.001e-12</TD><TD>-26.24</TD><TD>2'-5'-oligoadenylate synthetase activity</TD><TD>molecular function</TD><TD>GO:0001730</TD><TD>4</TD><TD>4</TD><TD>17306</TD><TD>26</TD>
<TD>OAS3,OASL,OAS2,OAS1</TD></TR>
<TR><TD>4.771e-12</TD><TD>-26.07</TD><TD>GSE21546_UNSTIM_VS_ANTI_CD3_STIM_ELK1_KO_DP_THYMOCYTES_UP</TD><TD>MSigDB lists</TD><TD>GSE21546_UNSTIM_VS_ANTI_CD3_STIM_ELK1_KO_DP_THYMOCYTES_UP</TD><TD>166</TD><TD>9</TD><TD>17275</TD><TD>29</TD>
<TD>IFI27,OAS3,OAS1,OASL,ISG15,IFIT2,RSAD2,IFI44,IFI44L</TD></TR>
<TR><TD>5.381e-12</TD><TD>-25.95</TD><TD>OAS1_C</TD><TD>pfam domains</TD><TD>PF10421</TD><TD>4</TD><TD>4</TD><TD>17385</TD><TD>28</TD>
<TD>OASL,OAS3,OAS2,OAS1</TD></TR>
<TR><TD>5.478e-12</TD><TD>-25.93</TD><TD>2-5A_synthase</TD><TD>interpro domains</TD><TD>IPR026774</TD><TD>4</TD><TD>4</TD><TD>18616</TD><TD>30</TD>
<TD>OASL,OAS3,OAS2,OAS1</TD></TR>
<TR><TD>5.478e-12</TD><TD>-25.93</TD><TD>2-5-oligoadenylate_synth_CS</TD><TD>interpro domains</TD><TD>IPR006117</TD><TD>4</TD><TD>4</TD><TD>18616</TD><TD>30</TD>
<TD>OAS2,OAS3,OASL,OAS1</TD></TR>
<TR><TD>5.478e-12</TD><TD>-25.93</TD><TD>2-5-oligoAdlate_synth_2_sf</TD><TD>interpro domains</TD><TD>IPR038121</TD><TD>4</TD><TD>4</TD><TD>18616</TD><TD>30</TD>
<TD>OAS2,OASL,OAS3,OAS1</TD></TR>
<TR><TD>5.478e-12</TD><TD>-25.93</TD><TD>2-5-oligoAdlate_synth_1_dom2/C</TD><TD>interpro domains</TD><TD>IPR018952</TD><TD>4</TD><TD>4</TD><TD>18616</TD><TD>30</TD>
<TD>OAS1,OAS2,OAS3,OASL</TD></TR>
<TR><TD>6.577e-12</TD><TD>-25.75</TD><TD>GSE18791_UNSTIM_VS_NEWCATSLE_VIRUS_DC_6H_DN</TD><TD>MSigDB lists</TD><TD>GSE18791_UNSTIM_VS_NEWCATSLE_VIRUS_DC_6H_DN</TD><TD>172</TD><TD>9</TD><TD>17275</TD><TD>29</TD>
<TD>OAS1,OASL,OAS2,OAS3,IFI44,IFI44L,IFIT2,ISG15,RSAD2</TD></TR>
<TR><TD>7.689e-12</TD><TD>-25.59</TD><TD>GSE18791_CTRL_VS_NEWCASTLE_VIRUS_DC_8H_DN</TD><TD>MSigDB lists</TD><TD>GSE18791_CTRL_VS_NEWCASTLE_VIRUS_DC_8H_DN</TD><TD>175</TD><TD>9</TD><TD>17275</TD><TD>29</TD>
<TD>IFI44L,IFI44,RSAD2,IFIT2,BCL6B,ISG15,OAS2,OASL,OAS3</TD></TR>
<TR><TD>8.095e-12</TD><TD>-25.54</TD><TD>GSE14000_UNSTIM_VS_4H_LPS_DC_TRANSLATED_RNA_DN</TD><TD>MSigDB lists</TD><TD>GSE14000_UNSTIM_VS_4H_LPS_DC_TRANSLATED_RNA_DN</TD><TD>176</TD><TD>9</TD><TD>17275</TD><TD>29</TD>
<TD>OAS2,OAS1,OASL,IFIT2,ISG15,RSAD2,IFI44,IFI44L,IFI27</TD></TR>
<TR><TD>8.916e-12</TD><TD>-25.44</TD><TD>REACTOME_INTERFERON_ALPHA_BETA_SIGNALING</TD><TD>MSigDB lists</TD><TD>REACTOME_INTERFERON_ALPHA_BETA_SIGNALING</TD><TD>63</TD><TD>7</TD><TD>17275</TD><TD>29</TD>
<TD>ISG15,IFI27,IFIT2,OASL,OAS2,OAS1,OAS3</TD></TR>
<TR><TD>9.914e-12</TD><TD>-25.34</TD><TD>GSE2770_TGFB_AND_IL4_ACT_VS_ACT_CD4_TCELL_2H_DN</TD><TD>MSigDB lists</TD><TD>GSE2770_TGFB_AND_IL4_ACT_VS_ACT_CD4_TCELL_2H_DN</TD><TD>180</TD><TD>9</TD><TD>17275</TD><TD>29</TD>
<TD>IFI27,OAS3,OAS2,OASL,OAS1,ISG15,IFIT2,IFI44,IFI44L</TD></TR>
<TR><TD>1.042e-11</TD><TD>-25.29</TD><TD>GSE14000_UNSTIM_VS_4H_LPS_DC_DN</TD><TD>MSigDB lists</TD><TD>GSE14000_UNSTIM_VS_4H_LPS_DC_DN</TD><TD>181</TD><TD>9</TD><TD>17275</TD><TD>29</TD>
<TD>OAS3,OAS2,OAS1,OASL,IFIT2,ISG15,IFI44L,IFI44,IFI27</TD></TR>
<TR><TD>1.084e-11</TD><TD>-25.25</TD><TD>-</TD><TD>gene3d domains</TD><TD>1.10.1410.20</TD><TD>4</TD><TD>4</TD><TD>8522</TD><TD>17</TD>
<TD>OAS2,OAS1,OASL,OAS3</TD></TR>
<TR><TD>1.097e-11</TD><TD>-25.24</TD><TD>response to virus</TD><TD>biological process</TD><TD>GO:0009615</TD><TD>281</TD><TD>10</TD><TD>18054</TD><TD>29</TD>
<TD>OASL,IFI44,ISG15,IFIT2,OAS1,IFI44L,RSAD2,IFI27,OAS2,OAS3</TD></TR>
<TR><TD>1.199e-11</TD><TD>-25.15</TD><TD>25A_SYNTH_1</TD><TD>prosite domains</TD><TD>PS00832</TD><TD>4</TD><TD>4</TD><TD>12079</TD><TD>24</TD>
<TD>OAS2,OAS3,OAS1,OASL</TD></TR>
<TR><TD>1.199e-11</TD><TD>-25.15</TD><TD>25A_SYNTH_2</TD><TD>prosite domains</TD><TD>PS00833</TD><TD>4</TD><TD>4</TD><TD>12079</TD><TD>24</TD>
<TD>OAS3,OAS2,OAS1,OASL</TD></TR>
<TR><TD>1.202e-11</TD><TD>-25.14</TD><TD>defense response to virus</TD><TD>biological process</TD><TD>GO:0051607</TD><TD>192</TD><TD>9</TD><TD>18054</TD><TD>29</TD>
<TD>RSAD2,IFI44L,OAS1,IFIT2,OAS3,OAS2,IFI27,OASL,ISG15</TD></TR>
<TR><TD>1.209e-11</TD><TD>-25.14</TD><TD>GSE10325_CD4_TCELL_VS_LUPUS_CD4_TCELL_DN</TD><TD>MSigDB lists</TD><TD>GSE10325_CD4_TCELL_VS_LUPUS_CD4_TCELL_DN</TD><TD>184</TD><TD>9</TD><TD>17275</TD><TD>29</TD>
<TD>IFI44,IFI44L,ISG15,RSAD2,OASL,OAS1,OAS2,OAS3,IFI27</TD></TR>
<TR><TD>1.209e-11</TD><TD>-25.14</TD><TD>GSE37533_PPARG2_FOXP3_VS_FOXP3_TRANSDUCED_CD4_TCELL_DN</TD><TD>MSigDB lists</TD><TD>GSE37533_PPARG2_FOXP3_VS_FOXP3_TRANSDUCED_CD4_TCELL_DN</TD><TD>184</TD><TD>9</TD><TD>17275</TD><TD>29</TD>
<TD>IFI44,IFI44L,ISG15,IFIT2,RSAD2,OAS2,OAS1,OASL,OAS3</TD></TR>
<TR><TD>1.209e-11</TD><TD>-25.14</TD><TD>GSE33424_CD161_INT_VS_NEG_CD8_TCELL_UP</TD><TD>MSigDB lists</TD><TD>GSE33424_CD161_INT_VS_NEG_CD8_TCELL_UP</TD><TD>184</TD><TD>9</TD><TD>17275</TD><TD>29</TD>
<TD>OAS3,OAS1,OAS2,OASL,RSAD2,ISG15,IFIT2,IFI44L,IFI44</TD></TR>
<TR><TD>1.269e-11</TD><TD>-25.09</TD><TD>GSE42021_CD24HI_VS_CD24INT_TREG_THYMUS_DN</TD><TD>MSigDB lists</TD><TD>GSE42021_CD24HI_VS_CD24INT_TREG_THYMUS_DN</TD><TD>185</TD><TD>9</TD><TD>17275</TD><TD>29</TD>
<TD>IFI27,IFI44L,IFI44,IFIT2,ISG15,OAS1,OAS2,OASL,OAS3</TD></TR>
<TR><TD>1.269e-11</TD><TD>-25.09</TD><TD>GSE21927_SPLEEN_C57BL6_VS_4T1_TUMOR_BALBC_MONOCYTES_DN</TD><TD>MSigDB lists</TD><TD>GSE21927_SPLEEN_C57BL6_VS_4T1_TUMOR_BALBC_MONOCYTES_DN</TD><TD>185</TD><TD>9</TD><TD>17275</TD><TD>29</TD>
<TD>ISG15,IFIT2,RSAD2,IFI44,IFI44L,OAS3,OASL,OAS2,OAS1</TD></TR>
<TR><TD>1.398e-11</TD><TD>-24.99</TD><TD>GSE26030_TH1_VS_TH17_DAY5_POST_POLARIZATION_UP</TD><TD>MSigDB lists</TD><TD>GSE26030_TH1_VS_TH17_DAY5_POST_POLARIZATION_UP</TD><TD>187</TD><TD>9</TD><TD>17275</TD><TD>29</TD>
<TD>IFIT2,ISG15,RSAD2,IFI44,IFI44L,OAS3,OASL,OAS2,OAS1</TD></TR>
<TR><TD>1.398e-11</TD><TD>-24.99</TD><TD>LTE2_UP.V1_DN</TD><TD>MSigDB lists</TD><TD>LTE2_UP.V1_DN</TD><TD>187</TD><TD>9</TD><TD>17275</TD><TD>29</TD>
<TD>LGR4,IFI27,OAS3,OASL,OAS1,OAS2,ISG15,IFI44L,IFI44</TD></TR>
<TR><TD>1.398e-11</TD><TD>-24.99</TD><TD>GSE13484_UNSTIM_VS_YF17D_VACCINE_STIM_PBMC_DN</TD><TD>MSigDB lists</TD><TD>GSE13484_UNSTIM_VS_YF17D_VACCINE_STIM_PBMC_DN</TD><TD>187</TD><TD>9</TD><TD>17275</TD><TD>29</TD>
<TD>OASL,OAS2,OAS1,OAS3,IFI44,IFI44L,IFIT2,ISG15,RSAD2</TD></TR>
<TR><TD>1.398e-11</TD><TD>-24.99</TD><TD>GSE19888_ADENOSINE_A3R_INH_VS_ACT_WITH_INHIBITOR_PRETREATMENT_IN_MAST_CELL_UP</TD><TD>MSigDB lists</TD><TD>GSE19888_ADENOSINE_A3R_INH_VS_ACT_WITH_INHIBITOR_PRETREATMENT_IN_MAST_CELL_UP</TD><TD>187</TD><TD>9</TD><TD>17275</TD><TD>29</TD>
<TD>OAS3,OAS2,OAS1,OASL,RSAD2,IFIT2,ISG15,IFI44L,IFI44</TD></TR>
<TR><TD>1.539e-11</TD><TD>-24.90</TD><TD>GSE42021_TCONV_PLN_VS_CD24HI_TCONV_THYMUS_DN</TD><TD>MSigDB lists</TD><TD>GSE42021_TCONV_PLN_VS_CD24HI_TCONV_THYMUS_DN</TD><TD>189</TD><TD>9</TD><TD>17275</TD><TD>29</TD>
<TD>TUBA1A,OAS3,OAS1,OASL,OAS2,ISG15,IFI44L,IFI44,IFI27</TD></TR>
<TR><TD>1.613e-11</TD><TD>-24.85</TD><TD>GSE19888_ADENOSINE_A3R_INH_PRETREAT_AND_ACT_BY_A3R_VS_TCELL_MEMBRANES_ACT_MAST_CELL_UP</TD><TD>MSigDB lists</TD><TD>GSE19888_ADENOSINE_A3R_INH_PRETREAT_AND_ACT_BY_A3R_VS_TCELL_MEMBRANES_ACT_MAST_CELL_UP</TD><TD>190</TD><TD>9</TD><TD>17275</TD><TD>29</TD>
<TD>IFIT2,ISG15,RSAD2,IFI44,IFI44L,OAS3,OAS1,OAS2,OASL</TD></TR>
<TR><TD>1.691e-11</TD><TD>-24.80</TD><TD>GSE22886_CTRL_VS_LPS_24H_DC_DN</TD><TD>MSigDB lists</TD><TD>GSE22886_CTRL_VS_LPS_24H_DC_DN</TD><TD>191</TD><TD>9</TD><TD>17275</TD><TD>29</TD>
<TD>RSAD2,ISG15,IFIT2,IFI44L,IFI44,OAS3,OAS2,OASL,IFI27</TD></TR>
<TR><TD>1.857e-11</TD><TD>-24.71</TD><TD>GSE7548_NAIVE_VS_DAY7_PCC_IMMUNIZATION_CD4_TCELL_DN</TD><TD>MSigDB lists</TD><TD>GSE7548_NAIVE_VS_DAY7_PCC_IMMUNIZATION_CD4_TCELL_DN</TD><TD>193</TD><TD>9</TD><TD>17275</TD><TD>29</TD>
<TD>IFI44L,IFI44,RSAD2,IFIT2,ISG15,OAS1,OASL,OAS2,IFI27</TD></TR>
<TR><TD>1.857e-11</TD><TD>-24.71</TD><TD>GSE22140_GERMFREE_VS_SPF_MOUSE_CD4_TCELL_UP</TD><TD>MSigDB lists</TD><TD>GSE22140_GERMFREE_VS_SPF_MOUSE_CD4_TCELL_UP</TD><TD>193</TD><TD>9</TD><TD>17275</TD><TD>29</TD>
<TD>IFI44L,IFI44,RSAD2,IFIT2,ISG15,OASL,OAS1,OAS2,IFI27</TD></TR>
<TR><TD>2.445e-11</TD><TD>-24.43</TD><TD>HALLMARK_INTERFERON_GAMMA_RESPONSE</TD><TD>MSigDB lists</TD><TD>HALLMARK_INTERFERON_GAMMA_RESPONSE</TD><TD>199</TD><TD>9</TD><TD>17275</TD><TD>29</TD>
<TD>IFI27,OASL,OAS2,OAS3,IFI44,IFI44L,IFIT2,ISG15,RSAD2</TD></TR>
<TR><TD>2.736e-11</TD><TD>-24.32</TD><TD>2-5-oligoadenylate_synth_N</TD><TD>interpro domains</TD><TD>IPR006116</TD><TD>5</TD><TD>4</TD><TD>18616</TD><TD>30</TD>
<TD>OAS3,OASL,OAS2,OAS1</TD></TR>
<TR><TD>2.751e-11</TD><TD>-24.32</TD><TD>GRANDVAUX_IRF3_TARGETS_UP</TD><TD>MSigDB lists</TD><TD>GRANDVAUX_IRF3_TARGETS_UP</TD><TD>15</TD><TD>5</TD><TD>17275</TD><TD>29</TD>
<TD>IFI44,RSAD2,ISG15,IFIT2,OAS2</TD></TR>
<TR><TD>5.985e-11</TD><TD>-23.54</TD><TD>25A_SYNTH_3</TD><TD>prosite domains</TD><TD>PS50152</TD><TD>5</TD><TD>4</TD><TD>12079</TD><TD>24</TD>
<TD>OAS1,OASL,OAS2,OAS3</TD></TR>
<TR><TD>7.822e-11</TD><TD>-23.27</TD><TD>BOWIE_RESPONSE_TO_TAMOXIFEN</TD><TD>MSigDB lists</TD><TD>BOWIE_RESPONSE_TO_TAMOXIFEN</TD><TD>18</TD><TD>5</TD><TD>17275</TD><TD>29</TD>
<TD>OAS1,OAS2,ISG15,IFI27,IFIT2</TD></TR>
<TR><TD>7.927e-11</TD><TD>-23.26</TD><TD>GSE6269_FLU_VS_E_COLI_INF_PBMC_UP</TD><TD>MSigDB lists</TD><TD>GSE6269_FLU_VS_E_COLI_INF_PBMC_UP</TD><TD>146</TD><TD>8</TD><TD>17275</TD><TD>29</TD>
<TD>OAS3,OASL,OAS1,OAS2,RSAD2,ISG15,IFI44L,IFI44</TD></TR>
<TR><TD>1.167e-10</TD><TD>-22.87</TD><TD>GO_RESPONSE_TO_VIRUS</TD><TD>MSigDB lists</TD><TD>GO_RESPONSE_TO_VIRUS</TD><TD>237</TD><TD>9</TD><TD>17275</TD><TD>29</TD>
<TD>OASL,OAS1,OAS2,OAS3,IFI44L,IFI44,RSAD2,ISG15,IFIT2</TD></TR>
<TR><TD>1.281e-10</TD><TD>-22.78</TD><TD>GSE6269_HEALTHY_VS_STAPH_AUREUS_INF_PBMC_UP</TD><TD>MSigDB lists</TD><TD>GSE6269_HEALTHY_VS_STAPH_AUREUS_INF_PBMC_UP</TD><TD>155</TD><TD>8</TD><TD>17275</TD><TD>29</TD>
<TD>OAS3,OAS2,OASL,OAS1,ISG15,RSAD2,IFI44,IFI44L</TD></TR>
<TR><TD>1.349e-10</TD><TD>-22.73</TD><TD>GO_DEFENSE_RESPONSE_TO_VIRUS</TD><TD>MSigDB lists</TD><TD>GO_DEFENSE_RESPONSE_TO_VIRUS</TD><TD>156</TD><TD>8</TD><TD>17275</TD><TD>29</TD>
<TD>OAS3,OAS1,OAS2,OASL,IFIT2,ISG15,RSAD2,IFI44L</TD></TR>
<TR><TD>1.572e-10</TD><TD>-22.57</TD><TD>GSE6269_FLU_VS_STREP_PNEUMO_INF_PBMC_UP</TD><TD>MSigDB lists</TD><TD>GSE6269_FLU_VS_STREP_PNEUMO_INF_PBMC_UP</TD><TD>159</TD><TD>8</TD><TD>17275</TD><TD>29</TD>
<TD>ISG15,RSAD2,IFI44,IFI44L,OAS3,OAS2,OAS1,OASL</TD></TR>
<TR><TD>1.825e-10</TD><TD>-22.42</TD><TD>GSE17974_IL4_AND_ANTI_IL12_VS_UNTREATED_24H_ACT_CD4_TCELL_DN</TD><TD>MSigDB lists</TD><TD>GSE17974_IL4_AND_ANTI_IL12_VS_UNTREATED_24H_ACT_CD4_TCELL_DN</TD><TD>162</TD><TD>8</TD><TD>17275</TD><TD>29</TD>
<TD>OASL,OAS1,OAS2,IFI44,IFI44L,IFIT2,ISG15,IFI27</TD></TR>
<TR><TD>2.393e-10</TD><TD>-22.15</TD><TD>UROSEVIC_RESPONSE_TO_IMIQUIMOD</TD><TD>MSigDB lists</TD><TD>UROSEVIC_RESPONSE_TO_IMIQUIMOD</TD><TD>22</TD><TD>5</TD><TD>17275</TD><TD>29</TD>
<TD>OAS2,OAS1,OASL,ISG15,RSAD2</TD></TR>
<TR><TD>2.441e-10</TD><TD>-22.13</TD><TD>GSE18791_CTRL_VS_NEWCASTLE_VIRUS_DC_4H_DN</TD><TD>MSigDB lists</TD><TD>GSE18791_CTRL_VS_NEWCASTLE_VIRUS_DC_4H_DN</TD><TD>168</TD><TD>8</TD><TD>17275</TD><TD>29</TD>
<TD>IFIT2,ISG15,RSAD2,IFI44,IFI44L,OAS3,OASL,OAS2</TD></TR>
<TR><TD>2.488e-10</TD><TD>-22.11</TD><TD>LIANG_SILENCED_BY_METHYLATION_2</TD><TD>MSigDB lists</TD><TD>LIANG_SILENCED_BY_METHYLATION_2</TD><TD>52</TD><TD>6</TD><TD>17275</TD><TD>29</TD>
<TD>IFI44,MCAM,IFI44L,IFIT2,OAS1,OAS2</TD></TR>
<TR><TD>2.560e-10</TD><TD>-22.09</TD><TD>GSE18791_UNSTIM_VS_NEWCATSLE_VIRUS_DC_10H_DN</TD><TD>MSigDB lists</TD><TD>GSE18791_UNSTIM_VS_NEWCATSLE_VIRUS_DC_10H_DN</TD><TD>169</TD><TD>8</TD><TD>17275</TD><TD>29</TD>
<TD>OAS3,OAS2,OASL,RSAD2,IFIT2,ISG15,IFI44L,IFI44</TD></TR>
<TR><TD>3.382e-10</TD><TD>-21.81</TD><TD>GSE9960_HEALTHY_VS_GRAM_POS_SEPSIS_PBMC_DN</TD><TD>MSigDB lists</TD><TD>GSE9960_HEALTHY_VS_GRAM_POS_SEPSIS_PBMC_DN</TD><TD>175</TD><TD>8</TD><TD>17275</TD><TD>29</TD>
<TD>IFI27,OAS3,OAS2,RSAD2,ISG15,IFIT2,IFI44L,IFI44</TD></TR>
<TR><TD>4.049e-10</TD><TD>-21.63</TD><TD>GSE18791_CTRL_VS_NEWCASTLE_VIRUS_DC_6H_DN</TD><TD>MSigDB lists</TD><TD>GSE18791_CTRL_VS_NEWCASTLE_VIRUS_DC_6H_DN</TD><TD>179</TD><TD>8</TD><TD>17275</TD><TD>29</TD>
<TD>RSAD2,ISG15,IFIT2,IFI44L,IFI44,OAS3,OASL,OAS2</TD></TR>
<TR><TD>4.424e-10</TD><TD>-21.54</TD><TD>MEK_UP.V1_DN</TD><TD>MSigDB lists</TD><TD>MEK_UP.V1_DN</TD><TD>181</TD><TD>8</TD><TD>17275</TD><TD>29</TD>
<TD>OAS2,OAS1,OASL,OAS3,IFI44L,IFI44,ISG15,IFI27</TD></TR>
<TR><TD>4.622e-10</TD><TD>-21.49</TD><TD>GSE42021_TREG_PLN_VS_CD24LO_TREG_THYMUS_DN</TD><TD>MSigDB lists</TD><TD>GSE42021_TREG_PLN_VS_CD24LO_TREG_THYMUS_DN</TD><TD>182</TD><TD>8</TD><TD>17275</TD><TD>29</TD>
<TD>IFI27,ISG15,IFI44L,IFI44,OAS3,OAS2,OASL,OAS1</TD></TR>
<TR><TD>5.042e-10</TD><TD>-21.41</TD><TD>GSE13485_DAY7_VS_DAY21_YF17D_VACCINE_PBMC_UP</TD><TD>MSigDB lists</TD><TD>GSE13485_DAY7_VS_DAY21_YF17D_VACCINE_PBMC_UP</TD><TD>184</TD><TD>8</TD><TD>17275</TD><TD>29</TD>
<TD>OAS1,OASL,OAS2,OAS3,IFI44L,RSAD2,ISG15,IFI27</TD></TR>
<TR><TD>5.495e-10</TD><TD>-21.32</TD><TD>GSE34205_HEALTHY_VS_FLU_INF_INFANT_PBMC_DN</TD><TD>MSigDB lists</TD><TD>GSE34205_HEALTHY_VS_FLU_INF_INFANT_PBMC_DN</TD><TD>186</TD><TD>8</TD><TD>17275</TD><TD>29</TD>
<TD>IFI27,OAS3,OAS2,OASL,ISG15,RSAD2,IFI44,IFI44L</TD></TR>
<TR><TD>5.885e-10</TD><TD>-21.25</TD><TD>MODULE_345</TD><TD>MSigDB lists</TD><TD>MODULE_345</TD><TD>113</TD><TD>7</TD><TD>17275</TD><TD>29</TD>
<TD>RSAD2,IFI27,ISG15,IFI44L,IFI44,OAS3,OAS1</TD></TR>
<TR><TD>5.950e-10</TD><TD>-21.24</TD><TD>EINAV_INTERFERON_SIGNATURE_IN_CANCER</TD><TD>MSigDB lists</TD><TD>EINAV_INTERFERON_SIGNATURE_IN_CANCER</TD><TD>26</TD><TD>5</TD><TD>17275</TD><TD>29</TD>
<TD>OAS1,OAS2,ISG15,IFI44L,IFI44</TD></TR>
<TR><TD>5.983e-10</TD><TD>-21.24</TD><TD>GSE37533_PPARG1_FOXP3_VS_PPARG2_FOXP3_TRANSDUCED_CD4_TCELL_PIOGLITAZONE_TREATED_DN</TD><TD>MSigDB lists</TD><TD>GSE37533_PPARG1_FOXP3_VS_PPARG2_FOXP3_TRANSDUCED_CD4_TCELL_PIOGLITAZONE_TREATED_DN</TD><TD>188</TD><TD>8</TD><TD>17275</TD><TD>29</TD>
<TD>OAS3,OAS1,OAS2,IFIT2,ISG15,RSAD2,IFI44,IFI44L</TD></TR>
<TR><TD>5.983e-10</TD><TD>-21.24</TD><TD>GSE10325_BCELL_VS_LUPUS_BCELL_DN</TD><TD>MSigDB lists</TD><TD>GSE10325_BCELL_VS_LUPUS_BCELL_DN</TD><TD>188</TD><TD>8</TD><TD>17275</TD><TD>29</TD>
<TD>IFI27,IFI44,IFI44L,ISG15,RSAD2,OAS2,OASL,OAS3</TD></TR>
<TR><TD>6.240e-10</TD><TD>-21.19</TD><TD>GSE34006_A2AR_KO_VS_A2AR_AGONIST_TREATED_TREG_UP</TD><TD>MSigDB lists</TD><TD>GSE34006_A2AR_KO_VS_A2AR_AGONIST_TREATED_TREG_UP</TD><TD>189</TD><TD>8</TD><TD>17275</TD><TD>29</TD>
<TD>IFIT2,ISG15,RSAD2,IFI44,OAS3,OAS2,OAS1,OASL</TD></TR>
<TR><TD>6.240e-10</TD><TD>-21.19</TD><TD>GSE7509_DC_VS_MONOCYTE_WITH_FCGRIIB_STIM_DN</TD><TD>MSigDB lists</TD><TD>GSE7509_DC_VS_MONOCYTE_WITH_FCGRIIB_STIM_DN</TD><TD>189</TD><TD>8</TD><TD>17275</TD><TD>29</TD>
<TD>OAS1,OAS2,OASL,IFIT2,ISG15,RSAD2,IFI44,IFI44L</TD></TR>
<TR><TD>6.507e-10</TD><TD>-21.15</TD><TD>GSE42021_TREG_PLN_VS_CD24INT_TREG_THYMUS_DN</TD><TD>MSigDB lists</TD><TD>GSE42021_TREG_PLN_VS_CD24INT_TREG_THYMUS_DN</TD><TD>190</TD><TD>8</TD><TD>17275</TD><TD>29</TD>
<TD>OAS3,OAS1,OASL,OAS2,ISG15,IFI44,IFI44L,IFI27</TD></TR>
<TR><TD>6.725e-10</TD><TD>-21.12</TD><TD>regulation of ribonuclease activity</TD><TD>biological process</TD><TD>GO:0060700</TD><TD>9</TD><TD>4</TD><TD>18054</TD><TD>29</TD>
<TD>OASL,OAS1,OAS3,OAS2</TD></TR>
<TR><TD>6.785e-10</TD><TD>-21.11</TD><TD>GSE22140_GERMFREE_VS_SPF_ARTHRITIC_MOUSE_CD4_TCELL_UP</TD><TD>MSigDB lists</TD><TD>GSE22140_GERMFREE_VS_SPF_ARTHRITIC_MOUSE_CD4_TCELL_UP</TD><TD>191</TD><TD>8</TD><TD>17275</TD><TD>29</TD>
<TD>ISG15,IFIT2,RSAD2,IFI44,IFI44L,OAS2,OASL,OAS1</TD></TR>
<TR><TD>6.842e-10</TD><TD>-21.10</TD><TD>Interferon Signaling</TD><TD>REACTOME pathways</TD><TD>R-HSA-913531</TD><TD>201</TD><TD>8</TD><TD>10287</TD><TD>18</TD>
<TD>OASL,OAS3,IFI27,RSAD2,OAS1,ISG15,OAS2,IFIT2</TD></TR>
<TR><TD>7.837e-10</TD><TD>-20.97</TD><TD>FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_DN</TD><TD>MSigDB lists</TD><TD>FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_DN</TD><TD>416</TD><TD>10</TD><TD>17275</TD><TD>29</TD>
<TD>IFIT2,RSAD2,IFI44,IFI44L,OAS3,KLHDC8B,OAS1,OASL,OAS2,IFI27</TD></TR>
<TR><TD>9.691e-10</TD><TD>-20.75</TD><TD>DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_UP</TD><TD>MSigDB lists</TD><TD>DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_UP</TD><TD>301</TD><TD>9</TD><TD>17275</TD><TD>29</TD>
<TD>IFIT2,ISG15,RSAD2,IFI44,IFI44L,OAS1,OASL,OAS2,IFI27</TD></TR>
<TR><TD>1.809e-09</TD><TD>-20.13</TD><TD>BENNETT_SYSTEMIC_LUPUS_ERYTHEMATOSUS</TD><TD>MSigDB lists</TD><TD>BENNETT_SYSTEMIC_LUPUS_ERYTHEMATOSUS</TD><TD>32</TD><TD>5</TD><TD>17275</TD><TD>29</TD>
<TD>OAS2,OAS1,OASL,ISG15,IFI44L</TD></TR>
<TR><TD>1.866e-09</TD><TD>-20.10</TD><TD>BOSCO_INTERFERON_INDUCED_ANTIVIRAL_MODULE</TD><TD>MSigDB lists</TD><TD>BOSCO_INTERFERON_INDUCED_ANTIVIRAL_MODULE</TD><TD>72</TD><TD>6</TD><TD>17275</TD><TD>29</TD>
<TD>OASL,OAS2,OAS3,IFI44L,IFI44,RSAD2</TD></TR>
<TR><TD>4.716e-09</TD><TD>-19.17</TD><TD>REACTOME_INTERFERON_SIGNALING</TD><TD>MSigDB lists</TD><TD>REACTOME_INTERFERON_SIGNALING</TD><TD>152</TD><TD>7</TD><TD>17275</TD><TD>29</TD>
<TD>IFI27,ISG15,IFIT2,OAS2,OAS1,OASL,OAS3</TD></TR>
<TR><TD>5.909e-09</TD><TD>-18.95</TD><TD>GSE18791_UNSTIM_VS_NEWCATSLE_VIRUS_DC_18H_DN</TD><TD>MSigDB lists</TD><TD>GSE18791_UNSTIM_VS_NEWCATSLE_VIRUS_DC_18H_DN</TD><TD>157</TD><TD>7</TD><TD>17275</TD><TD>29</TD>
<TD>IFI44,IFI44L,IFIT2,RSAD2,OASL,OAS1,OAS3</TD></TR>
<TR><TD>6.335e-09</TD><TD>-18.88</TD><TD>ROETH_TERT_TARGETS_UP</TD><TD>MSigDB lists</TD><TD>ROETH_TERT_TARGETS_UP</TD><TD>14</TD><TD>4</TD><TD>17275</TD><TD>29</TD>
<TD>RSAD2,IFI44,IFI44L,OASL</TD></TR>
<TR><TD>7.794e-09</TD><TD>-18.67</TD><TD>regulation of viral genome replication</TD><TD>biological process</TD><TD>GO:0045069</TD><TD>95</TD><TD>6</TD><TD>18054</TD><TD>29</TD>
<TD>ISG15,IFI27,OAS3,OASL,OAS1,RSAD2</TD></TR>
<TR><TD>9.460e-09</TD><TD>-18.48</TD><TD>GSE21546_ELK1_KO_VS_SAP1A_KO_AND_ELK1_KO_DP_THYMOCYTES_UP</TD><TD>MSigDB lists</TD><TD>GSE21546_ELK1_KO_VS_SAP1A_KO_AND_ELK1_KO_DP_THYMOCYTES_UP</TD><TD>168</TD><TD>7</TD><TD>17275</TD><TD>29</TD>
<TD>OAS3,OAS1,OASL,IFIT2,IFI27,ISG15,RSAD2</TD></TR>
<TR><TD>1.211e-08</TD><TD>-18.23</TD><TD>GO_NEGATIVE_REGULATION_OF_VIRAL_GENOME_REPLICATION</TD><TD>MSigDB lists</TD><TD>GO_NEGATIVE_REGULATION_OF_VIRAL_GENOME_REPLICATION</TD><TD>46</TD><TD>5</TD><TD>17275</TD><TD>29</TD>
<TD>OASL,OAS1,OAS3,ISG15,RSAD2</TD></TR>
<TR><TD>1.464e-08</TD><TD>-18.04</TD><TD>DER_IFN_BETA_RESPONSE_UP</TD><TD>MSigDB lists</TD><TD>DER_IFN_BETA_RESPONSE_UP</TD><TD>101</TD><TD>6</TD><TD>17275</TD><TD>29</TD>
<TD>IFI44,ISG15,IFIT2,OAS1,OASL,OAS2</TD></TR>
<TR><TD>1.526e-08</TD><TD>-18.00</TD><TD>GSE37534_GW1929_VS_PIOGLITAZONE_TREATED_CD4_TCELL_PPARG1_FOXP3_TRANSDUCED_UP</TD><TD>MSigDB lists</TD><TD>GSE37534_GW1929_VS_PIOGLITAZONE_TREATED_CD4_TCELL_PPARG1_FOXP3_TRANSDUCED_UP</TD><TD>180</TD><TD>7</TD><TD>17275</TD><TD>29</TD>
<TD>IFI27,IFIT2,ISG15,RSAD2,OASL,OAS1,OAS3</TD></TR>
<TR><TD>1.776e-08</TD><TD>-17.85</TD><TD>GSE24081_CONTROLLER_VS_PROGRESSOR_HIV_SPECIFIC_CD8_TCELL_DN</TD><TD>MSigDB lists</TD><TD>GSE24081_CONTROLLER_VS_PROGRESSOR_HIV_SPECIFIC_CD8_TCELL_DN</TD><TD>184</TD><TD>7</TD><TD>17275</TD><TD>29</TD>
<TD>IFI44L,IFI44,RSAD2,IFI27,OAS1,OAS2,OAS3</TD></TR>
<TR><TD>1.914e-08</TD><TD>-17.77</TD><TD>GSE34006_WT_VS_A2AR_KO_TREG_DN</TD><TD>MSigDB lists</TD><TD>GSE34006_WT_VS_A2AR_KO_TREG_DN</TD><TD>186</TD><TD>7</TD><TD>17275</TD><TD>29</TD>
<TD>OAS2,OASL,OAS1,OAS3,RSAD2,IFIT2,ISG15</TD></TR>
<TR><TD>1.928e-08</TD><TD>-17.76</TD><TD>MAHADEVAN_RESPONSE_TO_MP470_UP</TD><TD>MSigDB lists</TD><TD>MAHADEVAN_RESPONSE_TO_MP470_UP</TD><TD>18</TD><TD>4</TD><TD>17275</TD><TD>29</TD>
<TD>IFI44L,RSAD2,OAS2,OAS1</TD></TR>
<TR><TD>2.383e-08</TD><TD>-17.55</TD><TD>GSE36527_CD69_NEG_VS_POS_TREG_CD62L_LOS_KLRG1_NEG_UP</TD><TD>MSigDB lists</TD><TD>GSE36527_CD69_NEG_VS_POS_TREG_CD62L_LOS_KLRG1_NEG_UP</TD><TD>192</TD><TD>7</TD><TD>17275</TD><TD>29</TD>
<TD>OASL,OAS2,OAS1,IFI44,RSAD2,ISG15,IFIT2</TD></TR>
<TR><TD>3.505e-08</TD><TD>-17.17</TD><TD>negative regulation of viral genome replication</TD><TD>biological process</TD><TD>GO:0045071</TD><TD>59</TD><TD>5</TD><TD>18054</TD><TD>29</TD>
<TD>ISG15,OAS3,OASL,OAS1,RSAD2</TD></TR>
<TR><TD>3.757e-08</TD><TD>-17.10</TD><TD>GO_ADENYLYLTRANSFERASE_ACTIVITY</TD><TD>MSigDB lists</TD><TD>GO_ADENYLYLTRANSFERASE_ACTIVITY</TD><TD>21</TD><TD>4</TD><TD>17275</TD><TD>29</TD>
<TD>OAS3,OAS1,OASL,OAS2</TD></TR>
<TR><TD>3.848e-08</TD><TD>-17.07</TD><TD>regulation of nuclease activity</TD><TD>biological process</TD><TD>GO:0032069</TD><TD>22</TD><TD>4</TD><TD>18054</TD><TD>29</TD>
<TD>OAS2,OAS3,OASL,OAS1</TD></TR>
<TR><TD>5.025e-08</TD><TD>-16.81</TD><TD>MODULE_436</TD><TD>MSigDB lists</TD><TD>MODULE_436</TD><TD>124</TD><TD>6</TD><TD>17275</TD><TD>29</TD>
<TD>OAS3,OAS1,RSAD2,ISG15,IFI27,IFI44L</TD></TR>
<TR><TD>1.040e-07</TD><TD>-16.08</TD><TD>GO_REGULATION_OF_VIRAL_GENOME_REPLICATION</TD><TD>MSigDB lists</TD><TD>GO_REGULATION_OF_VIRAL_GENOME_REPLICATION</TD><TD>70</TD><TD>5</TD><TD>17275</TD><TD>29</TD>
<TD>RSAD2,ISG15,OAS1,OASL,OAS3</TD></TR>
<TR><TD>1.068e-07</TD><TD>-16.05</TD><TD>adenylyltransferase activity</TD><TD>molecular function</TD><TD>GO:0070566</TD><TD>30</TD><TD>4</TD><TD>17306</TD><TD>26</TD>
<TD>OAS3,OAS1,OAS2,OASL</TD></TR>
<TR><TD>1.160e-07</TD><TD>-15.97</TD><TD>regulation of viral life cycle</TD><TD>biological process</TD><TD>GO:1903900</TD><TD>149</TD><TD>6</TD><TD>18054</TD><TD>29</TD>
<TD>RSAD2,OASL,OAS1,IFI27,OAS3,ISG15</TD></TR>
<TR><TD>1.165e-07</TD><TD>-15.97</TD><TD>ZHOU_INFLAMMATORY_RESPONSE_LPS_UP</TD><TD>MSigDB lists</TD><TD>ZHOU_INFLAMMATORY_RESPONSE_LPS_UP</TD><TD>369</TD><TD>8</TD><TD>17275</TD><TD>29</TD>
<TD>CAPN6,OAS3,OASL,OAS1,OAS2,IFIT2,ISG15,IFI44</TD></TR>
<TR><TD>1.287e-07</TD><TD>-15.87</TD><TD>DER_IFN_ALPHA_RESPONSE_UP</TD><TD>MSigDB lists</TD><TD>DER_IFN_ALPHA_RESPONSE_UP</TD><TD>73</TD><TD>5</TD><TD>17275</TD><TD>29</TD>
<TD>OAS2,OASL,OAS1,IFI44,ISG15</TD></TR>
<TR><TD>1.703e-07</TD><TD>-15.59</TD><TD>KIM_LRRC3B_TARGETS</TD><TD>MSigDB lists</TD><TD>KIM_LRRC3B_TARGETS</TD><TD>30</TD><TD>4</TD><TD>17275</TD><TD>29</TD>
<TD>OAS2,IFI44,ISG15,IFI27</TD></TR>
<TR><TD>1.898e-07</TD><TD>-15.48</TD><TD>REACTOME_CYTOKINE_SIGNALING_IN_IMMUNE_SYSTEM</TD><TD>MSigDB lists</TD><TD>REACTOME_CYTOKINE_SIGNALING_IN_IMMUNE_SYSTEM</TD><TD>260</TD><TD>7</TD><TD>17275</TD><TD>29</TD>
<TD>IFI27,IFIT2,ISG15,OAS1,OASL,OAS2,OAS3</TD></TR>
<TR><TD>2.111e-07</TD><TD>-15.37</TD><TD>GO_INNATE_IMMUNE_RESPONSE</TD><TD>MSigDB lists</TD><TD>GO_INNATE_IMMUNE_RESPONSE</TD><TD>561</TD><TD>9</TD><TD>17275</TD><TD>29</TD>
<TD>OASL,OAS2,OAS1,OAS3,RSAD2,IFIT2,ISG15,LGR4,IFI27</TD></TR>
<TR><TD>2.231e-07</TD><TD>-15.32</TD><TD>negative regulation of viral life cycle</TD><TD>biological process</TD><TD>GO:1903901</TD><TD>85</TD><TD>5</TD><TD>18054</TD><TD>29</TD>
<TD>RSAD2,OASL,OAS1,OAS3,ISG15</TD></TR>
<TR><TD>2.745e-07</TD><TD>-15.11</TD><TD>GSE2706_R848_VS_R848_AND_LPS_2H_STIM_DC_DN</TD><TD>MSigDB lists</TD><TD>GSE2706_R848_VS_R848_AND_LPS_2H_STIM_DC_DN</TD><TD>165</TD><TD>6</TD><TD>17275</TD><TD>29</TD>
<TD>OASL,DIRAS1,RSAD2,ISG15,IFIT2,IFI44</TD></TR>
<TR><TD>2.771e-07</TD><TD>-15.10</TD><TD>GO_NEGATIVE_REGULATION_OF_VIRAL_PROCESS</TD><TD>MSigDB lists</TD><TD>GO_NEGATIVE_REGULATION_OF_VIRAL_PROCESS</TD><TD>85</TD><TD>5</TD><TD>17275</TD><TD>29</TD>
<TD>ISG15,RSAD2,OAS3,OASL,OAS1</TD></TR>
<TR><TD>3.053e-07</TD><TD>-15.00</TD><TD>GSE18791_CTRL_VS_NEWCASTLE_VIRUS_DC_16H_DN</TD><TD>MSigDB lists</TD><TD>GSE18791_CTRL_VS_NEWCASTLE_VIRUS_DC_16H_DN</TD><TD>168</TD><TD>6</TD><TD>17275</TD><TD>29</TD>
<TD>OASL,OAS2,OAS3,IFI44,ISG15,IFIT2</TD></TR>
<TR><TD>3.273e-07</TD><TD>-14.93</TD><TD>GSE37416_CTRL_VS_48H_F_TULARENSIS_LVS_NEUTROPHIL_UP</TD><TD>MSigDB lists</TD><TD>GSE37416_CTRL_VS_48H_F_TULARENSIS_LVS_NEUTROPHIL_UP</TD><TD>170</TD><TD>6</TD><TD>17275</TD><TD>29</TD>
<TD>RSAD2,KIFAP3,OAS3,OAS1,OAS2,OASL</TD></TR>
<TR><TD>3.507e-07</TD><TD>-14.86</TD><TD>GSE18791_CTRL_VS_NEWCASTLE_VIRUS_DC_10H_DN</TD><TD>MSigDB lists</TD><TD>GSE18791_CTRL_VS_NEWCASTLE_VIRUS_DC_10H_DN</TD><TD>172</TD><TD>6</TD><TD>17275</TD><TD>29</TD>
<TD>OAS2,OASL,OAS3,IFI44,IFIT2,ISG15</TD></TR>
<TR><TD>4.117e-07</TD><TD>-14.70</TD><TD>defense response to other organism</TD><TD>biological process</TD><TD>GO:0098542</TD><TD>842</TD><TD>10</TD><TD>18054</TD><TD>29</TD>
<TD>OASL,LGR4,ISG15,OAS1,IFIT2,RSAD2,IFI44L,OAS2,OAS3,IFI27</TD></TR>
<TR><TD>4.152e-07</TD><TD>-14.69</TD><TD>GSE34205_RSV_VS_FLU_INF_INFANT_PBMC_DN</TD><TD>MSigDB lists</TD><TD>GSE34205_RSV_VS_FLU_INF_INFANT_PBMC_DN</TD><TD>177</TD><TD>6</TD><TD>17275</TD><TD>29</TD>
<TD>IFI27,IFI44,IFI44L,OAS3,OAS2,OASL</TD></TR>
<TR><TD>4.161e-07</TD><TD>-14.69</TD><TD>GO_CYTOKINE_MEDIATED_SIGNALING_PATHWAY</TD><TD>MSigDB lists</TD><TD>GO_CYTOKINE_MEDIATED_SIGNALING_PATHWAY</TD><TD>436</TD><TD>8</TD><TD>17275</TD><TD>29</TD>
<TD>RSAD2,ISG15,IFIT2,OAS1,OAS2,OASL,OAS3,IFI27</TD></TR>
<TR><TD>4.456e-07</TD><TD>-14.62</TD><TD>NTP_transf_2</TD><TD>pfam domains</TD><TD>PF01909</TD><TD>10</TD><TD>3</TD><TD>17385</TD><TD>28</TD>
<TD>OAS2,OAS3,OAS1</TD></TR>
<TR><TD>4.497e-07</TD><TD>-14.61</TD><TD>Polymerase_NTP_transf_dom</TD><TD>interpro domains</TD><TD>IPR002934</TD><TD>10</TD><TD>3</TD><TD>18616</TD><TD>30</TD>
<TD>OAS2,OAS3,OAS1</TD></TR>
<TR><TD>4.583e-07</TD><TD>-14.60</TD><TD>GSE40685_TREG_VS_FOXP3_KO_TREG_PRECURSOR_UP</TD><TD>MSigDB lists</TD><TD>GSE40685_TREG_VS_FOXP3_KO_TREG_PRECURSOR_UP</TD><TD>180</TD><TD>6</TD><TD>17275</TD><TD>29</TD>
<TD>OAS2,OASL,IFI44L,IFIT2,IFI27,RSAD2</TD></TR>
<TR><TD>4.615e-07</TD><TD>-14.59</TD><TD>GO_IMMUNE_EFFECTOR_PROCESS</TD><TD>MSigDB lists</TD><TD>GO_IMMUNE_EFFECTOR_PROCESS</TD><TD>442</TD><TD>8</TD><TD>17275</TD><TD>29</TD>
<TD>IFI44L,RSAD2,ISG15,IFIT2,OASL,OAS1,OAS2,OAS3</TD></TR>
<TR><TD>4.735e-07</TD><TD>-14.56</TD><TD>GSE1925_CTRL_VS_24H_IFNG_STIM_MACROPHAGE_UP</TD><TD>MSigDB lists</TD><TD>GSE1925_CTRL_VS_24H_IFNG_STIM_MACROPHAGE_UP</TD><TD>181</TD><TD>6</TD><TD>17275</TD><TD>29</TD>
<TD>IFI27,ISG15,RSAD2,IFI44L,OAS3,OAS2</TD></TR>
<TR><TD>5.050e-07</TD><TD>-14.50</TD><TD>GSE1925_3H_VS_24H_IFNG_STIM_MACROPHAGE_DN</TD><TD>MSigDB lists</TD><TD>GSE1925_3H_VS_24H_IFNG_STIM_MACROPHAGE_DN</TD><TD>183</TD><TD>6</TD><TD>17275</TD><TD>29</TD>
<TD>OAS2,OAS3,IFI44L,RSAD2,IFI27,ISG15</TD></TR>
<TR><TD>5.215e-07</TD><TD>-14.47</TD><TD>GSE19888_ADENOSINE_A3R_INH_VS_TCELL_MEMBRANES_ACT_MAST_CELL_UP</TD><TD>MSigDB lists</TD><TD>GSE19888_ADENOSINE_A3R_INH_VS_TCELL_MEMBRANES_ACT_MAST_CELL_UP</TD><TD>184</TD><TD>6</TD><TD>17275</TD><TD>29</TD>
<TD>IFI44,ISG15,IFIT2,RSAD2,OAS1,OAS2</TD></TR>
<TR><TD>5.293e-07</TD><TD>-14.45</TD><TD>negative regulation of viral process</TD><TD>biological process</TD><TD>GO:0048525</TD><TD>101</TD><TD>5</TD><TD>18054</TD><TD>29</TD>
<TD>ISG15,OAS3,OASL,OAS1,RSAD2</TD></TR>
<TR><TD>5.734e-07</TD><TD>-14.37</TD><TD>GSE10325_MYELOID_VS_LUPUS_MYELOID_DN</TD><TD>MSigDB lists</TD><TD>GSE10325_MYELOID_VS_LUPUS_MYELOID_DN</TD><TD>187</TD><TD>6</TD><TD>17275</TD><TD>29</TD>
<TD>OASL,ISG15,IFI27,IFIT2,RSAD2,IFI44</TD></TR>
<TR><TD>5.734e-07</TD><TD>-14.37</TD><TD>GSE3982_CTRL_VS_LPS_48H_DC_DN</TD><TD>MSigDB lists</TD><TD>GSE3982_CTRL_VS_LPS_48H_DC_DN</TD><TD>187</TD><TD>6</TD><TD>17275</TD><TD>29</TD>
<TD>OAS1,RSAD2,ISG15,IFI27,IFI44L,IFI44</TD></TR>
<TR><TD>5.916e-07</TD><TD>-14.34</TD><TD>GSE8835_CD4_VS_CD8_TCELL_CLL_PATIENT_UP</TD><TD>MSigDB lists</TD><TD>GSE8835_CD4_VS_CD8_TCELL_CLL_PATIENT_UP</TD><TD>188</TD><TD>6</TD><TD>17275</TD><TD>29</TD>
<TD>OASL,OAS3,IFI44L,IFIT2,ISG15,RSAD2</TD></TR>
<TR><TD>6.034e-07</TD><TD>-14.32</TD><TD>innate immune response</TD><TD>biological process</TD><TD>GO:0045087</TD><TD>664</TD><TD>9</TD><TD>18054</TD><TD>29</TD>
<TD>OASL,LGR4,ISG15,OAS1,IFIT2,RSAD2,OAS3,OAS2,IFI27</TD></TR>
<TR><TD>6.103e-07</TD><TD>-14.31</TD><TD>GSE360_L_DONOVANI_VS_M_TUBERCULOSIS_DC_DN</TD><TD>MSigDB lists</TD><TD>GSE360_L_DONOVANI_VS_M_TUBERCULOSIS_DC_DN</TD><TD>189</TD><TD>6</TD><TD>17275</TD><TD>29</TD>
<TD>OAS2,OASL,IFI44,IFI44L,ISG15,IFIT2</TD></TR>
<TR><TD>6.556e-07</TD><TD>-14.24</TD><TD>GO_DEFENSE_RESPONSE_TO_OTHER_ORGANISM</TD><TD>MSigDB lists</TD><TD>GO_DEFENSE_RESPONSE_TO_OTHER_ORGANISM</TD><TD>463</TD><TD>8</TD><TD>17275</TD><TD>29</TD>
<TD>IFI44L,RSAD2,ISG15,IFIT2,OASL,OAS2,OAS1,OAS3</TD></TR>
<TR><TD>6.900e-07</TD><TD>-14.19</TD><TD>GSE18281_SUBCAPSULAR_VS_CENTRAL_CORTICAL_REGION_OF_THYMUS_DN</TD><TD>MSigDB lists</TD><TD>GSE18281_SUBCAPSULAR_VS_CENTRAL_CORTICAL_REGION_OF_THYMUS_DN</TD><TD>193</TD><TD>6</TD><TD>17275</TD><TD>29</TD>
<TD>OAS1,OAS2,OASL,RSAD2,IFIT2,IFI44</TD></TR>
<TR><TD>7.112e-07</TD><TD>-14.16</TD><TD>GSE38681_WT_VS_LYL1_KO_LYMPHOID_PRIMED_MULTIPOTENT_PROGENITOR_DN</TD><TD>MSigDB lists</TD><TD>GSE38681_WT_VS_LYL1_KO_LYMPHOID_PRIMED_MULTIPOTENT_PROGENITOR_DN</TD><TD>194</TD><TD>6</TD><TD>17275</TD><TD>29</TD>
<TD>OASL,OAS1,OAS2,ISG15,IFIT2,RSAD2</TD></TR>
<TR><TD>8.014e-07</TD><TD>-14.04</TD><TD>GRAESSMANN_RESPONSE_TO_MC_AND_SERUM_DEPRIVATION_UP</TD><TD>MSigDB lists</TD><TD>GRAESSMANN_RESPONSE_TO_MC_AND_SERUM_DEPRIVATION_UP</TD><TD>198</TD><TD>6</TD><TD>17275</TD><TD>29</TD>
<TD>OAS2,CAPN6,IFI44,RSAD2,IFIT2,ISG15</TD></TR>
<TR><TD>8.285e-07</TD><TD>-14.00</TD><TD>regulation of viral process</TD><TD>biological process</TD><TD>GO:0050792</TD><TD>208</TD><TD>6</TD><TD>18054</TD><TD>29</TD>
<TD>OASL,OAS1,RSAD2,ISG15,IFI27,OAS3</TD></TR>
<TR><TD>9.593e-07</TD><TD>-13.86</TD><TD>vpr (Vpr)</TD><TD>protein interactions</TD><TD>155807</TD><TD>653</TD><TD>9</TD><TD>17456</TD><TD>30</TD>
<TD>OAS1,IFI44L,OAS2,OASL,OAS3,ISG15,RSAD2,IFIT2,IFI27</TD></TR>
<TR><TD>1.050e-06</TD><TD>-13.77</TD><TD>MODULE_208</TD><TD>MSigDB lists</TD><TD>MODULE_208</TD><TD>111</TD><TD>5</TD><TD>17275</TD><TD>29</TD>
<TD>ISG15,IFI44,IFI44L,OAS3,OAS1</TD></TR>
<TR><TD>1.223e-06</TD><TD>-13.61</TD><TD>response to other organism</TD><TD>biological process</TD><TD>GO:0051707</TD><TD>1201</TD><TD>11</TD><TD>18054</TD><TD>29</TD>
<TD>ISG15,LGR4,OASL,IFI44,IFI27,OAS2,OAS3,IFI44L,RSAD2,IFIT2,OAS1</TD></TR>
<TR><TD>1.243e-06</TD><TD>-13.60</TD><TD>response to external biotic stimulus</TD><TD>biological process</TD><TD>GO:0043207</TD><TD>1203</TD><TD>11</TD><TD>18054</TD><TD>29</TD>
<TD>LGR4,OASL,IFI44,ISG15,IFIT2,OAS1,IFI44L,RSAD2,IFI27,OAS2,OAS3</TD></TR>
<TR><TD>1.318e-06</TD><TD>-13.54</TD><TD>GRAESSMANN_APOPTOSIS_BY_SERUM_DEPRIVATION_UP</TD><TD>MSigDB lists</TD><TD>GRAESSMANN_APOPTOSIS_BY_SERUM_DEPRIVATION_UP</TD><TD>508</TD><TD>8</TD><TD>17275</TD><TD>29</TD>
<TD>IFI44,IFIT2,ISG15,RSAD2,OASL,OAS2,OAS3,CAPN6</TD></TR>
<TR><TD>1.511e-06</TD><TD>-13.40</TD><TD>response to biotic stimulus</TD><TD>biological process</TD><TD>GO:0009607</TD><TD>1227</TD><TD>11</TD><TD>18054</TD><TD>29</TD>
<TD>RSAD2,IFI44L,OAS1,IFIT2,OAS2,OAS3,IFI27,IFI44,OASL,LGR4,ISG15</TD></TR>
<TR><TD>1.640e-06</TD><TD>-13.32</TD><TD>BROWNE_HCMV_INFECTION_4HR_UP</TD><TD>MSigDB lists</TD><TD>BROWNE_HCMV_INFECTION_4HR_UP</TD><TD>52</TD><TD>4</TD><TD>17275</TD><TD>29</TD>
<TD>RSAD2,IFIT2,ISG15,OASL</TD></TR>
<TR><TD>1.687e-06</TD><TD>-13.29</TD><TD>regulation of symbiosis, encompassing mutualism through parasitism</TD><TD>biological process</TD><TD>GO:0043903</TD><TD>235</TD><TD>6</TD><TD>18054</TD><TD>29</TD>
<TD>OAS3,IFI27,ISG15,RSAD2,OASL,OAS1</TD></TR>
<TR><TD>1.746e-06</TD><TD>-13.26</TD><TD>MODULE_292</TD><TD>MSigDB lists</TD><TD>MODULE_292</TD><TD>123</TD><TD>5</TD><TD>17275</TD><TD>29</TD>
<TD>OAS3,OAS1,ISG15,IFI44,IFI44L</TD></TR>
<TR><TD>1.891e-06</TD><TD>-13.18</TD><TD>MODULE_171</TD><TD>MSigDB lists</TD><TD>MODULE_171</TD><TD>125</TD><TD>5</TD><TD>17275</TD><TD>29</TD>
<TD>OAS1,OAS3,IFI44,IFI44L,ISG15</TD></TR>
<TR><TD>1.918e-06</TD><TD>-13.16</TD><TD>immune response</TD><TD>biological process</TD><TD>GO:0006955</TD><TD>1544</TD><TD>12</TD><TD>18054</TD><TD>29</TD>
<TD>OASL,IFI44,LGR4,ISG15,OAS1,IFIT2,RSAD2,IFI44L,OAS2,OAS3,IFI27,SBSPON</TD></TR>
<TR><TD>2.511e-06</TD><TD>-12.90</TD><TD>IFI44_fam</TD><TD>interpro domains</TD><TD>IPR024644</TD><TD>2</TD><TD>2</TD><TD>18616</TD><TD>30</TD>
<TD>IFI44L,IFI44</TD></TR>
<TR><TD>2.552e-06</TD><TD>-12.88</TD><TD>REACTOME_INTERFERON_GAMMA_SIGNALING</TD><TD>MSigDB lists</TD><TD>REACTOME_INTERFERON_GAMMA_SIGNALING</TD><TD>58</TD><TD>4</TD><TD>17275</TD><TD>29</TD>
<TD>OAS1,OAS2,OASL,OAS3</TD></TR>
<TR><TD>2.734e-06</TD><TD>-12.81</TD><TD>GO_DOUBLE_STRANDED_RNA_BINDING</TD><TD>MSigDB lists</TD><TD>GO_DOUBLE_STRANDED_RNA_BINDING</TD><TD>59</TD><TD>4</TD><TD>17275</TD><TD>29</TD>
<TD>OAS1,OASL,OAS2,OAS3</TD></TR>
<TR><TD>2.847e-06</TD><TD>-12.77</TD><TD>BOWIE_RESPONSE_TO_EXTRACELLULAR_MATRIX</TD><TD>MSigDB lists</TD><TD>BOWIE_RESPONSE_TO_EXTRACELLULAR_MATRIX</TD><TD>17</TD><TD>3</TD><TD>17275</TD><TD>29</TD>
<TD>IFIT2,ISG15,OAS1</TD></TR>
<TR><TD>3.128e-06</TD><TD>-12.68</TD><TD>CHANG_IMMORTALIZED_BY_HPV31_DN</TD><TD>MSigDB lists</TD><TD>CHANG_IMMORTALIZED_BY_HPV31_DN</TD><TD>61</TD><TD>4</TD><TD>17275</TD><TD>29</TD>
<TD>IFIT2,IFI27,IFI44,OAS2</TD></TR>
<TR><TD>3.304e-06</TD><TD>-12.62</TD><TD>GSE34156_UNTREATED_VS_6H_NOD2_AND_TLR1_TLR2_LIGAND_TREATED_MONOCYTE_DN</TD><TD>MSigDB lists</TD><TD>GSE34156_UNTREATED_VS_6H_NOD2_AND_TLR1_TLR2_LIGAND_TREATED_MONOCYTE_DN</TD><TD>140</TD><TD>5</TD><TD>17275</TD><TD>29</TD>
<TD>IFIT2,RSAD2,IFI44,OAS3,OAS2</TD></TR>
<TR><TD>3.667e-06</TD><TD>-12.52</TD><TD>GO_NEGATIVE_REGULATION_OF_MULTI_ORGANISM_PROCESS</TD><TD>MSigDB lists</TD><TD>GO_NEGATIVE_REGULATION_OF_MULTI_ORGANISM_PROCESS</TD><TD>143</TD><TD>5</TD><TD>17275</TD><TD>29</TD>
<TD>OAS3,OASL,OAS1,ISG15,RSAD2</TD></TR>
<TR><TD>3.676e-06</TD><TD>-12.51</TD><TD>GO_CELLULAR_RESPONSE_TO_CYTOKINE_STIMULUS</TD><TD>MSigDB lists</TD><TD>GO_CELLULAR_RESPONSE_TO_CYTOKINE_STIMULUS</TD><TD>583</TD><TD>8</TD><TD>17275</TD><TD>29</TD>
<TD>RSAD2,IFIT2,ISG15,OAS3,OAS1,OASL,OAS2,IFI27</TD></TR>
<TR><TD>4.039e-06</TD><TD>-12.42</TD><TD>GO_INTERFERON_GAMMA_MEDIATED_SIGNALING_PATHWAY</TD><TD>MSigDB lists</TD><TD>GO_INTERFERON_GAMMA_MEDIATED_SIGNALING_PATHWAY</TD><TD>65</TD><TD>4</TD><TD>17275</TD><TD>29</TD>
<TD>OAS3,OAS2,OAS1,OASL</TD></TR>
<TR><TD>4.163e-06</TD><TD>-12.39</TD><TD>WALLACE_PROSTATE_CANCER_RACE_UP</TD><TD>MSigDB lists</TD><TD>WALLACE_PROSTATE_CANCER_RACE_UP</TD><TD>263</TD><TD>6</TD><TD>17275</TD><TD>29</TD>
<TD>OAS2,ISG15,IFI27,RSAD2,IFI44,IFI44L</TD></TR>
<TR><TD>4.771e-06</TD><TD>-12.25</TD><TD>double-stranded RNA binding</TD><TD>molecular function</TD><TD>GO:0003725</TD><TD>76</TD><TD>4</TD><TD>17306</TD><TD>26</TD>
<TD>OAS3,OAS2,OASL,OAS1</TD></TR>
<TR><TD>4.868e-06</TD><TD>-12.23</TD><TD>human chr12q24.13</TD><TD>chromosome location</TD><TD>human chr12q24.13</TD><TD>29</TD><TD>3</TD><TD>26169</TD><TD>30</TD>
<TD>OAS1,OAS3,OAS2</TD></TR>
<TR><TD>5.121e-06</TD><TD>-12.18</TD><TD>interferon-gamma-mediated signaling pathway</TD><TD>biological process</TD><TD>GO:0060333</TD><TD>72</TD><TD>4</TD><TD>18054</TD><TD>29</TD>
<TD>OASL,OAS1,OAS3,OAS2</TD></TR>
<TR><TD>5.432e-06</TD><TD>-12.12</TD><TD>GO_RESPONSE_TO_BIOTIC_STIMULUS</TD><TD>MSigDB lists</TD><TD>GO_RESPONSE_TO_BIOTIC_STIMULUS</TD><TD>829</TD><TD>9</TD><TD>17275</TD><TD>29</TD>
<TD>IFI44L,IFI44,RSAD2,ISG15,IFIT2,OAS1,OAS2,OASL,OAS3</TD></TR>
<TR><TD>5.440e-06</TD><TD>-12.12</TD><TD>GSE21546_UNSTIM_VS_ANTI_CD3_STIM_SAP1A_KO_AND_ELK1_KO_DP_THYMOCYTES_UP</TD><TD>MSigDB lists</TD><TD>GSE21546_UNSTIM_VS_ANTI_CD3_STIM_SAP1A_KO_AND_ELK1_KO_DP_THYMOCYTES_UP</TD><TD>155</TD><TD>5</TD><TD>17275</TD><TD>29</TD>
<TD>OAS1,OASL,OAS3,IFI27,ISG15</TD></TR>
<TR><TD>6.161e-06</TD><TD>-12.00</TD><TD>GSE9960_GRAM_NEG_VS_GRAM_NEG_AND_POS_SEPSIS_PBMC_UP</TD><TD>MSigDB lists</TD><TD>GSE9960_GRAM_NEG_VS_GRAM_NEG_AND_POS_SEPSIS_PBMC_UP</TD><TD>159</TD><TD>5</TD><TD>17275</TD><TD>29</TD>
<TD>IFIT2,IFI44L,IFI44,CADM4,OAS2</TD></TR>
<TR><TD>6.352e-06</TD><TD>-11.97</TD><TD>GSE18791_CTRL_VS_NEWCASTLE_VIRUS_DC_14H_DN</TD><TD>MSigDB lists</TD><TD>GSE18791_CTRL_VS_NEWCASTLE_VIRUS_DC_14H_DN</TD><TD>160</TD><TD>5</TD><TD>17275</TD><TD>29</TD>
<TD>OAS3,IFI44,BCL6B,IFIT2,ISG15</TD></TR>
<TR><TD>7.256e-06</TD><TD>-11.83</TD><TD>immune system process</TD><TD>biological process</TD><TD>GO:0002376</TD><TD>2451</TD><TD>14</TD><TD>18054</TD><TD>29</TD>
<TD>LGR4,OASL,IFI44,KIFAP3,ISG15,IFIT2,OAS1,IFI44L,RSAD2,CTSV,IFI27,SBSPON,OAS2,OAS3</TD></TR>
<TR><TD>7.577e-06</TD><TD>-11.79</TD><TD>cytokine-mediated signaling pathway</TD><TD>biological process</TD><TD>GO:0019221</TD><TD>672</TD><TD>8</TD><TD>18054</TD><TD>29</TD>
<TD>IFI27,OAS2,OAS3,IFIT2,OAS1,RSAD2,ISG15,OASL</TD></TR>
<TR><TD>8.781e-06</TD><TD>-11.64</TD><TD>GSE2706_UNSTIM_VS_2H_LPS_AND_R848_DC_DN</TD><TD>MSigDB lists</TD><TD>GSE2706_UNSTIM_VS_2H_LPS_AND_R848_DC_DN</TD><TD>171</TD><TD>5</TD><TD>17275</TD><TD>29</TD>
<TD>RSAD2,IFIT2,ISG15,IFI44,OASL</TD></TR>
<TR><TD>8.820e-06</TD><TD>-11.64</TD><TD>SANA_TNF_SIGNALING_UP</TD><TD>MSigDB lists</TD><TD>SANA_TNF_SIGNALING_UP</TD><TD>79</TD><TD>4</TD><TD>17275</TD><TD>29</TD>
<TD>IFI44L,OAS1,OAS2,OAS3</TD></TR>
<TR><TD>1.008e-05</TD><TD>-11.50</TD><TD>GO_DEFENSE_RESPONSE</TD><TD>MSigDB lists</TD><TD>GO_DEFENSE_RESPONSE</TD><TD>1148</TD><TD>10</TD><TD>17275</TD><TD>29</TD>
<TD>OAS3,OASL,OAS1,OAS2,IFIT2,ISG15,RSAD2,IFI44L,LGR4,IFI27</TD></TR>
<TR><TD>1.067e-05</TD><TD>-11.45</TD><TD>GSE14000_UNSTIM_VS_16H_LPS_DC_TRANSLATED_RNA_DN</TD><TD>MSigDB lists</TD><TD>GSE14000_UNSTIM_VS_16H_LPS_DC_TRANSLATED_RNA_DN</TD><TD>178</TD><TD>5</TD><TD>17275</TD><TD>29</TD>
<TD>OAS3,OAS2,RSAD2,IFIT2,IFI44L</TD></TR>
<TR><TD>1.081e-05</TD><TD>-11.43</TD><TD>immune effector process</TD><TD>biological process</TD><TD>GO:0002252</TD><TD>943</TD><TD>9</TD><TD>18054</TD><TD>29</TD>
<TD>OASL,ISG15,IFI44L,RSAD2,IFIT2,OAS1,IFI27,OAS3,OAS2</TD></TR>
<TR><TD>1.126e-05</TD><TD>-11.39</TD><TD>GSE19888_ADENOSINE_A3R_INH_VS_INH_PRETREAT_AND_ACT_WITH_TCELL_MEMBRANES_MAST_CELL_UP</TD><TD>MSigDB lists</TD><TD>GSE19888_ADENOSINE_A3R_INH_VS_INH_PRETREAT_AND_ACT_WITH_TCELL_MEMBRANES_MAST_CELL_UP</TD><TD>180</TD><TD>5</TD><TD>17275</TD><TD>29</TD>
<TD>IFI44L,RSAD2,ISG15,OAS1,OAS2</TD></TR>
<TR><TD>1.157e-05</TD><TD>-11.37</TD><TD>ERB2_UP.V1_DN</TD><TD>MSigDB lists</TD><TD>ERB2_UP.V1_DN</TD><TD>181</TD><TD>5</TD><TD>17275</TD><TD>29</TD>
<TD>OAS2,OAS1,IFI44,IFI44L,IFI27</TD></TR>
<TR><TD>1.157e-05</TD><TD>-11.37</TD><TD>GSE8835_HEALTHY_VS_CLL_CD4_TCELL_UP</TD><TD>MSigDB lists</TD><TD>GSE8835_HEALTHY_VS_CLL_CD4_TCELL_UP</TD><TD>181</TD><TD>5</TD><TD>17275</TD><TD>29</TD>
<TD>IFI44L,IFIT2,RYR1,OAS1,OASL</TD></TR>
<TR><TD>1.160e-05</TD><TD>-11.36</TD><TD>IFNA21 (interferon alpha 21)</TD><TD>protein interactions</TD><TD>3452</TD><TD>26</TD><TD>3</TD><TD>17456</TD><TD>30</TD>
<TD>ISG15,IFI44,IFI44L</TD></TR>
<TR><TD>1.188e-05</TD><TD>-11.34</TD><TD>GSE39382_IL3_VS_IL3_IL33_TREATED_MAST_CELL_DN</TD><TD>MSigDB lists</TD><TD>GSE39382_IL3_VS_IL3_IL33_TREATED_MAST_CELL_DN</TD><TD>182</TD><TD>5</TD><TD>17275</TD><TD>29</TD>
<TD>OAS1,OAS3,ISG15,KIFAP3,IFIT2</TD></TR>
<TR><TD>1.188e-05</TD><TD>-11.34</TD><TD>GSE2706_UNSTIM_VS_8H_R848_DC_DN</TD><TD>MSigDB lists</TD><TD>GSE2706_UNSTIM_VS_8H_R848_DC_DN</TD><TD>182</TD><TD>5</TD><TD>17275</TD><TD>29</TD>
<TD>KIAA1211,IFI44,IFIT2,ISG15,OAS2</TD></TR>
<TR><TD>1.220e-05</TD><TD>-11.31</TD><TD>GSE28737_FOLLICULAR_VS_MARGINAL_ZONE_BCELL_BCL6_HET_DN</TD><TD>MSigDB lists</TD><TD>GSE28737_FOLLICULAR_VS_MARGINAL_ZONE_BCELL_BCL6_HET_DN</TD><TD>183</TD><TD>5</TD><TD>17275</TD><TD>29</TD>
<TD>MCAM,RSAD2,OAS2,OAS1,TUBA1A</TD></TR>
<TR><TD>1.240e-05</TD><TD>-11.30</TD><TD>GO_RESPONSE_TO_CYTOKINE</TD><TD>MSigDB lists</TD><TD>GO_RESPONSE_TO_CYTOKINE</TD><TD>688</TD><TD>8</TD><TD>17275</TD><TD>29</TD>
<TD>RSAD2,ISG15,IFIT2,OASL,OAS1,OAS2,OAS3,IFI27</TD></TR>
<TR><TD>1.253e-05</TD><TD>-11.29</TD><TD>GSE25085_FETAL_BM_VS_ADULT_BM_SP4_THYMIC_IMPLANT_UP</TD><TD>MSigDB lists</TD><TD>GSE25085_FETAL_BM_VS_ADULT_BM_SP4_THYMIC_IMPLANT_UP</TD><TD>184</TD><TD>5</TD><TD>17275</TD><TD>29</TD>
<TD>ISG15,IFIT2,RSAD2,OASL,OAS2</TD></TR>
<TR><TD>1.253e-05</TD><TD>-11.29</TD><TD>GSE1432_CTRL_VS_IFNG_24H_MICROGLIA_DN</TD><TD>MSigDB lists</TD><TD>GSE1432_CTRL_VS_IFNG_24H_MICROGLIA_DN</TD><TD>184</TD><TD>5</TD><TD>17275</TD><TD>29</TD>
<TD>IFI44,ISG15,IFI27,RSAD2,OAS3</TD></TR>
<TR><TD>1.257e-05</TD><TD>-11.28</TD><TD>defense response</TD><TD>biological process</TD><TD>GO:0006952</TD><TD>1230</TD><TD>10</TD><TD>18054</TD><TD>29</TD>
<TD>ISG15,OASL,LGR4,OAS2,OAS3,IFI27,RSAD2,IFI44L,OAS1,IFIT2</TD></TR>
<TR><TD>1.268e-05</TD><TD>-11.28</TD><TD>tat (Tat)</TD><TD>protein interactions</TD><TD>155871</TD><TD>1718</TD><TD>12</TD><TD>17456</TD><TD>30</TD>
<TD>CAMKK2,RYR1,OAS1,IFI44,TUBA1A,ISG15,OAS3,OAS2,OASL,CTSV,IFI27,IFIT2</TD></TR>
<TR><TD>1.320e-05</TD><TD>-11.24</TD><TD>GSE21380_NON_TFH_VS_TFH_CD4_TCELL_DN</TD><TD>MSigDB lists</TD><TD>GSE21380_NON_TFH_VS_TFH_CD4_TCELL_DN</TD><TD>186</TD><TD>5</TD><TD>17275</TD><TD>29</TD>
<TD>IFI44,ZNF518B,RSAD2,IFI27,OAS2</TD></TR>
<TR><TD>1.355e-05</TD><TD>-11.21</TD><TD>GSE2585_THYMIC_DC_VS_MTEC_DN</TD><TD>MSigDB lists</TD><TD>GSE2585_THYMIC_DC_VS_MTEC_DN</TD><TD>187</TD><TD>5</TD><TD>17275</TD><TD>29</TD>
<TD>OAS2,RSAD2,IFI27,ISG15,IFI44L</TD></TR>
<TR><TD>1.390e-05</TD><TD>-11.18</TD><TD>GSE5589_LPS_AND_IL10_VS_LPS_AND_IL6_STIM_IL6_KO_MACROPHAGE_45MIN_UP</TD><TD>MSigDB lists</TD><TD>GSE5589_LPS_AND_IL10_VS_LPS_AND_IL6_STIM_IL6_KO_MACROPHAGE_45MIN_UP</TD><TD>188</TD><TD>5</TD><TD>17275</TD><TD>29</TD>
<TD>OAS3,OAS1,OAS2,ISG15,RSAD2</TD></TR>
<TR><TD>1.463e-05</TD><TD>-11.13</TD><TD>response to stress</TD><TD>biological process</TD><TD>GO:0006950</TD><TD>3423</TD><TD>16</TD><TD>18054</TD><TD>29</TD>
<TD>ISG15,MGAT3,IFI44L,CTSV,IFI27,MCAM,PGF,OAS2,LGR4,OASL,IFIT2,RYR1,OAS1,CAMKK2,RSAD2,OAS3</TD></TR>
<TR><TD>1.501e-05</TD><TD>-11.11</TD><TD>GSE44649_WT_VS_MIR155_KO_NAIVE_CD8_TCELL_DN</TD><TD>MSigDB lists</TD><TD>GSE44649_WT_VS_MIR155_KO_NAIVE_CD8_TCELL_DN</TD><TD>191</TD><TD>5</TD><TD>17275</TD><TD>29</TD>
<TD>ISG15,TUBA1A,OASL,OAS1,OAS2</TD></TR>
<TR><TD>1.501e-05</TD><TD>-11.11</TD><TD>GO_REGULATION_OF_SYMBIOSIS_ENCOMPASSING_MUTUALISM_THROUGH_PARASITISM</TD><TD>MSigDB lists</TD><TD>GO_REGULATION_OF_SYMBIOSIS_ENCOMPASSING_MUTUALISM_THROUGH_PARASITISM</TD><TD>191</TD><TD>5</TD><TD>17275</TD><TD>29</TD>
<TD>OAS3,OASL,OAS1,ISG15,RSAD2</TD></TR>
<TR><TD>1.578e-05</TD><TD>-11.06</TD><TD>GSE3982_CTRL_VS_LPS_4H_MAC_DN</TD><TD>MSigDB lists</TD><TD>GSE3982_CTRL_VS_LPS_4H_MAC_DN</TD><TD>193</TD><TD>5</TD><TD>17275</TD><TD>29</TD>
<TD>IFI44L,IFI44,IFIT2,OASL,OAS1</TD></TR>
<TR><TD>1.618e-05</TD><TD>-11.03</TD><TD>GSE19888_CTRL_VS_TCELL_MEMBRANES_ACT_MAST_CELL_PRETREAT_A3R_INH_DN</TD><TD>MSigDB lists</TD><TD>GSE19888_CTRL_VS_TCELL_MEMBRANES_ACT_MAST_CELL_PRETREAT_A3R_INH_DN</TD><TD>194</TD><TD>5</TD><TD>17275</TD><TD>29</TD>
<TD>OAS1,OAS2,RSAD2,IFIT2,IFI44L</TD></TR>
<TR><TD>1.675e-05</TD><TD>-11.00</TD><TD>TSAI_RESPONSE_TO_RADIATION_THERAPY</TD><TD>MSigDB lists</TD><TD>TSAI_RESPONSE_TO_RADIATION_THERAPY</TD><TD>30</TD><TD>3</TD><TD>17275</TD><TD>29</TD>
<TD>ISG15,IFIT2,OAS3</TD></TR>
<TR><TD>1.700e-05</TD><TD>-10.98</TD><TD>chr12q24</TD><TD>MSigDB lists</TD><TD>chr12q24</TD><TD>196</TD><TD>5</TD><TD>17275</TD><TD>29</TD>
<TD>CAMKK2,OAS1,OASL,OAS2,OAS3</TD></TR>
<TR><TD>1.785e-05</TD><TD>-10.93</TD><TD>response to external stimulus</TD><TD>biological process</TD><TD>GO:0009605</TD><TD>2267</TD><TD>13</TD><TD>18054</TD><TD>29</TD>
<TD>LGR4,IFI44,OASL,ISG15,IFIT2,OAS1,IFI44L,RSAD2,CTSV,PGF,IFI27,OAS3,OAS2</TD></TR>
<TR><TD>1.814e-05</TD><TD>-10.92</TD><TD>Interferon gamma signaling</TD><TD>REACTOME pathways</TD><TD>R-HSA-877300</TD><TD>94</TD><TD>4</TD><TD>10287</TD><TD>18</TD>
<TD>OASL,OAS3,OAS1,OAS2</TD></TR>
<TR><TD>1.848e-05</TD><TD>-10.90</TD><TD>Cytokine Signaling in Immune system</TD><TD>REACTOME pathways</TD><TD>R-HSA-1280215</TD><TD>756</TD><TD>8</TD><TD>10287</TD><TD>18</TD>
<TD>ISG15,OAS2,IFIT2,OAS1,RSAD2,OASL,OAS3,IFI27</TD></TR>
<TR><TD>1.852e-05</TD><TD>-10.90</TD><TD>TAVOR_CEBPA_TARGETS_DN</TD><TD>MSigDB lists</TD><TD>TAVOR_CEBPA_TARGETS_DN</TD><TD>31</TD><TD>3</TD><TD>17275</TD><TD>29</TD>
<TD>ISG15,IFI27,OAS2</TD></TR>
<TR><TD>1.852e-05</TD><TD>-10.90</TD><TD>GROSS_ELK3_TARGETS_DN</TD><TD>MSigDB lists</TD><TD>GROSS_ELK3_TARGETS_DN</TD><TD>31</TD><TD>3</TD><TD>17275</TD><TD>29</TD>
<TD>OAS3,RSAD2,IFI44</TD></TR>
<TR><TD>2.033e-05</TD><TD>-10.80</TD><TD>GO_IMMUNE_SYSTEM_PROCESS</TD><TD>MSigDB lists</TD><TD>GO_IMMUNE_SYSTEM_PROCESS</TD><TD>1854</TD><TD>12</TD><TD>17275</TD><TD>29</TD>
<TD>LGR4,IFI27,OAS3,OASL,OAS2,OAS1,KIFAP3,ISG15,BCL6B,IFIT2,RSAD2,IFI44L</TD></TR>
<TR><TD>2.518e-05</TD><TD>-10.59</TD><TD>GO_IMMUNE_RESPONSE</TD><TD>MSigDB lists</TD><TD>GO_IMMUNE_RESPONSE</TD><TD>1003</TD><TD>9</TD><TD>17275</TD><TD>29</TD>
<TD>RSAD2,ISG15,IFIT2,OAS3,OASL,OAS2,OAS1,IFI27,LGR4</TD></TR>
<TR><TD>3.163e-05</TD><TD>-10.36</TD><TD>negative regulation of multi-organism process</TD><TD>biological process</TD><TD>GO:0043901</TD><TD>233</TD><TD>5</TD><TD>18054</TD><TD>29</TD>
<TD>OAS1,OASL,RSAD2,ISG15,OAS3</TD></TR>
<TR><TD>3.449e-05</TD><TD>-10.27</TD><TD>KRASNOSELSKAYA_ILF3_TARGETS_UP</TD><TD>MSigDB lists</TD><TD>KRASNOSELSKAYA_ILF3_TARGETS_UP</TD><TD>38</TD><TD>3</TD><TD>17275</TD><TD>29</TD>
<TD>OAS1,IFI27,ISG15</TD></TR>
<TR><TD>3.761e-05</TD><TD>-10.19</TD><TD>GO_CELLULAR_RESPONSE_TO_INTERFERON_GAMMA</TD><TD>MSigDB lists</TD><TD>GO_CELLULAR_RESPONSE_TO_INTERFERON_GAMMA</TD><TD>114</TD><TD>4</TD><TD>17275</TD><TD>29</TD>
<TD>OASL,OAS1,OAS2,OAS3</TD></TR>
<TR><TD>4.027e-05</TD><TD>-10.12</TD><TD>GO_NUCLEOTIDYLTRANSFERASE_ACTIVITY</TD><TD>MSigDB lists</TD><TD>GO_NUCLEOTIDYLTRANSFERASE_ACTIVITY</TD><TD>116</TD><TD>4</TD><TD>17275</TD><TD>29</TD>
<TD>OAS3,OASL,OAS1,OAS2</TD></TR>
<TR><TD>4.365e-05</TD><TD>-10.04</TD><TD>SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_1</TD><TD>MSigDB lists</TD><TD>SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_1</TD><TD>398</TD><TD>6</TD><TD>17275</TD><TD>29</TD>
<TD>MGAT3,PGF,CAMKK2,MCAM,OAS2,OAS1</TD></TR>
<TR><TD>4.371e-05</TD><TD>-10.04</TD><TD>nucleotidyltransferase activity</TD><TD>molecular function</TD><TD>GO:0016779</TD><TD>133</TD><TD>4</TD><TD>17306</TD><TD>26</TD>
<TD>OAS2,OASL,OAS1,OAS3</TD></TR>
<TR><TD>4.598e-05</TD><TD>-9.99</TD><TD>MISSIAGLIA_REGULATED_BY_METHYLATION_UP</TD><TD>MSigDB lists</TD><TD>MISSIAGLIA_REGULATED_BY_METHYLATION_UP</TD><TD>120</TD><TD>4</TD><TD>17275</TD><TD>29</TD>
<TD>ISG15,IFI44L,OAS2,OAS1</TD></TR>
<TR><TD>4.598e-05</TD><TD>-9.99</TD><TD>ZHU_CMV_ALL_UP</TD><TD>MSigDB lists</TD><TD>ZHU_CMV_ALL_UP</TD><TD>120</TD><TD>4</TD><TD>17275</TD><TD>29</TD>
<TD>ISG15,IFI27,OAS2,OAS1</TD></TR>
<TR><TD>5.564e-05</TD><TD>-9.80</TD><TD>ALTEMEIER_RESPONSE_TO_LPS_WITH_MECHANICAL_VENTILATION</TD><TD>MSigDB lists</TD><TD>ALTEMEIER_RESPONSE_TO_LPS_WITH_MECHANICAL_VENTILATION</TD><TD>126</TD><TD>4</TD><TD>17275</TD><TD>29</TD>
<TD>OAS2,OAS3,IFIT2,ISG15</TD></TR>
<TR><TD>6.099e-05</TD><TD>-9.70</TD><TD>JOHNSTONE_PARVB_TARGETS_2_UP</TD><TD>MSigDB lists</TD><TD>JOHNSTONE_PARVB_TARGETS_2_UP</TD><TD>129</TD><TD>4</TD><TD>17275</TD><TD>29</TD>
<TD>OASL,IFI27,ISG15,IFIT2</TD></TR>
<TR><TD>6.151e-05</TD><TD>-9.70</TD><TD>STAMBOLSKY_TARGETS_OF_MUTATED_TP53_DN</TD><TD>MSigDB lists</TD><TD>STAMBOLSKY_TARGETS_OF_MUTATED_TP53_DN</TD><TD>46</TD><TD>3</TD><TD>17275</TD><TD>29</TD>
<TD>ISG15,OAS1,OAS3</TD></TR>
<TR><TD>6.560e-05</TD><TD>-9.63</TD><TD>Type II interferon signaling (IFNG)</TD><TD>WikiPathways</TD><TD>WP619</TD><TD>37</TD><TD>3</TD><TD>5311</TD><TD>12</TD>
<TD>OAS1,ISG15,IFIT2</TD></TR>
<TR><TD>6.992e-05</TD><TD>-9.57</TD><TD>ZHU_CMV_8_HR_UP</TD><TD>MSigDB lists</TD><TD>ZHU_CMV_8_HR_UP</TD><TD>48</TD><TD>3</TD><TD>17275</TD><TD>29</TD>
<TD>ISG15,OAS1,OAS2</TD></TR>
<TR><TD>7.016e-05</TD><TD>-9.56</TD><TD>vpu (Vpu)</TD><TD>protein interactions</TD><TD>155945</TD><TD>257</TD><TD>5</TD><TD>17456</TD><TD>30</TD>
<TD>RSAD2,IFIT2,ISG15,IFI44L,OAS1</TD></TR>
<TR><TD>7.180e-05</TD><TD>-9.54</TD><TD>REACTOME_IMMUNE_SYSTEM</TD><TD>MSigDB lists</TD><TD>REACTOME_IMMUNE_SYSTEM</TD><TD>879</TD><TD>8</TD><TD>17275</TD><TD>29</TD>
<TD>IFI27,OAS2,OAS1,OASL,OAS3,KIFAP3,IFIT2,ISG15</TD></TR>
<TR><TD>7.280e-05</TD><TD>-9.53</TD><TD>GO_RESPONSE_TO_INTERFERON_GAMMA</TD><TD>MSigDB lists</TD><TD>GO_RESPONSE_TO_INTERFERON_GAMMA</TD><TD>135</TD><TD>4</TD><TD>17275</TD><TD>29</TD>
<TD>OAS2,OAS1,OASL,OAS3</TD></TR>
<TR><TD>7.440e-05</TD><TD>-9.51</TD><TD>BECKER_TAMOXIFEN_RESISTANCE_UP</TD><TD>MSigDB lists</TD><TD>BECKER_TAMOXIFEN_RESISTANCE_UP</TD><TD>49</TD><TD>3</TD><TD>17275</TD><TD>29</TD>
<TD>ISG15,IFI27,IFI44</TD></TR>
<TR><TD>7.898e-05</TD><TD>-9.45</TD><TD>TLDC</TD><TD>prosite domains</TD><TD>PS51886</TD><TD>7</TD><TD>2</TD><TD>12079</TD><TD>24</TD>
<TD>IFI44,IFI44L</TD></TR>
<TR><TD>8.413e-05</TD><TD>-9.38</TD><TD>HELLER_SILENCED_BY_METHYLATION_UP</TD><TD>MSigDB lists</TD><TD>HELLER_SILENCED_BY_METHYLATION_UP</TD><TD>274</TD><TD>5</TD><TD>17275</TD><TD>29</TD>
<TD>MCAM,IFI44,IFI44L,IFI27,ISG15</TD></TR>
<TR><TD>9.607e-05</TD><TD>-9.25</TD><TD>GSE2706_R848_VS_LPS_2H_STIM_DC_DN</TD><TD>MSigDB lists</TD><TD>GSE2706_R848_VS_LPS_2H_STIM_DC_DN</TD><TD>145</TD><TD>4</TD><TD>17275</TD><TD>29</TD>
<TD>OASL,IFI44,IFIT2,ISG15</TD></TR>
<TR><TD>1.151e-04</TD><TD>-9.07</TD><TD>multi-organism process</TD><TD>biological process</TD><TD>GO:0051704</TD><TD>2697</TD><TD>13</TD><TD>18054</TD><TD>29</TD>
<TD>ISG15,OASL,IFI44,LGR4,OAS3,OAS2,IFI27,CTSV,PGF,OAS1,IFIT2,RSAD2,IFI44L</TD></TR>
<TR><TD>1.159e-04</TD><TD>-9.06</TD><TD>NUYTTEN_NIPP1_TARGETS_UP</TD><TD>MSigDB lists</TD><TD>NUYTTEN_NIPP1_TARGETS_UP</TD><TD>692</TD><TD>7</TD><TD>17275</TD><TD>29</TD>
<TD>IFI44L,IFI44,RSAD2,ISG15,OAS2,OAS1,OASL</TD></TR>
<TR><TD>1.187e-04</TD><TD>-9.04</TD><TD>cellular response to interferon-gamma</TD><TD>biological process</TD><TD>GO:0071346</TD><TD>160</TD><TD>4</TD><TD>18054</TD><TD>29</TD>
<TD>OAS2,OAS3,OASL,OAS1</TD></TR>
<TR><TD>1.357e-04</TD><TD>-8.90</TD><TD>cellular response to cytokine stimulus</TD><TD>biological process</TD><TD>GO:0071345</TD><TD>1006</TD><TD>8</TD><TD>18054</TD><TD>29</TD>
<TD>OAS2,OAS3,IFI27,RSAD2,OAS1,IFIT2,ISG15,OASL</TD></TR>
<TR><TD>1.368e-04</TD><TD>-8.90</TD><TD>Influenza A</TD><TD>KEGG pathways</TD><TD>ko05164</TD><TD>172</TD><TD>4</TD><TD>7161</TD><TD>12</TD>
<TD>OAS1,OAS2,RSAD2,OAS3</TD></TR>
<TR><TD>1.368e-04</TD><TD>-8.90</TD><TD>Influenza A</TD><TD>KEGG pathways</TD><TD>hsa05164</TD><TD>172</TD><TD>4</TD><TD>7161</TD><TD>12</TD>
<TD>OAS3,OAS1,OAS2,RSAD2</TD></TR>
<TR><TD>1.439e-04</TD><TD>-8.85</TD><TD>GSE6259_DEC205_POS_DC_VS_BCELL_DN</TD><TD>MSigDB lists</TD><TD>GSE6259_DEC205_POS_DC_VS_BCELL_DN</TD><TD>161</TD><TD>4</TD><TD>17275</TD><TD>29</TD>
<TD>OAS2,IFIT2,ISG15,IFI44</TD></TR>
<TR><TD>1.483e-04</TD><TD>-8.82</TD><TD>SEMBA_FHIT_TARGETS_UP</TD><TD>MSigDB lists</TD><TD>SEMBA_FHIT_TARGETS_UP</TD><TD>11</TD><TD>2</TD><TD>17275</TD><TD>29</TD>
<TD>IFI44L,OAS1</TD></TR>
<TR><TD>1.582e-04</TD><TD>-8.75</TD><TD>GSE17974_IL4_AND_ANTI_IL12_VS_UNTREATED_48H_ACT_CD4_TCELL_DN</TD><TD>MSigDB lists</TD><TD>GSE17974_IL4_AND_ANTI_IL12_VS_UNTREATED_48H_ACT_CD4_TCELL_DN</TD><TD>165</TD><TD>4</TD><TD>17275</TD><TD>29</TD>
<TD>IFI44,IFI44L,KIFAP3,OAS1</TD></TR>
<TR><TD>1.619e-04</TD><TD>-8.73</TD><TD>GSE7509_UNSTIM_VS_IFNA_STIM_IMMATURE_DC_DN</TD><TD>MSigDB lists</TD><TD>GSE7509_UNSTIM_VS_IFNA_STIM_IMMATURE_DC_DN</TD><TD>166</TD><TD>4</TD><TD>17275</TD><TD>29</TD>
<TD>IFI44,IFIT2,ISG15,OAS3</TD></TR>
<TR><TD>1.676e-04</TD><TD>-8.69</TD><TD>vascular endothelial growth factor receptor binding</TD><TD>molecular function</TD><TD>GO:0005172</TD><TD>13</TD><TD>2</TD><TD>17306</TD><TD>26</TD>
<TD>CADM4,PGF</TD></TR>
<TR><TD>1.774e-04</TD><TD>-8.64</TD><TD>GSE18791_CTRL_VS_NEWCASTLE_VIRUS_DC_12H_DN</TD><TD>MSigDB lists</TD><TD>GSE18791_CTRL_VS_NEWCASTLE_VIRUS_DC_12H_DN</TD><TD>170</TD><TD>4</TD><TD>17275</TD><TD>29</TD>
<TD>IFI44,ISG15,IFIT2,OAS3</TD></TR>
<TR><TD>1.813e-04</TD><TD>-8.62</TD><TD>GAJATE_RESPONSE_TO_TRABECTEDIN_UP</TD><TD>MSigDB lists</TD><TD>GAJATE_RESPONSE_TO_TRABECTEDIN_UP</TD><TD>66</TD><TD>3</TD><TD>17275</TD><TD>29</TD>
<TD>ISG15,OASL,TUBA1A</TD></TR>
<TR><TD>1.815e-04</TD><TD>-8.61</TD><TD>GSE21360_PRIMARY_VS_QUATERNARY_MEMORY_CD8_TCELL_UP</TD><TD>MSigDB lists</TD><TD>GSE21360_PRIMARY_VS_QUATERNARY_MEMORY_CD8_TCELL_UP</TD><TD>171</TD><TD>4</TD><TD>17275</TD><TD>29</TD>
<TD>IFIT2,RSAD2,IFI44,IFI44L</TD></TR>
<TR><TD>1.815e-04</TD><TD>-8.61</TD><TD>GSE2706_2H_VS_8H_R848_STIM_DC_DN</TD><TD>MSigDB lists</TD><TD>GSE2706_2H_VS_8H_R848_STIM_DC_DN</TD><TD>171</TD><TD>4</TD><TD>17275</TD><TD>29</TD>
<TD>KIAA1211,IFI44L,IFI44,OAS2</TD></TR>
<TR><TD>1.828e-04</TD><TD>-8.61</TD><TD>response to interferon-gamma</TD><TD>biological process</TD><TD>GO:0034341</TD><TD>179</TD><TD>4</TD><TD>18054</TD><TD>29</TD>
<TD>OASL,OAS1,OAS2,OAS3</TD></TR>
<TR><TD>1.869e-04</TD><TD>-8.59</TD><TD>regulation of multi-organism process</TD><TD>biological process</TD><TD>GO:0043900</TD><TD>781</TD><TD>7</TD><TD>18054</TD><TD>29</TD>
<TD>ISG15,OAS3,IFI27,OAS1,OASL,LGR4,RSAD2</TD></TR>
<TR><TD>1.896e-04</TD><TD>-8.57</TD><TD>BROWNE_HCMV_INFECTION_6HR_UP</TD><TD>MSigDB lists</TD><TD>BROWNE_HCMV_INFECTION_6HR_UP</TD><TD>67</TD><TD>3</TD><TD>17275</TD><TD>29</TD>
<TD>ISG15,OASL,OAS1</TD></TR>
<TR><TD>1.983e-04</TD><TD>-8.53</TD><TD>GSE46242_CTRL_VS_EGR2_DELETED_ANERGIC_TH1_CD4_TCELL_UP</TD><TD>MSigDB lists</TD><TD>GSE46242_CTRL_VS_EGR2_DELETED_ANERGIC_TH1_CD4_TCELL_UP</TD><TD>175</TD><TD>4</TD><TD>17275</TD><TD>29</TD>
<TD>IFIT2,MGAT3,OAS3,OAS1</TD></TR>
<TR><TD>2.027e-04</TD><TD>-8.50</TD><TD>GSE2706_UNSTIM_VS_8H_LPS_AND_R848_DC_DN</TD><TD>MSigDB lists</TD><TD>GSE2706_UNSTIM_VS_8H_LPS_AND_R848_DC_DN</TD><TD>176</TD><TD>4</TD><TD>17275</TD><TD>29</TD>
<TD>OAS2,KIAA1211,RSAD2,IFI27</TD></TR>
<TR><TD>2.027e-04</TD><TD>-8.50</TD><TD>GSE13485_DAY1_VS_DAY3_YF17D_VACCINE_PBMC_DN</TD><TD>MSigDB lists</TD><TD>GSE13485_DAY1_VS_DAY3_YF17D_VACCINE_PBMC_DN</TD><TD>176</TD><TD>4</TD><TD>17275</TD><TD>29</TD>
<TD>RSAD2,ISG15,IFI44L,IFI44</TD></TR>
<TR><TD>2.071e-04</TD><TD>-8.48</TD><TD>JISON_SICKLE_CELL_DISEASE_UP</TD><TD>MSigDB lists</TD><TD>JISON_SICKLE_CELL_DISEASE_UP</TD><TD>177</TD><TD>4</TD><TD>17275</TD><TD>29</TD>
<TD>RSAD2,IFIT2,IFI44,OASL</TD></TR>
<TR><TD>2.098e-04</TD><TD>-8.47</TD><TD>TSAI_DNAJB4_TARGETS_UP</TD><TD>MSigDB lists</TD><TD>TSAI_DNAJB4_TARGETS_UP</TD><TD>13</TD><TD>2</TD><TD>17275</TD><TD>29</TD>
<TD>OAS3,ISG15</TD></TR>
<TR><TD>2.098e-04</TD><TD>-8.47</TD><TD>LEE_SP4_THYMOCYTE</TD><TD>MSigDB lists</TD><TD>LEE_SP4_THYMOCYTE</TD><TD>13</TD><TD>2</TD><TD>17275</TD><TD>29</TD>
<TD>IFI44L,RSAD2</TD></TR>
<TR><TD>2.205e-04</TD><TD>-8.42</TD><TD>cellular response to chemical stimulus</TD><TD>biological process</TD><TD>GO:0070887</TD><TD>2871</TD><TD>13</TD><TD>18054</TD><TD>29</TD>
<TD>LGR4,OASL,ISG15,RSAD2,CAMKK2,MGAT3,IFIT2,RYR1,OAS1,PGF,IFI27,OAS3,OAS2</TD></TR>
<TR><TD>2.209e-04</TD><TD>-8.42</TD><TD>GSE41867_DAY6_EFFECTOR_VS_DAY30_EXHAUSTED_CD8_TCELL_LCMV_CLONE13_UP</TD><TD>MSigDB lists</TD><TD>GSE41867_DAY6_EFFECTOR_VS_DAY30_EXHAUSTED_CD8_TCELL_LCMV_CLONE13_UP</TD><TD>180</TD><TD>4</TD><TD>17275</TD><TD>29</TD>
<TD>RSAD2,OAS3,OAS1,OAS2</TD></TR>
<TR><TD>2.209e-04</TD><TD>-8.42</TD><TD>GSE36826_WT_VS_IL1R_KO_SKIN_STAPH_AUREUS_INF_DN</TD><TD>MSigDB lists</TD><TD>GSE36826_WT_VS_IL1R_KO_SKIN_STAPH_AUREUS_INF_DN</TD><TD>180</TD><TD>4</TD><TD>17275</TD><TD>29</TD>
<TD>OASL,RSAD2,ISG15,KIFAP3</TD></TR>
<TR><TD>2.251e-04</TD><TD>-8.40</TD><TD>SANA_RESPONSE_TO_IFNG_UP</TD><TD>MSigDB lists</TD><TD>SANA_RESPONSE_TO_IFNG_UP</TD><TD>71</TD><TD>3</TD><TD>17275</TD><TD>29</TD>
<TD>IFI44L,OAS1,OAS2</TD></TR>
<TR><TD>2.304e-04</TD><TD>-8.38</TD><TD>GSE3203_UNTREATED_VS_IFNB_TREATED_LN_BCELL_DN</TD><TD>MSigDB lists</TD><TD>GSE3203_UNTREATED_VS_IFNB_TREATED_LN_BCELL_DN</TD><TD>182</TD><TD>4</TD><TD>17275</TD><TD>29</TD>
<TD>OAS2,OAS1,IFI44L,IFI44</TD></TR>
<TR><TD>2.304e-04</TD><TD>-8.38</TD><TD>GSE16385_ROSIGLITAZONE_VS_UNTREATED_IFNG_TNF_STIM_MACROPHAGE_UP</TD><TD>MSigDB lists</TD><TD>GSE16385_ROSIGLITAZONE_VS_UNTREATED_IFNG_TNF_STIM_MACROPHAGE_UP</TD><TD>182</TD><TD>4</TD><TD>17275</TD><TD>29</TD>
<TD>FAM102B,IFI27,OAS1,HS6ST2</TD></TR>
<TR><TD>2.353e-04</TD><TD>-8.35</TD><TD>GSE30083_SP1_VS_SP4_THYMOCYTE_DN</TD><TD>MSigDB lists</TD><TD>GSE30083_SP1_VS_SP4_THYMOCYTE_DN</TD><TD>183</TD><TD>4</TD><TD>17275</TD><TD>29</TD>
<TD>OASL,OAS1,OAS2,IFI44</TD></TR>
<TR><TD>2.353e-04</TD><TD>-8.35</TD><TD>GSE40685_TREG_VS_FOXP3_KO_TREG_PRECURSOR_DN</TD><TD>MSigDB lists</TD><TD>GSE40685_TREG_VS_FOXP3_KO_TREG_PRECURSOR_DN</TD><TD>183</TD><TD>4</TD><TD>17275</TD><TD>29</TD>
<TD>OAS2,IFI44L,IFIT2,RSAD2</TD></TR>
<TR><TD>2.402e-04</TD><TD>-8.33</TD><TD>GSE22196_HEALTHY_VS_OBESE_MOUSE_SKIN_GAMMADELTA_TCELL_UP</TD><TD>MSigDB lists</TD><TD>GSE22196_HEALTHY_VS_OBESE_MOUSE_SKIN_GAMMADELTA_TCELL_UP</TD><TD>184</TD><TD>4</TD><TD>17275</TD><TD>29</TD>
<TD>IFI27,IFI44,IFI44L,OAS2</TD></TR>
<TR><TD>2.445e-04</TD><TD>-8.32</TD><TD>MARIADASON_REGULATED_BY_HISTONE_ACETYLATION_UP</TD><TD>MSigDB lists</TD><TD>MARIADASON_REGULATED_BY_HISTONE_ACETYLATION_UP</TD><TD>73</TD><TD>3</TD><TD>17275</TD><TD>29</TD>
<TD>MCAM,CAPN6,ISG15</TD></TR>
<TR><TD>2.451e-04</TD><TD>-8.31</TD><TD>response to cytokine</TD><TD>biological process</TD><TD>GO:0034097</TD><TD>1096</TD><TD>8</TD><TD>18054</TD><TD>29</TD>
<TD>OASL,ISG15,RSAD2,OAS1,IFIT2,OAS3,OAS2,IFI27</TD></TR>
<TR><TD>2.452e-04</TD><TD>-8.31</TD><TD>GSE42021_CD24HI_VS_CD24LOW_TCONV_THYMUS_DN</TD><TD>MSigDB lists</TD><TD>GSE42021_CD24HI_VS_CD24LOW_TCONV_THYMUS_DN</TD><TD>185</TD><TD>4</TD><TD>17275</TD><TD>29</TD>
<TD>IFIT2,IFI44L,OAS2,OASL</TD></TR>
<TR><TD>2.503e-04</TD><TD>-8.29</TD><TD>GSE24634_IL4_VS_CTRL_TREATED_NAIVE_CD4_TCELL_DAY5_DN</TD><TD>MSigDB lists</TD><TD>GSE24634_IL4_VS_CTRL_TREATED_NAIVE_CD4_TCELL_DAY5_DN</TD><TD>186</TD><TD>4</TD><TD>17275</TD><TD>29</TD>
<TD>RSAD2,IFIT2,IFI44L,OAS2</TD></TR>
<TR><TD>2.555e-04</TD><TD>-8.27</TD><TD>GSE17721_POLYIC_VS_GARDIQUIMOD_1H_BMDC_UP</TD><TD>MSigDB lists</TD><TD>GSE17721_POLYIC_VS_GARDIQUIMOD_1H_BMDC_UP</TD><TD>187</TD><TD>4</TD><TD>17275</TD><TD>29</TD>
<TD>CAMKK2,CAPN6,HS6ST2,OAS3</TD></TR>
<TR><TD>2.555e-04</TD><TD>-8.27</TD><TD>GSE40666_WT_VS_STAT1_KO_CD8_TCELL_WITH_IFNA_STIM_90MIN_DN</TD><TD>MSigDB lists</TD><TD>GSE40666_WT_VS_STAT1_KO_CD8_TCELL_WITH_IFNA_STIM_90MIN_DN</TD><TD>187</TD><TD>4</TD><TD>17275</TD><TD>29</TD>
<TD>IFI44L,IFI44,RSAD2,OAS2</TD></TR>
<TR><TD>2.555e-04</TD><TD>-8.27</TD><TD>GSE1460_DP_VS_CD4_THYMOCYTE_DN</TD><TD>MSigDB lists</TD><TD>GSE1460_DP_VS_CD4_THYMOCYTE_DN</TD><TD>187</TD><TD>4</TD><TD>17275</TD><TD>29</TD>
<TD>OAS2,IFI44,IFI44L,RSAD2</TD></TR>
<TR><TD>2.608e-04</TD><TD>-8.25</TD><TD>GSE43863_TFH_VS_LY6C_INT_CXCR5POS_MEMORY_CD4_TCELL_UP</TD><TD>MSigDB lists</TD><TD>GSE43863_TFH_VS_LY6C_INT_CXCR5POS_MEMORY_CD4_TCELL_UP</TD><TD>188</TD><TD>4</TD><TD>17275</TD><TD>29</TD>
<TD>IFI27,ISG15,IFI44,IFI44L</TD></TR>
<TR><TD>2.608e-04</TD><TD>-8.25</TD><TD>GSE1432_CTRL_VS_IFNG_6H_MICROGLIA_DN</TD><TD>MSigDB lists</TD><TD>GSE1432_CTRL_VS_IFNG_6H_MICROGLIA_DN</TD><TD>188</TD><TD>4</TD><TD>17275</TD><TD>29</TD>
<TD>ISG15,RSAD2,IFI44,IFI44L</TD></TR>
<TR><TD>2.661e-04</TD><TD>-8.23</TD><TD>GSE12392_CD8A_POS_VS_NEG_SPLEEN_DC_DN</TD><TD>MSigDB lists</TD><TD>GSE12392_CD8A_POS_VS_NEG_SPLEEN_DC_DN</TD><TD>189</TD><TD>4</TD><TD>17275</TD><TD>29</TD>
<TD>IFI44,OAS1,OASL,OAS2</TD></TR>
<TR><TD>2.661e-04</TD><TD>-8.23</TD><TD>GSE43863_DAY6_EFF_VS_DAY150_MEM_TFH_CD4_TCELL_UP</TD><TD>MSigDB lists</TD><TD>GSE43863_DAY6_EFF_VS_DAY150_MEM_TFH_CD4_TCELL_UP</TD><TD>189</TD><TD>4</TD><TD>17275</TD><TD>29</TD>
<TD>IFI44,IFIT2,RSAD2,OAS1</TD></TR>
<TR><TD>2.770e-04</TD><TD>-8.19</TD><TD>GSE18893_TCONV_VS_TREG_24H_CULTURE_DN</TD><TD>MSigDB lists</TD><TD>GSE18893_TCONV_VS_TREG_24H_CULTURE_DN</TD><TD>191</TD><TD>4</TD><TD>17275</TD><TD>29</TD>
<TD>OASL,IFI44,IFI44L,IFIT2</TD></TR>
<TR><TD>2.826e-04</TD><TD>-8.17</TD><TD>GSE360_HIGH_DOSE_B_MALAYI_VS_M_TUBERCULOSIS_DC_DN</TD><TD>MSigDB lists</TD><TD>GSE360_HIGH_DOSE_B_MALAYI_VS_M_TUBERCULOSIS_DC_DN</TD><TD>192</TD><TD>4</TD><TD>17275</TD><TD>29</TD>
<TD>OAS2,IFI44,IFI44L,IFIT2</TD></TR>
<TR><TD>2.826e-04</TD><TD>-8.17</TD><TD>GSE22140_HEALTHY_VS_ARTHRITIC_GERMFREE_MOUSE_CD4_TCELL_DN</TD><TD>MSigDB lists</TD><TD>GSE22140_HEALTHY_VS_ARTHRITIC_GERMFREE_MOUSE_CD4_TCELL_DN</TD><TD>192</TD><TD>4</TD><TD>17275</TD><TD>29</TD>
<TD>IFI44,IFIT2,OAS2,OASL</TD></TR>
<TR><TD>2.882e-04</TD><TD>-8.15</TD><TD>GSE36527_CD62L_HIGH_VS_CD62L_LOW_TREG_CD69_NEG_KLRG1_NEG_UP</TD><TD>MSigDB lists</TD><TD>GSE36527_CD62L_HIGH_VS_CD62L_LOW_TREG_CD69_NEG_KLRG1_NEG_UP</TD><TD>193</TD><TD>4</TD><TD>17275</TD><TD>29</TD>
<TD>ISG15,IFIT2,OASL,OAS2</TD></TR>
<TR><TD>2.939e-04</TD><TD>-8.13</TD><TD>TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_MONOCYTE_UP</TD><TD>MSigDB lists</TD><TD>TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_MONOCYTE_UP</TD><TD>194</TD><TD>4</TD><TD>17275</TD><TD>29</TD>
<TD>OAS1,ISG15,IFI44L,IFI44</TD></TR>
<TR><TD>2.939e-04</TD><TD>-8.13</TD><TD>GSE360_LOW_DOSE_B_MALAYI_VS_M_TUBERCULOSIS_DC_DN</TD><TD>MSigDB lists</TD><TD>GSE360_LOW_DOSE_B_MALAYI_VS_M_TUBERCULOSIS_DC_DN</TD><TD>194</TD><TD>4</TD><TD>17275</TD><TD>29</TD>
<TD>OAS2,OASL,IFIT2,IFI44</TD></TR>
<TR><TD>2.997e-04</TD><TD>-8.11</TD><TD>GSE19401_PLN_VS_PEYERS_PATCH_FOLLICULAR_DC_DN</TD><TD>MSigDB lists</TD><TD>GSE19401_PLN_VS_PEYERS_PATCH_FOLLICULAR_DC_DN</TD><TD>195</TD><TD>4</TD><TD>17275</TD><TD>29</TD>
<TD>OASL,IFI44,RSAD2,IFIT2</TD></TR>
<TR><TD>3.375e-04</TD><TD>-7.99</TD><TD>IFNA5 (interferon alpha 5)</TD><TD>protein interactions</TD><TD>3442</TD><TD>16</TD><TD>2</TD><TD>17456</TD><TD>30</TD>
<TD>IFI44L,ISG15</TD></TR>
<TR><TD>3.643e-04</TD><TD>-7.92</TD><TD>XU_HGF_TARGETS_INDUCED_BY_AKT1_6HR</TD><TD>MSigDB lists</TD><TD>XU_HGF_TARGETS_INDUCED_BY_AKT1_6HR</TD><TD>17</TD><TD>2</TD><TD>17275</TD><TD>29</TD>
<TD>OAS3,ISG15</TD></TR>
<TR><TD>3.643e-04</TD><TD>-7.92</TD><TD>MOROSETTI_FACIOSCAPULOHUMERAL_MUSCULAR_DISTROPHY_UP</TD><TD>MSigDB lists</TD><TD>MOROSETTI_FACIOSCAPULOHUMERAL_MUSCULAR_DISTROPHY_UP</TD><TD>17</TD><TD>2</TD><TD>17275</TD><TD>29</TD>
<TD>IFI27,PGF</TD></TR>
<TR><TD>4.124e-04</TD><TD>-7.79</TD><TD>GO_CELLULAR_RESPONSE_TO_ORGANIC_SUBSTANCE</TD><TD>MSigDB lists</TD><TD>GO_CELLULAR_RESPONSE_TO_ORGANIC_SUBSTANCE</TD><TD>1777</TD><TD>10</TD><TD>17275</TD><TD>29</TD>
<TD>OAS3,OASL,OAS1,OAS2,ISG15,RYR1,PGF,IFIT2,RSAD2,IFI27</TD></TR>
<TR><TD>4.142e-04</TD><TD>-7.79</TD><TD>MODULE_46</TD><TD>MSigDB lists</TD><TD>MODULE_46</TD><TD>386</TD><TD>5</TD><TD>17275</TD><TD>29</TD>
<TD>IFI27,ISG15,IFI44,OAS1,OASL</TD></TR>
<TR><TD>4.342e-04</TD><TD>-7.74</TD><TD>MODULE_75</TD><TD>MSigDB lists</TD><TD>MODULE_75</TD><TD>390</TD><TD>5</TD><TD>17275</TD><TD>29</TD>
<TD>OAS1,OASL,IFI44,IFI27,ISG15</TD></TR>
<TR><TD>4.420e-04</TD><TD>-7.72</TD><TD>cell surface receptor signaling pathway</TD><TD>biological process</TD><TD>GO:0007166</TD><TD>2250</TD><TD>11</TD><TD>18054</TD><TD>29</TD>
<TD>OASL,LGR4,ISG15,RSAD2,OAS1,IFIT2,OAS2,OAS3,ADGRL1,IFI27,PGF</TD></TR>
<TR><TD>4.831e-04</TD><TD>-7.64</TD><TD>ZHU_CMV_24_HR_UP</TD><TD>MSigDB lists</TD><TD>ZHU_CMV_24_HR_UP</TD><TD>92</TD><TD>3</TD><TD>17275</TD><TD>29</TD>
<TD>OAS1,ISG15,IFI27</TD></TR>
<TR><TD>5.074e-04</TD><TD>-7.59</TD><TD>GO_RESPONSE_TO_INTERFERON_ALPHA</TD><TD>MSigDB lists</TD><TD>GO_RESPONSE_TO_INTERFERON_ALPHA</TD><TD>20</TD><TD>2</TD><TD>17275</TD><TD>29</TD>
<TD>IFIT2,OAS1</TD></TR>
<TR><TD>5.877e-04</TD><TD>-7.44</TD><TD>IRF7_01</TD><TD>MSigDB lists</TD><TD>IRF7_01</TD><TD>233</TD><TD>4</TD><TD>17275</TD><TD>29</TD>
<TD>OASL,HS6ST2,ISG15,IFIT2</TD></TR>
<TR><TD>6.156e-04</TD><TD>-7.39</TD><TD>NEWMAN_ERCC6_TARGETS_UP</TD><TD>MSigDB lists</TD><TD>NEWMAN_ERCC6_TARGETS_UP</TD><TD>22</TD><TD>2</TD><TD>17275</TD><TD>29</TD>
<TD>KIAA1211,IFIT2</TD></TR>
<TR><TD>6.156e-04</TD><TD>-7.39</TD><TD>GO_REGULATION_OF_NUCLEASE_ACTIVITY</TD><TD>MSigDB lists</TD><TD>GO_REGULATION_OF_NUCLEASE_ACTIVITY</TD><TD>22</TD><TD>2</TD><TD>17275</TD><TD>29</TD>
<TD>OAS1,OAS3</TD></TR>
<TR><TD>6.347e-04</TD><TD>-7.36</TD><TD>BROWNE_HCMV_INFECTION_12HR_UP</TD><TD>MSigDB lists</TD><TD>BROWNE_HCMV_INFECTION_12HR_UP</TD><TD>101</TD><TD>3</TD><TD>17275</TD><TD>29</TD>
<TD>IFI44,IFI44L,OAS2</TD></TR>
<TR><TD>6.355e-04</TD><TD>-7.36</TD><TD>cellular response to organic substance</TD><TD>biological process</TD><TD>GO:0071310</TD><TD>2346</TD><TD>11</TD><TD>18054</TD><TD>29</TD>
<TD>ISG15,LGR4,OASL,PGF,IFI27,OAS2,OAS3,RSAD2,IFIT2,OAS1,RYR1</TD></TR>
<TR><TD>7.716e-04</TD><TD>-7.17</TD><TD>GOZGIT_ESR1_TARGETS_DN</TD><TD>MSigDB lists</TD><TD>GOZGIT_ESR1_TARGETS_DN</TD><TD>676</TD><TD>6</TD><TD>17275</TD><TD>29</TD>
<TD>IFI27,IFIT2,IFI44L,HS6ST2,TUBA1A,OAS2</TD></TR>
<TR><TD>7.970e-04</TD><TD>-7.13</TD><TD>CHIANG_LIVER_CANCER_SUBCLASS_INTERFERON_UP</TD><TD>MSigDB lists</TD><TD>CHIANG_LIVER_CANCER_SUBCLASS_INTERFERON_UP</TD><TD>25</TD><TD>2</TD><TD>17275</TD><TD>29</TD>
<TD>ISG15,IFI27</TD></TR>
<TR><TD>8.226e-04</TD><TD>-7.10</TD><TD>GO_REGULATION_OF_MULTI_ORGANISM_PROCESS</TD><TD>MSigDB lists</TD><TD>GO_REGULATION_OF_MULTI_ORGANISM_PROCESS</TD><TD>449</TD><TD>5</TD><TD>17275</TD><TD>29</TD>
<TD>OAS1,OASL,OAS3,RSAD2,ISG15</TD></TR>
<TR><TD>8.379e-04</TD><TD>-7.08</TD><TD>purine ribonucleoside triphosphate binding</TD><TD>molecular function</TD><TD>GO:0035639</TD><TD>1799</TD><TD>9</TD><TD>17306</TD><TD>26</TD>
<TD>OAS3,CAMKK2,OAS2,OAS1,IFI44L,DIRAS1,RYR1,OASL,TUBA1A</TD></TR>
<TR><TD>8.484e-04</TD><TD>-7.07</TD><TD>carbohydrate derivative binding</TD><TD>molecular function</TD><TD>GO:0097367</TD><TD>2207</TD><TD>10</TD><TD>17306</TD><TD>26</TD>
<TD>CAMKK2,OAS3,OAS1,PGF,OAS2,RYR1,DIRAS1,IFI44L,TUBA1A,OASL</TD></TR>
<TR><TD>8.625e-04</TD><TD>-7.06</TD><TD>XU_AKT1_TARGETS_6HR</TD><TD>MSigDB lists</TD><TD>XU_AKT1_TARGETS_6HR</TD><TD>26</TD><TD>2</TD><TD>17275</TD><TD>29</TD>
<TD>ISG15,OAS3</TD></TR>
<TR><TD>9.256e-04</TD><TD>-6.99</TD><TD>GSE25677_MPL_VS_MPL_AND_R848_STIM_BCELL_DN</TD><TD>MSigDB lists</TD><TD>GSE25677_MPL_VS_MPL_AND_R848_STIM_BCELL_DN</TD><TD>115</TD><TD>3</TD><TD>17275</TD><TD>29</TD>
<TD>OAS2,OAS3,HS6ST2</TD></TR>
<TR><TD>9.256e-04</TD><TD>-6.99</TD><TD>AZARE_NEOPLASTIC_TRANSFORMATION_BY_STAT3_UP</TD><TD>MSigDB lists</TD><TD>AZARE_NEOPLASTIC_TRANSFORMATION_BY_STAT3_UP</TD><TD>115</TD><TD>3</TD><TD>17275</TD><TD>29</TD>
<TD>IFI27,OAS2,OAS1</TD></TR>
<TR><TD>9.886e-04</TD><TD>-6.92</TD><TD>C2-set_2</TD><TD>pfam domains</TD><TD>PF08205</TD><TD>29</TD><TD>2</TD><TD>17385</TD><TD>28</TD>
<TD>CADM4,MCAM</TD></TR>
<TR><TD>9.921e-04</TD><TD>-6.92</TD><TD>CD80_C2-set</TD><TD>interpro domains</TD><TD>IPR013162</TD><TD>29</TD><TD>2</TD><TD>18616</TD><TD>30</TD>
<TD>CADM4,MCAM</TD></TR>
<TR><TD>1.071e-03</TD><TD>-6.84</TD><TD>Immune System</TD><TD>REACTOME pathways</TD><TD>R-HSA-168256</TD><TD>2101</TD><TD>10</TD><TD>10287</TD><TD>18</TD>
<TD>OAS1,ISG15,IFIT2,OAS2,OAS3,OASL,IFI27,CTSV,KIFAP3,RSAD2</TD></TR>
<TR><TD>1.072e-03</TD><TD>-6.84</TD><TD>YAGI_AML_WITH_T_9_11_TRANSLOCATION</TD><TD>MSigDB lists</TD><TD>YAGI_AML_WITH_T_9_11_TRANSLOCATION</TD><TD>121</TD><TD>3</TD><TD>17275</TD><TD>29</TD>
<TD>RYR1,IFI44L,OAS1</TD></TR>
<TR><TD>1.084e-03</TD><TD>-6.83</TD><TD>purine ribonucleotide binding</TD><TD>molecular function</TD><TD>GO:0032555</TD><TD>1864</TD><TD>9</TD><TD>17306</TD><TD>26</TD>
<TD>OAS3,CAMKK2,OAS2,OAS1,IFI44L,DIRAS1,RYR1,OASL,TUBA1A</TD></TR>
<TR><TD>1.140e-03</TD><TD>-6.78</TD><TD>purine nucleotide binding</TD><TD>molecular function</TD><TD>GO:0017076</TD><TD>1877</TD><TD>9</TD><TD>17306</TD><TD>26</TD>
<TD>CAMKK2,OAS3,OAS1,OAS2,DIRAS1,RYR1,IFI44L,TUBA1A,OASL</TD></TR>
<TR><TD>1.154e-03</TD><TD>-6.76</TD><TD>ribonucleotide binding</TD><TD>molecular function</TD><TD>GO:0032553</TD><TD>1880</TD><TD>9</TD><TD>17306</TD><TD>26</TD>
<TD>RYR1,DIRAS1,IFI44L,TUBA1A,OASL,CAMKK2,OAS3,OAS1,OAS2</TD></TR>
<TR><TD>1.166e-03</TD><TD>-6.75</TD><TD>HORIUCHI_WTAP_TARGETS_UP</TD><TD>MSigDB lists</TD><TD>HORIUCHI_WTAP_TARGETS_UP</TD><TD>280</TD><TD>4</TD><TD>17275</TD><TD>29</TD>
<TD>IFIT2,RSAD2,IFI44,KIAA1211</TD></TR>
<TR><TD>1.166e-03</TD><TD>-6.75</TD><TD>Hepatitis C</TD><TD>KEGG pathways</TD><TD>ko05160</TD><TD>131</TD><TD>3</TD><TD>7161</TD><TD>12</TD>
<TD>OAS3,OAS2,OAS1</TD></TR>
<TR><TD>1.166e-03</TD><TD>-6.75</TD><TD>Hepatitis C</TD><TD>KEGG pathways</TD><TD>hsa05160</TD><TD>131</TD><TD>3</TD><TD>7161</TD><TD>12</TD>
<TD>OAS2,OAS1,OAS3</TD></TR>
<TR><TD>1.189e-03</TD><TD>-6.73</TD><TD>adrenal_gland-adrenal_gland-adrenal_cortical_carcinoma-cortisol_and_virilizing_syndrome-producing</TD><TD>COSMIC cancer mutations</TD><TD>adrenal_gland-adrenal_gland-adrenal_cortical_carcinoma-cortisol_and_virilizing_syndrome-producing</TD><TD>34</TD><TD>2</TD><TD>17255</TD><TD>26</TD>
<TD>KIAA1211,CAMKK2</TD></TR>
<TR><TD>1.205e-03</TD><TD>-6.72</TD><TD>INSYN2A (inhibitory synaptic factor 2A)</TD><TD>protein interactions</TD><TD>642938</TD><TD>30</TD><TD>2</TD><TD>17456</TD><TD>30</TD>
<TD>TUBA1A,CAMKK2</TD></TR>
<TR><TD>1.211e-03</TD><TD>-6.72</TD><TD>response to organic substance</TD><TD>biological process</TD><TD>GO:0010033</TD><TD>2956</TD><TD>12</TD><TD>18054</TD><TD>29</TD>
<TD>ISG15,LGR4,OASL,IFI27,PGF,CTSV,OAS2,OAS3,RSAD2,IFIT2,OAS1,RYR1</TD></TR>
<TR><TD>1.219e-03</TD><TD>-6.71</TD><TD>Measles</TD><TD>KEGG pathways</TD><TD>ko05162</TD><TD>133</TD><TD>3</TD><TD>7161</TD><TD>12</TD>
<TD>OAS1,OAS2,OAS3</TD></TR>
<TR><TD>1.219e-03</TD><TD>-6.71</TD><TD>Measles</TD><TD>KEGG pathways</TD><TD>hsa05162</TD><TD>133</TD><TD>3</TD><TD>7161</TD><TD>12</TD>
<TD>OAS3,OAS2,OAS1</TD></TR>
<TR><TD>1.290e-03</TD><TD>-6.65</TD><TD>ALK_DN.V1_DN</TD><TD>MSigDB lists</TD><TD>ALK_DN.V1_DN</TD><TD>129</TD><TD>3</TD><TD>17275</TD><TD>29</TD>
<TD>OAS1,IFI27,IFI44L</TD></TR>
<TR><TD>1.319e-03</TD><TD>-6.63</TD><TD>KRAS.KIDNEY_UP.V1_DN</TD><TD>MSigDB lists</TD><TD>KRAS.KIDNEY_UP.V1_DN</TD><TD>130</TD><TD>3</TD><TD>17275</TD><TD>29</TD>
<TD>OAS1,IFI44L,RSAD2</TD></TR>
<TR><TD>1.502e-03</TD><TD>-6.50</TD><TD>beta-1,4-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity</TD><TD>molecular function</TD><TD>GO:0003830</TD><TD>1</TD><TD>1</TD><TD>17306</TD><TD>26</TD>
<TD>MGAT3</TD></TR>
<TR><TD>1.528e-03</TD><TD>-6.48</TD><TD>cellularization cleavage furrow</TD><TD>cellular component</TD><TD>GO:0110070</TD><TD>1</TD><TD>1</TD><TD>18985</TD><TD>29</TD>
<TD>KLHDC8B</TD></TR>
<TR><TD>1.531e-03</TD><TD>-6.48</TD><TD>GO_RESPONSE_TO_EXTERNAL_STIMULUS</TD><TD>MSigDB lists</TD><TD>GO_RESPONSE_TO_EXTERNAL_STIMULUS</TD><TD>1727</TD><TD>9</TD><TD>17275</TD><TD>29</TD>
<TD>IFI44L,IFI44,RSAD2,IFIT2,ISG15,OASL,OAS1,OAS2,OAS3</TD></TR>
<TR><TD>1.533e-03</TD><TD>-6.48</TD><TD>MEL18_DN.V1_DN</TD><TD>MSigDB lists</TD><TD>MEL18_DN.V1_DN</TD><TD>137</TD><TD>3</TD><TD>17275</TD><TD>29</TD>
<TD>OAS1,IFI27,IFIT2</TD></TR>
<TR><TD>1.548e-03</TD><TD>-6.47</TD><TD>IQGAP3 (IQ motif containing GTPase activating protein 3)</TD><TD>protein interactions</TD><TD>128239</TD><TD>34</TD><TD>2</TD><TD>17456</TD><TD>30</TD>
<TD>KIFAP3,LGR4</TD></TR>
<TR><TD>1.606e-03</TD><TD>-6.43</TD><TD>positive regulation of calcium-dependent cell-cell adhesion</TD><TD>biological process</TD><TD>GO:0046587</TD><TD>1</TD><TD>1</TD><TD>18054</TD><TD>29</TD>
<TD>KIFAP3</TD></TR>
<TR><TD>1.606e-03</TD><TD>-6.43</TD><TD>intestinal stem cell homeostasis</TD><TD>biological process</TD><TD>GO:0036335</TD><TD>1</TD><TD>1</TD><TD>18054</TD><TD>29</TD>
<TD>LGR4</TD></TR>
<TR><TD>1.611e-03</TD><TD>-6.43</TD><TD>Glyco_transf_17</TD><TD>pfam domains</TD><TD>PF04724</TD><TD>1</TD><TD>1</TD><TD>17385</TD><TD>28</TD>
<TD>MGAT3</TD></TR>
<TR><TD>1.612e-03</TD><TD>-6.43</TD><TD>Interferon-induced_IFIT2</TD><TD>interpro domains</TD><TD>IPR024124</TD><TD>1</TD><TD>1</TD><TD>18616</TD><TD>30</TD>
<TD>IFIT2</TD></TR>
<TR><TD>1.612e-03</TD><TD>-6.43</TD><TD>RyR1</TD><TD>interpro domains</TD><TD>IPR033215</TD><TD>1</TD><TD>1</TD><TD>18616</TD><TD>30</TD>
<TD>RYR1</TD></TR>
<TR><TD>1.612e-03</TD><TD>-6.43</TD><TD>Cadm4</TD><TD>interpro domains</TD><TD>IPR028807</TD><TD>1</TD><TD>1</TD><TD>18616</TD><TD>30</TD>
<TD>CADM4</TD></TR>
<TR><TD>1.612e-03</TD><TD>-6.43</TD><TD>Glyco_trans_17</TD><TD>interpro domains</TD><TD>IPR006813</TD><TD>1</TD><TD>1</TD><TD>18616</TD><TD>30</TD>
<TD>MGAT3</TD></TR>
<TR><TD>1.612e-03</TD><TD>-6.43</TD><TD>Latrophilin-1</TD><TD>interpro domains</TD><TD>IPR031234</TD><TD>1</TD><TD>1</TD><TD>18616</TD><TD>30</TD>
<TD>ADGRL1</TD></TR>
<TR><TD>1.612e-03</TD><TD>-6.43</TD><TD>KAP3</TD><TD>interpro domains</TD><TD>IPR008658</TD><TD>1</TD><TD>1</TD><TD>18616</TD><TD>30</TD>
<TD>KIFAP3</TD></TR>
<TR><TD>1.612e-03</TD><TD>-6.43</TD><TD>SBSPON</TD><TD>interpro domains</TD><TD>IPR039942</TD><TD>1</TD><TD>1</TD><TD>18616</TD><TD>30</TD>
<TD>SBSPON</TD></TR>
<TR><TD>1.622e-03</TD><TD>-6.42</TD><TD>GRAESSMANN_APOPTOSIS_BY_DOXORUBICIN_UP</TD><TD>MSigDB lists</TD><TD>GRAESSMANN_APOPTOSIS_BY_DOXORUBICIN_UP</TD><TD>1072</TD><TD>7</TD><TD>17275</TD><TD>29</TD>
<TD>IFI44,RSAD2,ISG15,PGF,OASL,OAS2,OAS3</TD></TR>
<TR><TD>1.695e-03</TD><TD>-6.38</TD><TD>MODULE_44</TD><TD>MSigDB lists</TD><TD>MODULE_44</TD><TD>310</TD><TD>4</TD><TD>17275</TD><TD>29</TD>
<TD>IFI27,ISG15,IFI44L,IFI44</TD></TR>
<TR><TD>1.719e-03</TD><TD>-6.37</TD><TD>alp14 (microtubule polymerase alp14)</TD><TD>protein interactions</TD><TD>2539497</TD><TD>1</TD><TD>1</TD><TD>17456</TD><TD>30</TD>
<TD>TUBA1A</TD></TR>
<TR><TD>1.719e-03</TD><TD>-6.37</TD><TD>NPC1L1 (NPC1 like intracellular cholesterol transporter 1)</TD><TD>protein interactions</TD><TD>29881</TD><TD>1</TD><TD>1</TD><TD>17456</TD><TD>30</TD>
<TD>LGR4</TD></TR>
<TR><TD>1.719e-03</TD><TD>-6.37</TD><TD>RSPO4 (R-spondin 4)</TD><TD>protein interactions</TD><TD>343637</TD><TD>1</TD><TD>1</TD><TD>17456</TD><TD>30</TD>
<TD>LGR4</TD></TR>
<TR><TD>1.719e-03</TD><TD>-6.37</TD><TD>CCDC157 (coiled-coil domain containing 157)</TD><TD>protein interactions</TD><TD>550631</TD><TD>1</TD><TD>1</TD><TD>17456</TD><TD>30</TD>
<TD>LGR4</TD></TR>
<TR><TD>1.727e-03</TD><TD>-6.36</TD><TD>cortisol_and_virilizing_syndrome-producing</TD><TD>COSMIC cancer mutations</TD><TD>cortisol_and_virilizing_syndrome-producing</TD><TD>41</TD><TD>2</TD><TD>17255</TD><TD>26</TD>
<TD>CAMKK2,KIAA1211</TD></TR>
<TR><TD>1.747e-03</TD><TD>-6.35</TD><TD>ZHAN_MULTIPLE_MYELOMA_LB_DN</TD><TD>MSigDB lists</TD><TD>ZHAN_MULTIPLE_MYELOMA_LB_DN</TD><TD>37</TD><TD>2</TD><TD>17275</TD><TD>29</TD>
<TD>IFI27,RSAD2</TD></TR>
<TR><TD>1.750e-03</TD><TD>-6.35</TD><TD>Reactions specific to the hybrid N-glycan synthesis pathway</TD><TD>REACTOME pathways</TD><TD>R-HSA-975574</TD><TD>1</TD><TD>1</TD><TD>10287</TD><TD>18</TD>
<TD>MGAT3</TD></TR>
<TR><TD>1.804e-03</TD><TD>-6.32</TD><TD>GSE5589_WT_VS_IL10_KO_LPS_AND_IL10_STIM_MACROPHAGE_180MIN_UP</TD><TD>MSigDB lists</TD><TD>GSE5589_WT_VS_IL10_KO_LPS_AND_IL10_STIM_MACROPHAGE_180MIN_UP</TD><TD>145</TD><TD>3</TD><TD>17275</TD><TD>29</TD>
<TD>RSAD2,IFIT2,OAS3</TD></TR>
<TR><TD>1.832e-03</TD><TD>-6.30</TD><TD>HEPACAM2 (HEPACAM family member 2)</TD><TD>protein interactions</TD><TD>253012</TD><TD>37</TD><TD>2</TD><TD>17456</TD><TD>30</TD>
<TD>LGR4,CADM4</TD></TR>
<TR><TD>1.832e-03</TD><TD>-6.30</TD><TD>HLA-DPB1 (major histocompatibility complex, class II, DP beta 1)</TD><TD>protein interactions</TD><TD>3115</TD><TD>37</TD><TD>2</TD><TD>17456</TD><TD>30</TD>
<TD>CTSV,LGR4</TD></TR>
<TR><TD>1.843e-03</TD><TD>-6.30</TD><TD>ZHAN_MULTIPLE_MYELOMA_HP_UP</TD><TD>MSigDB lists</TD><TD>ZHAN_MULTIPLE_MYELOMA_HP_UP</TD><TD>38</TD><TD>2</TD><TD>17275</TD><TD>29</TD>
<TD>RSAD2,OAS2</TD></TR>
<TR><TD>1.876e-03</TD><TD>-6.28</TD><TD>GSE21063_CTRL_VS_ANTI_IGM_STIM_BCELL_8H_UP</TD><TD>MSigDB lists</TD><TD>GSE21063_CTRL_VS_ANTI_IGM_STIM_BCELL_8H_UP</TD><TD>147</TD><TD>3</TD><TD>17275</TD><TD>29</TD>
<TD>FAM102B,ISG15,MGAT3</TD></TR>
<TR><TD>1.949e-03</TD><TD>-6.24</TD><TD>GSE9960_HEALTHY_VS_SEPSIS_PBMC_DN</TD><TD>MSigDB lists</TD><TD>GSE9960_HEALTHY_VS_SEPSIS_PBMC_DN</TD><TD>149</TD><TD>3</TD><TD>17275</TD><TD>29</TD>
<TD>IFI27,PGF,RSAD2</TD></TR>
<TR><TD>2.034e-03</TD><TD>-6.20</TD><TD>VNN2 (vanin 2)</TD><TD>protein interactions</TD><TD>8875</TD><TD>39</TD><TD>2</TD><TD>17456</TD><TD>30</TD>
<TD>ADGRL1,CTSV</TD></TR>
<TR><TD>2.070e-03</TD><TD>-6.18</TD><TD>ubiquitin</TD><TD>pfam domains</TD><TD>PF00240</TD><TD>42</TD><TD>2</TD><TD>17385</TD><TD>28</TD>
<TD>ISG15,OASL</TD></TR>
<TR><TD>2.102e-03</TD><TD>-6.16</TD><TD>GSE35825_IFNA_VS_IFNG_STIM_MACROPHAGE_UP</TD><TD>MSigDB lists</TD><TD>GSE35825_IFNA_VS_IFNG_STIM_MACROPHAGE_UP</TD><TD>153</TD><TD>3</TD><TD>17275</TD><TD>29</TD>
<TD>RSAD2,IFIT2,OAS2</TD></TR>
<TR><TD>2.181e-03</TD><TD>-6.13</TD><TD>PETROVA_ENDOTHELIUM_LYMPHATIC_VS_BLOOD_DN</TD><TD>MSigDB lists</TD><TD>PETROVA_ENDOTHELIUM_LYMPHATIC_VS_BLOOD_DN</TD><TD>155</TD><TD>3</TD><TD>17275</TD><TD>29</TD>
<TD>IFI27,PGF,ISG15</TD></TR>
<TR><TD>2.222e-03</TD><TD>-6.11</TD><TD>GSE21360_NAIVE_VS_SECONDARY_MEMORY_CD8_TCELL_DN</TD><TD>MSigDB lists</TD><TD>GSE21360_NAIVE_VS_SECONDARY_MEMORY_CD8_TCELL_DN</TD><TD>156</TD><TD>3</TD><TD>17275</TD><TD>29</TD>
<TD>IFIT2,IFI44,OAS3</TD></TR>
<TR><TD>2.222e-03</TD><TD>-6.11</TD><TD>GSE6566_STRONG_VS_WEAK_DC_STIMULATED_CD4_TCELL_UP</TD><TD>MSigDB lists</TD><TD>GSE6566_STRONG_VS_WEAK_DC_STIMULATED_CD4_TCELL_UP</TD><TD>156</TD><TD>3</TD><TD>17275</TD><TD>29</TD>
<TD>FAM102B,OAS2,OAS3</TD></TR>
<TR><TD>2.225e-03</TD><TD>-6.11</TD><TD>response to stimulus</TD><TD>biological process</TD><TD>GO:0050896</TD><TD>8044</TD><TD>21</TD><TD>18054</TD><TD>29</TD>
<TD>IFI44,KIFAP3,ISG15,IFI44L,MGAT3,IFI27,PGF,CTSV,MCAM,ADGRL1,OAS2,LGR4,OASL,RSAD2,CAMKK2,IFIT2,RYR1,OAS1,DIRAS1,SBSPON,OAS3</TD></TR>
<TR><TD>2.230e-03</TD><TD>-6.11</TD><TD>FLNA (filamin A)</TD><TD>protein interactions</TD><TD>2316</TD><TD>326</TD><TD>4</TD><TD>17456</TD><TD>30</TD>
<TD>KIAA1211,CAPN6,CAMKK2,ISG15</TD></TR>
<TR><TD>2.246e-03</TD><TD>-6.10</TD><TD>PRKG1 (protein kinase cGMP-dependent 1)</TD><TD>protein interactions</TD><TD>5592</TD><TD>41</TD><TD>2</TD><TD>17456</TD><TD>30</TD>
<TD>RYR1,OAS2</TD></TR>
<TR><TD>2.262e-03</TD><TD>-6.09</TD><TD>MTOR_UP.V1_UP</TD><TD>MSigDB lists</TD><TD>MTOR_UP.V1_UP</TD><TD>157</TD><TD>3</TD><TD>17275</TD><TD>29</TD>
<TD>IFIT2,ZNF518B,OAS2</TD></TR>
<TR><TD>2.345e-03</TD><TD>-6.06</TD><TD>SNF5_DN.V1_UP</TD><TD>MSigDB lists</TD><TD>SNF5_DN.V1_UP</TD><TD>159</TD><TD>3</TD><TD>17275</TD><TD>29</TD>
<TD>OASL,IFI44L,IFIT2</TD></TR>
<TR><TD>2.376e-03</TD><TD>-6.04</TD><TD>human chr1p31.1</TD><TD>chromosome location</TD><TD>human chr1p31.1</TD><TD>63</TD><TD>2</TD><TD>26169</TD><TD>30</TD>
<TD>IFI44,IFI44L</TD></TR>
<TR><TD>2.424e-03</TD><TD>-6.02</TD><TD>YANG_BCL3_TARGETS_UP</TD><TD>MSigDB lists</TD><TD>YANG_BCL3_TARGETS_UP</TD><TD>342</TD><TD>4</TD><TD>17275</TD><TD>29</TD>
<TD>IFI44L,IFIT2,RSAD2,OASL</TD></TR>
<TR><TD>2.428e-03</TD><TD>-6.02</TD><TD>NOD-like receptor signaling pathway</TD><TD>KEGG pathways</TD><TD>hsa04621</TD><TD>169</TD><TD>3</TD><TD>7161</TD><TD>12</TD>
<TD>OAS1,OAS2,OAS3</TD></TR>
<TR><TD>2.428e-03</TD><TD>-6.02</TD><TD>NOD-like receptor signaling pathway</TD><TD>KEGG pathways</TD><TD>ko04621</TD><TD>169</TD><TD>3</TD><TD>7161</TD><TD>12</TD>
<TD>OAS1,OAS2,OAS3</TD></TR>
<TR><TD>2.464e-03</TD><TD>-6.01</TD><TD>SAGIV_CD24_TARGETS_DN</TD><TD>MSigDB lists</TD><TD>SAGIV_CD24_TARGETS_DN</TD><TD>44</TD><TD>2</TD><TD>17275</TD><TD>29</TD>
<TD>MCAM,OASL</TD></TR>
<TR><TD>2.517e-03</TD><TD>-5.98</TD><TD>GSE7218_IGM_VS_IGG_SIGNAL_THGOUGH_ANTIGEN_BCELL_DN</TD><TD>MSigDB lists</TD><TD>GSE7218_IGM_VS_IGG_SIGNAL_THGOUGH_ANTIGEN_BCELL_DN</TD><TD>163</TD><TD>3</TD><TD>17275</TD><TD>29</TD>
<TD>IFI44,IFIT2,RSAD2</TD></TR>
<TR><TD>2.561e-03</TD><TD>-5.97</TD><TD>GSE2770_UNTREATED_VS_ACT_CD4_TCELL_48H_DN</TD><TD>MSigDB lists</TD><TD>GSE2770_UNTREATED_VS_ACT_CD4_TCELL_48H_DN</TD><TD>164</TD><TD>3</TD><TD>17275</TD><TD>29</TD>
<TD>IFIT2,ISG15,RSAD2</TD></TR>
<TR><TD>2.576e-03</TD><TD>-5.96</TD><TD>GO_REGULATION_OF_TOLL_LIKE_RECEPTOR_SIGNALING_PATHWAY</TD><TD>MSigDB lists</TD><TD>GO_REGULATION_OF_TOLL_LIKE_RECEPTOR_SIGNALING_PATHWAY</TD><TD>45</TD><TD>2</TD><TD>17275</TD><TD>29</TD>
<TD>LGR4,RSAD2</TD></TR>
<TR><TD>2.643e-03</TD><TD>-5.94</TD><TD>nucleotide binding</TD><TD>molecular function</TD><TD>GO:0000166</TD><TD>2113</TD><TD>9</TD><TD>17306</TD><TD>26</TD>
<TD>IFI44L,DIRAS1,RYR1,OASL,TUBA1A,OAS3,CAMKK2,OAS2,OAS1</TD></TR>
<TR><TD>2.650e-03</TD><TD>-5.93</TD><TD>GSE7509_UNSTIM_VS_FCGRIIB_STIM_DC_DN</TD><TD>MSigDB lists</TD><TD>GSE7509_UNSTIM_VS_FCGRIIB_STIM_DC_DN</TD><TD>166</TD><TD>3</TD><TD>17275</TD><TD>29</TD>
<TD>IFIT2,ISG15,OAS3</TD></TR>
<TR><TD>2.652e-03</TD><TD>-5.93</TD><TD>nucleoside phosphate binding</TD><TD>molecular function</TD><TD>GO:1901265</TD><TD>2114</TD><TD>9</TD><TD>17306</TD><TD>26</TD>
<TD>IFI44L,DIRAS1,RYR1,OASL,TUBA1A,OAS3,CAMKK2,OAS2,OAS1</TD></TR>
<TR><TD>2.744e-03</TD><TD>-5.90</TD><TD>ACTN1 (actinin alpha 1)</TD><TD>protein interactions</TD><TD>87</TD><TD>164</TD><TD>3</TD><TD>17456</TD><TD>30</TD>
<TD>OAS1,TUBA1A,ISG15</TD></TR>
<TR><TD>2.882e-03</TD><TD>-5.85</TD><TD>GSE2706_UNSTIM_VS_2H_LPS_DC_DN</TD><TD>MSigDB lists</TD><TD>GSE2706_UNSTIM_VS_2H_LPS_DC_DN</TD><TD>171</TD><TD>3</TD><TD>17275</TD><TD>29</TD>
<TD>IFI44,ISG15,OASL</TD></TR>
<TR><TD>2.882e-03</TD><TD>-5.85</TD><TD>GSE25123_WT_VS_PPARG_KO_MACROPHAGE_UP</TD><TD>MSigDB lists</TD><TD>GSE25123_WT_VS_PPARG_KO_MACROPHAGE_UP</TD><TD>171</TD><TD>3</TD><TD>17275</TD><TD>29</TD>
<TD>OASL,RSAD2,IFI44</TD></TR>
<TR><TD>2.930e-03</TD><TD>-5.83</TD><TD>GSE41867_NAIVE_VS_DAY30_LCMV_CLONE13_EXHAUSTED_CD8_TCELL_UP</TD><TD>MSigDB lists</TD><TD>GSE41867_NAIVE_VS_DAY30_LCMV_CLONE13_EXHAUSTED_CD8_TCELL_UP</TD><TD>172</TD><TD>3</TD><TD>17275</TD><TD>29</TD>
<TD>OAS1,OASL,OAS3</TD></TR>
<TR><TD>2.930e-03</TD><TD>-5.83</TD><TD>GSE46242_CTRL_VS_EGR2_DELETED_TH1_CD4_TCELL_DN</TD><TD>MSigDB lists</TD><TD>GSE46242_CTRL_VS_EGR2_DELETED_TH1_CD4_TCELL_DN</TD><TD>172</TD><TD>3</TD><TD>17275</TD><TD>29</TD>
<TD>IFIT2,CAPN6,OAS1</TD></TR>
<TR><TD>2.942e-03</TD><TD>-5.83</TD><TD>MX1 (MX dynamin like GTPase 1)</TD><TD>protein interactions</TD><TD>4599</TD><TD>47</TD><TD>2</TD><TD>17456</TD><TD>30</TD>
<TD>ISG15,TUBA1A</TD></TR>
<TR><TD>2.978e-03</TD><TD>-5.82</TD><TD>GAUSSMANN_MLL_AF4_FUSION_TARGETS_F_UP</TD><TD>MSigDB lists</TD><TD>GAUSSMANN_MLL_AF4_FUSION_TARGETS_F_UP</TD><TD>173</TD><TD>3</TD><TD>17275</TD><TD>29</TD>
<TD>ISG15,IFI44,HS6ST2</TD></TR>
<TR><TD>2.981e-03</TD><TD>-5.82</TD><TD>UBQ</TD><TD>smart domains</TD><TD>SM00213</TD><TD>41</TD><TD>2</TD><TD>9476</TD><TD>19</TD>
<TD>ISG15,OASL</TD></TR>
<TR><TD>3.003e-03</TD><TD>-5.81</TD><TD>latrotoxin receptor activity</TD><TD>molecular function</TD><TD>GO:0016524</TD><TD>2</TD><TD>1</TD><TD>17306</TD><TD>26</TD>
<TD>ADGRL1</TD></TR>
<TR><TD>3.003e-03</TD><TD>-5.81</TD><TD>kininogen binding</TD><TD>molecular function</TD><TD>GO:0030984</TD><TD>2</TD><TD>1</TD><TD>17306</TD><TD>26</TD>
<TD>CTSV</TD></TR>
<TR><TD>3.027e-03</TD><TD>-5.80</TD><TD>GSE37416_CTRL_VS_24H_F_TULARENSIS_LVS_NEUTROPHIL_UP</TD><TD>MSigDB lists</TD><TD>GSE37416_CTRL_VS_24H_F_TULARENSIS_LVS_NEUTROPHIL_UP</TD><TD>174</TD><TD>3</TD><TD>17275</TD><TD>29</TD>
<TD>IFIT2,PGF,TUBA1A</TD></TR>
<TR><TD>3.126e-03</TD><TD>-5.77</TD><TD>GSE2706_2H_VS_8H_R848_AND_LPS_STIM_DC_DN</TD><TD>MSigDB lists</TD><TD>GSE2706_2H_VS_8H_R848_AND_LPS_STIM_DC_DN</TD><TD>176</TD><TD>3</TD><TD>17275</TD><TD>29</TD>
<TD>ISG15,IFI27,KIAA1211</TD></TR>
<TR><TD>3.126e-03</TD><TD>-5.77</TD><TD>GSE2706_UNSTIM_VS_2H_R848_DC_DN</TD><TD>MSigDB lists</TD><TD>GSE2706_UNSTIM_VS_2H_R848_DC_DN</TD><TD>176</TD><TD>3</TD><TD>17275</TD><TD>29</TD>
<TD>RSAD2,ISG15,IFIT2</TD></TR>
<TR><TD>3.142e-03</TD><TD>-5.76</TD><TD>Herpes simplex infection</TD><TD>KEGG pathways</TD><TD>hsa05168</TD><TD>185</TD><TD>3</TD><TD>7161</TD><TD>12</TD>
<TD>OAS3,OAS1,OAS2</TD></TR>
<TR><TD>3.142e-03</TD><TD>-5.76</TD><TD>Herpes simplex infection</TD><TD>KEGG pathways</TD><TD>ko05168</TD><TD>185</TD><TD>3</TD><TD>7161</TD><TD>12</TD>
<TD>OAS2,OAS1,OAS3</TD></TR>
<TR><TD>3.177e-03</TD><TD>-5.75</TD><TD>GSE16755_CTRL_VS_IFNA_TREATED_MAC_DN</TD><TD>MSigDB lists</TD><TD>GSE16755_CTRL_VS_IFNA_TREATED_MAC_DN</TD><TD>177</TD><TD>3</TD><TD>17275</TD><TD>29</TD>
<TD>OAS3,ISG15,IFI44</TD></TR>
<TR><TD>3.177e-03</TD><TD>-5.75</TD><TD>GSE24210_TCONV_VS_TREG_DN</TD><TD>MSigDB lists</TD><TD>GSE24210_TCONV_VS_TREG_DN</TD><TD>177</TD><TD>3</TD><TD>17275</TD><TD>29</TD>
<TD>IFI44L,IFI44,MCAM</TD></TR>
<TR><TD>3.177e-03</TD><TD>-5.75</TD><TD>GSE7219_WT_VS_NIK_NFKB2_KO_DC_UP</TD><TD>MSigDB lists</TD><TD>GSE7219_WT_VS_NIK_NFKB2_KO_DC_UP</TD><TD>177</TD><TD>3</TD><TD>17275</TD><TD>29</TD>
<TD>RSAD2,IFI44,OAS3</TD></TR>
<TR><TD>3.193e-03</TD><TD>-5.75</TD><TD>RPGR (retinitis pigmentosa GTPase regulator)</TD><TD>protein interactions</TD><TD>6103</TD><TD>49</TD><TD>2</TD><TD>17456</TD><TD>30</TD>
<TD>KIFAP3,TUBA1A</TD></TR>
<TR><TD>3.193e-03</TD><TD>-5.75</TD><TD>IFIT1 (interferon induced protein with tetratricopeptide repeats 1)</TD><TD>protein interactions</TD><TD>3434</TD><TD>49</TD><TD>2</TD><TD>17456</TD><TD>30</TD>
<TD>IFIT2,ISG15</TD></TR>
<TR><TD>3.210e-03</TD><TD>-5.74</TD><TD>interleukin-10 secretion</TD><TD>biological process</TD><TD>GO:0072608</TD><TD>2</TD><TD>1</TD><TD>18054</TD><TD>29</TD>
<TD>ISG15</TD></TR>
<TR><TD>3.210e-03</TD><TD>-5.74</TD><TD>canonical Wnt signaling pathway involved in metanephric kidney development</TD><TD>biological process</TD><TD>GO:0061290</TD><TD>2</TD><TD>1</TD><TD>18054</TD><TD>29</TD>
<TD>LGR4</TD></TR>
<TR><TD>3.210e-03</TD><TD>-5.74</TD><TD>cell-cell signaling involved in metanephros development</TD><TD>biological process</TD><TD>GO:0072204</TD><TD>2</TD><TD>1</TD><TD>18054</TD><TD>29</TD>
<TD>LGR4</TD></TR>
<TR><TD>3.210e-03</TD><TD>-5.74</TD><TD>regulation of calcium-dependent cell-cell adhesion</TD><TD>biological process</TD><TD>GO:0046586</TD><TD>2</TD><TD>1</TD><TD>18054</TD><TD>29</TD>
<TD>KIFAP3</TD></TR>
<TR><TD>3.210e-03</TD><TD>-5.74</TD><TD>cell-cell signaling involved in kidney development</TD><TD>biological process</TD><TD>GO:0060995</TD><TD>2</TD><TD>1</TD><TD>18054</TD><TD>29</TD>
<TD>LGR4</TD></TR>
<TR><TD>3.210e-03</TD><TD>-5.74</TD><TD>positive regulation of toll-like receptor 7 signaling pathway</TD><TD>biological process</TD><TD>GO:0034157</TD><TD>2</TD><TD>1</TD><TD>18054</TD><TD>29</TD>
<TD>RSAD2</TD></TR>
<TR><TD>3.210e-03</TD><TD>-5.74</TD><TD>Wnt signaling pathway involved in kidney development</TD><TD>biological process</TD><TD>GO:0061289</TD><TD>2</TD><TD>1</TD><TD>18054</TD><TD>29</TD>
<TD>LGR4</TD></TR>
<TR><TD>3.221e-03</TD><TD>-5.74</TD><TD>C2_Calpain</TD><TD>interpro domains</TD><TD>IPR033884</TD><TD>2</TD><TD>1</TD><TD>18616</TD><TD>30</TD>
<TD>CAPN6</TD></TR>
<TR><TD>3.221e-03</TD><TD>-5.74</TD><TD>FAM102-like</TD><TD>interpro domains</TD><TD>IPR039931</TD><TD>2</TD><TD>1</TD><TD>18616</TD><TD>30</TD>
<TD>FAM102B</TD></TR>
<TR><TD>3.228e-03</TD><TD>-5.74</TD><TD>GSE2770_TGFB_AND_IL4_VS_IL12_TREATED_ACT_CD4_TCELL_2H_DN</TD><TD>MSigDB lists</TD><TD>GSE2770_TGFB_AND_IL4_VS_IL12_TREATED_ACT_CD4_TCELL_2H_DN</TD><TD>178</TD><TD>3</TD><TD>17275</TD><TD>29</TD>
<TD>IFIT2,RSAD2,OASL</TD></TR>
<TR><TD>3.228e-03</TD><TD>-5.74</TD><TD>GSE26669_CD4_VS_CD8_TCELL_IN_MLR_COSTIM_BLOCK_UP</TD><TD>MSigDB lists</TD><TD>GSE26669_CD4_VS_CD8_TCELL_IN_MLR_COSTIM_BLOCK_UP</TD><TD>178</TD><TD>3</TD><TD>17275</TD><TD>29</TD>
<TD>IFI44L,IFIT2,CAMKK2</TD></TR>
<TR><TD>3.228e-03</TD><TD>-5.74</TD><TD>STTTCRNTTT_IRF_Q6</TD><TD>MSigDB lists</TD><TD>STTTCRNTTT_IRF_Q6</TD><TD>178</TD><TD>3</TD><TD>17275</TD><TD>29</TD>
<TD>IFIT2,ISG15,IFI44</TD></TR>
<TR><TD>3.228e-03</TD><TD>-5.74</TD><TD>GSE13485_DAY3_VS_DAY21_YF17D_VACCINE_PBMC_UP</TD><TD>MSigDB lists</TD><TD>GSE13485_DAY3_VS_DAY21_YF17D_VACCINE_PBMC_UP</TD><TD>178</TD><TD>3</TD><TD>17275</TD><TD>29</TD>
<TD>OAS3,OAS2,IFI44</TD></TR>
<TR><TD>3.228e-03</TD><TD>-5.74</TD><TD>GSE1460_INTRATHYMIC_T_PROGENITOR_VS_DP_THYMOCYTE_UP</TD><TD>MSigDB lists</TD><TD>GSE1460_INTRATHYMIC_T_PROGENITOR_VS_DP_THYMOCYTE_UP</TD><TD>178</TD><TD>3</TD><TD>17275</TD><TD>29</TD>
<TD>IFI44L,IFI44,TUBA1A</TD></TR>
<TR><TD>3.279e-03</TD><TD>-5.72</TD><TD>GSE11961_FOLLICULAR_BCELL_VS_MEMORY_BCELL_DAY7_UP</TD><TD>MSigDB lists</TD><TD>GSE11961_FOLLICULAR_BCELL_VS_MEMORY_BCELL_DAY7_UP</TD><TD>179</TD><TD>3</TD><TD>17275</TD><TD>29</TD>
<TD>CAMKK2,OAS1,OAS3</TD></TR>
<TR><TD>3.279e-03</TD><TD>-5.72</TD><TD>GSE40443_INDUCED_VS_TOTAL_TREG_DN</TD><TD>MSigDB lists</TD><TD>GSE40443_INDUCED_VS_TOTAL_TREG_DN</TD><TD>179</TD><TD>3</TD><TD>17275</TD><TD>29</TD>
<TD>OAS3,OAS1,IFI44</TD></TR>
<TR><TD>3.331e-03</TD><TD>-5.70</TD><TD>GSE24634_TEFF_VS_TCONV_DAY5_IN_CULTURE_DN</TD><TD>MSigDB lists</TD><TD>GSE24634_TEFF_VS_TCONV_DAY5_IN_CULTURE_DN</TD><TD>180</TD><TD>3</TD><TD>17275</TD><TD>29</TD>
<TD>OAS3,IFI44L,IFI44</TD></TR>
<TR><TD>3.383e-03</TD><TD>-5.69</TD><TD>GSE3982_MAC_VS_NEUTROPHIL_LPS_STIM_UP</TD><TD>MSigDB lists</TD><TD>GSE3982_MAC_VS_NEUTROPHIL_LPS_STIM_UP</TD><TD>181</TD><TD>3</TD><TD>17275</TD><TD>29</TD>
<TD>OAS1,IFI27,IFI44</TD></TR>
<TR><TD>3.383e-03</TD><TD>-5.69</TD><TD>KRAS.DF.V1_UP</TD><TD>MSigDB lists</TD><TD>KRAS.DF.V1_UP</TD><TD>181</TD><TD>3</TD><TD>17275</TD><TD>29</TD>
<TD>IFI44,IFI44L,IFI27</TD></TR>
<TR><TD>3.383e-03</TD><TD>-5.69</TD><TD>GSE30083_SP1_VS_SP3_THYMOCYTE_DN</TD><TD>MSigDB lists</TD><TD>GSE30083_SP1_VS_SP3_THYMOCYTE_DN</TD><TD>181</TD><TD>3</TD><TD>17275</TD><TD>29</TD>
<TD>IFI44,OAS2,OAS1</TD></TR>
<TR><TD>3.425e-03</TD><TD>-5.68</TD><TD>GTCAGGA_MIR378</TD><TD>MSigDB lists</TD><TD>GTCAGGA_MIR378</TD><TD>52</TD><TD>2</TD><TD>17275</TD><TD>29</TD>
<TD>CAMKK2,HS6ST2</TD></TR>
<TR><TD>3.434e-03</TD><TD>-5.67</TD><TD>PLA2G7 (phospholipase A2 group VII)</TD><TD>protein interactions</TD><TD>7941</TD><TD>2</TD><TD>1</TD><TD>17456</TD><TD>30</TD>
<TD>TUBA1A</TD></TR>
<TR><TD>3.434e-03</TD><TD>-5.67</TD><TD>IFNL3 (interferon lambda 3)</TD><TD>protein interactions</TD><TD>282617</TD><TD>2</TD><TD>1</TD><TD>17456</TD><TD>30</TD>
<TD>ISG15</TD></TR>
<TR><TD>3.434e-03</TD><TD>-5.67</TD><TD>HS3ST1 (heparan sulfate-glucosamine 3-sulfotransferase 1)</TD><TD>protein interactions</TD><TD>9957</TD><TD>2</TD><TD>1</TD><TD>17456</TD><TD>30</TD>
<TD>LGR4</TD></TR>
<TR><TD>3.436e-03</TD><TD>-5.67</TD><TD>GSE17186_CD21LOW_VS_CD21HIGH_TRANSITIONAL_BCELL_UP</TD><TD>MSigDB lists</TD><TD>GSE17186_CD21LOW_VS_CD21HIGH_TRANSITIONAL_BCELL_UP</TD><TD>182</TD><TD>3</TD><TD>17275</TD><TD>29</TD>
<TD>OAS1,OAS2,IFI44</TD></TR>
<TR><TD>3.436e-03</TD><TD>-5.67</TD><TD>GSE40685_NAIVE_CD4_TCELL_VS_TREG_DN</TD><TD>MSigDB lists</TD><TD>GSE40685_NAIVE_CD4_TCELL_VS_TREG_DN</TD><TD>182</TD><TD>3</TD><TD>17275</TD><TD>29</TD>
<TD>RYR1,LGR4,OAS2</TD></TR>
<TR><TD>3.436e-03</TD><TD>-5.67</TD><TD>GSE17721_LPS_VS_CPG_24H_BMDC_UP</TD><TD>MSigDB lists</TD><TD>GSE17721_LPS_VS_CPG_24H_BMDC_UP</TD><TD>182</TD><TD>3</TD><TD>17275</TD><TD>29</TD>
<TD>TUBA1A,IFIT2,RSAD2</TD></TR>
<TR><TD>3.436e-03</TD><TD>-5.67</TD><TD>GSE36078_UNTREATED_VS_AD5_T425A_HEXON_INF_MOUSE_LUNG_DC_UP</TD><TD>MSigDB lists</TD><TD>GSE36078_UNTREATED_VS_AD5_T425A_HEXON_INF_MOUSE_LUNG_DC_UP</TD><TD>182</TD><TD>3</TD><TD>17275</TD><TD>29</TD>
<TD>RSAD2,IFI44,OAS1</TD></TR>
<TR><TD>3.436e-03</TD><TD>-5.67</TD><TD>GSE37534_UNTREATED_VS_ROSIGLITAZONE_TREATED_CD4_TCELL_PPARG1_AND_FOXP3_TRASDUCED_DN</TD><TD>MSigDB lists</TD><TD>GSE37534_UNTREATED_VS_ROSIGLITAZONE_TREATED_CD4_TCELL_PPARG1_AND_FOXP3_TRASDUCED_DN</TD><TD>182</TD><TD>3</TD><TD>17275</TD><TD>29</TD>
<TD>IFI27,IFIT2,IFI44L</TD></TR>
<TR><TD>3.443e-03</TD><TD>-5.67</TD><TD>KUMAR_TARGETS_OF_MLL_AF9_FUSION</TD><TD>MSigDB lists</TD><TD>KUMAR_TARGETS_OF_MLL_AF9_FUSION</TD><TD>377</TD><TD>4</TD><TD>17275</TD><TD>29</TD>
<TD>RSAD2,IFIT2,RYR1,ISG15</TD></TR>
<TR><TD>3.489e-03</TD><TD>-5.66</TD><TD>EGFR_UP.V1_DN</TD><TD>MSigDB lists</TD><TD>EGFR_UP.V1_DN</TD><TD>183</TD><TD>3</TD><TD>17275</TD><TD>29</TD>
<TD>IFI27,IFI44,IFI44L</TD></TR>
<TR><TD>3.489e-03</TD><TD>-5.66</TD><TD>GSE21379_WT_VS_SAP_KO_TFH_CD4_TCELL_DN</TD><TD>MSigDB lists</TD><TD>GSE21379_WT_VS_SAP_KO_TFH_CD4_TCELL_DN</TD><TD>183</TD><TD>3</TD><TD>17275</TD><TD>29</TD>
<TD>RSAD2,IFI44,OASL</TD></TR>
<TR><TD>3.543e-03</TD><TD>-5.64</TD><TD>GSE41867_DAY15_EFFECTOR_VS_DAY30_EXHAUSTED_CD8_TCELL_LCMV_CLONE13_UP</TD><TD>MSigDB lists</TD><TD>GSE41867_DAY15_EFFECTOR_VS_DAY30_EXHAUSTED_CD8_TCELL_LCMV_CLONE13_UP</TD><TD>184</TD><TD>3</TD><TD>17275</TD><TD>29</TD>
<TD>OAS2,OAS3,RSAD2</TD></TR>
<TR><TD>3.543e-03</TD><TD>-5.64</TD><TD>GSE369_PRE_VS_POST_IL6_INJECTION_IFNG_KO_LIVER_DN</TD><TD>MSigDB lists</TD><TD>GSE369_PRE_VS_POST_IL6_INJECTION_IFNG_KO_LIVER_DN</TD><TD>184</TD><TD>3</TD><TD>17275</TD><TD>29</TD>
<TD>OASL,OAS1,OAS2</TD></TR>
<TR><TD>3.543e-03</TD><TD>-5.64</TD><TD>GSE2770_IL12_VS_TGFB_AND_IL12_TREATED_ACT_CD4_TCELL_48H_UP</TD><TD>MSigDB lists</TD><TD>GSE2770_IL12_VS_TGFB_AND_IL12_TREATED_ACT_CD4_TCELL_48H_UP</TD><TD>184</TD><TD>3</TD><TD>17275</TD><TD>29</TD>
<TD>RSAD2,OAS3,OAS1</TD></TR>
<TR><TD>3.543e-03</TD><TD>-5.64</TD><TD>GSE7852_TREG_VS_TCONV_LN_DN</TD><TD>MSigDB lists</TD><TD>GSE7852_TREG_VS_TCONV_LN_DN</TD><TD>184</TD><TD>3</TD><TD>17275</TD><TD>29</TD>
<TD>CAMKK2,RYR1,IFIT2</TD></TR>
<TR><TD>3.543e-03</TD><TD>-5.64</TD><TD>GSE28737_WT_VS_BCL6_KO_MARGINAL_ZONE_BCELL_UP</TD><TD>MSigDB lists</TD><TD>GSE28737_WT_VS_BCL6_KO_MARGINAL_ZONE_BCELL_UP</TD><TD>184</TD><TD>3</TD><TD>17275</TD><TD>29</TD>
<TD>RSAD2,OAS3,OAS2</TD></TR>
<TR><TD>3.543e-03</TD><TD>-5.64</TD><TD>GSE36078_WT_VS_IL1R_KO_LUNG_DC_AFTER_AD5_T425A_HEXON_INF_DN</TD><TD>MSigDB lists</TD><TD>GSE36078_WT_VS_IL1R_KO_LUNG_DC_AFTER_AD5_T425A_HEXON_INF_DN</TD><TD>184</TD><TD>3</TD><TD>17275</TD><TD>29</TD>
<TD>IFI44,RSAD2,OASL</TD></TR>
<TR><TD>3.543e-03</TD><TD>-5.64</TD><TD>GSE17721_LPS_VS_POLYIC_16H_BMDC_DN</TD><TD>MSigDB lists</TD><TD>GSE17721_LPS_VS_POLYIC_16H_BMDC_DN</TD><TD>184</TD><TD>3</TD><TD>17275</TD><TD>29</TD>
<TD>OAS2,RYR1,RSAD2</TD></TR>
<TR><TD>3.547e-03</TD><TD>-5.64</TD><TD>IVANOVA_HEMATOPOIESIS_STEM_CELL_AND_PROGENITOR</TD><TD>MSigDB lists</TD><TD>IVANOVA_HEMATOPOIESIS_STEM_CELL_AND_PROGENITOR</TD><TD>626</TD><TD>5</TD><TD>17275</TD><TD>29</TD>
<TD>KIAA1211,KIFAP3,MGAT3,HS6ST2,CADM4</TD></TR>
<TR><TD>3.556e-03</TD><TD>-5.64</TD><TD>GO_REGULATION_OF_MORPHOGENESIS_OF_A_BRANCHING_STRUCTURE</TD><TD>MSigDB lists</TD><TD>GO_REGULATION_OF_MORPHOGENESIS_OF_A_BRANCHING_STRUCTURE</TD><TD>53</TD><TD>2</TD><TD>17275</TD><TD>29</TD>
<TD>PGF,LGR4</TD></TR>
<TR><TD>3.597e-03</TD><TD>-5.63</TD><TD>GSE11961_GERMINAL_CENTER_BCELL_DAY7_VS_PLASMA_CELL_DAY7_DN</TD><TD>MSigDB lists</TD><TD>GSE11961_GERMINAL_CENTER_BCELL_DAY7_VS_PLASMA_CELL_DAY7_DN</TD><TD>185</TD><TD>3</TD><TD>17275</TD><TD>29</TD>
<TD>OAS2,ZNF518B,MCAM</TD></TR>
<TR><TD>3.597e-03</TD><TD>-5.63</TD><TD>GSE17721_0.5H_VS_8H_LPS_BMDC_UP</TD><TD>MSigDB lists</TD><TD>GSE17721_0.5H_VS_8H_LPS_BMDC_UP</TD><TD>185</TD><TD>3</TD><TD>17275</TD><TD>29</TD>
<TD>TUBA1A,PGF,ZNF518B</TD></TR>
<TR><TD>3.597e-03</TD><TD>-5.63</TD><TD>GSE46606_IRF4HIGH_VS_WT_CD40L_IL2_IL5_DAY3_STIMULATED_BCELL_DN</TD><TD>MSigDB lists</TD><TD>GSE46606_IRF4HIGH_VS_WT_CD40L_IL2_IL5_DAY3_STIMULATED_BCELL_DN</TD><TD>185</TD><TD>3</TD><TD>17275</TD><TD>29</TD>
<TD>OASL,OAS1,KIAA1211</TD></TR>
<TR><TD>3.597e-03</TD><TD>-5.63</TD><TD>GSE21927_GMCSF_IL6_VS_GMCSF_GCSF_TREATED_BONE_MARROW_DN</TD><TD>MSigDB lists</TD><TD>GSE21927_GMCSF_IL6_VS_GMCSF_GCSF_TREATED_BONE_MARROW_DN</TD><TD>185</TD><TD>3</TD><TD>17275</TD><TD>29</TD>
<TD>IFI27,ISG15,OAS3</TD></TR>
<TR><TD>3.597e-03</TD><TD>-5.63</TD><TD>GSE30083_SP2_VS_SP4_THYMOCYTE_UP</TD><TD>MSigDB lists</TD><TD>GSE30083_SP2_VS_SP4_THYMOCYTE_UP</TD><TD>185</TD><TD>3</TD><TD>17275</TD><TD>29</TD>
<TD>MCAM,TUBA1A,KLHDC8B</TD></TR>
<TR><TD>3.636e-03</TD><TD>-5.62</TD><TD>regulation of morphogenesis of a branching structure</TD><TD>biological process</TD><TD>GO:0060688</TD><TD>56</TD><TD>2</TD><TD>18054</TD><TD>29</TD>
<TD>PGF,LGR4</TD></TR>
<TR><TD>3.652e-03</TD><TD>-5.61</TD><TD>GSE43863_TFH_VS_LY6C_LOW_CXCR5NEG_EFFECTOR_CD4_TCELL_UP</TD><TD>MSigDB lists</TD><TD>GSE43863_TFH_VS_LY6C_LOW_CXCR5NEG_EFFECTOR_CD4_TCELL_UP</TD><TD>186</TD><TD>3</TD><TD>17275</TD><TD>29</TD>
<TD>RSAD2,IFIT2,IFI27</TD></TR>
<TR><TD>3.652e-03</TD><TD>-5.61</TD><TD>GSE1460_INTRATHYMIC_T_PROGENITOR_VS_CD4_THYMOCYTE_DN</TD><TD>MSigDB lists</TD><TD>GSE1460_INTRATHYMIC_T_PROGENITOR_VS_CD4_THYMOCYTE_DN</TD><TD>186</TD><TD>3</TD><TD>17275</TD><TD>29</TD>
<TD>OAS2,IFI44L,IFI44</TD></TR>
<TR><TD>3.652e-03</TD><TD>-5.61</TD><TD>GSE40277_EOS_AND_LEF1_TRANSDUCED_VS_GATA1_AND_SATB1_TRANSDUCED_CD4_TCELL_DN</TD><TD>MSigDB lists</TD><TD>GSE40277_EOS_AND_LEF1_TRANSDUCED_VS_GATA1_AND_SATB1_TRANSDUCED_CD4_TCELL_DN</TD><TD>186</TD><TD>3</TD><TD>17275</TD><TD>29</TD>
<TD>OAS2,CAMKK2,IFI44</TD></TR>
<TR><TD>3.652e-03</TD><TD>-5.61</TD><TD>spindle microtubule</TD><TD>cellular component</TD><TD>GO:0005876</TD><TD>59</TD><TD>2</TD><TD>18985</TD><TD>29</TD>
<TD>CAPN6,KIFAP3</TD></TR>
<TR><TD>3.708e-03</TD><TD>-5.60</TD><TD>GSE40666_WT_VS_STAT4_KO_CD8_TCELL_WITH_IFNA_STIM_90MIN_DN</TD><TD>MSigDB lists</TD><TD>GSE40666_WT_VS_STAT4_KO_CD8_TCELL_WITH_IFNA_STIM_90MIN_DN</TD><TD>187</TD><TD>3</TD><TD>17275</TD><TD>29</TD>
<TD>ZNF518B,OAS1,OAS2</TD></TR>
<TR><TD>3.708e-03</TD><TD>-5.60</TD><TD>GSE13484_3H_UNSTIM_VS_YF17D_VACCINE_STIM_PBMC_DN</TD><TD>MSigDB lists</TD><TD>GSE13484_3H_UNSTIM_VS_YF17D_VACCINE_STIM_PBMC_DN</TD><TD>187</TD><TD>3</TD><TD>17275</TD><TD>29</TD>
<TD>OASL,OAS1,OAS2</TD></TR>
<TR><TD>3.708e-03</TD><TD>-5.60</TD><TD>GSE17721_PAM3CSK4_VS_CPG_2H_BMDC_DN</TD><TD>MSigDB lists</TD><TD>GSE17721_PAM3CSK4_VS_CPG_2H_BMDC_DN</TD><TD>187</TD><TD>3</TD><TD>17275</TD><TD>29</TD>
<TD>OASL,IFIT2,CAPN6</TD></TR>
<TR><TD>3.708e-03</TD><TD>-5.60</TD><TD>GSE4748_CTRL_VS_LPS_STIM_DC_3H_UP</TD><TD>MSigDB lists</TD><TD>GSE4748_CTRL_VS_LPS_STIM_DC_3H_UP</TD><TD>187</TD><TD>3</TD><TD>17275</TD><TD>29</TD>
<TD>IFI44,PGF,HS6ST2</TD></TR>
<TR><TD>3.708e-03</TD><TD>-5.60</TD><TD>GSE17301_IFNA2_VS_IFNA2_AND_ACD3_ACD28_STIM_CD8_TCELL_DN</TD><TD>MSigDB lists</TD><TD>GSE17301_IFNA2_VS_IFNA2_AND_ACD3_ACD28_STIM_CD8_TCELL_DN</TD><TD>187</TD><TD>3</TD><TD>17275</TD><TD>29</TD>
<TD>RSAD2,RYR1,OAS1</TD></TR>
<TR><TD>3.708e-03</TD><TD>-5.60</TD><TD>GSE1432_1H_VS_6H_IFNG_MICROGLIA_DN</TD><TD>MSigDB lists</TD><TD>GSE1432_1H_VS_6H_IFNG_MICROGLIA_DN</TD><TD>187</TD><TD>3</TD><TD>17275</TD><TD>29</TD>
<TD>RSAD2,IFI44L,IFI44</TD></TR>
<TR><TD>3.764e-03</TD><TD>-5.58</TD><TD>GSE34392_ST2_KO_VS_WT_DAY8_LCMV_EFFECTOR_CD8_TCELL_DN</TD><TD>MSigDB lists</TD><TD>GSE34392_ST2_KO_VS_WT_DAY8_LCMV_EFFECTOR_CD8_TCELL_DN</TD><TD>188</TD><TD>3</TD><TD>17275</TD><TD>29</TD>
<TD>IFIT2,ISG15,RSAD2</TD></TR>
<TR><TD>3.764e-03</TD><TD>-5.58</TD><TD>GSE23568_ID3_TRANSDUCED_VS_ID3_KO_CD8_TCELL_UP</TD><TD>MSigDB lists</TD><TD>GSE23568_ID3_TRANSDUCED_VS_ID3_KO_CD8_TCELL_UP</TD><TD>188</TD><TD>3</TD><TD>17275</TD><TD>29</TD>
<TD>ISG15,IFI27,TUBA1A</TD></TR>
<TR><TD>3.764e-03</TD><TD>-5.58</TD><TD>GSE41978_ID2_KO_VS_BIM_KO_KLRG1_LOW_EFFECTOR_CD8_TCELL_UP</TD><TD>MSigDB lists</TD><TD>GSE41978_ID2_KO_VS_BIM_KO_KLRG1_LOW_EFFECTOR_CD8_TCELL_UP</TD><TD>188</TD><TD>3</TD><TD>17275</TD><TD>29</TD>
<TD>ISG15,OASL,OAS3</TD></TR>
<TR><TD>3.792e-03</TD><TD>-5.57</TD><TD>Ubiquitin_dom</TD><TD>interpro domains</TD><TD>IPR000626</TD><TD>57</TD><TD>2</TD><TD>18616</TD><TD>30</TD>
<TD>OASL,ISG15</TD></TR>
<TR><TD>3.820e-03</TD><TD>-5.57</TD><TD>GSE24142_ADULT_VS_FETAL_DN2_THYMOCYTE_UP</TD><TD>MSigDB lists</TD><TD>GSE24142_ADULT_VS_FETAL_DN2_THYMOCYTE_UP</TD><TD>189</TD><TD>3</TD><TD>17275</TD><TD>29</TD>
<TD>IFIT2,RSAD2,OAS1</TD></TR>
<TR><TD>3.820e-03</TD><TD>-5.57</TD><TD>GSE22140_GERMFREE_VS_SPF_MOUSE_CD4_TCELL_DN</TD><TD>MSigDB lists</TD><TD>GSE22140_GERMFREE_VS_SPF_MOUSE_CD4_TCELL_DN</TD><TD>189</TD><TD>3</TD><TD>17275</TD><TD>29</TD>
<TD>OASL,IFI44,IFIT2</TD></TR>
<TR><TD>3.820e-03</TD><TD>-5.57</TD><TD>GSE21927_BALBC_VS_C57BL6_MONOCYTE_TUMOR_UP</TD><TD>MSigDB lists</TD><TD>GSE21927_BALBC_VS_C57BL6_MONOCYTE_TUMOR_UP</TD><TD>189</TD><TD>3</TD><TD>17275</TD><TD>29</TD>
<TD>OAS3,IFI27,ISG15</TD></TR>
<TR><TD>3.820e-03</TD><TD>-5.57</TD><TD>GSE3982_EOSINOPHIL_VS_MAST_CELL_UP</TD><TD>MSigDB lists</TD><TD>GSE3982_EOSINOPHIL_VS_MAST_CELL_UP</TD><TD>189</TD><TD>3</TD><TD>17275</TD><TD>29</TD>
<TD>OASL,RSAD2,CAMKK2</TD></TR>
<TR><TD>3.820e-03</TD><TD>-5.57</TD><TD>GSE14699_NAIVE_VS_DELETIONAL_TOLERANCE_CD8_TCELL_DN</TD><TD>MSigDB lists</TD><TD>GSE14699_NAIVE_VS_DELETIONAL_TOLERANCE_CD8_TCELL_DN</TD><TD>189</TD><TD>3</TD><TD>17275</TD><TD>29</TD>
<TD>CAMKK2,IFIT2,RSAD2</TD></TR>
<TR><TD>3.824e-03</TD><TD>-5.57</TD><TD>LUCAS_HNF4A_TARGETS_UP</TD><TD>MSigDB lists</TD><TD>LUCAS_HNF4A_TARGETS_UP</TD><TD>55</TD><TD>2</TD><TD>17275</TD><TD>29</TD>
<TD>CAMKK2,KIFAP3</TD></TR>
<TR><TD>3.865e-03</TD><TD>-5.56</TD><TD>RBFOX1 (RNA binding fox-1 homolog 1)</TD><TD>protein interactions</TD><TD>54715</TD><TD>54</TD><TD>2</TD><TD>17456</TD><TD>30</TD>
<TD>CTSV,KIFAP3</TD></TR>
<TR><TD>3.877e-03</TD><TD>-5.55</TD><TD>GSE19401_UNSTIM_VS_PAM2CSK4_STIM_FOLLICULAR_DC_DN</TD><TD>MSigDB lists</TD><TD>GSE19401_UNSTIM_VS_PAM2CSK4_STIM_FOLLICULAR_DC_DN</TD><TD>190</TD><TD>3</TD><TD>17275</TD><TD>29</TD>
<TD>OASL,ISG15,IFI27</TD></TR>
<TR><TD>3.877e-03</TD><TD>-5.55</TD><TD>GOLDRATH_NAIVE_VS_MEMORY_CD8_TCELL_UP</TD><TD>MSigDB lists</TD><TD>GOLDRATH_NAIVE_VS_MEMORY_CD8_TCELL_UP</TD><TD>190</TD><TD>3</TD><TD>17275</TD><TD>29</TD>
<TD>ISG15,RSAD2,TUBA1A</TD></TR>
<TR><TD>3.877e-03</TD><TD>-5.55</TD><TD>GSE37301_MULTIPOTENT_PROGENITOR_VS_GRAN_MONO_PROGENITOR_UP</TD><TD>MSigDB lists</TD><TD>GSE37301_MULTIPOTENT_PROGENITOR_VS_GRAN_MONO_PROGENITOR_UP</TD><TD>190</TD><TD>3</TD><TD>17275</TD><TD>29</TD>
<TD>RSAD2,IFIT2,ISG15</TD></TR>
<TR><TD>3.877e-03</TD><TD>-5.55</TD><TD>GSE17580_UNINFECTED_VS_S_MANSONI_INF_TREG_UP</TD><TD>MSigDB lists</TD><TD>GSE17580_UNINFECTED_VS_S_MANSONI_INF_TREG_UP</TD><TD>190</TD><TD>3</TD><TD>17275</TD><TD>29</TD>
<TD>IFIT2,OAS2,OASL</TD></TR>
<TR><TD>3.877e-03</TD><TD>-5.55</TD><TD>HALLMARK_KRAS_SIGNALING_DN</TD><TD>MSigDB lists</TD><TD>HALLMARK_KRAS_SIGNALING_DN</TD><TD>190</TD><TD>3</TD><TD>17275</TD><TD>29</TD>
<TD>IFI44L,RSAD2,RYR1</TD></TR>
<TR><TD>3.877e-03</TD><TD>-5.55</TD><TD>GSE34156_NOD2_LIGAND_VS_TLR1_TLR2_LIGAND_6H_TREATED_MONOCYTE_UP</TD><TD>MSigDB lists</TD><TD>GSE34156_NOD2_LIGAND_VS_TLR1_TLR2_LIGAND_6H_TREATED_MONOCYTE_UP</TD><TD>190</TD><TD>3</TD><TD>17275</TD><TD>29</TD>
<TD>ISG15,IFIT2,RSAD2</TD></TR>
<TR><TD>3.934e-03</TD><TD>-5.54</TD><TD>GSE22935_24H_VS_48H_MBOVIS_BCG_STIM_MYD88_KO_MACROPHAGE_DN</TD><TD>MSigDB lists</TD><TD>GSE22935_24H_VS_48H_MBOVIS_BCG_STIM_MYD88_KO_MACROPHAGE_DN</TD><TD>191</TD><TD>3</TD><TD>17275</TD><TD>29</TD>
<TD>IFI27,CAMKK2,BCL6B</TD></TR>
<TR><TD>3.934e-03</TD><TD>-5.54</TD><TD>GSE17721_12H_VS_24H_LPS_BMDC_UP</TD><TD>MSigDB lists</TD><TD>GSE17721_12H_VS_24H_LPS_BMDC_UP</TD><TD>191</TD><TD>3</TD><TD>17275</TD><TD>29</TD>
<TD>OAS2,ISG15,CAMKK2</TD></TR>
<TR><TD>3.934e-03</TD><TD>-5.54</TD><TD>GSE43955_1H_VS_42H_ACT_CD4_TCELL_WITH_TGFB_IL6_DN</TD><TD>MSigDB lists</TD><TD>GSE43955_1H_VS_42H_ACT_CD4_TCELL_WITH_TGFB_IL6_DN</TD><TD>191</TD><TD>3</TD><TD>17275</TD><TD>29</TD>
<TD>PGF,MGAT3,RSAD2</TD></TR>
<TR><TD>3.962e-03</TD><TD>-5.53</TD><TD>INGRAM_SHH_TARGETS_DN</TD><TD>MSigDB lists</TD><TD>INGRAM_SHH_TARGETS_DN</TD><TD>56</TD><TD>2</TD><TD>17275</TD><TD>29</TD>
<TD>TUBA1A,FAM102B</TD></TR>
<TR><TD>3.962e-03</TD><TD>-5.53</TD><TD>LEE_LIVER_CANCER_MYC_E2F1_UP</TD><TD>MSigDB lists</TD><TD>LEE_LIVER_CANCER_MYC_E2F1_UP</TD><TD>56</TD><TD>2</TD><TD>17275</TD><TD>29</TD>
<TD>IFI44,IFIT2</TD></TR>
<TR><TD>3.992e-03</TD><TD>-5.52</TD><TD>GSE15930_STIM_VS_STIM_AND_TRICHOSTATINA_48H_CD8_T_CELL_DN</TD><TD>MSigDB lists</TD><TD>GSE15930_STIM_VS_STIM_AND_TRICHOSTATINA_48H_CD8_T_CELL_DN</TD><TD>192</TD><TD>3</TD><TD>17275</TD><TD>29</TD>
<TD>RSAD2,IFI27,ISG15</TD></TR>
<TR><TD>3.992e-03</TD><TD>-5.52</TD><TD>GSE1925_CTRL_VS_IFNG_PRIMED_MACROPHAGE_24H_IFNG_STIM_DN</TD><TD>MSigDB lists</TD><TD>GSE1925_CTRL_VS_IFNG_PRIMED_MACROPHAGE_24H_IFNG_STIM_DN</TD><TD>192</TD><TD>3</TD><TD>17275</TD><TD>29</TD>
<TD>RSAD2,IFI27,ISG15</TD></TR>
<TR><TD>3.992e-03</TD><TD>-5.52</TD><TD>GSE30962_ACUTE_VS_CHRONIC_LCMV_PRIMARY_INF_CD8_TCELL_DN</TD><TD>MSigDB lists</TD><TD>GSE30962_ACUTE_VS_CHRONIC_LCMV_PRIMARY_INF_CD8_TCELL_DN</TD><TD>192</TD><TD>3</TD><TD>17275</TD><TD>29</TD>
<TD>ZNF518B,KIFAP3,RSAD2</TD></TR>
<TR><TD>3.992e-03</TD><TD>-5.52</TD><TD>GSE18281_CORTICAL_VS_MEDULLARY_THYMOCYTE_UP</TD><TD>MSigDB lists</TD><TD>GSE18281_CORTICAL_VS_MEDULLARY_THYMOCYTE_UP</TD><TD>192</TD><TD>3</TD><TD>17275</TD><TD>29</TD>
<TD>IFIT2,ISG15,RSAD2</TD></TR>
<TR><TD>3.992e-03</TD><TD>-5.52</TD><TD>GSE37301_MULTIPOTENT_PROGENITOR_VS_GRAN_MONO_PROGENITOR_DN</TD><TD>MSigDB lists</TD><TD>GSE37301_MULTIPOTENT_PROGENITOR_VS_GRAN_MONO_PROGENITOR_DN</TD><TD>192</TD><TD>3</TD><TD>17275</TD><TD>29</TD>
<TD>RSAD2,IFIT2,ISG15</TD></TR>
<TR><TD>4.007e-03</TD><TD>-5.52</TD><TD>HOMER3 (homer scaffold protein 3)</TD><TD>protein interactions</TD><TD>9454</TD><TD>55</TD><TD>2</TD><TD>17456</TD><TD>30</TD>
<TD>RYR1,IFIT2</TD></TR>
<TR><TD>4.051e-03</TD><TD>-5.51</TD><TD>GSE15930_STIM_VS_STIM_AND_IFNAB_48H_CD8_T_CELL_DN</TD><TD>MSigDB lists</TD><TD>GSE15930_STIM_VS_STIM_AND_IFNAB_48H_CD8_T_CELL_DN</TD><TD>193</TD><TD>3</TD><TD>17275</TD><TD>29</TD>
<TD>IFIT2,ISG15,RSAD2</TD></TR>
<TR><TD>4.075e-03</TD><TD>-5.50</TD><TD>response to chemical</TD><TD>biological process</TD><TD>GO:0042221</TD><TD>4367</TD><TD>14</TD><TD>18054</TD><TD>29</TD>
<TD>OASL,LGR4,ISG15,RSAD2,CAMKK2,RYR1,OAS1,MGAT3,IFIT2,OAS2,OAS3,PGF,CTSV,IFI27</TD></TR>
<TR><TD>4.101e-03</TD><TD>-5.50</TD><TD>BILBAN_B_CLL_LPL_UP</TD><TD>MSigDB lists</TD><TD>BILBAN_B_CLL_LPL_UP</TD><TD>57</TD><TD>2</TD><TD>17275</TD><TD>29</TD>
<TD>OAS1,OAS2</TD></TR>
<TR><TD>4.101e-03</TD><TD>-5.50</TD><TD>GO_SPINDLE_MICROTUBULE</TD><TD>MSigDB lists</TD><TD>GO_SPINDLE_MICROTUBULE</TD><TD>57</TD><TD>2</TD><TD>17275</TD><TD>29</TD>
<TD>KIFAP3,CAPN6</TD></TR>
<TR><TD>4.169e-03</TD><TD>-5.48</TD><TD>GSE360_DC_VS_MAC_B_MALAYI_HIGH_DOSE_DN</TD><TD>MSigDB lists</TD><TD>GSE360_DC_VS_MAC_B_MALAYI_HIGH_DOSE_DN</TD><TD>195</TD><TD>3</TD><TD>17275</TD><TD>29</TD>
<TD>OAS2,ISG15,IFI44</TD></TR>
<TR><TD>4.351e-03</TD><TD>-5.44</TD><TD>GSE360_CTRL_VS_M_TUBERCULOSIS_DC_DN</TD><TD>MSigDB lists</TD><TD>GSE360_CTRL_VS_M_TUBERCULOSIS_DC_DN</TD><TD>198</TD><TD>3</TD><TD>17275</TD><TD>29</TD>
<TD>IFIT2,IFI44,OAS2</TD></TR>
<TR><TD>4.501e-03</TD><TD>-5.40</TD><TD>vascular endothelial growth factor receptor 1 binding</TD><TD>molecular function</TD><TD>GO:0043183</TD><TD>3</TD><TD>1</TD><TD>17306</TD><TD>26</TD>
<TD>CADM4</TD></TR>
<TR><TD>4.501e-03</TD><TD>-5.40</TD><TD>heparan sulfate 6-O-sulfotransferase activity</TD><TD>molecular function</TD><TD>GO:0017095</TD><TD>3</TD><TD>1</TD><TD>17306</TD><TD>26</TD>
<TD>HS6ST2</TD></TR>
<TR><TD>4.512e-03</TD><TD>-5.40</TD><TD>RYANODINER</TD><TD>prints domains</TD><TD>PR00795</TD><TD>3</TD><TD>1</TD><TD>4648</TD><TD>7</TD>
<TD>RYR1</TD></TR>
<TR><TD>4.512e-03</TD><TD>-5.40</TD><TD>LATROPHILIN</TD><TD>prints domains</TD><TD>PR01444</TD><TD>3</TD><TD>1</TD><TD>4648</TD><TD>7</TD>
<TD>ADGRL1</TD></TR>
<TR><TD>4.576e-03</TD><TD>-5.39</TD><TD>ryanodine receptor complex</TD><TD>cellular component</TD><TD>GO:1990425</TD><TD>3</TD><TD>1</TD><TD>18985</TD><TD>29</TD>
<TD>RYR1</TD></TR>
<TR><TD>4.576e-03</TD><TD>-5.39</TD><TD>kinesin II complex</TD><TD>cellular component</TD><TD>GO:0016939</TD><TD>3</TD><TD>1</TD><TD>18985</TD><TD>29</TD>
<TD>KIFAP3</TD></TR>
<TR><TD>4.683e-03</TD><TD>-5.36</TD><TD>LEE_LIVER_CANCER_E2F1_UP</TD><TD>MSigDB lists</TD><TD>LEE_LIVER_CANCER_E2F1_UP</TD><TD>61</TD><TD>2</TD><TD>17275</TD><TD>29</TD>
<TD>IFI44,IFIT2</TD></TR>
<TR><TD>4.722e-03</TD><TD>-5.36</TD><TD>UBIQUITIN_2</TD><TD>prosite domains</TD><TD>PS50053</TD><TD>52</TD><TD>2</TD><TD>12079</TD><TD>24</TD>
<TD>OASL,ISG15</TD></TR>
<TR><TD>4.722e-03</TD><TD>-5.36</TD><TD>nephron tubule morphogenesis</TD><TD>biological process</TD><TD>GO:0072078</TD><TD>64</TD><TD>2</TD><TD>18054</TD><TD>29</TD>
<TD>LGR4,PGF</TD></TR>
<TR><TD>4.764e-03</TD><TD>-5.35</TD><TD>HAN_SATB1_TARGETS_DN</TD><TD>MSigDB lists</TD><TD>HAN_SATB1_TARGETS_DN</TD><TD>413</TD><TD>4</TD><TD>17275</TD><TD>29</TD>
<TD>OAS1,OAS3,MCAM,IFIT2</TD></TR>
<TR><TD>4.805e-03</TD><TD>-5.34</TD><TD>BAELDE_DIABETIC_NEPHROPATHY_DN</TD><TD>MSigDB lists</TD><TD>BAELDE_DIABETIC_NEPHROPATHY_DN</TD><TD>414</TD><TD>4</TD><TD>17275</TD><TD>29</TD>
<TD>OAS2,OAS1,IFI44,ISG15</TD></TR>
<TR><TD>4.811e-03</TD><TD>-5.34</TD><TD>regulation of toll-like receptor 7 signaling pathway</TD><TD>biological process</TD><TD>GO:0034155</TD><TD>3</TD><TD>1</TD><TD>18054</TD><TD>29</TD>
<TD>RSAD2</TD></TR>
<TR><TD>4.811e-03</TD><TD>-5.34</TD><TD>positive regulation of toll-like receptor 9 signaling pathway</TD><TD>biological process</TD><TD>GO:0034165</TD><TD>3</TD><TD>1</TD><TD>18054</TD><TD>29</TD>
<TD>RSAD2</TD></TR>
<TR><TD>4.824e-03</TD><TD>-5.33</TD><TD>RyR</TD><TD>pfam domains</TD><TD>PF02026</TD><TD>3</TD><TD>1</TD><TD>17385</TD><TD>28</TD>
<TD>RYR1</TD></TR>
<TR><TD>4.824e-03</TD><TD>-5.33</TD><TD>RR_TM4-6</TD><TD>pfam domains</TD><TD>PF06459</TD><TD>3</TD><TD>1</TD><TD>17385</TD><TD>28</TD>
<TD>RYR1</TD></TR>
<TR><TD>4.824e-03</TD><TD>-5.33</TD><TD>DUF4592</TD><TD>pfam domains</TD><TD>PF15262</TD><TD>3</TD><TD>1</TD><TD>17385</TD><TD>28</TD>
<TD>KIAA1211</TD></TR>
<TR><TD>4.824e-03</TD><TD>-5.33</TD><TD>Latrophilin</TD><TD>pfam domains</TD><TD>PF02354</TD><TD>3</TD><TD>1</TD><TD>17385</TD><TD>28</TD>
<TD>ADGRL1</TD></TR>
<TR><TD>4.827e-03</TD><TD>-5.33</TD><TD>Ryanrecept_TM4-6</TD><TD>interpro domains</TD><TD>IPR009460</TD><TD>3</TD><TD>1</TD><TD>18616</TD><TD>30</TD>
<TD>RYR1</TD></TR>
<TR><TD>4.827e-03</TD><TD>-5.33</TD><TD>Heparan_SO4-6-sulfoTrfase</TD><TD>interpro domains</TD><TD>IPR010635</TD><TD>3</TD><TD>1</TD><TD>18616</TD><TD>30</TD>
<TD>HS6ST2</TD></TR>
<TR><TD>4.827e-03</TD><TD>-5.33</TD><TD>Ryan_recept</TD><TD>interpro domains</TD><TD>IPR013333</TD><TD>3</TD><TD>1</TD><TD>18616</TD><TD>30</TD>
<TD>RYR1</TD></TR>
<TR><TD>4.827e-03</TD><TD>-5.33</TD><TD>SPRY1_RyR</TD><TD>interpro domains</TD><TD>IPR035761</TD><TD>3</TD><TD>1</TD><TD>18616</TD><TD>30</TD>
<TD>RYR1</TD></TR>
<TR><TD>4.827e-03</TD><TD>-5.33</TD><TD>DUF4592</TD><TD>interpro domains</TD><TD>IPR028030</TD><TD>3</TD><TD>1</TD><TD>18616</TD><TD>30</TD>
<TD>KIAA1211</TD></TR>
<TR><TD>4.827e-03</TD><TD>-5.33</TD><TD>GPCR_2_latrophilin</TD><TD>interpro domains</TD><TD>IPR003924</TD><TD>3</TD><TD>1</TD><TD>18616</TD><TD>30</TD>
<TD>ADGRL1</TD></TR>
<TR><TD>4.827e-03</TD><TD>-5.33</TD><TD>Ryanodine_rcpt</TD><TD>interpro domains</TD><TD>IPR003032</TD><TD>3</TD><TD>1</TD><TD>18616</TD><TD>30</TD>
<TD>RYR1</TD></TR>
<TR><TD>4.827e-03</TD><TD>-5.33</TD><TD>SPRY3_RyR</TD><TD>interpro domains</TD><TD>IPR035762</TD><TD>3</TD><TD>1</TD><TD>18616</TD><TD>30</TD>
<TD>RYR1</TD></TR>
<TR><TD>4.827e-03</TD><TD>-5.33</TD><TD>GPCR_2_latrophilin_rcpt_C</TD><TD>interpro domains</TD><TD>IPR003334</TD><TD>3</TD><TD>1</TD><TD>18616</TD><TD>30</TD>
<TD>ADGRL1</TD></TR>
<TR><TD>4.827e-03</TD><TD>-5.33</TD><TD>SPRY2_RyR</TD><TD>interpro domains</TD><TD>IPR035764</TD><TD>3</TD><TD>1</TD><TD>18616</TD><TD>30</TD>
<TD>RYR1</TD></TR>
<TR><TD>4.846e-03</TD><TD>-5.33</TD><TD>anion binding</TD><TD>molecular function</TD><TD>GO:0043168</TD><TD>2769</TD><TD>10</TD><TD>17306</TD><TD>26</TD>
<TD>IFI44L,DIRAS1,RYR1,OASL,TUBA1A,OAS3,CAMKK2,OAS2,PGF,OAS1</TD></TR>
<TR><TD>4.925e-03</TD><TD>-5.31</TD><TD>RIGGINS_TAMOXIFEN_RESISTANCE_DN</TD><TD>MSigDB lists</TD><TD>RIGGINS_TAMOXIFEN_RESISTANCE_DN</TD><TD>207</TD><TD>3</TD><TD>17275</TD><TD>29</TD>
<TD>IFI27,ISG15,OAS1</TD></TR>
<TR><TD>5.014e-03</TD><TD>-5.30</TD><TD>nephron epithelium morphogenesis</TD><TD>biological process</TD><TD>GO:0072088</TD><TD>66</TD><TD>2</TD><TD>18054</TD><TD>29</TD>
<TD>LGR4,PGF</TD></TR>
<TR><TD>5.065e-03</TD><TD>-5.29</TD><TD>GINM1 (glycoprotein integral membrane 1)</TD><TD>protein interactions</TD><TD>116254</TD><TD>62</TD><TD>2</TD><TD>17456</TD><TD>30</TD>
<TD>CTSV,HS6ST2</TD></TR>
<TR><TD>5.094e-03</TD><TD>-5.28</TD><TD>human chr12q24.31</TD><TD>chromosome location</TD><TD>human chr12q24.31</TD><TD>93</TD><TD>2</TD><TD>26169</TD><TD>30</TD>
<TD>CAMKK2,OASL</TD></TR>
<TR><TD>5.147e-03</TD><TD>-5.27</TD><TD>IFNA10 (interferon alpha 10)</TD><TD>protein interactions</TD><TD>3446</TD><TD>3</TD><TD>1</TD><TD>17456</TD><TD>30</TD>
<TD>ISG15</TD></TR>
<TR><TD>5.147e-03</TD><TD>-5.27</TD><TD>LRRC25 (leucine rich repeat containing 25)</TD><TD>protein interactions</TD><TD>126364</TD><TD>3</TD><TD>1</TD><TD>17456</TD><TD>30</TD>
<TD>ISG15</TD></TR>
<TR><TD>5.147e-03</TD><TD>-5.27</TD><TD>IFNW1 (interferon omega 1)</TD><TD>protein interactions</TD><TD>3467</TD><TD>3</TD><TD>1</TD><TD>17456</TD><TD>30</TD>
<TD>ISG15</TD></TR>
<TR><TD>5.147e-03</TD><TD>-5.27</TD><TD>FBLL1 (fibrillarin like 1)</TD><TD>protein interactions</TD><TD>345630</TD><TD>3</TD><TD>1</TD><TD>17456</TD><TD>30</TD>
<TD>LGR4</TD></TR>
<TR><TD>5.147e-03</TD><TD>-5.27</TD><TD>Map9 (microtubule-associated protein 9)</TD><TD>protein interactions</TD><TD>213582</TD><TD>3</TD><TD>1</TD><TD>17456</TD><TD>30</TD>
<TD>OASL</TD></TR>
<TR><TD>5.147e-03</TD><TD>-5.27</TD><TD>RSPO3 (R-spondin 3)</TD><TD>protein interactions</TD><TD>84870</TD><TD>3</TD><TD>1</TD><TD>17456</TD><TD>30</TD>
<TD>LGR4</TD></TR>
<TR><TD>5.163e-03</TD><TD>-5.27</TD><TD>nephron morphogenesis</TD><TD>biological process</TD><TD>GO:0072028</TD><TD>67</TD><TD>2</TD><TD>18054</TD><TD>29</TD>
<TD>LGR4,PGF</TD></TR>
<TR><TD>5.315e-03</TD><TD>-5.24</TD><TD>renal tubule morphogenesis</TD><TD>biological process</TD><TD>GO:0061333</TD><TD>68</TD><TD>2</TD><TD>18054</TD><TD>29</TD>
<TD>PGF,LGR4</TD></TR>
<TR><TD>5.373e-03</TD><TD>-5.23</TD><TD>lung-left_lower_lobe-carcinoma-adenocarcinoma</TD><TD>COSMIC cancer mutations</TD><TD>lung-left_lower_lobe-carcinoma-adenocarcinoma</TD><TD>73</TD><TD>2</TD><TD>17255</TD><TD>26</TD>
<TD>DIRAS1,RYR1</TD></TR>
<TR><TD>5.461e-03</TD><TD>-5.21</TD><TD>LINDSTEDT_DENDRITIC_CELL_MATURATION_A</TD><TD>MSigDB lists</TD><TD>LINDSTEDT_DENDRITIC_CELL_MATURATION_A</TD><TD>66</TD><TD>2</TD><TD>17275</TD><TD>29</TD>
<TD>ISG15,IFIT2</TD></TR>
<TR><TD>5.468e-03</TD><TD>-5.21</TD><TD>regulation of toll-like receptor signaling pathway</TD><TD>biological process</TD><TD>GO:0034121</TD><TD>69</TD><TD>2</TD><TD>18054</TD><TD>29</TD>
<TD>LGR4,RSAD2</TD></TR>
<TR><TD>5.686e-03</TD><TD>-5.17</TD><TD>MZF1_01</TD><TD>MSigDB lists</TD><TD>MZF1_01</TD><TD>218</TD><TD>3</TD><TD>17275</TD><TD>29</TD>
<TD>BCL6B,PGF,MGAT3</TD></TR>
<TR><TD>5.788e-03</TD><TD>-5.15</TD><TD>WESTON_VEGFA_TARGETS_3HR</TD><TD>MSigDB lists</TD><TD>WESTON_VEGFA_TARGETS_3HR</TD><TD>68</TD><TD>2</TD><TD>17275</TD><TD>29</TD>
<TD>IFI27,PGF</TD></TR>
<TR><TD>5.996e-03</TD><TD>-5.12</TD><TD>calcium-induced calcium release activity</TD><TD>molecular function</TD><TD>GO:0048763</TD><TD>4</TD><TD>1</TD><TD>17306</TD><TD>26</TD>
<TD>RYR1</TD></TR>
<TR><TD>5.996e-03</TD><TD>-5.12</TD><TD>ryanodine-sensitive calcium-release channel activity</TD><TD>molecular function</TD><TD>GO:0005219</TD><TD>4</TD><TD>1</TD><TD>17306</TD><TD>26</TD>
<TD>RYR1</TD></TR>
<TR><TD>6.097e-03</TD><TD>-5.10</TD><TD>terminal cisterna</TD><TD>cellular component</TD><TD>GO:0014802</TD><TD>4</TD><TD>1</TD><TD>18985</TD><TD>29</TD>
<TD>RYR1</TD></TR>
<TR><TD>6.111e-03</TD><TD>-5.10</TD><TD>left_lower_lobe</TD><TD>COSMIC cancer mutations</TD><TD>left_lower_lobe</TD><TD>78</TD><TD>2</TD><TD>17255</TD><TD>26</TD>
<TD>RYR1,DIRAS1</TD></TR>
<TR><TD>6.123e-03</TD><TD>-5.10</TD><TD>DER_IFN_GAMMA_RESPONSE_UP</TD><TD>MSigDB lists</TD><TD>DER_IFN_GAMMA_RESPONSE_UP</TD><TD>70</TD><TD>2</TD><TD>17275</TD><TD>29</TD>
<TD>ISG15,IFIT2</TD></TR>
<TR><TD>6.410e-03</TD><TD>-5.05</TD><TD>negative regulation of barbed-end actin filament capping</TD><TD>biological process</TD><TD>GO:2000813</TD><TD>4</TD><TD>1</TD><TD>18054</TD><TD>29</TD>
<TD>KIAA1211</TD></TR>
<TR><TD>6.410e-03</TD><TD>-5.05</TD><TD>response to odorant</TD><TD>biological process</TD><TD>GO:1990834</TD><TD>4</TD><TD>1</TD><TD>18054</TD><TD>29</TD>
<TD>CTSV</TD></TR>
<TR><TD>6.410e-03</TD><TD>-5.05</TD><TD>epithelial cell proliferation involved in renal tubule morphogenesis</TD><TD>biological process</TD><TD>GO:2001013</TD><TD>4</TD><TD>1</TD><TD>18054</TD><TD>29</TD>
<TD>LGR4</TD></TR>
<TR><TD>6.410e-03</TD><TD>-5.05</TD><TD>regulation of lactation</TD><TD>biological process</TD><TD>GO:1903487</TD><TD>4</TD><TD>1</TD><TD>18054</TD><TD>29</TD>
<TD>OAS2</TD></TR>
<TR><TD>6.410e-03</TD><TD>-5.05</TD><TD>CAMKK-AMPK signaling cascade</TD><TD>biological process</TD><TD>GO:0061762</TD><TD>4</TD><TD>1</TD><TD>18054</TD><TD>29</TD>
<TD>CAMKK2</TD></TR>
<TR><TD>6.410e-03</TD><TD>-5.05</TD><TD>negative regulation of protein catabolic process in the vacuole</TD><TD>biological process</TD><TD>GO:1904351</TD><TD>4</TD><TD>1</TD><TD>18054</TD><TD>29</TD>
<TD>MGAT3</TD></TR>
<TR><TD>6.410e-03</TD><TD>-5.05</TD><TD>negative regulation of lysosomal protein catabolic process</TD><TD>biological process</TD><TD>GO:1905166</TD><TD>4</TD><TD>1</TD><TD>18054</TD><TD>29</TD>
<TD>MGAT3</TD></TR>
<TR><TD>6.427e-03</TD><TD>-5.05</TD><TD>NT-C2</TD><TD>pfam domains</TD><TD>PF10358</TD><TD>4</TD><TD>1</TD><TD>17385</TD><TD>28</TD>
<TD>FAM102B</TD></TR>
<TR><TD>6.427e-03</TD><TD>-5.05</TD><TD>Ifi-6-16</TD><TD>pfam domains</TD><TD>PF06140</TD><TD>4</TD><TD>1</TD><TD>17385</TD><TD>28</TD>
<TD>IFI27</TD></TR>
<TR><TD>6.431e-03</TD><TD>-5.05</TD><TD>IFI6/IFI27-like_sf</TD><TD>interpro domains</TD><TD>IPR038213</TD><TD>4</TD><TD>1</TD><TD>18616</TD><TD>30</TD>
<TD>IFI27</TD></TR>
<TR><TD>6.431e-03</TD><TD>-5.05</TD><TD>NT-C2</TD><TD>interpro domains</TD><TD>IPR019448</TD><TD>4</TD><TD>1</TD><TD>18616</TD><TD>30</TD>
<TD>FAM102B</TD></TR>
<TR><TD>6.431e-03</TD><TD>-5.05</TD><TD>IFI6/IFI27-like</TD><TD>interpro domains</TD><TD>IPR009311</TD><TD>4</TD><TD>1</TD><TD>18616</TD><TD>30</TD>
<TD>IFI27</TD></TR>
<TR><TD>6.437e-03</TD><TD>-5.05</TD><TD>IRF_Q6</TD><TD>MSigDB lists</TD><TD>IRF_Q6</TD><TD>228</TD><TD>3</TD><TD>17275</TD><TD>29</TD>
<TD>IFI44,ISG15,IFIT2</TD></TR>
<TR><TD>6.515e-03</TD><TD>-5.03</TD><TD>TBP_01</TD><TD>MSigDB lists</TD><TD>TBP_01</TD><TD>229</TD><TD>3</TD><TD>17275</TD><TD>29</TD>
<TD>DIRAS1,KLHDC8B,MGAT3</TD></TR>
<TR><TD>6.592e-03</TD><TD>-5.02</TD><TD>NRG1 (neuregulin 1)</TD><TD>protein interactions</TD><TD>3084</TD><TD>71</TD><TD>2</TD><TD>17456</TD><TD>30</TD>
<TD>LGR4,ADGRL1</TD></TR>
<TR><TD>6.699e-03</TD><TD>-5.01</TD><TD>CHEN_HOXA5_TARGETS_6HR_DN</TD><TD>MSigDB lists</TD><TD>CHEN_HOXA5_TARGETS_6HR_DN</TD><TD>4</TD><TD>1</TD><TD>17275</TD><TD>29</TD>
<TD>TUBA1A</TD></TR>
<TR><TD>6.749e-03</TD><TD>-5.00</TD><TD>GO_RIBONUCLEOTIDE_BINDING</TD><TD>MSigDB lists</TD><TD>GO_RIBONUCLEOTIDE_BINDING</TD><TD>1752</TD><TD>8</TD><TD>17275</TD><TD>29</TD>
<TD>DIRAS1,CAMKK2,OASL,OAS1,OAS2,OAS3,TUBA1A,IFI44L</TD></TR>
<TR><TD>6.766e-03</TD><TD>-5.00</TD><TD>nephron tubule development</TD><TD>biological process</TD><TD>GO:0072080</TD><TD>77</TD><TD>2</TD><TD>18054</TD><TD>29</TD>
<TD>LGR4,PGF</TD></TR>
<TR><TD>6.773e-03</TD><TD>-4.99</TD><TD>IFIT3 (interferon induced protein with tetratricopeptide repeats 3)</TD><TD>protein interactions</TD><TD>3437</TD><TD>72</TD><TD>2</TD><TD>17456</TD><TD>30</TD>
<TD>IFIT2,ISG15</TD></TR>
<TR><TD>6.773e-03</TD><TD>-4.99</TD><TD>GPR21 (G protein-coupled receptor 21)</TD><TD>protein interactions</TD><TD>2844</TD><TD>72</TD><TD>2</TD><TD>17456</TD><TD>30</TD>
<TD>ADGRL1,LGR4</TD></TR>
<TR><TD>6.833e-03</TD><TD>-4.99</TD><TD>CP2_02</TD><TD>MSigDB lists</TD><TD>CP2_02</TD><TD>233</TD><TD>3</TD><TD>17275</TD><TD>29</TD>
<TD>KIFAP3,RYR1,CAPN6</TD></TR>
<TR><TD>6.857e-03</TD><TD>-4.98</TD><TD>RGPD4 (RANBP2 like and GRIP domain containing 4)</TD><TD>protein interactions</TD><TD>285190</TD><TD>4</TD><TD>1</TD><TD>17456</TD><TD>30</TD>
<TD>LGR4</TD></TR>
<TR><TD>6.857e-03</TD><TD>-4.98</TD><TD>DSCAM (DS cell adhesion molecule)</TD><TD>protein interactions</TD><TD>1826</TD><TD>4</TD><TD>1</TD><TD>17456</TD><TD>30</TD>
<TD>LGR4</TD></TR>
<TR><TD>6.996e-03</TD><TD>-4.96</TD><TD>ISRE_01</TD><TD>MSigDB lists</TD><TD>ISRE_01</TD><TD>235</TD><TD>3</TD><TD>17275</TD><TD>29</TD>
<TD>ISG15,IFIT2,IFI44</TD></TR>
<TR><TD>7.181e-03</TD><TD>-4.94</TD><TD>AGGGCCA_MIR328</TD><TD>MSigDB lists</TD><TD>AGGGCCA_MIR328</TD><TD>76</TD><TD>2</TD><TD>17275</TD><TD>29</TD>
<TD>LGR4,CADM4</TD></TR>
<TR><TD>7.285e-03</TD><TD>-4.92</TD><TD>renal tubule development</TD><TD>biological process</TD><TD>GO:0061326</TD><TD>80</TD><TD>2</TD><TD>18054</TD><TD>29</TD>
<TD>PGF,LGR4</TD></TR>
<TR><TD>7.365e-03</TD><TD>-4.91</TD><TD>SCIBETTA_KDM5B_TARGETS_DN</TD><TD>MSigDB lists</TD><TD>SCIBETTA_KDM5B_TARGETS_DN</TD><TD>77</TD><TD>2</TD><TD>17275</TD><TD>29</TD>
<TD>MCAM,ISG15</TD></TR>
<TR><TD>7.365e-03</TD><TD>-4.91</TD><TD>HERNANDEZ_ABERRANT_MITOSIS_BY_DOCETACEL_2NM_UP</TD><TD>MSigDB lists</TD><TD>HERNANDEZ_ABERRANT_MITOSIS_BY_DOCETACEL_2NM_UP</TD><TD>77</TD><TD>2</TD><TD>17275</TD><TD>29</TD>
<TD>MCAM,IFI44</TD></TR>
<TR><TD>7.413e-03</TD><TD>-4.90</TD><TD>regulation of cellular process</TD><TD>biological process</TD><TD>GO:0050794</TD><TD>10791</TD><TD>24</TD><TD>18054</TD><TD>29</TD>
<TD>CAMKK2,RSAD2,IFIT2,DIRAS1,OAS1,RYR1,OAS3,BCL6B,LGR4,OASL,CAPN6,MGAT3,CADM4,CTSV,MCAM,IFI27,ADGRL1,PGF,OAS2,KIAA1211,TUBA1A,ZNF518B,KIFAP3,ISG15</TD></TR>
<TR><TD>7.490e-03</TD><TD>-4.89</TD><TD>intraciliary transport particle B binding</TD><TD>molecular function</TD><TD>GO:0120170</TD><TD>5</TD><TD>1</TD><TD>17306</TD><TD>26</TD>
<TD>KIFAP3</TD></TR>
<TR><TD>7.493e-03</TD><TD>-4.89</TD><TD>ENK_UV_RESPONSE_KERATINOCYTE_DN</TD><TD>MSigDB lists</TD><TD>ENK_UV_RESPONSE_KERATINOCYTE_DN</TD><TD>470</TD><TD>4</TD><TD>17275</TD><TD>29</TD>
<TD>CAMKK2,KIFAP3,IFI44L,IFI44</TD></TR>
<TR><TD>7.497e-03</TD><TD>-4.89</TD><TD>NF1_Q6</TD><TD>MSigDB lists</TD><TD>NF1_Q6</TD><TD>241</TD><TD>3</TD><TD>17275</TD><TD>29</TD>
<TD>KLHDC8B,PGF,MCAM</TD></TR>
<TR><TD>7.551e-03</TD><TD>-4.89</TD><TD>GO_RENAL_TUBULE_DEVELOPMENT</TD><TD>MSigDB lists</TD><TD>GO_RENAL_TUBULE_DEVELOPMENT</TD><TD>78</TD><TD>2</TD><TD>17275</TD><TD>29</TD>
<TD>PGF,LGR4</TD></TR>
<TR><TD>7.834e-03</TD><TD>-4.85</TD><TD>CGAS (cyclic GMP-AMP synthase)</TD><TD>protein interactions</TD><TD>115004</TD><TD>239</TD><TD>3</TD><TD>17456</TD><TD>30</TD>
<TD>OASL,OAS2,IFIT2</TD></TR>
<TR><TD>7.877e-03</TD><TD>-4.84</TD><TD>cell communication</TD><TD>biological process</TD><TD>GO:0007154</TD><TD>5208</TD><TD>15</TD><TD>18054</TD><TD>29</TD>
<TD>OASL,LGR4,ISG15,KIFAP3,RSAD2,CAMKK2,OAS1,DIRAS1,IFIT2,OAS3,OAS2,PGF,ADGRL1,IFI27,CTSV</TD></TR>
<TR><TD>7.907e-03</TD><TD>-4.84</TD><TD>FAM189A2 (family with sequence similarity 189 member A2)</TD><TD>protein interactions</TD><TD>9413</TD><TD>78</TD><TD>2</TD><TD>17456</TD><TD>30</TD>
<TD>LGR4,ADGRL1</TD></TR>
<TR><TD>7.925e-03</TD><TD>-4.84</TD><TD>C2_NT</TD><TD>prosite domains</TD><TD>PS51840</TD><TD>4</TD><TD>1</TD><TD>12079</TD><TD>24</TD>
<TD>FAM102B</TD></TR>
<TR><TD>7.929e-03</TD><TD>-4.84</TD><TD>MAHAJAN_RESPONSE_TO_IL1A_UP</TD><TD>MSigDB lists</TD><TD>MAHAJAN_RESPONSE_TO_IL1A_UP</TD><TD>80</TD><TD>2</TD><TD>17275</TD><TD>29</TD>
<TD>IFIT2,OASL</TD></TR>
<TR><TD>7.957e-03</TD><TD>-4.83</TD><TD>-</TD><TD>gene3d domains</TD><TD>1.10.246.160</TD><TD>4</TD><TD>1</TD><TD>8522</TD><TD>17</TD>
<TD>IFI27</TD></TR>
<TR><TD>8.005e-03</TD><TD>-4.83</TD><TD>kidney morphogenesis</TD><TD>biological process</TD><TD>GO:0060993</TD><TD>84</TD><TD>2</TD><TD>18054</TD><TD>29</TD>
<TD>LGR4,PGF</TD></TR>
<TR><TD>8.007e-03</TD><TD>-4.83</TD><TD>regulation of barbed-end actin filament capping</TD><TD>biological process</TD><TD>GO:2000812</TD><TD>5</TD><TD>1</TD><TD>18054</TD><TD>29</TD>
<TD>KIAA1211</TD></TR>
<TR><TD>8.007e-03</TD><TD>-4.83</TD><TD>calmodulin dependent kinase signaling pathway</TD><TD>biological process</TD><TD>GO:0099004</TD><TD>5</TD><TD>1</TD><TD>18054</TD><TD>29</TD>
<TD>CAMKK2</TD></TR>
<TR><TD>8.007e-03</TD><TD>-4.83</TD><TD>interleukin-10 production</TD><TD>biological process</TD><TD>GO:0032613</TD><TD>5</TD><TD>1</TD><TD>18054</TD><TD>29</TD>
<TD>ISG15</TD></TR>
<TR><TD>8.007e-03</TD><TD>-4.83</TD><TD>vascular wound healing</TD><TD>biological process</TD><TD>GO:0061042</TD><TD>5</TD><TD>1</TD><TD>18054</TD><TD>29</TD>
<TD>MCAM</TD></TR>
<TR><TD>8.028e-03</TD><TD>-4.82</TD><TD>Gal_Lectin</TD><TD>pfam domains</TD><TD>PF02140</TD><TD>5</TD><TD>1</TD><TD>17385</TD><TD>28</TD>
<TD>ADGRL1</TD></TR>
<TR><TD>8.033e-03</TD><TD>-4.82</TD><TD>Lectin_gal-bd_dom</TD><TD>interpro domains</TD><TD>IPR000922</TD><TD>5</TD><TD>1</TD><TD>18616</TD><TD>30</TD>
<TD>ADGRL1</TD></TR>
<TR><TD>8.274e-03</TD><TD>-4.79</TD><TD>small molecule binding</TD><TD>molecular function</TD><TD>GO:0036094</TD><TD>2501</TD><TD>9</TD><TD>17306</TD><TD>26</TD>
<TD>OAS2,OAS1,OAS3,CAMKK2,OASL,TUBA1A,IFI44L,DIRAS1,RYR1</TD></TR>
<TR><TD>8.316e-03</TD><TD>-4.79</TD><TD>GO_KIDNEY_MORPHOGENESIS</TD><TD>MSigDB lists</TD><TD>GO_KIDNEY_MORPHOGENESIS</TD><TD>82</TD><TD>2</TD><TD>17275</TD><TD>29</TD>
<TD>PGF,LGR4</TD></TR>
<TR><TD>8.366e-03</TD><TD>-4.78</TD><TD>LU_TUMOR_ENDOTHELIAL_MARKERS_DN</TD><TD>MSigDB lists</TD><TD>LU_TUMOR_ENDOTHELIAL_MARKERS_DN</TD><TD>5</TD><TD>1</TD><TD>17275</TD><TD>29</TD>
<TD>HS6ST2</TD></TR>
<TR><TD>8.366e-03</TD><TD>-4.78</TD><TD>CALVET_IRINOTECAN_SENSITIVE_VS_REVERTED_UP</TD><TD>MSigDB lists</TD><TD>CALVET_IRINOTECAN_SENSITIVE_VS_REVERTED_UP</TD><TD>5</TD><TD>1</TD><TD>17275</TD><TD>29</TD>
<TD>PGF</TD></TR>
<TR><TD>8.366e-03</TD><TD>-4.78</TD><TD>KREPPEL_CD99_TARGETS_UP</TD><TD>MSigDB lists</TD><TD>KREPPEL_CD99_TARGETS_UP</TD><TD>5</TD><TD>1</TD><TD>17275</TD><TD>29</TD>
<TD>PGF</TD></TR>
<TR><TD>8.471e-03</TD><TD>-4.77</TD><TD>NF1_Q6_01</TD><TD>MSigDB lists</TD><TD>NF1_Q6_01</TD><TD>252</TD><TD>3</TD><TD>17275</TD><TD>29</TD>
<TD>KLHDC8B,PGF,MCAM</TD></TR>
<TR><TD>8.504e-03</TD><TD>-4.77</TD><TD>Cep152 (centrosomal protein 152)</TD><TD>protein interactions</TD><TD>99100</TD><TD>81</TD><TD>2</TD><TD>17456</TD><TD>30</TD>
<TD>KIAA1211,LGR4</TD></TR>
<TR><TD>8.511e-03</TD><TD>-4.77</TD><TD>TGACAGNY_MEIS1_01</TD><TD>MSigDB lists</TD><TD>TGACAGNY_MEIS1_01</TD><TD>771</TD><TD>5</TD><TD>17275</TD><TD>29</TD>
<TD>BCL6B,KIFAP3,CAMKK2,CAPN6,MCAM</TD></TR>
<TR><TD>8.513e-03</TD><TD>-4.77</TD><TD>SREBP1_02</TD><TD>MSigDB lists</TD><TD>SREBP1_02</TD><TD>83</TD><TD>2</TD><TD>17275</TD><TD>29</TD>
<TD>HS6ST2,BCL6B</TD></TR>
<TR><TD>8.565e-03</TD><TD>-4.76</TD><TD>FUT4 (fucosyltransferase 4)</TD><TD>protein interactions</TD><TD>2526</TD><TD>5</TD><TD>1</TD><TD>17456</TD><TD>30</TD>
<TD>ISG15</TD></TR>
<TR><TD>8.707e-03</TD><TD>-4.74</TD><TD>MAP4 (microtubule associated protein 4)</TD><TD>protein interactions</TD><TD>4134</TD><TD>82</TD><TD>2</TD><TD>17456</TD><TD>30</TD>
<TD>ISG15,LGR4</TD></TR>
<TR><TD>8.913e-03</TD><TD>-4.72</TD><TD>RAP1GDS1 (Rap1 GTPase-GDP dissociation stimulator 1)</TD><TD>protein interactions</TD><TD>5910</TD><TD>83</TD><TD>2</TD><TD>17456</TD><TD>30</TD>
<TD>DIRAS1,KIFAP3</TD></TR>
<TR><TD>8.937e-03</TD><TD>-4.72</TD><TD>LU_EZH2_TARGETS_UP</TD><TD>MSigDB lists</TD><TD>LU_EZH2_TARGETS_UP</TD><TD>257</TD><TD>3</TD><TD>17275</TD><TD>29</TD>
<TD>OASL,IFI27,ISG15</TD></TR>
<TR><TD>9.007e-03</TD><TD>-4.71</TD><TD>GLYCHORMONER</TD><TD>prints domains</TD><TD>PR00373</TD><TD>6</TD><TD>1</TD><TD>4648</TD><TD>7</TD>
<TD>LGR4</TD></TR>
<TR><TD>9.131e-03</TD><TD>-4.70</TD><TD>periciliary membrane compartment</TD><TD>cellular component</TD><TD>GO:1990075</TD><TD>6</TD><TD>1</TD><TD>18985</TD><TD>29</TD>
<TD>KIFAP3</TD></TR>
<TR><TD>9.446e-03</TD><TD>-4.66</TD><TD>cellular response to stimulus</TD><TD>biological process</TD><TD>GO:0051716</TD><TD>6423</TD><TD>17</TD><TD>18054</TD><TD>29</TD>
<TD>OASL,LGR4,RYR1,OAS1,DIRAS1,IFIT2,RSAD2,CAMKK2,OAS3,ISG15,KIFAP3,MGAT3,OAS2,PGF,CTSV,ADGRL1,IFI27</TD></TR>
<TR><TD>9.487e-03</TD><TD>-4.66</TD><TD>signal transduction</TD><TD>biological process</TD><TD>GO:0007165</TD><TD>4772</TD><TD>14</TD><TD>18054</TD><TD>29</TD>
<TD>OASL,LGR4,ISG15,KIFAP3,OAS1,DIRAS1,IFIT2,RSAD2,CAMKK2,OAS3,OAS2,IFI27,ADGRL1,PGF</TD></TR>
<TR><TD>9.516e-03</TD><TD>-4.65</TD><TD>WANG_SMARCE1_TARGETS_UP</TD><TD>MSigDB lists</TD><TD>WANG_SMARCE1_TARGETS_UP</TD><TD>263</TD><TD>3</TD><TD>17275</TD><TD>29</TD>
<TD>HS6ST2,DIRAS1,IFIT2</TD></TR>
<TR><TD>9.516e-03</TD><TD>-4.65</TD><TD>MULLIGHAN_MLL_SIGNATURE_2_DN</TD><TD>MSigDB lists</TD><TD>MULLIGHAN_MLL_SIGNATURE_2_DN</TD><TD>263</TD><TD>3</TD><TD>17275</TD><TD>29</TD>
<TD>IFI44,PGF,KIFAP3</TD></TR>
<TR><TD>9.600e-03</TD><TD>-4.65</TD><TD>heparan sulfate proteoglycan biosynthetic process, enzymatic modification</TD><TD>biological process</TD><TD>GO:0015015</TD><TD>6</TD><TD>1</TD><TD>18054</TD><TD>29</TD>
<TD>HS6ST2</TD></TR>
<TR><TD>9.600e-03</TD><TD>-4.65</TD><TD>ISG15-protein conjugation</TD><TD>biological process</TD><TD>GO:0032020</TD><TD>6</TD><TD>1</TD><TD>18054</TD><TD>29</TD>
<TD>ISG15</TD></TR>
<TR><TD>9.600e-03</TD><TD>-4.65</TD><TD>positive regulation of mast cell chemotaxis</TD><TD>biological process</TD><TD>GO:0060754</TD><TD>6</TD><TD>1</TD><TD>18054</TD><TD>29</TD>
<TD>PGF</TD></TR>
<TR><TD>9.615e-03</TD><TD>-4.64</TD><TD>KRAS.600_UP.V1_DN</TD><TD>MSigDB lists</TD><TD>KRAS.600_UP.V1_DN</TD><TD>264</TD><TD>3</TD><TD>17275</TD><TD>29</TD>
<TD>OAS1,CADM4,IFI44L</TD></TR>
<TR><TD>9.626e-03</TD><TD>-4.64</TD><TD>RIH_assoc</TD><TD>pfam domains</TD><TD>PF08454</TD><TD>6</TD><TD>1</TD><TD>17385</TD><TD>28</TD>
<TD>RYR1</TD></TR>
<TR><TD>9.626e-03</TD><TD>-4.64</TD><TD>Ins145_P3_rec</TD><TD>pfam domains</TD><TD>PF08709</TD><TD>6</TD><TD>1</TD><TD>17385</TD><TD>28</TD>
<TD>RYR1</TD></TR>
<TR><TD>9.626e-03</TD><TD>-4.64</TD><TD>TLD</TD><TD>pfam domains</TD><TD>PF07534</TD><TD>6</TD><TD>1</TD><TD>17385</TD><TD>28</TD>
<TD>IFI44</TD></TR>
<TR><TD>9.626e-03</TD><TD>-4.64</TD><TD>RYDR_ITPR</TD><TD>pfam domains</TD><TD>PF01365</TD><TD>6</TD><TD>1</TD><TD>17385</TD><TD>28</TD>
<TD>RYR1</TD></TR>
<TR><TD>9.632e-03</TD><TD>-4.64</TD><TD>RIH_dom</TD><TD>interpro domains</TD><TD>IPR000699</TD><TD>6</TD><TD>1</TD><TD>18616</TD><TD>30</TD>
<TD>RYR1</TD></TR>
<TR><TD>9.632e-03</TD><TD>-4.64</TD><TD>RyR/IP3R_RIH_dom_sf</TD><TD>interpro domains</TD><TD>IPR035910</TD><TD>6</TD><TD>1</TD><TD>18616</TD><TD>30</TD>
<TD>RYR1</TD></TR>
<TR><TD>9.632e-03</TD><TD>-4.64</TD><TD>RIH_assoc-dom</TD><TD>interpro domains</TD><TD>IPR013662</TD><TD>6</TD><TD>1</TD><TD>18616</TD><TD>30</TD>
<TD>RYR1</TD></TR>
<TR><TD>9.632e-03</TD><TD>-4.64</TD><TD>TLDc_dom</TD><TD>interpro domains</TD><TD>IPR006571</TD><TD>6</TD><TD>1</TD><TD>18616</TD><TD>30</TD>
<TD>IFI44</TD></TR>
<TR><TD>9.632e-03</TD><TD>-4.64</TD><TD>Ins145_P3_rcpt</TD><TD>interpro domains</TD><TD>IPR014821</TD><TD>6</TD><TD>1</TD><TD>18616</TD><TD>30</TD>
<TD>RYR1</TD></TR>
<TR><TD>9.632e-03</TD><TD>-4.64</TD><TD>Gphrmn_rcpt_fam</TD><TD>interpro domains</TD><TD>IPR002131</TD><TD>6</TD><TD>1</TD><TD>18616</TD><TD>30</TD>
<TD>LGR4</TD></TR>
<TR><TD>9.897e-03</TD><TD>-4.62</TD><TD>SUEL_LECTIN</TD><TD>prosite domains</TD><TD>PS50228</TD><TD>5</TD><TD>1</TD><TD>12079</TD><TD>24</TD>
<TD>ADGRL1</TD></TR>
<TR><TD>9.946e-03</TD><TD>-4.61</TD><TD>GSE37532_VISCERAL_ADIPOSE_TISSUE_VS_LN_DERIVED_TCONV_CD4_TCELL_DN</TD><TD>MSigDB lists</TD><TD>GSE37532_VISCERAL_ADIPOSE_TISSUE_VS_LN_DERIVED_TCONV_CD4_TCELL_DN</TD><TD>90</TD><TD>2</TD><TD>17275</TD><TD>29</TD>
<TD>LGR4,IFI44L</TD></TR>
<TR><TD>9.973e-03</TD><TD>-4.61</TD><TD>MANSC1 (MANSC domain containing 1)</TD><TD>protein interactions</TD><TD>54682</TD><TD>88</TD><TD>2</TD><TD>17456</TD><TD>30</TD>
<TD>DIRAS1,LGR4</TD></TR>
<TR><TD>1.027e-02</TD><TD>-4.58</TD><TD>CACNA1S (calcium voltage-gated channel subunit alpha1 S)</TD><TD>protein interactions</TD><TD>779</TD><TD>6</TD><TD>1</TD><TD>17456</TD><TD>30</TD>
<TD>RYR1</TD></TR>
<TR><TD>1.027e-02</TD><TD>-4.58</TD><TD>TKTL1 (transketolase like 1)</TD><TD>protein interactions</TD><TD>8277</TD><TD>6</TD><TD>1</TD><TD>17456</TD><TD>30</TD>
<TD>TUBA1A</TD></TR>
<TR><TD>1.027e-02</TD><TD>-4.58</TD><TD>ZDHHC1 (zinc finger DHHC-type containing 1)</TD><TD>protein interactions</TD><TD>29800</TD><TD>6</TD><TD>1</TD><TD>17456</TD><TD>30</TD>
<TD>LGR4</TD></TR>
<TR><TD>1.027e-02</TD><TD>-4.58</TD><TD>PGF (placental growth factor)</TD><TD>protein interactions</TD><TD>5228</TD><TD>6</TD><TD>1</TD><TD>17456</TD><TD>30</TD>
<TD>PGF</TD></TR>
<TR><TD>1.027e-02</TD><TD>-4.58</TD><TD>Psma2 (proteasome (prosome, macropain) subunit, alpha type 2)</TD><TD>protein interactions</TD><TD>19166</TD><TD>6</TD><TD>1</TD><TD>17456</TD><TD>30</TD>
<TD>TUBA1A</TD></TR>
<TR><TD>1.035e-02</TD><TD>-4.57</TD><TD>nephron epithelium development</TD><TD>biological process</TD><TD>GO:0072009</TD><TD>96</TD><TD>2</TD><TD>18054</TD><TD>29</TD>
<TD>LGR4,PGF</TD></TR>
<TR><TD>1.037e-02</TD><TD>-4.57</TD><TD>GO_NEPHRON_EPITHELIUM_DEVELOPMENT</TD><TD>MSigDB lists</TD><TD>GO_NEPHRON_EPITHELIUM_DEVELOPMENT</TD><TD>92</TD><TD>2</TD><TD>17275</TD><TD>29</TD>
<TD>LGR4,PGF</TD></TR>
<TR><TD>1.053e-02</TD><TD>-4.55</TD><TD>DURAND_STROMA_S_UP</TD><TD>MSigDB lists</TD><TD>DURAND_STROMA_S_UP</TD><TD>273</TD><TD>3</TD><TD>17275</TD><TD>29</TD>
<TD>IFI27,CAPN6,OASL</TD></TR>
<TR><TD>1.065e-02</TD><TD>-4.54</TD><TD>junctional membrane complex</TD><TD>cellular component</TD><TD>GO:0030314</TD><TD>7</TD><TD>1</TD><TD>18985</TD><TD>29</TD>
<TD>RYR1</TD></TR>
<TR><TD>1.068e-02</TD><TD>-4.54</TD><TD>MODULE_84</TD><TD>MSigDB lists</TD><TD>MODULE_84</TD><TD>521</TD><TD>4</TD><TD>17275</TD><TD>29</TD>
<TD>ISG15,IFI27,IFI44,IFI44L</TD></TR>
<TR><TD>1.076e-02</TD><TD>-4.53</TD><TD>antigen processing and presentation of exogenous peptide antigen via MHC class II</TD><TD>biological process</TD><TD>GO:0019886</TD><TD>98</TD><TD>2</TD><TD>18054</TD><TD>29</TD>
<TD>KIFAP3,CTSV</TD></TR>
<TR><TD>1.098e-02</TD><TD>-4.51</TD><TD>antigen processing and presentation of peptide or polysaccharide antigen via MHC class II</TD><TD>biological process</TD><TD>GO:0002504</TD><TD>99</TD><TD>2</TD><TD>18054</TD><TD>29</TD>
<TD>KIFAP3,CTSV</TD></TR>
<TR><TD>1.098e-02</TD><TD>-4.51</TD><TD>antigen processing and presentation of peptide antigen via MHC class II</TD><TD>biological process</TD><TD>GO:0002495</TD><TD>99</TD><TD>2</TD><TD>18054</TD><TD>29</TD>
<TD>CTSV,KIFAP3</TD></TR>
<TR><TD>1.101e-02</TD><TD>-4.51</TD><TD>transferase activity, transferring phosphorus-containing groups</TD><TD>molecular function</TD><TD>GO:0016772</TD><TD>923</TD><TD>5</TD><TD>17306</TD><TD>26</TD>
<TD>OASL,OAS2,OAS1,OAS3,CAMKK2</TD></TR>
<TR><TD>1.119e-02</TD><TD>-4.49</TD><TD>plus-end-directed vesicle transport along microtubule</TD><TD>biological process</TD><TD>GO:0072383</TD><TD>7</TD><TD>1</TD><TD>18054</TD><TD>29</TD>
<TD>KIFAP3</TD></TR>
<TR><TD>1.119e-02</TD><TD>-4.49</TD><TD>positive regulation of T-helper 2 cell cytokine production</TD><TD>biological process</TD><TD>GO:2000553</TD><TD>7</TD><TD>1</TD><TD>18054</TD><TD>29</TD>
<TD>RSAD2</TD></TR>
<TR><TD>1.119e-02</TD><TD>-4.49</TD><TD>autophagic cell death</TD><TD>biological process</TD><TD>GO:0048102</TD><TD>7</TD><TD>1</TD><TD>18054</TD><TD>29</TD>
<TD>CTSV</TD></TR>
<TR><TD>1.119e-02</TD><TD>-4.49</TD><TD>regulation of mast cell chemotaxis</TD><TD>biological process</TD><TD>GO:0060753</TD><TD>7</TD><TD>1</TD><TD>18054</TD><TD>29</TD>
<TD>PGF</TD></TR>
<TR><TD>1.122e-02</TD><TD>-4.49</TD><TD>Inhibitor_I29</TD><TD>pfam domains</TD><TD>PF08246</TD><TD>7</TD><TD>1</TD><TD>17385</TD><TD>28</TD>
<TD>CTSV</TD></TR>
<TR><TD>1.123e-02</TD><TD>-4.49</TD><TD>Elp3/MiaB/NifB</TD><TD>interpro domains</TD><TD>IPR006638</TD><TD>7</TD><TD>1</TD><TD>18616</TD><TD>30</TD>
<TD>RSAD2</TD></TR>
<TR><TD>1.123e-02</TD><TD>-4.49</TD><TD>Prot_inhib_I29</TD><TD>interpro domains</TD><TD>IPR013201</TD><TD>7</TD><TD>1</TD><TD>18616</TD><TD>30</TD>
<TD>CTSV</TD></TR>
<TR><TD>1.123e-02</TD><TD>-4.49</TD><TD>PD_growth_factor_CS</TD><TD>interpro domains</TD><TD>IPR023581</TD><TD>7</TD><TD>1</TD><TD>18616</TD><TD>30</TD>
<TD>PGF</TD></TR>
<TR><TD>1.125e-02</TD><TD>-4.49</TD><TD>BROWNE_HCMV_INFECTION_8HR_UP</TD><TD>MSigDB lists</TD><TD>BROWNE_HCMV_INFECTION_8HR_UP</TD><TD>96</TD><TD>2</TD><TD>17275</TD><TD>29</TD>
<TD>OAS1,OAS2</TD></TR>
<TR><TD>1.169e-02</TD><TD>-4.45</TD><TD>chr1p</TD><TD>MSigDB lists</TD><TD>chr1p</TD><TD>7</TD><TD>1</TD><TD>17275</TD><TD>29</TD>
<TD>IFI44</TD></TR>
<TR><TD>1.194e-02</TD><TD>-4.43</TD><TD>GROSS_HYPOXIA_VIA_ELK3_AND_HIF1A_DN</TD><TD>MSigDB lists</TD><TD>GROSS_HYPOXIA_VIA_ELK3_AND_HIF1A_DN</TD><TD>99</TD><TD>2</TD><TD>17275</TD><TD>29</TD>
<TD>BCL6B,CAMKK2</TD></TR>
<TR><TD>1.196e-02</TD><TD>-4.43</TD><TD>vascular endothelial growth factor receptor 2 binding</TD><TD>molecular function</TD><TD>GO:0043184</TD><TD>8</TD><TD>1</TD><TD>17306</TD><TD>26</TD>
<TD>CADM4</TD></TR>
<TR><TD>1.197e-02</TD><TD>-4.43</TD><TD>FAM110C (family with sequence similarity 110 member C)</TD><TD>protein interactions</TD><TD>642273</TD><TD>7</TD><TD>1</TD><TD>17456</TD><TD>30</TD>
<TD>TUBA1A</TD></TR>
<TR><TD>1.197e-02</TD><TD>-4.43</TD><TD>RFLNB (refilin B)</TD><TD>protein interactions</TD><TD>359845</TD><TD>7</TD><TD>1</TD><TD>17456</TD><TD>30</TD>
<TD>CAPN6</TD></TR>
<TR><TD>1.197e-02</TD><TD>-4.43</TD><TD>PKHD1 (PKHD1 ciliary IPT domain containing fibrocystin/polyductin)</TD><TD>protein interactions</TD><TD>5314</TD><TD>7</TD><TD>1</TD><TD>17456</TD><TD>30</TD>
<TD>LGR4</TD></TR>
<TR><TD>1.199e-02</TD><TD>-4.42</TD><TD>ALPHATUBULIN</TD><TD>prints domains</TD><TD>PR01162</TD><TD>8</TD><TD>1</TD><TD>4648</TD><TD>7</TD>
<TD>TUBA1A</TD></TR>
<TR><TD>1.217e-02</TD><TD>-4.41</TD><TD>ICHIBA_GRAFT_VERSUS_HOST_DISEASE_D7_UP</TD><TD>MSigDB lists</TD><TD>ICHIBA_GRAFT_VERSUS_HOST_DISEASE_D7_UP</TD><TD>100</TD><TD>2</TD><TD>17275</TD><TD>29</TD>
<TD>ISG15,IFI27</TD></TR>
<TR><TD>1.240e-02</TD><TD>-4.39</TD><TD>WESTON_VEGFA_TARGETS</TD><TD>MSigDB lists</TD><TD>WESTON_VEGFA_TARGETS</TD><TD>101</TD><TD>2</TD><TD>17275</TD><TD>29</TD>
<TD>PGF,IFI27</TD></TR>
<TR><TD>1.261e-02</TD><TD>-4.37</TD><TD>cysteine-type endopeptidase activity</TD><TD>molecular function</TD><TD>GO:0004197</TD><TD>114</TD><TD>2</TD><TD>17306</TD><TD>26</TD>
<TD>CTSV,CAPN6</TD></TR>
<TR><TD>1.263e-02</TD><TD>-4.37</TD><TD>GO_NEGATIVE_REGULATION_OF_PROTEIN_SECRETION</TD><TD>MSigDB lists</TD><TD>GO_NEGATIVE_REGULATION_OF_PROTEIN_SECRETION</TD><TD>102</TD><TD>2</TD><TD>17275</TD><TD>29</TD>
<TD>RSAD2,LGR4</TD></TR>
<TR><TD>1.263e-02</TD><TD>-4.37</TD><TD>PLASARI_TGFB1_SIGNALING_VIA_NFIC_1HR_DN</TD><TD>MSigDB lists</TD><TD>PLASARI_TGFB1_SIGNALING_VIA_NFIC_1HR_DN</TD><TD>102</TD><TD>2</TD><TD>17275</TD><TD>29</TD>
<TD>CADM4,IFI44</TD></TR>
<TR><TD>1.278e-02</TD><TD>-4.36</TD><TD>regulation of toll-like receptor 9 signaling pathway</TD><TD>biological process</TD><TD>GO:0034163</TD><TD>8</TD><TD>1</TD><TD>18054</TD><TD>29</TD>
<TD>RSAD2</TD></TR>
<TR><TD>1.278e-02</TD><TD>-4.36</TD><TD>release of sequestered calcium ion into cytosol by sarcoplasmic reticulum</TD><TD>biological process</TD><TD>GO:0014808</TD><TD>8</TD><TD>1</TD><TD>18054</TD><TD>29</TD>
<TD>RYR1</TD></TR>
<TR><TD>1.278e-02</TD><TD>-4.36</TD><TD>regulation of lysosomal protein catabolic process</TD><TD>biological process</TD><TD>GO:1905165</TD><TD>8</TD><TD>1</TD><TD>18054</TD><TD>29</TD>
<TD>MGAT3</TD></TR>
<TR><TD>1.278e-02</TD><TD>-4.36</TD><TD>glomerular filtration</TD><TD>biological process</TD><TD>GO:0003094</TD><TD>8</TD><TD>1</TD><TD>18054</TD><TD>29</TD>
<TD>MCAM</TD></TR>
<TR><TD>1.278e-02</TD><TD>-4.36</TD><TD>plus-end-directed organelle transport along microtubule</TD><TD>biological process</TD><TD>GO:0072386</TD><TD>8</TD><TD>1</TD><TD>18054</TD><TD>29</TD>
<TD>KIFAP3</TD></TR>
<TR><TD>1.278e-02</TD><TD>-4.36</TD><TD>metanephric nephron tubule morphogenesis</TD><TD>biological process</TD><TD>GO:0072282</TD><TD>8</TD><TD>1</TD><TD>18054</TD><TD>29</TD>
<TD>LGR4</TD></TR>
<TR><TD>1.278e-02</TD><TD>-4.36</TD><TD>positive regulation of protein localization to early endosome</TD><TD>biological process</TD><TD>GO:1902966</TD><TD>8</TD><TD>1</TD><TD>18054</TD><TD>29</TD>
<TD>MGAT3</TD></TR>
<TR><TD>1.278e-02</TD><TD>-4.36</TD><TD>regulation of protein localization to early endosome</TD><TD>biological process</TD><TD>GO:1902965</TD><TD>8</TD><TD>1</TD><TD>18054</TD><TD>29</TD>
<TD>MGAT3</TD></TR>
<TR><TD>1.282e-02</TD><TD>-4.36</TD><TD>Somatomedin_B-like_dom_sf</TD><TD>interpro domains</TD><TD>IPR036024</TD><TD>8</TD><TD>1</TD><TD>18616</TD><TD>30</TD>
<TD>SBSPON</TD></TR>
<TR><TD>1.282e-02</TD><TD>-4.36</TD><TD>Alpha_tubulin</TD><TD>interpro domains</TD><TD>IPR002452</TD><TD>8</TD><TD>1</TD><TD>18616</TD><TD>30</TD>
<TD>TUBA1A</TD></TR>
<TR><TD>1.282e-02</TD><TD>-4.36</TD><TD>Peptidase_C1A_papain-like</TD><TD>interpro domains</TD><TD>IPR039417</TD><TD>8</TD><TD>1</TD><TD>18616</TD><TD>30</TD>
<TD>CTSV</TD></TR>
<TR><TD>1.309e-02</TD><TD>-4.34</TD><TD>HELLER_HDAC_TARGETS_UP</TD><TD>MSigDB lists</TD><TD>HELLER_HDAC_TARGETS_UP</TD><TD>296</TD><TD>3</TD><TD>17275</TD><TD>29</TD>
<TD>TUBA1A,CADM4,ISG15</TD></TR>
<TR><TD>1.311e-02</TD><TD>-4.33</TD><TD>PEDERSEN_METASTASIS_BY_ERBB2_ISOFORM_4</TD><TD>MSigDB lists</TD><TD>PEDERSEN_METASTASIS_BY_ERBB2_ISOFORM_4</TD><TD>104</TD><TD>2</TD><TD>17275</TD><TD>29</TD>
<TD>KIAA1211,TUBA1A</TD></TR>
<TR><TD>1.333e-02</TD><TD>-4.32</TD><TD>DOUGLAS_BMI1_TARGETS_DN</TD><TD>MSigDB lists</TD><TD>DOUGLAS_BMI1_TARGETS_DN</TD><TD>298</TD><TD>3</TD><TD>17275</TD><TD>29</TD>
<TD>IFIT2,OAS3,OAS1</TD></TR>
<TR><TD>1.335e-02</TD><TD>-4.32</TD><TD>GO_RENAL_FILTRATION</TD><TD>MSigDB lists</TD><TD>GO_RENAL_FILTRATION</TD><TD>8</TD><TD>1</TD><TD>17275</TD><TD>29</TD>
<TD>MCAM</TD></TR>
<TR><TD>1.335e-02</TD><TD>-4.32</TD><TD>SIMBULAN_UV_RESPONSE_NORMAL_UP</TD><TD>MSigDB lists</TD><TD>SIMBULAN_UV_RESPONSE_NORMAL_UP</TD><TD>8</TD><TD>1</TD><TD>17275</TD><TD>29</TD>
<TD>IFI27</TD></TR>
<TR><TD>1.335e-02</TD><TD>-4.32</TD><TD>TSUTSUMI_FBXW8_TARGETS</TD><TD>MSigDB lists</TD><TD>TSUTSUMI_FBXW8_TARGETS</TD><TD>8</TD><TD>1</TD><TD>17275</TD><TD>29</TD>
<TD>RYR1</TD></TR>
<TR><TD>1.367e-02</TD><TD>-4.29</TD><TD>junctional sarcoplasmic reticulum membrane</TD><TD>cellular component</TD><TD>GO:0014701</TD><TD>9</TD><TD>1</TD><TD>18985</TD><TD>29</TD>
<TD>RYR1</TD></TR>
<TR><TD>1.367e-02</TD><TD>-4.29</TD><TD>DCT (dopachrome tautomerase)</TD><TD>protein interactions</TD><TD>1638</TD><TD>8</TD><TD>1</TD><TD>17456</TD><TD>30</TD>
<TD>LGR4</TD></TR>
<TR><TD>1.367e-02</TD><TD>-4.29</TD><TD>DCDC1 (doublecortin domain containing 1)</TD><TD>protein interactions</TD><TD>341019</TD><TD>8</TD><TD>1</TD><TD>17456</TD><TD>30</TD>
<TD>TUBA1A</TD></TR>
<TR><TD>1.367e-02</TD><TD>-4.29</TD><TD>AKR1D1 (aldo-keto reductase family 1 member D1)</TD><TD>protein interactions</TD><TD>6718</TD><TD>8</TD><TD>1</TD><TD>17456</TD><TD>30</TD>
<TD>DIRAS1</TD></TR>
<TR><TD>1.367e-02</TD><TD>-4.29</TD><TD>KEL (Kell metallo-endopeptidase (Kell blood group))</TD><TD>protein interactions</TD><TD>3792</TD><TD>8</TD><TD>1</TD><TD>17456</TD><TD>30</TD>
<TD>TUBA1A</TD></TR>
<TR><TD>1.367e-02</TD><TD>-4.29</TD><TD>TBC1D3 (TBC1 domain family member 3)</TD><TD>protein interactions</TD><TD>729873</TD><TD>8</TD><TD>1</TD><TD>17456</TD><TD>30</TD>
<TD>TUBA1A</TD></TR>
<TR><TD>1.367e-02</TD><TD>-4.29</TD><TD>PIGG (phosphatidylinositol glycan anchor biosynthesis class G)</TD><TD>protein interactions</TD><TD>54872</TD><TD>8</TD><TD>1</TD><TD>17456</TD><TD>30</TD>
<TD>LGR4</TD></TR>
<TR><TD>1.367e-02</TD><TD>-4.29</TD><TD>CD69 (CD69 molecule)</TD><TD>protein interactions</TD><TD>969</TD><TD>8</TD><TD>1</TD><TD>17456</TD><TD>30</TD>
<TD>CADM4</TD></TR>
<TR><TD>1.367e-02</TD><TD>-4.29</TD><TD>GIMAP8 (GTPase, IMAP family member 8)</TD><TD>protein interactions</TD><TD>155038</TD><TD>8</TD><TD>1</TD><TD>17456</TD><TD>30</TD>
<TD>OAS2</TD></TR>
<TR><TD>1.367e-02</TD><TD>-4.29</TD><TD>ROS1 (ROS proto-oncogene 1, receptor tyrosine kinase)</TD><TD>protein interactions</TD><TD>6098</TD><TD>8</TD><TD>1</TD><TD>17456</TD><TD>30</TD>
<TD>ADGRL1</TD></TR>
<TR><TD>1.367e-02</TD><TD>-4.29</TD><TD>TRIM40 (tripartite motif containing 40)</TD><TD>protein interactions</TD><TD>135644</TD><TD>8</TD><TD>1</TD><TD>17456</TD><TD>30</TD>
<TD>LGR4</TD></TR>
<TR><TD>1.368e-02</TD><TD>-4.29</TD><TD>MHC class II antigen presentation</TD><TD>REACTOME pathways</TD><TD>R-HSA-2132295</TD><TD>103</TD><TD>2</TD><TD>10287</TD><TD>18</TD>
<TD>KIFAP3,CTSV</TD></TR>
<TR><TD>1.383e-02</TD><TD>-4.28</TD><TD>PDGF_1</TD><TD>prosite domains</TD><TD>PS00249</TD><TD>7</TD><TD>1</TD><TD>12079</TD><TD>24</TD>
<TD>PGF</TD></TR>
<TR><TD>1.389e-02</TD><TD>-4.28</TD><TD>SPIELMAN_LYMPHOBLAST_EUROPEAN_VS_ASIAN_DN</TD><TD>MSigDB lists</TD><TD>SPIELMAN_LYMPHOBLAST_EUROPEAN_VS_ASIAN_DN</TD><TD>563</TD><TD>4</TD><TD>17275</TD><TD>29</TD>
<TD>OAS3,OAS2,CAMKK2,KIFAP3</TD></TR>
<TR><TD>1.392e-02</TD><TD>-4.27</TD><TD>VEGF binds to VEGFR leading to receptor dimerization</TD><TD>REACTOME pathways</TD><TD>R-HSA-195399</TD><TD>8</TD><TD>1</TD><TD>10287</TD><TD>18</TD>
<TD>PGF</TD></TR>
<TR><TD>1.392e-02</TD><TD>-4.27</TD><TD>VEGF ligand-receptor interactions</TD><TD>REACTOME pathways</TD><TD>R-HSA-194313</TD><TD>8</TD><TD>1</TD><TD>10287</TD><TD>18</TD>
<TD>PGF</TD></TR>
<TR><TD>1.396e-02</TD><TD>-4.27</TD><TD>Elp3</TD><TD>smart domains</TD><TD>SM00729</TD><TD>7</TD><TD>1</TD><TD>9476</TD><TD>19</TD>
<TD>RSAD2</TD></TR>
<TR><TD>1.396e-02</TD><TD>-4.27</TD><TD>Inhibitor_I29</TD><TD>smart domains</TD><TD>SM00848</TD><TD>7</TD><TD>1</TD><TD>9476</TD><TD>19</TD>
<TD>CTSV</TD></TR>
<TR><TD>1.404e-02</TD><TD>-4.27</TD><TD>large_intestine-colon-adenoma</TD><TD>COSMIC cancer mutations</TD><TD>large_intestine-colon-adenoma</TD><TD>632</TD><TD>4</TD><TD>17255</TD><TD>26</TD>
<TD>KIFAP3,RYR1,HS6ST2,ZNF518B</TD></TR>
<TR><TD>1.408e-02</TD><TD>-4.26</TD><TD>CERVERA_SDHB_TARGETS_1_UP</TD><TD>MSigDB lists</TD><TD>CERVERA_SDHB_TARGETS_1_UP</TD><TD>108</TD><TD>2</TD><TD>17275</TD><TD>29</TD>
<TD>IFIT2,TUBA1A</TD></TR>
<TR><TD>1.422e-02</TD><TD>-4.25</TD><TD>PAFAH1B1 (platelet activating factor acetylhydrolase 1b regulatory subunit 1)</TD><TD>protein interactions</TD><TD>5048</TD><TD>106</TD><TD>2</TD><TD>17456</TD><TD>30</TD>
<TD>ISG15,TUBA1A</TD></TR>
<TR><TD>1.433e-02</TD><TD>-4.25</TD><TD>GO_CYTOSKELETON_DEPENDENT_INTRACELLULAR_TRANSPORT</TD><TD>MSigDB lists</TD><TD>GO_CYTOSKELETON_DEPENDENT_INTRACELLULAR_TRANSPORT</TD><TD>109</TD><TD>2</TD><TD>17275</TD><TD>29</TD>
<TD>TUBA1A,KIFAP3</TD></TR>
<TR><TD>1.437e-02</TD><TD>-4.24</TD><TD>interferon-gamma secretion</TD><TD>biological process</TD><TD>GO:0072643</TD><TD>9</TD><TD>1</TD><TD>18054</TD><TD>29</TD>
<TD>ISG15</TD></TR>
<TR><TD>1.437e-02</TD><TD>-4.24</TD><TD>positive regulation of synapse maturation</TD><TD>biological process</TD><TD>GO:0090129</TD><TD>9</TD><TD>1</TD><TD>18054</TD><TD>29</TD>
<TD>ADGRL1</TD></TR>
<TR><TD>1.437e-02</TD><TD>-4.24</TD><TD>renal filtration</TD><TD>biological process</TD><TD>GO:0097205</TD><TD>9</TD><TD>1</TD><TD>18054</TD><TD>29</TD>
<TD>MCAM</TD></TR>
<TR><TD>1.437e-02</TD><TD>-4.24</TD><TD>release of sequestered calcium ion into cytosol by endoplasmic reticulum</TD><TD>biological process</TD><TD>GO:1903514</TD><TD>9</TD><TD>1</TD><TD>18054</TD><TD>29</TD>
<TD>RYR1</TD></TR>
<TR><TD>1.441e-02</TD><TD>-4.24</TD><TD>Radical_SAM</TD><TD>pfam domains</TD><TD>PF04055</TD><TD>9</TD><TD>1</TD><TD>17385</TD><TD>28</TD>
<TD>RSAD2</TD></TR>
<TR><TD>1.441e-02</TD><TD>-4.24</TD><TD>PDGF</TD><TD>pfam domains</TD><TD>PF00341</TD><TD>9</TD><TD>1</TD><TD>17385</TD><TD>28</TD>
<TD>PGF</TD></TR>
<TR><TD>1.441e-02</TD><TD>-4.24</TD><TD>rSAM</TD><TD>interpro domains</TD><TD>IPR007197</TD><TD>9</TD><TD>1</TD><TD>18616</TD><TD>30</TD>
<TD>RSAD2</TD></TR>
<TR><TD>1.441e-02</TD><TD>-4.24</TD><TD>PDGF/VEGF_dom</TD><TD>interpro domains</TD><TD>IPR000072</TD><TD>9</TD><TD>1</TD><TD>18616</TD><TD>30</TD>
<TD>PGF</TD></TR>
<TR><TD>1.474e-02</TD><TD>-4.22</TD><TD>CD79B (CD79b molecule)</TD><TD>protein interactions</TD><TD>974</TD><TD>108</TD><TD>2</TD><TD>17456</TD><TD>30</TD>
<TD>TUBA1A,LGR4</TD></TR>
<TR><TD>1.482e-02</TD><TD>-4.21</TD><TD>DODD_NASOPHARYNGEAL_CARCINOMA_DN</TD><TD>MSigDB lists</TD><TD>DODD_NASOPHARYNGEAL_CARCINOMA_DN</TD><TD>1230</TD><TD>6</TD><TD>17275</TD><TD>29</TD>
<TD>MCAM,IFI44,IFI44L,CAMKK2,RSAD2,OAS3</TD></TR>
<TR><TD>1.484e-02</TD><TD>-4.21</TD><TD>GO_PURINE_CONTAINING_COMPOUND_BIOSYNTHETIC_PROCESS</TD><TD>MSigDB lists</TD><TD>GO_PURINE_CONTAINING_COMPOUND_BIOSYNTHETIC_PROCESS</TD><TD>111</TD><TD>2</TD><TD>17275</TD><TD>29</TD>
<TD>OAS2,OAS1</TD></TR>
<TR><TD>1.500e-02</TD><TD>-4.20</TD><TD>THOC2 (THO complex 2)</TD><TD>protein interactions</TD><TD>57187</TD><TD>109</TD><TD>2</TD><TD>17456</TD><TD>30</TD>
<TD>FAM102B,LGR4</TD></TR>
<TR><TD>1.501e-02</TD><TD>-4.20</TD><TD>PID_VEGF_VEGFR_PATHWAY</TD><TD>MSigDB lists</TD><TD>PID_VEGF_VEGFR_PATHWAY</TD><TD>9</TD><TD>1</TD><TD>17275</TD><TD>29</TD>
<TD>PGF</TD></TR>
<TR><TD>1.501e-02</TD><TD>-4.20</TD><TD>HOFFMAN_CLOCK_TARGETS_DN</TD><TD>MSigDB lists</TD><TD>HOFFMAN_CLOCK_TARGETS_DN</TD><TD>9</TD><TD>1</TD><TD>17275</TD><TD>29</TD>
<TD>MGAT3</TD></TR>
<TR><TD>1.501e-02</TD><TD>-4.20</TD><TD>YIH_RESPONSE_TO_ARSENITE_C5</TD><TD>MSigDB lists</TD><TD>YIH_RESPONSE_TO_ARSENITE_C5</TD><TD>9</TD><TD>1</TD><TD>17275</TD><TD>29</TD>
<TD>PGF</TD></TR>
<TR><TD>1.507e-02</TD><TD>-4.20</TD><TD>ACEVEDO_LIVER_CANCER_UP</TD><TD>MSigDB lists</TD><TD>ACEVEDO_LIVER_CANCER_UP</TD><TD>888</TD><TD>5</TD><TD>17275</TD><TD>29</TD>
<TD>TUBA1A,IFI27,KIFAP3,IFIT2,IFI44</TD></TR>
<TR><TD>1.535e-02</TD><TD>-4.18</TD><TD>GSE21033_3H_VS_24H_POLYIC_STIM_DC_DN</TD><TD>MSigDB lists</TD><TD>GSE21033_3H_VS_24H_POLYIC_STIM_DC_DN</TD><TD>113</TD><TD>2</TD><TD>17275</TD><TD>29</TD>
<TD>IFIT2,KIFAP3</TD></TR>
<TR><TD>1.537e-02</TD><TD>-4.18</TD><TD>SERPINB11 (serpin family B member 11 (gene/pseudogene))</TD><TD>protein interactions</TD><TD>89778</TD><TD>9</TD><TD>1</TD><TD>17456</TD><TD>30</TD>
<TD>TUBA1A</TD></TR>
<TR><TD>1.537e-02</TD><TD>-4.18</TD><TD>POTEJ (POTE ankyrin domain family member J)</TD><TD>protein interactions</TD><TD>653781</TD><TD>9</TD><TD>1</TD><TD>17456</TD><TD>30</TD>
<TD>LGR4</TD></TR>
<TR><TD>1.537e-02</TD><TD>-4.18</TD><TD>NXPH3 (neurexophilin 3)</TD><TD>protein interactions</TD><TD>11248</TD><TD>9</TD><TD>1</TD><TD>17456</TD><TD>30</TD>
<TD>TUBA1A</TD></TR>
<TR><TD>1.537e-02</TD><TD>-4.18</TD><TD>QTRT2 (queuine tRNA-ribosyltransferase accessory subunit 2)</TD><TD>protein interactions</TD><TD>79691</TD><TD>9</TD><TD>1</TD><TD>17456</TD><TD>30</TD>
<TD>ISG15</TD></TR>
<TR><TD>1.537e-02</TD><TD>-4.18</TD><TD>IFNA2 (interferon alpha 2)</TD><TD>protein interactions</TD><TD>3440</TD><TD>9</TD><TD>1</TD><TD>17456</TD><TD>30</TD>
<TD>ISG15</TD></TR>
<TR><TD>1.537e-02</TD><TD>-4.18</TD><TD>IFNA14 (interferon alpha 14)</TD><TD>protein interactions</TD><TD>3448</TD><TD>9</TD><TD>1</TD><TD>17456</TD><TD>30</TD>
<TD>ISG15</TD></TR>
<TR><TD>1.537e-02</TD><TD>-4.18</TD><TD>TRIM5 (tripartite motif containing 5)</TD><TD>protein interactions</TD><TD>574288</TD><TD>9</TD><TD>1</TD><TD>17456</TD><TD>30</TD>
<TD>TUBA1A</TD></TR>
<TR><TD>1.560e-02</TD><TD>-4.16</TD><TD>GO_NEPHRON_DEVELOPMENT</TD><TD>MSigDB lists</TD><TD>GO_NEPHRON_DEVELOPMENT</TD><TD>114</TD><TD>2</TD><TD>17275</TD><TD>29</TD>
<TD>PGF,LGR4</TD></TR>
<TR><TD>1.560e-02</TD><TD>-4.16</TD><TD>GSE3720_UNSTIM_VS_PMA_STIM_VD1_GAMMADELTA_TCELL_DN</TD><TD>MSigDB lists</TD><TD>GSE3720_UNSTIM_VS_PMA_STIM_VD1_GAMMADELTA_TCELL_DN</TD><TD>114</TD><TD>2</TD><TD>17275</TD><TD>29</TD>
<TD>PGF,KLHDC8B</TD></TR>
<TR><TD>1.577e-02</TD><TD>-4.15</TD><TD>Degradation of the extracellular matrix</TD><TD>REACTOME pathways</TD><TD>R-HSA-1474228</TD><TD>111</TD><TD>2</TD><TD>10287</TD><TD>18</TD>
<TD>CAPN6,CTSV</TD></TR>
<TR><TD>1.579e-02</TD><TD>-4.15</TD><TD>ATP6V0D1 (ATPase H+ transporting V0 subunit d1)</TD><TD>protein interactions</TD><TD>9114</TD><TD>112</TD><TD>2</TD><TD>17456</TD><TD>30</TD>
<TD>MCAM,ADGRL1</TD></TR>
<TR><TD>1.593e-02</TD><TD>-4.14</TD><TD>PDGF</TD><TD>smart domains</TD><TD>SM00141</TD><TD>8</TD><TD>1</TD><TD>9476</TD><TD>19</TD>
<TD>PGF</TD></TR>
<TR><TD>1.593e-02</TD><TD>-4.14</TD><TD>human chr2p25.2</TD><TD>chromosome location</TD><TD>human chr2p25.2</TD><TD>14</TD><TD>1</TD><TD>26169</TD><TD>30</TD>
<TD>RSAD2</TD></TR>
<TR><TD>1.594e-02</TD><TD>-4.14</TD><TD>second-messenger-mediated signaling</TD><TD>biological process</TD><TD>GO:0019932</TD><TD>333</TD><TD>3</TD><TD>18054</TD><TD>29</TD>
<TD>LGR4,CAMKK2,ADGRL1</TD></TR>
<TR><TD>1.595e-02</TD><TD>-4.14</TD><TD>cellular response to caffeine</TD><TD>biological process</TD><TD>GO:0071313</TD><TD>10</TD><TD>1</TD><TD>18054</TD><TD>29</TD>
<TD>RYR1</TD></TR>
<TR><TD>1.595e-02</TD><TD>-4.14</TD><TD>regulation of protein catabolic process in the vacuole</TD><TD>biological process</TD><TD>GO:1904350</TD><TD>10</TD><TD>1</TD><TD>18054</TD><TD>29</TD>
<TD>MGAT3</TD></TR>
<TR><TD>1.595e-02</TD><TD>-4.14</TD><TD>metanephric glomerulus development</TD><TD>biological process</TD><TD>GO:0072224</TD><TD>10</TD><TD>1</TD><TD>18054</TD><TD>29</TD>
<TD>LGR4</TD></TR>
<TR><TD>1.599e-02</TD><TD>-4.14</TD><TD>MIR</TD><TD>pfam domains</TD><TD>PF02815</TD><TD>10</TD><TD>1</TD><TD>17385</TD><TD>28</TD>
<TD>RYR1</TD></TR>
<TR><TD>1.600e-02</TD><TD>-4.14</TD><TD>Pept_asp_AS</TD><TD>interpro domains</TD><TD>IPR025661</TD><TD>10</TD><TD>1</TD><TD>18616</TD><TD>30</TD>
<TD>CTSV</TD></TR>
<TR><TD>1.600e-02</TD><TD>-4.14</TD><TD>Somatomedin_B_dom</TD><TD>interpro domains</TD><TD>IPR001212</TD><TD>10</TD><TD>1</TD><TD>18616</TD><TD>30</TD>
<TD>SBSPON</TD></TR>
<TR><TD>1.600e-02</TD><TD>-4.14</TD><TD>MIR_motif</TD><TD>interpro domains</TD><TD>IPR016093</TD><TD>10</TD><TD>1</TD><TD>18616</TD><TD>30</TD>
<TD>RYR1</TD></TR>
<TR><TD>1.600e-02</TD><TD>-4.14</TD><TD>MIR_dom_sf</TD><TD>interpro domains</TD><TD>IPR036300</TD><TD>10</TD><TD>1</TD><TD>18616</TD><TD>30</TD>
<TD>RYR1</TD></TR>
<TR><TD>1.613e-02</TD><TD>-4.13</TD><TD>GSE22611_NOD2_TRANSD_VS_CTRL_TRANSD_HEK293_MDP_STIM_2H_DN</TD><TD>MSigDB lists</TD><TD>GSE22611_NOD2_TRANSD_VS_CTRL_TRANSD_HEK293_MDP_STIM_2H_DN</TD><TD>116</TD><TD>2</TD><TD>17275</TD><TD>29</TD>
<TD>HS6ST2,CADM4</TD></TR>
<TR><TD>1.641e-02</TD><TD>-4.11</TD><TD>protein tag</TD><TD>molecular function</TD><TD>GO:0031386</TD><TD>11</TD><TD>1</TD><TD>17306</TD><TD>26</TD>
<TD>ISG15</TD></TR>
<TR><TD>1.646e-02</TD><TD>-4.11</TD><TD>PAPAIN</TD><TD>prints domains</TD><TD>PR00705</TD><TD>11</TD><TD>1</TD><TD>4648</TD><TD>7</TD>
<TD>CTSV</TD></TR>
<TR><TD>1.646e-02</TD><TD>-4.11</TD><TD>UBIQUITIN</TD><TD>prints domains</TD><TD>PR00348</TD><TD>11</TD><TD>1</TD><TD>4648</TD><TD>7</TD>
<TD>ISG15</TD></TR>
<TR><TD>1.667e-02</TD><TD>-4.09</TD><TD>SHIRAISHI_PLZF_TARGETS_UP</TD><TD>MSigDB lists</TD><TD>SHIRAISHI_PLZF_TARGETS_UP</TD><TD>10</TD><TD>1</TD><TD>17275</TD><TD>29</TD>
<TD>OAS3</TD></TR>
<TR><TD>1.667e-02</TD><TD>-4.09</TD><TD>GO_SARCOPLASMIC_RETICULUM_CALCIUM_ION_TRANSPORT</TD><TD>MSigDB lists</TD><TD>GO_SARCOPLASMIC_RETICULUM_CALCIUM_ION_TRANSPORT</TD><TD>10</TD><TD>1</TD><TD>17275</TD><TD>29</TD>
<TD>RYR1</TD></TR>
<TR><TD>1.683e-02</TD><TD>-4.08</TD><TD>nephron development</TD><TD>biological process</TD><TD>GO:0072006</TD><TD>124</TD><TD>2</TD><TD>18054</TD><TD>29</TD>
<TD>LGR4,PGF</TD></TR>
<TR><TD>1.692e-02</TD><TD>-4.08</TD><TD>PANGAS_TUMOR_SUPPRESSION_BY_SMAD1_AND_SMAD5_UP</TD><TD>MSigDB lists</TD><TD>PANGAS_TUMOR_SUPPRESSION_BY_SMAD1_AND_SMAD5_UP</TD><TD>119</TD><TD>2</TD><TD>17275</TD><TD>29</TD>
<TD>CADM4,HS6ST2</TD></TR>
<TR><TD>1.706e-02</TD><TD>-4.07</TD><TD>TCP11L2 (t-complex 11 like 2)</TD><TD>protein interactions</TD><TD>255394</TD><TD>10</TD><TD>1</TD><TD>17456</TD><TD>30</TD>
<TD>TUBA1A</TD></TR>
<TR><TD>1.706e-02</TD><TD>-4.07</TD><TD>SULT4A1 (sulfotransferase family 4A member 1)</TD><TD>protein interactions</TD><TD>25830</TD><TD>10</TD><TD>1</TD><TD>17456</TD><TD>30</TD>
<TD>BCL6B</TD></TR>
<TR><TD>1.706e-02</TD><TD>-4.07</TD><TD>IFNE (interferon epsilon)</TD><TD>protein interactions</TD><TD>338376</TD><TD>10</TD><TD>1</TD><TD>17456</TD><TD>30</TD>
<TD>TUBA1A</TD></TR>
<TR><TD>1.706e-02</TD><TD>-4.07</TD><TD>EDIL3 (EGF like repeats and discoidin domains 3)</TD><TD>protein interactions</TD><TD>10085</TD><TD>10</TD><TD>1</TD><TD>17456</TD><TD>30</TD>
<TD>ADGRL1</TD></TR>
<TR><TD>1.706e-02</TD><TD>-4.07</TD><TD>IFNA4 (interferon alpha 4)</TD><TD>protein interactions</TD><TD>3441</TD><TD>10</TD><TD>1</TD><TD>17456</TD><TD>30</TD>
<TD>ISG15</TD></TR>
<TR><TD>1.706e-02</TD><TD>-4.07</TD><TD>RSPO2 (R-spondin 2)</TD><TD>protein interactions</TD><TD>340419</TD><TD>10</TD><TD>1</TD><TD>17456</TD><TD>30</TD>
<TD>LGR4</TD></TR>
<TR><TD>1.706e-02</TD><TD>-4.07</TD><TD>ASCL2 (achaete-scute family bHLH transcription factor 2)</TD><TD>protein interactions</TD><TD>430</TD><TD>10</TD><TD>1</TD><TD>17456</TD><TD>30</TD>
<TD>TUBA1A</TD></TR>
<TR><TD>1.706e-02</TD><TD>-4.07</TD><TD>DEPDC7 (DEP domain containing 7)</TD><TD>protein interactions</TD><TD>91614</TD><TD>10</TD><TD>1</TD><TD>17456</TD><TD>30</TD>
<TD>ISG15</TD></TR>
<TR><TD>1.706e-02</TD><TD>-4.07</TD><TD>human chr11p14.1</TD><TD>chromosome location</TD><TD>human chr11p14.1</TD><TD>15</TD><TD>1</TD><TD>26169</TD><TD>30</TD>
<TD>LGR4</TD></TR>
<TR><TD>1.713e-02</TD><TD>-4.07</TD><TD>growth factor receptor binding</TD><TD>molecular function</TD><TD>GO:0070851</TD><TD>134</TD><TD>2</TD><TD>17306</TD><TD>26</TD>
<TD>CADM4,PGF</TD></TR>
<TR><TD>1.734e-02</TD><TD>-4.05</TD><TD>GO_GLYCOPROTEIN_METABOLIC_PROCESS</TD><TD>MSigDB lists</TD><TD>GO_GLYCOPROTEIN_METABOLIC_PROCESS</TD><TD>329</TD><TD>3</TD><TD>17275</TD><TD>29</TD>
<TD>OAS2,HS6ST2,MGAT3</TD></TR>
<TR><TD>1.738e-02</TD><TD>-4.05</TD><TD>GTP binding</TD><TD>molecular function</TD><TD>GO:0005525</TD><TD>369</TD><TD>3</TD><TD>17306</TD><TD>26</TD>
<TD>IFI44L,DIRAS1,TUBA1A</TD></TR>
<TR><TD>1.742e-02</TD><TD>-4.05</TD><TD>signaling</TD><TD>biological process</TD><TD>GO:0023052</TD><TD>5103</TD><TD>14</TD><TD>18054</TD><TD>29</TD>
<TD>OASL,LGR4,ISG15,KIFAP3,RSAD2,CAMKK2,DIRAS1,OAS1,IFIT2,OAS2,OAS3,IFI27,PGF,ADGRL1</TD></TR>
<TR><TD>1.753e-02</TD><TD>-4.04</TD><TD>positive regulation of protein localization to endosome</TD><TD>biological process</TD><TD>GO:1905668</TD><TD>11</TD><TD>1</TD><TD>18054</TD><TD>29</TD>
<TD>MGAT3</TD></TR>
<TR><TD>1.753e-02</TD><TD>-4.04</TD><TD>cellular response to interferon-alpha</TD><TD>biological process</TD><TD>GO:0035457</TD><TD>11</TD><TD>1</TD><TD>18054</TD><TD>29</TD>
<TD>IFIT2</TD></TR>
<TR><TD>1.753e-02</TD><TD>-4.04</TD><TD>regulation of T-helper 2 cell cytokine production</TD><TD>biological process</TD><TD>GO:2000551</TD><TD>11</TD><TD>1</TD><TD>18054</TD><TD>29</TD>
<TD>RSAD2</TD></TR>
<TR><TD>1.753e-02</TD><TD>-4.04</TD><TD>metanephric tubule morphogenesis</TD><TD>biological process</TD><TD>GO:0072173</TD><TD>11</TD><TD>1</TD><TD>18054</TD><TD>29</TD>
<TD>LGR4</TD></TR>
<TR><TD>1.758e-02</TD><TD>-4.04</TD><TD>GAIN</TD><TD>pfam domains</TD><TD>PF16489</TD><TD>11</TD><TD>1</TD><TD>17385</TD><TD>28</TD>
<TD>ADGRL1</TD></TR>
<TR><TD>1.759e-02</TD><TD>-4.04</TD><TD>Ubiquitin</TD><TD>interpro domains</TD><TD>IPR019956</TD><TD>11</TD><TD>1</TD><TD>18616</TD><TD>30</TD>
<TD>ISG15</TD></TR>
<TR><TD>1.759e-02</TD><TD>-4.04</TD><TD>Pept_his_AS</TD><TD>interpro domains</TD><TD>IPR025660</TD><TD>11</TD><TD>1</TD><TD>18616</TD><TD>30</TD>
<TD>CTSV</TD></TR>
<TR><TD>1.759e-02</TD><TD>-4.04</TD><TD>C2_III</TD><TD>interpro domains</TD><TD>IPR033883</TD><TD>11</TD><TD>1</TD><TD>18616</TD><TD>30</TD>
<TD>CAPN6</TD></TR>
<TR><TD>1.759e-02</TD><TD>-4.04</TD><TD>GAIN_dom_N</TD><TD>interpro domains</TD><TD>IPR032471</TD><TD>11</TD><TD>1</TD><TD>18616</TD><TD>30</TD>
<TD>ADGRL1</TD></TR>
<TR><TD>1.761e-02</TD><TD>-4.04</TD><TD>adenylate cyclase-activating G protein-coupled receptor signaling pathway</TD><TD>biological process</TD><TD>GO:0007189</TD><TD>127</TD><TD>2</TD><TD>18054</TD><TD>29</TD>
<TD>LGR4,ADGRL1</TD></TR>
<TR><TD>1.775e-02</TD><TD>-4.03</TD><TD>PDGF_2</TD><TD>prosite domains</TD><TD>PS50278</TD><TD>9</TD><TD>1</TD><TD>12079</TD><TD>24</TD>
<TD>PGF</TD></TR>
<TR><TD>1.776e-02</TD><TD>-4.03</TD><TD>purine ribonucleoside binding</TD><TD>molecular function</TD><TD>GO:0032550</TD><TD>372</TD><TD>3</TD><TD>17306</TD><TD>26</TD>
<TD>IFI44L,DIRAS1,TUBA1A</TD></TR>
<TR><TD>1.787e-02</TD><TD>-4.02</TD><TD>kidney epithelium development</TD><TD>biological process</TD><TD>GO:0072073</TD><TD>128</TD><TD>2</TD><TD>18054</TD><TD>29</TD>
<TD>LGR4,PGF</TD></TR>
<TR><TD>1.798e-02</TD><TD>-4.02</TD><TD>GCN1 (GCN1 activator of EIF2AK4)</TD><TD>protein interactions</TD><TD>10985</TD><TD>120</TD><TD>2</TD><TD>17456</TD><TD>30</TD>
<TD>CAMKK2,LGR4</TD></TR>
<TR><TD>1.801e-02</TD><TD>-4.02</TD><TD>MODULE_188</TD><TD>MSigDB lists</TD><TD>MODULE_188</TD><TD>123</TD><TD>2</TD><TD>17275</TD><TD>29</TD>
<TD>OAS1,RSAD2</TD></TR>
<TR><TD>1.814e-02</TD><TD>-4.01</TD><TD>ribonucleoside binding</TD><TD>molecular function</TD><TD>GO:0032549</TD><TD>375</TD><TD>3</TD><TD>17306</TD><TD>26</TD>
<TD>IFI44L,DIRAS1,TUBA1A</TD></TR>
<TR><TD>1.814e-02</TD><TD>-4.01</TD><TD>purine nucleoside binding</TD><TD>molecular function</TD><TD>GO:0001883</TD><TD>375</TD><TD>3</TD><TD>17306</TD><TD>26</TD>
<TD>TUBA1A,DIRAS1,IFI44L</TD></TR>
<TR><TD>1.829e-02</TD><TD>-4.00</TD><TD>GO_KIDNEY_EPITHELIUM_DEVELOPMENT</TD><TD>MSigDB lists</TD><TD>GO_KIDNEY_EPITHELIUM_DEVELOPMENT</TD><TD>124</TD><TD>2</TD><TD>17275</TD><TD>29</TD>
<TD>LGR4,PGF</TD></TR>
<TR><TD>1.832e-02</TD><TD>-4.00</TD><TD>DORN_ADENOVIRUS_INFECTION_32HR_UP</TD><TD>MSigDB lists</TD><TD>DORN_ADENOVIRUS_INFECTION_32HR_UP</TD><TD>11</TD><TD>1</TD><TD>17275</TD><TD>29</TD>
<TD>IFIT2</TD></TR>
<TR><TD>1.832e-02</TD><TD>-4.00</TD><TD>IIZUKA_LIVER_CANCER_PROGRESSION_G1_G2_UP</TD><TD>MSigDB lists</TD><TD>IIZUKA_LIVER_CANCER_PROGRESSION_G1_G2_UP</TD><TD>11</TD><TD>1</TD><TD>17275</TD><TD>29</TD>
<TD>OAS2</TD></TR>
<TR><TD>1.832e-02</TD><TD>-4.00</TD><TD>KUROKAWA_LIVER_CANCER_CHEMOTHERAPY_UP</TD><TD>MSigDB lists</TD><TD>KUROKAWA_LIVER_CANCER_CHEMOTHERAPY_UP</TD><TD>11</TD><TD>1</TD><TD>17275</TD><TD>29</TD>
<TD>OASL</TD></TR>
<TR><TD>1.832e-02</TD><TD>-4.00</TD><TD>IIZUKA_LIVER_CANCER_PROGRESSION_L1_G1_DN</TD><TD>MSigDB lists</TD><TD>IIZUKA_LIVER_CANCER_PROGRESSION_L1_G1_DN</TD><TD>11</TD><TD>1</TD><TD>17275</TD><TD>29</TD>
<TD>CAMKK2</TD></TR>
<TR><TD>1.832e-02</TD><TD>-4.00</TD><TD>GO_CELL_DIFFERENTIATION_INVOLVED_IN_METANEPHROS_DEVELOPMENT</TD><TD>MSigDB lists</TD><TD>GO_CELL_DIFFERENTIATION_INVOLVED_IN_METANEPHROS_DEVELOPMENT</TD><TD>11</TD><TD>1</TD><TD>17275</TD><TD>29</TD>
<TD>LGR4</TD></TR>
<TR><TD>1.832e-02</TD><TD>-4.00</TD><TD>CHUANG_OXIDATIVE_STRESS_RESPONSE_DN</TD><TD>MSigDB lists</TD><TD>CHUANG_OXIDATIVE_STRESS_RESPONSE_DN</TD><TD>11</TD><TD>1</TD><TD>17275</TD><TD>29</TD>
<TD>TUBA1A</TD></TR>
<TR><TD>1.855e-02</TD><TD>-3.99</TD><TD>GO_TRANSFERASE_ACTIVITY_TRANSFERRING_PHOSPHORUS_CONTAINING_GROUPS</TD><TD>MSigDB lists</TD><TD>GO_TRANSFERASE_ACTIVITY_TRANSFERRING_PHOSPHORUS_CONTAINING_GROUPS</TD><TD>936</TD><TD>5</TD><TD>17275</TD><TD>29</TD>
<TD>CAMKK2,OAS3,OAS2,OAS1,OASL</TD></TR>
<TR><TD>1.860e-02</TD><TD>-3.98</TD><TD>protein phosphatase binding</TD><TD>molecular function</TD><TD>GO:0019903</TD><TD>140</TD><TD>2</TD><TD>17306</TD><TD>26</TD>
<TD>CADM4,KIFAP3</TD></TR>
<TR><TD>1.862e-02</TD><TD>-3.98</TD><TD>CTAWWWATA_RSRFC4_Q2</TD><TD>MSigDB lists</TD><TD>CTAWWWATA_RSRFC4_Q2</TD><TD>338</TD><TD>3</TD><TD>17275</TD><TD>29</TD>
<TD>KLHDC8B,DIRAS1,MGAT3</TD></TR>
<TR><TD>1.864e-02</TD><TD>-3.98</TD><TD>TUBB (tubulin beta class I)</TD><TD>protein interactions</TD><TD>203068</TD><TD>330</TD><TD>3</TD><TD>17456</TD><TD>30</TD>
<TD>IFIT2,TUBA1A,LGR4</TD></TR>
<TR><TD>1.865e-02</TD><TD>-3.98</TD><TD>NF-kB Signaling Pathway</TD><TD>SMPDB pathways</TD><TD>SMP0063813</TD><TD>26</TD><TD>1</TD><TD>1394</TD><TD>1</TD>
<TD>CAMKK2</TD></TR>
<TR><TD>1.875e-02</TD><TD>-3.98</TD><TD>SEZ6L2 (seizure related 6 homolog like 2)</TD><TD>protein interactions</TD><TD>26470</TD><TD>11</TD><TD>1</TD><TD>17456</TD><TD>30</TD>
<TD>OASL</TD></TR>
<TR><TD>1.875e-02</TD><TD>-3.98</TD><TD>ARHGEF40 (Rho guanine nucleotide exchange factor 40)</TD><TD>protein interactions</TD><TD>55701</TD><TD>11</TD><TD>1</TD><TD>17456</TD><TD>30</TD>
<TD>LGR4</TD></TR>
<TR><TD>1.875e-02</TD><TD>-3.98</TD><TD>IFNA8 (interferon alpha 8)</TD><TD>protein interactions</TD><TD>3445</TD><TD>11</TD><TD>1</TD><TD>17456</TD><TD>30</TD>
<TD>ISG15</TD></TR>
<TR><TD>1.875e-02</TD><TD>-3.98</TD><TD>VSX1 (visual system homeobox 1)</TD><TD>protein interactions</TD><TD>30813</TD><TD>11</TD><TD>1</TD><TD>17456</TD><TD>30</TD>
<TD>TUBA1A</TD></TR>
<TR><TD>1.875e-02</TD><TD>-3.98</TD><TD>IFNA1 (interferon alpha 1)</TD><TD>protein interactions</TD><TD>3439</TD><TD>11</TD><TD>1</TD><TD>17456</TD><TD>30</TD>
<TD>ISG15</TD></TR>
<TR><TD>1.875e-02</TD><TD>-3.98</TD><TD>ZNF695 (zinc finger protein 695)</TD><TD>protein interactions</TD><TD>57116</TD><TD>11</TD><TD>1</TD><TD>17456</TD><TD>30</TD>
<TD>TUBA1A</TD></TR>
<TR><TD>1.875e-02</TD><TD>-3.98</TD><TD>UBA7 (ubiquitin like modifier activating enzyme 7)</TD><TD>protein interactions</TD><TD>7318</TD><TD>11</TD><TD>1</TD><TD>17456</TD><TD>30</TD>
<TD>ISG15</TD></TR>
<TR><TD>1.885e-02</TD><TD>-3.97</TD><TD>heparan sulfate biosynthesis (late stages)</TD><TD>BIOCYC pathways</TD><TD>META_PWY-6558</TD><TD>17</TD><TD>1</TD><TD>902</TD><TD>1</TD>
<TD>HS6ST2</TD></TR>
<TR><TD>1.891e-02</TD><TD>-3.97</TD><TD>COLINA_TARGETS_OF_4EBP1_AND_4EBP2</TD><TD>MSigDB lists</TD><TD>COLINA_TARGETS_OF_4EBP1_AND_4EBP2</TD><TD>340</TD><TD>3</TD><TD>17275</TD><TD>29</TD>
<TD>ISG15,IFIT2,IFI44</TD></TR>
<TR><TD>1.905e-02</TD><TD>-3.96</TD><TD>nucleoside binding</TD><TD>molecular function</TD><TD>GO:0001882</TD><TD>382</TD><TD>3</TD><TD>17306</TD><TD>26</TD>
<TD>DIRAS1,IFI44L,TUBA1A</TD></TR>
<TR><TD>1.911e-02</TD><TD>-3.96</TD><TD>regulation of protein localization to endosome</TD><TD>biological process</TD><TD>GO:1905666</TD><TD>12</TD><TD>1</TD><TD>18054</TD><TD>29</TD>
<TD>MGAT3</TD></TR>
<TR><TD>1.916e-02</TD><TD>-3.95</TD><TD>Sulfotransfer_2</TD><TD>pfam domains</TD><TD>PF03567</TD><TD>12</TD><TD>1</TD><TD>17385</TD><TD>28</TD>
<TD>HS6ST2</TD></TR>
<TR><TD>1.917e-02</TD><TD>-3.95</TD><TD>Sulfotransferase</TD><TD>interpro domains</TD><TD>IPR005331</TD><TD>12</TD><TD>1</TD><TD>18616</TD><TD>30</TD>
<TD>HS6ST2</TD></TR>
<TR><TD>1.917e-02</TD><TD>-3.95</TD><TD>Calpain_III</TD><TD>interpro domains</TD><TD>IPR022683</TD><TD>12</TD><TD>1</TD><TD>18616</TD><TD>30</TD>
<TD>CAPN6</TD></TR>
<TR><TD>1.920e-02</TD><TD>-3.95</TD><TD>ATP binding</TD><TD>molecular function</TD><TD>GO:0005524</TD><TD>1465</TD><TD>6</TD><TD>17306</TD><TD>26</TD>
<TD>CAMKK2,RYR1,OAS3,OAS1,OASL,OAS2</TD></TR>
<TR><TD>1.935e-02</TD><TD>-3.94</TD><TD>GRUETZMANN_PANCREATIC_CANCER_UP</TD><TD>MSigDB lists</TD><TD>GRUETZMANN_PANCREATIC_CANCER_UP</TD><TD>343</TD><TD>3</TD><TD>17275</TD><TD>29</TD>
<TD>OAS1,TUBA1A,IFI44L</TD></TR>
<TR><TD>1.941e-02</TD><TD>-3.94</TD><TD>GSE13547_WT_VS_ZFX_KO_BCELL_ANTI_IGM_STIM_12H_UP</TD><TD>MSigDB lists</TD><TD>GSE13547_WT_VS_ZFX_KO_BCELL_ANTI_IGM_STIM_12H_UP</TD><TD>128</TD><TD>2</TD><TD>17275</TD><TD>29</TD>
<TD>PGF,IFI44L</TD></TR>
<TR><TD>1.969e-02</TD><TD>-3.93</TD><TD>GGGNNTTTCC_NFKB_Q6_01</TD><TD>MSigDB lists</TD><TD>GGGNNTTTCC_NFKB_Q6_01</TD><TD>129</TD><TD>2</TD><TD>17275</TD><TD>29</TD>
<TD>BCL6B,TUBA1A</TD></TR>
<TR><TD>1.969e-02</TD><TD>-3.93</TD><TD>DARWICHE_SKIN_TUMOR_PROMOTER_UP</TD><TD>MSigDB lists</TD><TD>DARWICHE_SKIN_TUMOR_PROMOTER_UP</TD><TD>129</TD><TD>2</TD><TD>17275</TD><TD>29</TD>
<TD>MCAM,RYR1</TD></TR>
<TR><TD>1.969e-02</TD><TD>-3.93</TD><TD>TSENG_IRS1_TARGETS_DN</TD><TD>MSigDB lists</TD><TD>TSENG_IRS1_TARGETS_DN</TD><TD>129</TD><TD>2</TD><TD>17275</TD><TD>29</TD>
<TD>RSAD2,CAPN6</TD></TR>
<TR><TD>1.970e-02</TD><TD>-3.93</TD><TD>SMB_1</TD><TD>prosite domains</TD><TD>PS00524</TD><TD>10</TD><TD>1</TD><TD>12079</TD><TD>24</TD>
<TD>SBSPON</TD></TR>
<TR><TD>1.970e-02</TD><TD>-3.93</TD><TD>SMB_2</TD><TD>prosite domains</TD><TD>PS50958</TD><TD>10</TD><TD>1</TD><TD>12079</TD><TD>24</TD>
<TD>SBSPON</TD></TR>
<TR><TD>1.970e-02</TD><TD>-3.93</TD><TD>MIR</TD><TD>prosite domains</TD><TD>PS50919</TD><TD>10</TD><TD>1</TD><TD>12079</TD><TD>24</TD>
<TD>RYR1</TD></TR>
<TR><TD>1.970e-02</TD><TD>-3.93</TD><TD>THIOL_PROTEASE_ASN</TD><TD>prosite domains</TD><TD>PS00640</TD><TD>10</TD><TD>1</TD><TD>12079</TD><TD>24</TD>
<TD>CTSV</TD></TR>
<TR><TD>1.988e-02</TD><TD>-3.92</TD><TD>MIR</TD><TD>smart domains</TD><TD>SM00472</TD><TD>10</TD><TD>1</TD><TD>9476</TD><TD>19</TD>
<TD>RYR1</TD></TR>
<TR><TD>1.997e-02</TD><TD>-3.91</TD><TD>TSUNODA_CISPLATIN_RESISTANCE_UP</TD><TD>MSigDB lists</TD><TD>TSUNODA_CISPLATIN_RESISTANCE_UP</TD><TD>12</TD><TD>1</TD><TD>17275</TD><TD>29</TD>
<TD>IFI27</TD></TR>
<TR><TD>1.997e-02</TD><TD>-3.91</TD><TD>LU_TUMOR_VASCULATURE_DN</TD><TD>MSigDB lists</TD><TD>LU_TUMOR_VASCULATURE_DN</TD><TD>12</TD><TD>1</TD><TD>17275</TD><TD>29</TD>
<TD>HS6ST2</TD></TR>
<TR><TD>1.998e-02</TD><TD>-3.91</TD><TD>guanyl nucleotide binding</TD><TD>molecular function</TD><TD>GO:0019001</TD><TD>389</TD><TD>3</TD><TD>17306</TD><TD>26</TD>
<TD>IFI44L,DIRAS1,TUBA1A</TD></TR>
<TR><TD>1.998e-02</TD><TD>-3.91</TD><TD>guanyl ribonucleotide binding</TD><TD>molecular function</TD><TD>GO:0032561</TD><TD>389</TD><TD>3</TD><TD>17306</TD><TD>26</TD>
<TD>IFI44L,DIRAS1,TUBA1A</TD></TR>
<TR><TD>1.998e-02</TD><TD>-3.91</TD><TD>KRAS.LUNG.BREAST_UP.V1_DN</TD><TD>MSigDB lists</TD><TD>KRAS.LUNG.BREAST_UP.V1_DN</TD><TD>130</TD><TD>2</TD><TD>17275</TD><TD>29</TD>
<TD>IFI44L,RYR1</TD></TR>
<TR><TD>2.027e-02</TD><TD>-3.90</TD><TD>DARWICHE_SQUAMOUS_CELL_CARCINOMA_UP</TD><TD>MSigDB lists</TD><TD>DARWICHE_SQUAMOUS_CELL_CARCINOMA_UP</TD><TD>131</TD><TD>2</TD><TD>17275</TD><TD>29</TD>
<TD>MCAM,RYR1</TD></TR>
<TR><TD>2.029e-02</TD><TD>-3.90</TD><TD>biliary_tract-gallbladder-carcinoma-adenocarcinoma</TD><TD>COSMIC cancer mutations</TD><TD>biliary_tract-gallbladder-carcinoma-adenocarcinoma</TD><TD>2872</TD><TD>9</TD><TD>17255</TD><TD>26</TD>
<TD>OAS3,IFI44,MGAT3,KIFAP3,RYR1,KIAA1211,LGR4,CAMKK2,FAM102B</TD></TR>
<TR><TD>2.029e-02</TD><TD>-3.90</TD><TD>gallbladder</TD><TD>COSMIC cancer mutations</TD><TD>gallbladder</TD><TD>2872</TD><TD>9</TD><TD>17255</TD><TD>26</TD>
<TD>FAM102B,CAMKK2,LGR4,KIAA1211,RYR1,KIFAP3,MGAT3,IFI44,OAS3</TD></TR>
<TR><TD>2.044e-02</TD><TD>-3.89</TD><TD>CTSK (cathepsin K)</TD><TD>protein interactions</TD><TD>1513</TD><TD>12</TD><TD>1</TD><TD>17456</TD><TD>30</TD>
<TD>CTSV</TD></TR>
<TR><TD>2.044e-02</TD><TD>-3.89</TD><TD>CIAO2A (cytosolic iron-sulfur assembly component 2A)</TD><TD>protein interactions</TD><TD>84191</TD><TD>12</TD><TD>1</TD><TD>17456</TD><TD>30</TD>
<TD>RSAD2</TD></TR>
<TR><TD>2.044e-02</TD><TD>-3.89</TD><TD>CCNL1 (cyclin L1)</TD><TD>protein interactions</TD><TD>57018</TD><TD>12</TD><TD>1</TD><TD>17456</TD><TD>30</TD>
<TD>ISG15</TD></TR>
<TR><TD>2.044e-02</TD><TD>-3.89</TD><TD>FAM120C (family with sequence similarity 120C)</TD><TD>protein interactions</TD><TD>54954</TD><TD>12</TD><TD>1</TD><TD>17456</TD><TD>30</TD>
<TD>ISG15</TD></TR>
<TR><TD>2.044e-02</TD><TD>-3.89</TD><TD>AKAP6 (A-kinase anchoring protein 6)</TD><TD>protein interactions</TD><TD>9472</TD><TD>12</TD><TD>1</TD><TD>17456</TD><TD>30</TD>
<TD>RYR1</TD></TR>
<TR><TD>2.044e-02</TD><TD>-3.89</TD><TD>RSPO1 (R-spondin 1)</TD><TD>protein interactions</TD><TD>284654</TD><TD>12</TD><TD>1</TD><TD>17456</TD><TD>30</TD>
<TD>LGR4</TD></TR>
<TR><TD>2.044e-02</TD><TD>-3.89</TD><TD>ACOT8 (acyl-CoA thioesterase 8)</TD><TD>protein interactions</TD><TD>10005</TD><TD>12</TD><TD>1</TD><TD>17456</TD><TD>30</TD>
<TD>ISG15</TD></TR>
<TR><TD>2.044e-02</TD><TD>-3.89</TD><TD>Kif3c (kinesin family member 3C)</TD><TD>protein interactions</TD><TD>16570</TD><TD>12</TD><TD>1</TD><TD>17456</TD><TD>30</TD>
<TD>KIFAP3</TD></TR>
<TR><TD>2.044e-02</TD><TD>-3.89</TD><TD>MUC13 (mucin 13, cell surface associated)</TD><TD>protein interactions</TD><TD>56667</TD><TD>12</TD><TD>1</TD><TD>17456</TD><TD>30</TD>
<TD>KIFAP3</TD></TR>
<TR><TD>2.044e-02</TD><TD>-3.89</TD><TD>LRRTM2 (leucine rich repeat transmembrane neuronal 2)</TD><TD>protein interactions</TD><TD>26045</TD><TD>12</TD><TD>1</TD><TD>17456</TD><TD>30</TD>
<TD>LGR4</TD></TR>
<TR><TD>2.044e-02</TD><TD>-3.89</TD><TD>RL1 (neurovirulence protein ICP34.5)</TD><TD>protein interactions</TD><TD>2703395</TD><TD>12</TD><TD>1</TD><TD>17456</TD><TD>30</TD>
<TD>TUBA1A</TD></TR>
<TR><TD>2.056e-02</TD><TD>-3.88</TD><TD>KRAS.300_UP.V1_DN</TD><TD>MSigDB lists</TD><TD>KRAS.300_UP.V1_DN</TD><TD>132</TD><TD>2</TD><TD>17275</TD><TD>29</TD>
<TD>OAS1,IFI44L</TD></TR>
<TR><TD>2.059e-02</TD><TD>-3.88</TD><TD>IRS4 (insulin receptor substrate 4)</TD><TD>protein interactions</TD><TD>8471</TD><TD>129</TD><TD>2</TD><TD>17456</TD><TD>30</TD>
<TD>TUBA1A,LGR4</TD></TR>
<TR><TD>2.069e-02</TD><TD>-3.88</TD><TD>negative regulation of vascular endothelial growth factor receptor signaling pathway</TD><TD>biological process</TD><TD>GO:0030948</TD><TD>13</TD><TD>1</TD><TD>18054</TD><TD>29</TD>
<TD>CADM4</TD></TR>
<TR><TD>2.069e-02</TD><TD>-3.88</TD><TD>cellular response to purine-containing compound</TD><TD>biological process</TD><TD>GO:0071415</TD><TD>13</TD><TD>1</TD><TD>18054</TD><TD>29</TD>
<TD>RYR1</TD></TR>
<TR><TD>2.071e-02</TD><TD>-3.88</TD><TD>GO_GUANYL_NUCLEOTIDE_BINDING</TD><TD>MSigDB lists</TD><TD>GO_GUANYL_NUCLEOTIDE_BINDING</TD><TD>352</TD><TD>3</TD><TD>17275</TD><TD>29</TD>
<TD>DIRAS1,TUBA1A,IFI44L</TD></TR>
<TR><TD>2.074e-02</TD><TD>-3.88</TD><TD>OLF</TD><TD>pfam domains</TD><TD>PF02191</TD><TD>13</TD><TD>1</TD><TD>17385</TD><TD>28</TD>
<TD>ADGRL1</TD></TR>
<TR><TD>2.074e-02</TD><TD>-3.88</TD><TD>Peptidase_C1</TD><TD>pfam domains</TD><TD>PF00112</TD><TD>13</TD><TD>1</TD><TD>17385</TD><TD>28</TD>
<TD>CTSV</TD></TR>
<TR><TD>2.074e-02</TD><TD>-3.88</TD><TD>Calpain_III</TD><TD>pfam domains</TD><TD>PF01067</TD><TD>13</TD><TD>1</TD><TD>17385</TD><TD>28</TD>
<TD>CAPN6</TD></TR>
<TR><TD>2.075e-02</TD><TD>-3.87</TD><TD>Calpain_domain_III</TD><TD>interpro domains</TD><TD>IPR022682</TD><TD>13</TD><TD>1</TD><TD>18616</TD><TD>30</TD>
<TD>CAPN6</TD></TR>
<TR><TD>2.075e-02</TD><TD>-3.87</TD><TD>Olfac-like_dom</TD><TD>interpro domains</TD><TD>IPR003112</TD><TD>13</TD><TD>1</TD><TD>18616</TD><TD>30</TD>
<TD>ADGRL1</TD></TR>
<TR><TD>2.075e-02</TD><TD>-3.87</TD><TD>Peptidase_C1A_C</TD><TD>interpro domains</TD><TD>IPR000668</TD><TD>13</TD><TD>1</TD><TD>18616</TD><TD>30</TD>
<TD>CTSV</TD></TR>
<TR><TD>2.075e-02</TD><TD>-3.87</TD><TD>Calpain_III_sf</TD><TD>interpro domains</TD><TD>IPR036213</TD><TD>13</TD><TD>1</TD><TD>18616</TD><TD>30</TD>
<TD>CAPN6</TD></TR>
<TR><TD>2.081e-02</TD><TD>-3.87</TD><TD>Endosomal/Vacuolar pathway</TD><TD>REACTOME pathways</TD><TD>R-HSA-1236977</TD><TD>12</TD><TD>1</TD><TD>10287</TD><TD>18</TD>
<TD>CTSV</TD></TR>
<TR><TD>2.085e-02</TD><TD>-3.87</TD><TD>BMI1_DN.V1_DN</TD><TD>MSigDB lists</TD><TD>BMI1_DN.V1_DN</TD><TD>133</TD><TD>2</TD><TD>17275</TD><TD>29</TD>
<TD>IFI44L,IFI27</TD></TR>
<TR><TD>2.091e-02</TD><TD>-3.87</TD><TD>CALPAIN</TD><TD>prints domains</TD><TD>PR00704</TD><TD>14</TD><TD>1</TD><TD>4648</TD><TD>7</TD>
<TD>CAPN6</TD></TR>
<TR><TD>2.106e-02</TD><TD>-3.86</TD><TD>heparan sulfate biosynthesis (late stages)</TD><TD>BIOCYC pathways</TD><TD>HUMAN_PWY-6558</TD><TD>19</TD><TD>1</TD><TD>902</TD><TD>1</TD>
<TD>HS6ST2</TD></TR>
<TR><TD>2.144e-02</TD><TD>-3.84</TD><TD>Apoptosis</TD><TD>KEGG pathways</TD><TD>hsa04210</TD><TD>138</TD><TD>2</TD><TD>7161</TD><TD>12</TD>
<TD>TUBA1A,CTSV</TD></TR>
<TR><TD>2.144e-02</TD><TD>-3.84</TD><TD>Apoptosis</TD><TD>KEGG pathways</TD><TD>ko04210</TD><TD>138</TD><TD>2</TD><TD>7161</TD><TD>12</TD>
<TD>TUBA1A,CTSV</TD></TR>
<TR><TD>2.144e-02</TD><TD>-3.84</TD><TD>RAAGNYNNCTTY_UNKNOWN</TD><TD>MSigDB lists</TD><TD>RAAGNYNNCTTY_UNKNOWN</TD><TD>135</TD><TD>2</TD><TD>17275</TD><TD>29</TD>
<TD>MCAM,TUBA1A</TD></TR>
<TR><TD>2.144e-02</TD><TD>-3.84</TD><TD>RORA2_01</TD><TD>MSigDB lists</TD><TD>RORA2_01</TD><TD>135</TD><TD>2</TD><TD>17275</TD><TD>29</TD>
<TD>CAMKK2,RYR1</TD></TR>
<TR><TD>2.144e-02</TD><TD>-3.84</TD><TD>DARWICHE_PAPILLOMA_RISK_HIGH_UP</TD><TD>MSigDB lists</TD><TD>DARWICHE_PAPILLOMA_RISK_HIGH_UP</TD><TD>135</TD><TD>2</TD><TD>17275</TD><TD>29</TD>
<TD>MCAM,RYR1</TD></TR>
<TR><TD>2.161e-02</TD><TD>-3.83</TD><TD>CAFFAREL_RESPONSE_TO_THC_24HR_3_DN</TD><TD>MSigDB lists</TD><TD>CAFFAREL_RESPONSE_TO_THC_24HR_3_DN</TD><TD>13</TD><TD>1</TD><TD>17275</TD><TD>29</TD>
<TD>RYR1</TD></TR>
<TR><TD>2.161e-02</TD><TD>-3.83</TD><TD>BIOCARTA_CACAM_PATHWAY</TD><TD>MSigDB lists</TD><TD>BIOCARTA_CACAM_PATHWAY</TD><TD>13</TD><TD>1</TD><TD>17275</TD><TD>29</TD>
<TD>CAMKK2</TD></TR>
<TR><TD>2.161e-02</TD><TD>-3.83</TD><TD>chrxq23</TD><TD>MSigDB lists</TD><TD>chrxq23</TD><TD>13</TD><TD>1</TD><TD>17275</TD><TD>29</TD>
<TD>CAPN6</TD></TR>
<TR><TD>2.161e-02</TD><TD>-3.83</TD><TD>VICENT_METASTASIS_UP</TD><TD>MSigDB lists</TD><TD>VICENT_METASTASIS_UP</TD><TD>13</TD><TD>1</TD><TD>17275</TD><TD>29</TD>
<TD>MCAM</TD></TR>
<TR><TD>2.161e-02</TD><TD>-3.83</TD><TD>HO_LIVER_CANCER_VASCULAR_INVASION</TD><TD>MSigDB lists</TD><TD>HO_LIVER_CANCER_VASCULAR_INVASION</TD><TD>13</TD><TD>1</TD><TD>17275</TD><TD>29</TD>
<TD>RYR1</TD></TR>
<TR><TD>2.165e-02</TD><TD>-3.83</TD><TD>THIOL_PROTEASE_HIS</TD><TD>prosite domains</TD><TD>PS00639</TD><TD>11</TD><TD>1</TD><TD>12079</TD><TD>24</TD>
<TD>CTSV</TD></TR>
<TR><TD>2.171e-02</TD><TD>-3.83</TD><TD>negative regulation of protein secretion</TD><TD>biological process</TD><TD>GO:0050709</TD><TD>142</TD><TD>2</TD><TD>18054</TD><TD>29</TD>
<TD>RSAD2,LGR4</TD></TR>
<TR><TD>2.174e-02</TD><TD>-3.83</TD><TD>GCM_PTK2</TD><TD>MSigDB lists</TD><TD>GCM_PTK2</TD><TD>136</TD><TD>2</TD><TD>17275</TD><TD>29</TD>
<TD>DIRAS1,MGAT3</TD></TR>
<TR><TD>2.174e-02</TD><TD>-3.83</TD><TD>GSE43863_NAIVE_VS_LY6C_LOW_CXCR5NEG_CD4_EFF_TCELL_D6_LCMV_UP</TD><TD>MSigDB lists</TD><TD>GSE43863_NAIVE_VS_LY6C_LOW_CXCR5NEG_CD4_EFF_TCELL_D6_LCMV_UP</TD><TD>136</TD><TD>2</TD><TD>17275</TD><TD>29</TD>
<TD>BCL6B,MCAM</TD></TR>
<TR><TD>2.180e-02</TD><TD>-3.83</TD><TD>EIF4G1 (eukaryotic translation initiation factor 4 gamma 1)</TD><TD>protein interactions</TD><TD>1981</TD><TD>133</TD><TD>2</TD><TD>17456</TD><TD>30</TD>
<TD>LGR4,ISG15</TD></TR>
<TR><TD>2.204e-02</TD><TD>-3.81</TD><TD>MODULE_301</TD><TD>MSigDB lists</TD><TD>MODULE_301</TD><TD>137</TD><TD>2</TD><TD>17275</TD><TD>29</TD>
<TD>OAS1,RSAD2</TD></TR>
<TR><TD>2.211e-02</TD><TD>-3.81</TD><TD>FASN (fatty acid synthase)</TD><TD>protein interactions</TD><TD>2194</TD><TD>134</TD><TD>2</TD><TD>17456</TD><TD>30</TD>
<TD>ISG15,LGR4</TD></TR>
<TR><TD>2.212e-02</TD><TD>-3.81</TD><TD>RAB28 (RAB28, member RAS oncogene family)</TD><TD>protein interactions</TD><TD>9364</TD><TD>13</TD><TD>1</TD><TD>17456</TD><TD>30</TD>
<TD>CTSV</TD></TR>
<TR><TD>2.212e-02</TD><TD>-3.81</TD><TD>FAM187B (family with sequence similarity 187 member B)</TD><TD>protein interactions</TD><TD>148109</TD><TD>13</TD><TD>1</TD><TD>17456</TD><TD>30</TD>
<TD>TUBA1A</TD></TR>
<TR><TD>2.212e-02</TD><TD>-3.81</TD><TD>ANTXR2 (ANTXR cell adhesion molecule 2)</TD><TD>protein interactions</TD><TD>118429</TD><TD>13</TD><TD>1</TD><TD>17456</TD><TD>30</TD>
<TD>LGR4</TD></TR>
<TR><TD>2.212e-02</TD><TD>-3.81</TD><TD>ALDH1L2 (aldehyde dehydrogenase 1 family member L2)</TD><TD>protein interactions</TD><TD>160428</TD><TD>13</TD><TD>1</TD><TD>17456</TD><TD>30</TD>
<TD>TUBA1A</TD></TR>
<TR><TD>2.212e-02</TD><TD>-3.81</TD><TD>KIF3C (kinesin family member 3C)</TD><TD>protein interactions</TD><TD>3797</TD><TD>13</TD><TD>1</TD><TD>17456</TD><TD>30</TD>
<TD>KIFAP3</TD></TR>
<TR><TD>2.212e-02</TD><TD>-3.81</TD><TD>NPC1 (NPC intracellular cholesterol transporter 1)</TD><TD>protein interactions</TD><TD>4864</TD><TD>13</TD><TD>1</TD><TD>17456</TD><TD>30</TD>
<TD>LGR4</TD></TR>
<TR><TD>2.226e-02</TD><TD>-3.80</TD><TD>negative regulation of vascular endothelial growth factor signaling pathway</TD><TD>biological process</TD><TD>GO:1900747</TD><TD>14</TD><TD>1</TD><TD>18054</TD><TD>29</TD>
<TD>CADM4</TD></TR>
<TR><TD>2.226e-02</TD><TD>-3.80</TD><TD>ossification involved in bone maturation</TD><TD>biological process</TD><TD>GO:0043931</TD><TD>14</TD><TD>1</TD><TD>18054</TD><TD>29</TD>
<TD>RYR1</TD></TR>
<TR><TD>2.226e-02</TD><TD>-3.80</TD><TD>positive regulation of actin filament depolymerization</TD><TD>biological process</TD><TD>GO:0030836</TD><TD>14</TD><TD>1</TD><TD>18054</TD><TD>29</TD>
<TD>KIAA1211</TD></TR>
<TR><TD>2.226e-02</TD><TD>-3.80</TD><TD>sarcoplasmic reticulum calcium ion transport</TD><TD>biological process</TD><TD>GO:0070296</TD><TD>14</TD><TD>1</TD><TD>18054</TD><TD>29</TD>
<TD>RYR1</TD></TR>
<TR><TD>2.226e-02</TD><TD>-3.80</TD><TD>regulation of Rac protein signal transduction</TD><TD>biological process</TD><TD>GO:0035020</TD><TD>14</TD><TD>1</TD><TD>18054</TD><TD>29</TD>
<TD>CADM4</TD></TR>
<TR><TD>2.226e-02</TD><TD>-3.80</TD><TD>regulation of synapse maturation</TD><TD>biological process</TD><TD>GO:0090128</TD><TD>14</TD><TD>1</TD><TD>18054</TD><TD>29</TD>
<TD>ADGRL1</TD></TR>
<TR><TD>2.226e-02</TD><TD>-3.80</TD><TD>induction of positive chemotaxis</TD><TD>biological process</TD><TD>GO:0050930</TD><TD>14</TD><TD>1</TD><TD>18054</TD><TD>29</TD>
<TD>PGF</TD></TR>
<TR><TD>2.231e-02</TD><TD>-3.80</TD><TD>heparan sulfate sulfotransferase activity</TD><TD>molecular function</TD><TD>GO:0034483</TD><TD>15</TD><TD>1</TD><TD>17306</TD><TD>26</TD>
<TD>HS6ST2</TD></TR>
<TR><TD>2.233e-02</TD><TD>-3.80</TD><TD>Calpain_cysteine_protease</TD><TD>interpro domains</TD><TD>IPR022684</TD><TD>14</TD><TD>1</TD><TD>18616</TD><TD>30</TD>
<TD>CAPN6</TD></TR>
<TR><TD>2.233e-02</TD><TD>-3.80</TD><TD>Neurexin-like</TD><TD>interpro domains</TD><TD>IPR003585</TD><TD>14</TD><TD>1</TD><TD>18616</TD><TD>30</TD>
<TD>CADM4</TD></TR>
<TR><TD>2.244e-02</TD><TD>-3.80</TD><TD>Papain-like_cys_pep_sf</TD><TD>interpro domains</TD><TD>IPR038765</TD><TD>144</TD><TD>2</TD><TD>18616</TD><TD>30</TD>
<TD>CAPN6,CTSV</TD></TR>
<TR><TD>2.264e-02</TD><TD>-3.79</TD><TD>GSE16385_IFNG_TNF_VS_ROSIGLITAZONE_STIM_MACROPHAGE_DN</TD><TD>MSigDB lists</TD><TD>GSE16385_IFNG_TNF_VS_ROSIGLITAZONE_STIM_MACROPHAGE_DN</TD><TD>139</TD><TD>2</TD><TD>17275</TD><TD>29</TD>
<TD>ISG15,OASL</TD></TR>
<TR><TD>2.269e-02</TD><TD>-3.79</TD><TD>human chr8q21.11</TD><TD>chromosome location</TD><TD>human chr8q21.11</TD><TD>20</TD><TD>1</TD><TD>26169</TD><TD>30</TD>
<TD>SBSPON</TD></TR>
<TR><TD>2.277e-02</TD><TD>-3.78</TD><TD>CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_2</TD><TD>MSigDB lists</TD><TD>CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_2</TD><TD>365</TD><TD>3</TD><TD>17275</TD><TD>29</TD>
<TD>OASL,IFIT2,RSAD2</TD></TR>
<TR><TD>2.284e-02</TD><TD>-3.78</TD><TD>adenyl ribonucleotide binding</TD><TD>molecular function</TD><TD>GO:0032559</TD><TD>1523</TD><TD>6</TD><TD>17306</TD><TD>26</TD>
<TD>OAS3,CAMKK2,RYR1,OASL,OAS2,OAS1</TD></TR>
<TR><TD>2.286e-02</TD><TD>-3.78</TD><TD>cAMP-mediated signaling</TD><TD>biological process</TD><TD>GO:0019933</TD><TD>146</TD><TD>2</TD><TD>18054</TD><TD>29</TD>
<TD>ADGRL1,LGR4</TD></TR>
<TR><TD>2.293e-02</TD><TD>-3.78</TD><TD>BERENJENO_TRANSFORMED_BY_RHOA_DN</TD><TD>MSigDB lists</TD><TD>BERENJENO_TRANSFORMED_BY_RHOA_DN</TD><TD>366</TD><TD>3</TD><TD>17275</TD><TD>29</TD>
<TD>IFI27,KIFAP3,CAPN6</TD></TR>
<TR><TD>2.295e-02</TD><TD>-3.77</TD><TD>GREGORY_SYNTHETIC_LETHAL_WITH_IMATINIB</TD><TD>MSigDB lists</TD><TD>GREGORY_SYNTHETIC_LETHAL_WITH_IMATINIB</TD><TD>140</TD><TD>2</TD><TD>17275</TD><TD>29</TD>
<TD>CADM4,CAPN6</TD></TR>
<TR><TD>2.325e-02</TD><TD>-3.76</TD><TD>GSE14415_NATURAL_TREG_VS_FOXP3_KO_NATURAL_TREG_UP</TD><TD>MSigDB lists</TD><TD>GSE14415_NATURAL_TREG_VS_FOXP3_KO_NATURAL_TREG_UP</TD><TD>141</TD><TD>2</TD><TD>17275</TD><TD>29</TD>
<TD>RSAD2,IFI44</TD></TR>
<TR><TD>2.326e-02</TD><TD>-3.76</TD><TD>HOWLIN_CITED1_TARGETS_2_UP</TD><TD>MSigDB lists</TD><TD>HOWLIN_CITED1_TARGETS_2_UP</TD><TD>14</TD><TD>1</TD><TD>17275</TD><TD>29</TD>
<TD>IFI44</TD></TR>
<TR><TD>2.326e-02</TD><TD>-3.76</TD><TD>GO_BONE_MATURATION</TD><TD>MSigDB lists</TD><TD>GO_BONE_MATURATION</TD><TD>14</TD><TD>1</TD><TD>17275</TD><TD>29</TD>
<TD>RYR1</TD></TR>
<TR><TD>2.326e-02</TD><TD>-3.76</TD><TD>GO_ANGIOGENESIS_INVOLVED_IN_WOUND_HEALING</TD><TD>MSigDB lists</TD><TD>GO_ANGIOGENESIS_INVOLVED_IN_WOUND_HEALING</TD><TD>14</TD><TD>1</TD><TD>17275</TD><TD>29</TD>
<TD>MCAM</TD></TR>
<TR><TD>2.326e-02</TD><TD>-3.76</TD><TD>GO_ENDOPLASMIC_RETICULUM_SUBCOMPARTMENT</TD><TD>MSigDB lists</TD><TD>GO_ENDOPLASMIC_RETICULUM_SUBCOMPARTMENT</TD><TD>14</TD><TD>1</TD><TD>17275</TD><TD>29</TD>
<TD>RYR1</TD></TR>
<TR><TD>2.326e-02</TD><TD>-3.76</TD><TD>GO_POSITIVE_REGULATION_OF_TYPE_2_IMMUNE_RESPONSE</TD><TD>MSigDB lists</TD><TD>GO_POSITIVE_REGULATION_OF_TYPE_2_IMMUNE_RESPONSE</TD><TD>14</TD><TD>1</TD><TD>17275</TD><TD>29</TD>
<TD>RSAD2</TD></TR>
<TR><TD>2.326e-02</TD><TD>-3.76</TD><TD>VISALA_RESPONSE_TO_HEAT_SHOCK_AND_AGING_UP</TD><TD>MSigDB lists</TD><TD>VISALA_RESPONSE_TO_HEAT_SHOCK_AND_AGING_UP</TD><TD>14</TD><TD>1</TD><TD>17275</TD><TD>29</TD>
<TD>TUBA1A</TD></TR>
<TR><TD>2.326e-02</TD><TD>-3.76</TD><TD>GO_POSITIVE_REGULATION_OF_T_CELL_CYTOKINE_PRODUCTION</TD><TD>MSigDB lists</TD><TD>GO_POSITIVE_REGULATION_OF_T_CELL_CYTOKINE_PRODUCTION</TD><TD>14</TD><TD>1</TD><TD>17275</TD><TD>29</TD>
<TD>RSAD2</TD></TR>
<TR><TD>2.326e-02</TD><TD>-3.76</TD><TD>DORN_ADENOVIRUS_INFECTION_48HR_UP</TD><TD>MSigDB lists</TD><TD>DORN_ADENOVIRUS_INFECTION_48HR_UP</TD><TD>14</TD><TD>1</TD><TD>17275</TD><TD>29</TD>
<TD>IFIT2</TD></TR>
<TR><TD>2.326e-02</TD><TD>-3.76</TD><TD>HAN_SATB1_TARGETS_UP</TD><TD>MSigDB lists</TD><TD>HAN_SATB1_TARGETS_UP</TD><TD>368</TD><TD>3</TD><TD>17275</TD><TD>29</TD>
<TD>IFIT2,CAPN6,OAS1</TD></TR>
<TR><TD>2.345e-02</TD><TD>-3.75</TD><TD>calcium-mediated signaling</TD><TD>biological process</TD><TD>GO:0019722</TD><TD>148</TD><TD>2</TD><TD>18054</TD><TD>29</TD>
<TD>CAMKK2,ADGRL1</TD></TR>
<TR><TD>2.358e-02</TD><TD>-3.75</TD><TD>adenyl nucleotide binding</TD><TD>molecular function</TD><TD>GO:0030554</TD><TD>1534</TD><TD>6</TD><TD>17306</TD><TD>26</TD>
<TD>RYR1,CAMKK2,OAS3,OAS1,OASL,OAS2</TD></TR>
<TR><TD>2.359e-02</TD><TD>-3.75</TD><TD>TARTE_PLASMA_CELL_VS_PLASMABLAST_UP</TD><TD>MSigDB lists</TD><TD>TARTE_PLASMA_CELL_VS_PLASMABLAST_UP</TD><TD>370</TD><TD>3</TD><TD>17275</TD><TD>29</TD>
<TD>IFI44,MCAM,IFI44L</TD></TR>
<TR><TD>2.374e-02</TD><TD>-3.74</TD><TD>negative regulation of peptide secretion</TD><TD>biological process</TD><TD>GO:0002792</TD><TD>149</TD><TD>2</TD><TD>18054</TD><TD>29</TD>
<TD>LGR4,RSAD2</TD></TR>
<TR><TD>2.375e-02</TD><TD>-3.74</TD><TD>SENGUPTA_NASOPHARYNGEAL_CARCINOMA_WITH_LMP1_UP</TD><TD>MSigDB lists</TD><TD>SENGUPTA_NASOPHARYNGEAL_CARCINOMA_WITH_LMP1_UP</TD><TD>371</TD><TD>3</TD><TD>17275</TD><TD>29</TD>
<TD>IFIT2,RSAD2,OAS1</TD></TR>
<TR><TD>2.378e-02</TD><TD>-3.74</TD><TD>lamin binding</TD><TD>molecular function</TD><TD>GO:0005521</TD><TD>16</TD><TD>1</TD><TD>17306</TD><TD>26</TD>
<TD>IFI27</TD></TR>
<TR><TD>2.380e-02</TD><TD>-3.74</TD><TD>POLG2 (DNA polymerase gamma 2, accessory subunit)</TD><TD>protein interactions</TD><TD>11232</TD><TD>14</TD><TD>1</TD><TD>17456</TD><TD>30</TD>
<TD>IFIT2</TD></TR>
<TR><TD>2.380e-02</TD><TD>-3.74</TD><TD>TRAC (T cell receptor alpha constant)</TD><TD>protein interactions</TD><TD>28755</TD><TD>14</TD><TD>1</TD><TD>17456</TD><TD>30</TD>
<TD>TUBA1A</TD></TR>
<TR><TD>2.380e-02</TD><TD>-3.74</TD><TD>SGCA (sarcoglycan alpha)</TD><TD>protein interactions</TD><TD>6442</TD><TD>14</TD><TD>1</TD><TD>17456</TD><TD>30</TD>
<TD>LGR4</TD></TR>
<TR><TD>2.380e-02</TD><TD>-3.74</TD><TD>GRM7 (glutamate metabotropic receptor 7)</TD><TD>protein interactions</TD><TD>2917</TD><TD>14</TD><TD>1</TD><TD>17456</TD><TD>30</TD>
<TD>TUBA1A</TD></TR>
<TR><TD>2.380e-02</TD><TD>-3.74</TD><TD>Kif2c (kinesin family member 2C)</TD><TD>protein interactions</TD><TD>73804</TD><TD>14</TD><TD>1</TD><TD>17456</TD><TD>30</TD>
<TD>TUBA1A</TD></TR>
<TR><TD>2.381e-02</TD><TD>-3.74</TD><TD>human chrXq26.2</TD><TD>chromosome location</TD><TD>human chrXq26.2</TD><TD>21</TD><TD>1</TD><TD>26169</TD><TD>30</TD>
<TD>HS6ST2</TD></TR>
<TR><TD>2.381e-02</TD><TD>-3.74</TD><TD>calpain_III</TD><TD>smart domains</TD><TD>SM00720</TD><TD>12</TD><TD>1</TD><TD>9476</TD><TD>19</TD>
<TD>CAPN6</TD></TR>
<TR><TD>2.383e-02</TD><TD>-3.74</TD><TD>metanephric nephron tubule development</TD><TD>biological process</TD><TD>GO:0072234</TD><TD>15</TD><TD>1</TD><TD>18054</TD><TD>29</TD>
<TD>LGR4</TD></TR>
<TR><TD>2.383e-02</TD><TD>-3.74</TD><TD>angiogenesis involved in wound healing</TD><TD>biological process</TD><TD>GO:0060055</TD><TD>15</TD><TD>1</TD><TD>18054</TD><TD>29</TD>
<TD>MCAM</TD></TR>
<TR><TD>2.383e-02</TD><TD>-3.74</TD><TD>negative regulation of cellular response to vascular endothelial growth factor stimulus</TD><TD>biological process</TD><TD>GO:1902548</TD><TD>15</TD><TD>1</TD><TD>18054</TD><TD>29</TD>
<TD>CADM4</TD></TR>
<TR><TD>2.384e-02</TD><TD>-3.74</TD><TD>V-set</TD><TD>pfam domains</TD><TD>PF07686</TD><TD>149</TD><TD>2</TD><TD>17385</TD><TD>28</TD>
<TD>CADM4,MCAM</TD></TR>
<TR><TD>2.387e-02</TD><TD>-3.74</TD><TD>MODULE_238</TD><TD>MSigDB lists</TD><TD>MODULE_238</TD><TD>143</TD><TD>2</TD><TD>17275</TD><TD>29</TD>
<TD>RSAD2,OAS1</TD></TR>
<TR><TD>2.390e-02</TD><TD>-3.73</TD><TD>Peptidase_C2</TD><TD>pfam domains</TD><TD>PF00648</TD><TD>15</TD><TD>1</TD><TD>17385</TD><TD>28</TD>
<TD>CAPN6</TD></TR>
<TR><TD>2.391e-02</TD><TD>-3.73</TD><TD>Peptidase_C2_calpain_cat</TD><TD>interpro domains</TD><TD>IPR001300</TD><TD>15</TD><TD>1</TD><TD>18616</TD><TD>30</TD>
<TD>CAPN6</TD></TR>
<TR><TD>2.399e-02</TD><TD>-3.73</TD><TD>EEF1A2 (eukaryotic translation elongation factor 1 alpha 2)</TD><TD>protein interactions</TD><TD>1917</TD><TD>140</TD><TD>2</TD><TD>17456</TD><TD>30</TD>
<TD>ISG15,LGR4</TD></TR>
<TR><TD>2.407e-02</TD><TD>-3.73</TD><TD>SCHLOSSER_SERUM_RESPONSE_DN</TD><TD>MSigDB lists</TD><TD>SCHLOSSER_SERUM_RESPONSE_DN</TD><TD>665</TD><TD>4</TD><TD>17275</TD><TD>29</TD>
<TD>RSAD2,KIFAP3,OAS1,OAS2</TD></TR>
<TR><TD>2.424e-02</TD><TD>-3.72</TD><TD>Trafficking and processing of endosomal TLR</TD><TD>REACTOME pathways</TD><TD>R-HSA-1679131</TD><TD>14</TD><TD>1</TD><TD>10287</TD><TD>18</TD>
<TD>CTSV</TD></TR>
<TR><TD>2.431e-02</TD><TD>-3.72</TD><TD>DISC1 (DISC1 scaffold protein)</TD><TD>protein interactions</TD><TD>27185</TD><TD>141</TD><TD>2</TD><TD>17456</TD><TD>30</TD>
<TD>MGAT3,KIFAP3</TD></TR>
<TR><TD>2.450e-02</TD><TD>-3.71</TD><TD>FOSTER_TOLERANT_MACROPHAGE_UP</TD><TD>MSigDB lists</TD><TD>FOSTER_TOLERANT_MACROPHAGE_UP</TD><TD>145</TD><TD>2</TD><TD>17275</TD><TD>29</TD>
<TD>IFI44,OAS3</TD></TR>
<TR><TD>2.472e-02</TD><TD>-3.70</TD><TD>microtubule</TD><TD>cellular component</TD><TD>GO:0005874</TD><TD>414</TD><TD>3</TD><TD>18985</TD><TD>29</TD>
<TD>KIFAP3,TUBA1A,CAPN6</TD></TR>
<TR><TD>2.481e-02</TD><TD>-3.70</TD><TD>MIKKELSEN_MCV6_LCP_WITH_H3K4ME3</TD><TD>MSigDB lists</TD><TD>MIKKELSEN_MCV6_LCP_WITH_H3K4ME3</TD><TD>146</TD><TD>2</TD><TD>17275</TD><TD>29</TD>
<TD>RSAD2,OAS2</TD></TR>
<TR><TD>2.490e-02</TD><TD>-3.69</TD><TD>GO_HEPARAN_SULFATE_SULFOTRANSFERASE_ACTIVITY</TD><TD>MSigDB lists</TD><TD>GO_HEPARAN_SULFATE_SULFOTRANSFERASE_ACTIVITY</TD><TD>15</TD><TD>1</TD><TD>17275</TD><TD>29</TD>
<TD>HS6ST2</TD></TR>
<TR><TD>2.490e-02</TD><TD>-3.69</TD><TD>TIMOFEEVA_GROWTH_STRESS_VIA_STAT1_DN</TD><TD>MSigDB lists</TD><TD>TIMOFEEVA_GROWTH_STRESS_VIA_STAT1_DN</TD><TD>15</TD><TD>1</TD><TD>17275</TD><TD>29</TD>
<TD>ISG15</TD></TR>
<TR><TD>2.490e-02</TD><TD>-3.69</TD><TD>LIANG_HEMATOPOIESIS_STEM_CELL_NUMBER_QTL</TD><TD>MSigDB lists</TD><TD>LIANG_HEMATOPOIESIS_STEM_CELL_NUMBER_QTL</TD><TD>15</TD><TD>1</TD><TD>17275</TD><TD>29</TD>
<TD>TUBA1A</TD></TR>
<TR><TD>2.490e-02</TD><TD>-3.69</TD><TD>ZEMBUTSU_SENSITIVITY_TO_CYCLOPHOSPHAMIDE</TD><TD>MSigDB lists</TD><TD>ZEMBUTSU_SENSITIVITY_TO_CYCLOPHOSPHAMIDE</TD><TD>15</TD><TD>1</TD><TD>17275</TD><TD>29</TD>
<TD>DIRAS1</TD></TR>
<TR><TD>2.510e-02</TD><TD>-3.68</TD><TD>GO_MICROTUBULE</TD><TD>MSigDB lists</TD><TD>GO_MICROTUBULE</TD><TD>379</TD><TD>3</TD><TD>17275</TD><TD>29</TD>
<TD>CAPN6,KIFAP3,TUBA1A</TD></TR>
<TR><TD>2.515e-02</TD><TD>-3.68</TD><TD>central_nervous_system-brain-primitive_neuroectodermal_tumour-medulloblastoma-large_cell</TD><TD>COSMIC cancer mutations</TD><TD>central_nervous_system-brain-primitive_neuroectodermal_tumour-medulloblastoma-large_cell</TD><TD>1134</TD><TD>5</TD><TD>17255</TD><TD>26</TD>
<TD>RYR1,KIFAP3,IFI44L,HS6ST2,MCAM</TD></TR>
<TR><TD>2.525e-02</TD><TD>-3.68</TD><TD>calcium-dependent cysteine-type endopeptidase activity</TD><TD>molecular function</TD><TD>GO:0004198</TD><TD>17</TD><TD>1</TD><TD>17306</TD><TD>26</TD>
<TD>CAPN6</TD></TR>
<TR><TD>2.528e-02</TD><TD>-3.68</TD><TD>FTSJ3 (FtsJ RNA 2'-O-methyltransferase 3)</TD><TD>protein interactions</TD><TD>117246</TD><TD>144</TD><TD>2</TD><TD>17456</TD><TD>30</TD>
<TD>OAS3,LGR4</TD></TR>
<TR><TD>2.540e-02</TD><TD>-3.67</TD><TD>positive regulation of type 2 immune response</TD><TD>biological process</TD><TD>GO:0002830</TD><TD>16</TD><TD>1</TD><TD>18054</TD><TD>29</TD>
<TD>RSAD2</TD></TR>
<TR><TD>2.540e-02</TD><TD>-3.67</TD><TD>modulation by host of viral genome replication</TD><TD>biological process</TD><TD>GO:0044827</TD><TD>16</TD><TD>1</TD><TD>18054</TD><TD>29</TD>
<TD>IFI27</TD></TR>
<TR><TD>2.545e-02</TD><TD>-3.67</TD><TD>GSE4590_PRE_BCELL_VS_LARGE_PRE_BCELL_UP</TD><TD>MSigDB lists</TD><TD>GSE4590_PRE_BCELL_VS_LARGE_PRE_BCELL_UP</TD><TD>148</TD><TD>2</TD><TD>17275</TD><TD>29</TD>
<TD>RSAD2,ISG15</TD></TR>
<TR><TD>2.545e-02</TD><TD>-3.67</TD><TD>RAY_TUMORIGENESIS_BY_ERBB2_CDC25A_DN</TD><TD>MSigDB lists</TD><TD>RAY_TUMORIGENESIS_BY_ERBB2_CDC25A_DN</TD><TD>148</TD><TD>2</TD><TD>17275</TD><TD>29</TD>
<TD>OAS2,RSAD2</TD></TR>
<TR><TD>2.545e-02</TD><TD>-3.67</TD><TD>GSE40666_UNTREATED_VS_IFNA_STIM_CD8_TCELL_90MIN_UP</TD><TD>MSigDB lists</TD><TD>GSE40666_UNTREATED_VS_IFNA_STIM_CD8_TCELL_90MIN_UP</TD><TD>148</TD><TD>2</TD><TD>17275</TD><TD>29</TD>
<TD>IFI44,BCL6B</TD></TR>
<TR><TD>2.548e-02</TD><TD>-3.67</TD><TD>CRYBG1 (crystallin beta-gamma domain containing 1)</TD><TD>protein interactions</TD><TD>202</TD><TD>15</TD><TD>1</TD><TD>17456</TD><TD>30</TD>
<TD>KIFAP3</TD></TR>
<TR><TD>2.548e-02</TD><TD>-3.67</TD><TD>TIMM17A (translocase of inner mitochondrial membrane 17A)</TD><TD>protein interactions</TD><TD>10440</TD><TD>15</TD><TD>1</TD><TD>17456</TD><TD>30</TD>
<TD>TUBA1A</TD></TR>
<TR><TD>2.548e-02</TD><TD>-3.67</TD><TD>GCHFR (GTP cyclohydrolase I feedback regulator)</TD><TD>protein interactions</TD><TD>2644</TD><TD>15</TD><TD>1</TD><TD>17456</TD><TD>30</TD>
<TD>CAMKK2</TD></TR>
<TR><TD>2.548e-02</TD><TD>-3.67</TD><TD>ZNRF3 (zinc and ring finger 3)</TD><TD>protein interactions</TD><TD>84133</TD><TD>15</TD><TD>1</TD><TD>17456</TD><TD>30</TD>
<TD>LGR4</TD></TR>
<TR><TD>2.548e-02</TD><TD>-3.67</TD><TD>ITM2A (integral membrane protein 2A)</TD><TD>protein interactions</TD><TD>9452</TD><TD>15</TD><TD>1</TD><TD>17456</TD><TD>30</TD>
<TD>LGR4</TD></TR>
<TR><TD>2.548e-02</TD><TD>-3.67</TD><TD>K3 (K3)</TD><TD>protein interactions</TD><TD>4961486</TD><TD>15</TD><TD>1</TD><TD>17456</TD><TD>30</TD>
<TD>TUBA1A</TD></TR>
<TR><TD>2.548e-02</TD><TD>-3.67</TD><TD>TPSB2 (tryptase beta 2 (gene/pseudogene))</TD><TD>protein interactions</TD><TD>64499</TD><TD>15</TD><TD>1</TD><TD>17456</TD><TD>30</TD>
<TD>TUBA1A</TD></TR>
<TR><TD>2.548e-02</TD><TD>-3.67</TD><TD>EML1 (EMAP like 1)</TD><TD>protein interactions</TD><TD>2009</TD><TD>15</TD><TD>1</TD><TD>17456</TD><TD>30</TD>
<TD>TUBA1A</TD></TR>
<TR><TD>2.548e-02</TD><TD>-3.67</TD><TD>HELZ2 (helicase with zinc finger 2)</TD><TD>protein interactions</TD><TD>85441</TD><TD>15</TD><TD>1</TD><TD>17456</TD><TD>30</TD>
<TD>ISG15</TD></TR>
<TR><TD>2.548e-02</TD><TD>-3.67</TD><TD>MMRN1 (multimerin 1)</TD><TD>protein interactions</TD><TD>22915</TD><TD>15</TD><TD>1</TD><TD>17456</TD><TD>30</TD>
<TD>CTSV</TD></TR>
<TR><TD>2.550e-02</TD><TD>-3.67</TD><TD>heparan sulfate biosynthesis</TD><TD>BIOCYC pathways</TD><TD>META_PWY-6564</TD><TD>23</TD><TD>1</TD><TD>902</TD><TD>1</TD>
<TD>HS6ST2</TD></TR>
<TR><TD>2.554e-02</TD><TD>-3.67</TD><TD>OLF</TD><TD>prosite domains</TD><TD>PS51132</TD><TD>13</TD><TD>1</TD><TD>12079</TD><TD>24</TD>
<TD>ADGRL1</TD></TR>
<TR><TD>2.570e-02</TD><TD>-3.66</TD><TD>Oxytocin signaling pathway</TD><TD>KEGG pathways</TD><TD>hsa04921</TD><TD>152</TD><TD>2</TD><TD>7161</TD><TD>12</TD>
<TD>CAMKK2,RYR1</TD></TR>
<TR><TD>2.570e-02</TD><TD>-3.66</TD><TD>Oxytocin signaling pathway</TD><TD>KEGG pathways</TD><TD>ko04921</TD><TD>152</TD><TD>2</TD><TD>7161</TD><TD>12</TD>
<TD>RYR1,CAMKK2</TD></TR>
<TR><TD>2.577e-02</TD><TD>-3.66</TD><TD>DARWICHE_PAPILLOMA_RISK_LOW_UP</TD><TD>MSigDB lists</TD><TD>DARWICHE_PAPILLOMA_RISK_LOW_UP</TD><TD>149</TD><TD>2</TD><TD>17275</TD><TD>29</TD>
<TD>RYR1,MCAM</TD></TR>
<TR><TD>2.577e-02</TD><TD>-3.66</TD><TD>GSE2770_TGFB_AND_IL4_VS_TGFB_AND_IL12_TREATED_ACT_CD4_TCELL_2H_UP</TD><TD>MSigDB lists</TD><TD>GSE2770_TGFB_AND_IL4_VS_TGFB_AND_IL12_TREATED_ACT_CD4_TCELL_2H_UP</TD><TD>149</TD><TD>2</TD><TD>17275</TD><TD>29</TD>
<TD>IFI44L,RSAD2</TD></TR>
<TR><TD>2.577e-02</TD><TD>-3.66</TD><TD>GSE14386_UNTREATED_VS_IFNA_TREATED_ACT_PBMC_MS_PATIENT_DN</TD><TD>MSigDB lists</TD><TD>GSE14386_UNTREATED_VS_IFNA_TREATED_ACT_PBMC_MS_PATIENT_DN</TD><TD>149</TD><TD>2</TD><TD>17275</TD><TD>29</TD>
<TD>RSAD2,IFI44</TD></TR>
<TR><TD>2.577e-02</TD><TD>-3.66</TD><TD>GSE4748_LPS_VS_LPS_AND_CYANOBACTERIUM_LPSLIKE_STIM_DC_3H_DN</TD><TD>MSigDB lists</TD><TD>GSE4748_LPS_VS_LPS_AND_CYANOBACTERIUM_LPSLIKE_STIM_DC_3H_DN</TD><TD>149</TD><TD>2</TD><TD>17275</TD><TD>29</TD>
<TD>KLHDC8B,CAPN6</TD></TR>
<TR><TD>2.577e-02</TD><TD>-3.66</TD><TD>GSE25123_WT_VS_PPARG_KO_MACROPHAGE_ROSIGLITAZONE_STIM_DN</TD><TD>MSigDB lists</TD><TD>GSE25123_WT_VS_PPARG_KO_MACROPHAGE_ROSIGLITAZONE_STIM_DN</TD><TD>149</TD><TD>2</TD><TD>17275</TD><TD>29</TD>
<TD>MCAM,ISG15</TD></TR>
<TR><TD>2.577e-02</TD><TD>-3.66</TD><TD>OLF</TD><TD>smart domains</TD><TD>SM00284</TD><TD>13</TD><TD>1</TD><TD>9476</TD><TD>19</TD>
<TD>ADGRL1</TD></TR>
<TR><TD>2.577e-02</TD><TD>-3.66</TD><TD>Pept_C1</TD><TD>smart domains</TD><TD>SM00645</TD><TD>13</TD><TD>1</TD><TD>9476</TD><TD>19</TD>
<TD>CTSV</TD></TR>
<TR><TD>2.586e-02</TD><TD>-3.66</TD><TD>male sex differentiation</TD><TD>biological process</TD><TD>GO:0046661</TD><TD>156</TD><TD>2</TD><TD>18054</TD><TD>29</TD>
<TD>CTSV,LGR4</TD></TR>
<TR><TD>2.589e-02</TD><TD>-3.65</TD><TD>VEGFR1 specific signals</TD><TD>Pathway Interaction DB</TD><TD>vegfr1_pathway</TD><TD>29</TD><TD>1</TD><TD>2226</TD><TD>2</TD>
<TD>PGF</TD></TR>
<TR><TD>2.609e-02</TD><TD>-3.65</TD><TD>TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_ERYTHROCYTE_UP</TD><TD>MSigDB lists</TD><TD>TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_ERYTHROCYTE_UP</TD><TD>150</TD><TD>2</TD><TD>17275</TD><TD>29</TD>
<TD>OAS2,IFI44</TD></TR>
<TR><TD>2.650e-02</TD><TD>-3.63</TD><TD>N-glycan biosynthesis, complex type</TD><TD>KEGG pathways</TD><TD>hsa_M00075</TD><TD>16</TD><TD>1</TD><TD>7161</TD><TD>12</TD>
<TD>MGAT3</TD></TR>
<TR><TD>2.650e-02</TD><TD>-3.63</TD><TD>N-glycan biosynthesis, complex type</TD><TD>KEGG pathways</TD><TD>M00075</TD><TD>16</TD><TD>1</TD><TD>7161</TD><TD>12</TD>
<TD>MGAT3</TD></TR>
<TR><TD>2.654e-02</TD><TD>-3.63</TD><TD>GALE_APL_WITH_FLT3_MUTATED_DN</TD><TD>MSigDB lists</TD><TD>GALE_APL_WITH_FLT3_MUTATED_DN</TD><TD>16</TD><TD>1</TD><TD>17275</TD><TD>29</TD>
<TD>OASL</TD></TR>
<TR><TD>2.654e-02</TD><TD>-3.63</TD><TD>GOUYER_TATI_TARGETS_DN</TD><TD>MSigDB lists</TD><TD>GOUYER_TATI_TARGETS_DN</TD><TD>16</TD><TD>1</TD><TD>17275</TD><TD>29</TD>
<TD>MCAM</TD></TR>
<TR><TD>2.654e-02</TD><TD>-3.63</TD><TD>GO_LIGAND_GATED_CALCIUM_CHANNEL_ACTIVITY</TD><TD>MSigDB lists</TD><TD>GO_LIGAND_GATED_CALCIUM_CHANNEL_ACTIVITY</TD><TD>16</TD><TD>1</TD><TD>17275</TD><TD>29</TD>
<TD>RYR1</TD></TR>
<TR><TD>2.673e-02</TD><TD>-3.62</TD><TD>GSE6674_UNSTIM_VS_CPG_STIM_BCELL_DN</TD><TD>MSigDB lists</TD><TD>GSE6674_UNSTIM_VS_CPG_STIM_BCELL_DN</TD><TD>152</TD><TD>2</TD><TD>17275</TD><TD>29</TD>
<TD>OAS3,LGR4</TD></TR>
<TR><TD>2.673e-02</TD><TD>-3.62</TD><TD>GSE18791_CTRL_VS_NEWCASTLE_VIRUS_DC_2H_DN</TD><TD>MSigDB lists</TD><TD>GSE18791_CTRL_VS_NEWCASTLE_VIRUS_DC_2H_DN</TD><TD>152</TD><TD>2</TD><TD>17275</TD><TD>29</TD>
<TD>ISG15,IFIT2</TD></TR>
<TR><TD>2.697e-02</TD><TD>-3.61</TD><TD>bone maturation</TD><TD>biological process</TD><TD>GO:0070977</TD><TD>17</TD><TD>1</TD><TD>18054</TD><TD>29</TD>
<TD>RYR1</TD></TR>
<TR><TD>2.697e-02</TD><TD>-3.61</TD><TD>cell differentiation involved in metanephros development</TD><TD>biological process</TD><TD>GO:0072202</TD><TD>17</TD><TD>1</TD><TD>18054</TD><TD>29</TD>
<TD>LGR4</TD></TR>
<TR><TD>2.697e-02</TD><TD>-3.61</TD><TD>response to caffeine</TD><TD>biological process</TD><TD>GO:0031000</TD><TD>17</TD><TD>1</TD><TD>18054</TD><TD>29</TD>
<TD>RYR1</TD></TR>
<TR><TD>2.697e-02</TD><TD>-3.61</TD><TD>metanephric nephron epithelium development</TD><TD>biological process</TD><TD>GO:0072243</TD><TD>17</TD><TD>1</TD><TD>18054</TD><TD>29</TD>
<TD>LGR4</TD></TR>
<TR><TD>2.697e-02</TD><TD>-3.61</TD><TD>response to diuretic</TD><TD>biological process</TD><TD>GO:0036270</TD><TD>17</TD><TD>1</TD><TD>18054</TD><TD>29</TD>
<TD>RYR1</TD></TR>
<TR><TD>2.704e-02</TD><TD>-3.61</TD><TD>MMR_HSR1</TD><TD>pfam domains</TD><TD>PF01926</TD><TD>17</TD><TD>1</TD><TD>17385</TD><TD>28</TD>
<TD>IFI44L</TD></TR>
<TR><TD>2.706e-02</TD><TD>-3.61</TD><TD>GO_NUCLEOSIDE_PHOSPHATE_BIOSYNTHETIC_PROCESS</TD><TD>MSigDB lists</TD><TD>GO_NUCLEOSIDE_PHOSPHATE_BIOSYNTHETIC_PROCESS</TD><TD>153</TD><TD>2</TD><TD>17275</TD><TD>29</TD>
<TD>OAS1,OAS2</TD></TR>
<TR><TD>2.716e-02</TD><TD>-3.61</TD><TD>FLRT1 (fibronectin leucine rich transmembrane protein 1)</TD><TD>protein interactions</TD><TD>23769</TD><TD>16</TD><TD>1</TD><TD>17456</TD><TD>30</TD>
<TD>ADGRL1</TD></TR>
<TR><TD>2.716e-02</TD><TD>-3.61</TD><TD>SOCS7 (suppressor of cytokine signaling 7)</TD><TD>protein interactions</TD><TD>30837</TD><TD>16</TD><TD>1</TD><TD>17456</TD><TD>30</TD>
<TD>TUBA1A</TD></TR>
<TR><TD>2.716e-02</TD><TD>-3.61</TD><TD>L2HGDH (L-2-hydroxyglutarate dehydrogenase)</TD><TD>protein interactions</TD><TD>79944</TD><TD>16</TD><TD>1</TD><TD>17456</TD><TD>30</TD>
<TD>CTSV</TD></TR>
<TR><TD>2.716e-02</TD><TD>-3.61</TD><TD>DAAM2 (dishevelled associated activator of morphogenesis 2)</TD><TD>protein interactions</TD><TD>23500</TD><TD>16</TD><TD>1</TD><TD>17456</TD><TD>30</TD>
<TD>LGR4</TD></TR>
<TR><TD>2.716e-02</TD><TD>-3.61</TD><TD>THTPA (thiamine triphosphatase)</TD><TD>protein interactions</TD><TD>79178</TD><TD>16</TD><TD>1</TD><TD>17456</TD><TD>30</TD>
<TD>TUBA1A</TD></TR>
<TR><TD>2.716e-02</TD><TD>-3.61</TD><TD>Klc3 (kinesin light chain 3)</TD><TD>protein interactions</TD><TD>232943</TD><TD>16</TD><TD>1</TD><TD>17456</TD><TD>30</TD>
<TD>OASL</TD></TR>
<TR><TD>2.716e-02</TD><TD>-3.61</TD><TD>SNX20 (sorting nexin 20)</TD><TD>protein interactions</TD><TD>124460</TD><TD>16</TD><TD>1</TD><TD>17456</TD><TD>30</TD>
<TD>DIRAS1</TD></TR>
<TR><TD>2.738e-02</TD><TD>-3.60</TD><TD>AATGTGA_MIR23A_MIR23B</TD><TD>MSigDB lists</TD><TD>AATGTGA_MIR23A_MIR23B</TD><TD>392</TD><TD>3</TD><TD>17275</TD><TD>29</TD>
<TD>CAPN6,LGR4,HS6ST2</TD></TR>
<TR><TD>2.739e-02</TD><TD>-3.60</TD><TD>MULLIGHAN_NPM1_SIGNATURE_3_DN</TD><TD>MSigDB lists</TD><TD>MULLIGHAN_NPM1_SIGNATURE_3_DN</TD><TD>154</TD><TD>2</TD><TD>17275</TD><TD>29</TD>
<TD>RYR1,CAMKK2</TD></TR>
<TR><TD>2.772e-02</TD><TD>-3.59</TD><TD>heparan sulfate biosynthesis</TD><TD>BIOCYC pathways</TD><TD>HUMAN_PWY-6564</TD><TD>25</TD><TD>1</TD><TD>902</TD><TD>1</TD>
<TD>HS6ST2</TD></TR>
<TR><TD>2.773e-02</TD><TD>-3.59</TD><TD>4.1m</TD><TD>smart domains</TD><TD>SM00294</TD><TD>14</TD><TD>1</TD><TD>9476</TD><TD>19</TD>
<TD>CADM4</TD></TR>
<TR><TD>2.805e-02</TD><TD>-3.57</TD><TD>GSE7768_OVA_ALONE_VS_OVA_WITH_MPL_IMMUNIZED_MOUSE_WHOLE_SPLEEN_6H_DN</TD><TD>MSigDB lists</TD><TD>GSE7768_OVA_ALONE_VS_OVA_WITH_MPL_IMMUNIZED_MOUSE_WHOLE_SPLEEN_6H_DN</TD><TD>156</TD><TD>2</TD><TD>17275</TD><TD>29</TD>
<TD>ISG15,FAM102B</TD></TR>
<TR><TD>2.817e-02</TD><TD>-3.57</TD><TD>KIM_PTEN_TARGETS_UP</TD><TD>MSigDB lists</TD><TD>KIM_PTEN_TARGETS_UP</TD><TD>17</TD><TD>1</TD><TD>17275</TD><TD>29</TD>
<TD>IFI44</TD></TR>
<TR><TD>2.817e-02</TD><TD>-3.57</TD><TD>GO_RESPONSE_TO_CAFFEINE</TD><TD>MSigDB lists</TD><TD>GO_RESPONSE_TO_CAFFEINE</TD><TD>17</TD><TD>1</TD><TD>17275</TD><TD>29</TD>
<TD>RYR1</TD></TR>
<TR><TD>2.817e-02</TD><TD>-3.57</TD><TD>BIOCARTA_MTA3_PATHWAY</TD><TD>MSigDB lists</TD><TD>BIOCARTA_MTA3_PATHWAY</TD><TD>17</TD><TD>1</TD><TD>17275</TD><TD>29</TD>
<TD>TUBA1A</TD></TR>
<TR><TD>2.817e-02</TD><TD>-3.57</TD><TD>GO_LAMIN_BINDING</TD><TD>MSigDB lists</TD><TD>GO_LAMIN_BINDING</TD><TD>17</TD><TD>1</TD><TD>17275</TD><TD>29</TD>
<TD>IFI27</TD></TR>
<TR><TD>2.817e-02</TD><TD>-3.57</TD><TD>PIONTEK_PKD1_TARGETS_DN</TD><TD>MSigDB lists</TD><TD>PIONTEK_PKD1_TARGETS_DN</TD><TD>17</TD><TD>1</TD><TD>17275</TD><TD>29</TD>
<TD>TUBA1A</TD></TR>
<TR><TD>2.817e-02</TD><TD>-3.57</TD><TD>TUOMISTO_TUMOR_SUPPRESSION_BY_COL13A1_DN</TD><TD>MSigDB lists</TD><TD>TUOMISTO_TUMOR_SUPPRESSION_BY_COL13A1_DN</TD><TD>17</TD><TD>1</TD><TD>17275</TD><TD>29</TD>
<TD>MCAM</TD></TR>
<TR><TD>2.818e-02</TD><TD>-3.57</TD><TD>protein-hormone receptor activity</TD><TD>molecular function</TD><TD>GO:0016500</TD><TD>19</TD><TD>1</TD><TD>17306</TD><TD>26</TD>
<TD>LGR4</TD></TR>
<TR><TD>2.838e-02</TD><TD>-3.56</TD><TD>CAIRO_LIVER_DEVELOPMENT_UP</TD><TD>MSigDB lists</TD><TD>CAIRO_LIVER_DEVELOPMENT_UP</TD><TD>157</TD><TD>2</TD><TD>17275</TD><TD>29</TD>
<TD>CAPN6,KIFAP3</TD></TR>
<TR><TD>2.838e-02</TD><TD>-3.56</TD><TD>SERVITJA_ISLET_HNF1A_TARGETS_UP</TD><TD>MSigDB lists</TD><TD>SERVITJA_ISLET_HNF1A_TARGETS_UP</TD><TD>157</TD><TD>2</TD><TD>17275</TD><TD>29</TD>
<TD>IFIT2,MCAM</TD></TR>
<TR><TD>2.854e-02</TD><TD>-3.56</TD><TD>metanephric tubule development</TD><TD>biological process</TD><TD>GO:0072170</TD><TD>18</TD><TD>1</TD><TD>18054</TD><TD>29</TD>
<TD>LGR4</TD></TR>
<TR><TD>2.854e-02</TD><TD>-3.56</TD><TD>positive regulation of branching involved in ureteric bud morphogenesis</TD><TD>biological process</TD><TD>GO:0090190</TD><TD>18</TD><TD>1</TD><TD>18054</TD><TD>29</TD>
<TD>LGR4</TD></TR>
<TR><TD>2.866e-02</TD><TD>-3.55</TD><TD>RIGGI_EWING_SARCOMA_PROGENITOR_UP</TD><TD>MSigDB lists</TD><TD>RIGGI_EWING_SARCOMA_PROGENITOR_UP</TD><TD>399</TD><TD>3</TD><TD>17275</TD><TD>29</TD>
<TD>PGF,IFI44,MCAM</TD></TR>
<TR><TD>2.883e-02</TD><TD>-3.55</TD><TD>ANXA3 (annexin A3)</TD><TD>protein interactions</TD><TD>306</TD><TD>17</TD><TD>1</TD><TD>17456</TD><TD>30</TD>
<TD>ISG15</TD></TR>
<TR><TD>2.883e-02</TD><TD>-3.55</TD><TD>SCPEP1 (serine carboxypeptidase 1)</TD><TD>protein interactions</TD><TD>59342</TD><TD>17</TD><TD>1</TD><TD>17456</TD><TD>30</TD>
<TD>TUBA1A</TD></TR>
<TR><TD>2.883e-02</TD><TD>-3.55</TD><TD>HOMER2 (homer scaffold protein 2)</TD><TD>protein interactions</TD><TD>9455</TD><TD>17</TD><TD>1</TD><TD>17456</TD><TD>30</TD>
<TD>RYR1</TD></TR>
<TR><TD>2.883e-02</TD><TD>-3.55</TD><TD>Ppp4r3a (protein phosphatase 4 regulatory subunit 3A)</TD><TD>protein interactions</TD><TD>68734</TD><TD>17</TD><TD>1</TD><TD>17456</TD><TD>30</TD>
<TD>FAM102B</TD></TR>
<TR><TD>2.883e-02</TD><TD>-3.55</TD><TD>MRPS17 (mitochondrial ribosomal protein S17)</TD><TD>protein interactions</TD><TD>51373</TD><TD>17</TD><TD>1</TD><TD>17456</TD><TD>30</TD>
<TD>KIFAP3</TD></TR>
<TR><TD>2.883e-02</TD><TD>-3.55</TD><TD>CXCR1 (C-X-C motif chemokine receptor 1)</TD><TD>protein interactions</TD><TD>3577</TD><TD>17</TD><TD>1</TD><TD>17456</TD><TD>30</TD>
<TD>TUBA1A</TD></TR>
<TR><TD>2.883e-02</TD><TD>-3.55</TD><TD>Lrr1 (leucine rich repeat protein 1)</TD><TD>protein interactions</TD><TD>69706</TD><TD>17</TD><TD>1</TD><TD>17456</TD><TD>30</TD>
<TD>TUBA1A</TD></TR>
<TR><TD>2.901e-02</TD><TD>-3.54</TD><TD>Cell-type Dependent Selectivity of CCK2R Signaling</TD><TD>WikiPathways</TD><TD>WP3679</TD><TD>13</TD><TD>1</TD><TD>5311</TD><TD>12</TD>
<TD>RYR1</TD></TR>
<TR><TD>2.903e-02</TD><TD>-3.54</TD><TD>BOQUEST_STEM_CELL_CULTURED_VS_FRESH_UP</TD><TD>MSigDB lists</TD><TD>BOQUEST_STEM_CELL_CULTURED_VS_FRESH_UP</TD><TD>401</TD><TD>3</TD><TD>17275</TD><TD>29</TD>
<TD>OASL,IFI44,CAPN6</TD></TR>
<TR><TD>2.905e-02</TD><TD>-3.54</TD><TD>GSE6259_FLT3L_INDUCED_DEC205_POS_DC_VS_CD8_TCELL_DN</TD><TD>MSigDB lists</TD><TD>GSE6259_FLT3L_INDUCED_DEC205_POS_DC_VS_CD8_TCELL_DN</TD><TD>159</TD><TD>2</TD><TD>17275</TD><TD>29</TD>
<TD>ISG15,OAS2</TD></TR>
<TR><TD>2.921e-02</TD><TD>-3.53</TD><TD>SCHAEFFER_PROSTATE_DEVELOPMENT_48HR_DN</TD><TD>MSigDB lists</TD><TD>SCHAEFFER_PROSTATE_DEVELOPMENT_48HR_DN</TD><TD>402</TD><TD>3</TD><TD>17275</TD><TD>29</TD>
<TD>KIAA1211,KIFAP3,CAMKK2</TD></TR>
<TR><TD>2.939e-02</TD><TD>-3.53</TD><TD>GSE45365_WT_VS_IFNAR_KO_BCELL_MCMV_INFECTION_DN</TD><TD>MSigDB lists</TD><TD>GSE45365_WT_VS_IFNAR_KO_BCELL_MCMV_INFECTION_DN</TD><TD>160</TD><TD>2</TD><TD>17275</TD><TD>29</TD>
<TD>ISG15,KLHDC8B</TD></TR>
<TR><TD>2.939e-02</TD><TD>-3.53</TD><TD>WNT_UP.V1_DN</TD><TD>MSigDB lists</TD><TD>WNT_UP.V1_DN</TD><TD>160</TD><TD>2</TD><TD>17275</TD><TD>29</TD>
<TD>ISG15,OAS1</TD></TR>
<TR><TD>2.939e-02</TD><TD>-3.53</TD><TD>PKCA_DN.V1_UP</TD><TD>MSigDB lists</TD><TD>PKCA_DN.V1_UP</TD><TD>160</TD><TD>2</TD><TD>17275</TD><TD>29</TD>
<TD>OAS3,OAS2</TD></TR>
<TR><TD>2.939e-02</TD><TD>-3.53</TD><TD>GSE7218_UNSTIM_VS_ANTIGEN_STIM_THROUGH_IGG_BCELL_DN</TD><TD>MSigDB lists</TD><TD>GSE7218_UNSTIM_VS_ANTIGEN_STIM_THROUGH_IGG_BCELL_DN</TD><TD>160</TD><TD>2</TD><TD>17275</TD><TD>29</TD>
<TD>IFI44,OAS3</TD></TR>
<TR><TD>2.939e-02</TD><TD>-3.53</TD><TD>GSE7768_OVA_ALONE_VS_OVA_WITH_LPS_IMMUNIZED_MOUSE_WHOLE_SPLEEN_6H_DN</TD><TD>MSigDB lists</TD><TD>GSE7768_OVA_ALONE_VS_OVA_WITH_LPS_IMMUNIZED_MOUSE_WHOLE_SPLEEN_6H_DN</TD><TD>160</TD><TD>2</TD><TD>17275</TD><TD>29</TD>
<TD>FAM102B,RSAD2</TD></TR>
<TR><TD>2.941e-02</TD><TD>-3.53</TD><TD>CALPAIN_CAT</TD><TD>prosite domains</TD><TD>PS50203</TD><TD>15</TD><TD>1</TD><TD>12079</TD><TD>24</TD>
<TD>CAPN6</TD></TR>
<TR><TD>2.966e-02</TD><TD>-3.52</TD><TD>RANBP2 (RAN binding protein 2)</TD><TD>protein interactions</TD><TD>5903</TD><TD>157</TD><TD>2</TD><TD>17456</TD><TD>30</TD>
<TD>LGR4,KIFAP3</TD></TR>
<TR><TD>2.968e-02</TD><TD>-3.52</TD><TD>CysPc</TD><TD>smart domains</TD><TD>SM00230</TD><TD>15</TD><TD>1</TD><TD>9476</TD><TD>19</TD>
<TD>CAPN6</TD></TR>
<TR><TD>2.973e-02</TD><TD>-3.52</TD><TD>GSE26488_WT_VS_HDAC7_KO_DOUBLE_POSITIVE_THYMOCYTE_DN</TD><TD>MSigDB lists</TD><TD>GSE26488_WT_VS_HDAC7_KO_DOUBLE_POSITIVE_THYMOCYTE_DN</TD><TD>161</TD><TD>2</TD><TD>17275</TD><TD>29</TD>
<TD>IFIT2,OASL</TD></TR>
<TR><TD>2.973e-02</TD><TD>-3.52</TD><TD>GSE21063_CTRL_VS_ANTI_IGM_STIM_BCELL_3H_UP</TD><TD>MSigDB lists</TD><TD>GSE21063_CTRL_VS_ANTI_IGM_STIM_BCELL_3H_UP</TD><TD>161</TD><TD>2</TD><TD>17275</TD><TD>29</TD>
<TD>RYR1,IFI44L</TD></TR>
<TR><TD>2.980e-02</TD><TD>-3.51</TD><TD>GO_ORGAN_MATURATION</TD><TD>MSigDB lists</TD><TD>GO_ORGAN_MATURATION</TD><TD>18</TD><TD>1</TD><TD>17275</TD><TD>29</TD>
<TD>RYR1</TD></TR>
<TR><TD>2.980e-02</TD><TD>-3.51</TD><TD>REACTOME_N_GLYCAN_ANTENNAE_ELONGATION_IN_THE_MEDIAL_TRANS_GOLGI</TD><TD>MSigDB lists</TD><TD>REACTOME_N_GLYCAN_ANTENNAE_ELONGATION_IN_THE_MEDIAL_TRANS_GOLGI</TD><TD>18</TD><TD>1</TD><TD>17275</TD><TD>29</TD>
<TD>MGAT3</TD></TR>
<TR><TD>2.980e-02</TD><TD>-3.51</TD><TD>REACTOME_POST_CHAPERONIN_TUBULIN_FOLDING_PATHWAY</TD><TD>MSigDB lists</TD><TD>REACTOME_POST_CHAPERONIN_TUBULIN_FOLDING_PATHWAY</TD><TD>18</TD><TD>1</TD><TD>17275</TD><TD>29</TD>
<TD>TUBA1A</TD></TR>
<TR><TD>2.988e-02</TD><TD>-3.51</TD><TD>regulation of localization</TD><TD>biological process</TD><TD>GO:0032879</TD><TD>2846</TD><TD>9</TD><TD>18054</TD><TD>29</TD>
<TD>RSAD2,MGAT3,CADM4,RYR1,IFI27,MCAM,PGF,OAS2,LGR4</TD></TR>
<TR><TD>2.998e-02</TD><TD>-3.51</TD><TD>cyclic-nucleotide-mediated signaling</TD><TD>biological process</TD><TD>GO:0019935</TD><TD>169</TD><TD>2</TD><TD>18054</TD><TD>29</TD>
<TD>LGR4,ADGRL1</TD></TR>
<TR><TD>2.998e-02</TD><TD>-3.51</TD><TD>FORTSCHEGGER_PHF8_TARGETS_DN</TD><TD>MSigDB lists</TD><TD>FORTSCHEGGER_PHF8_TARGETS_DN</TD><TD>712</TD><TD>4</TD><TD>17275</TD><TD>29</TD>
<TD>OASL,IFI44,IFIT2,ISG15</TD></TR>
<TR><TD>3.001e-02</TD><TD>-3.51</TD><TD>SMC3 (structural maintenance of chromosomes 3)</TD><TD>protein interactions</TD><TD>9126</TD><TD>158</TD><TD>2</TD><TD>17456</TD><TD>30</TD>
<TD>KIFAP3,CAMKK2</TD></TR>
<TR><TD>3.007e-02</TD><TD>-3.50</TD><TD>GSE3920_UNTREATED_VS_IFNB_TREATED_ENDOTHELIAL_CELL_DN</TD><TD>MSigDB lists</TD><TD>GSE3920_UNTREATED_VS_IFNB_TREATED_ENDOTHELIAL_CELL_DN</TD><TD>162</TD><TD>2</TD><TD>17275</TD><TD>29</TD>
<TD>IFIT2,IFI44</TD></TR>
<TR><TD>3.007e-02</TD><TD>-3.50</TD><TD>mitochondrial outer membrane</TD><TD>cellular component</TD><TD>GO:0005741</TD><TD>178</TD><TD>2</TD><TD>18985</TD><TD>29</TD>
<TD>IFI27,RSAD2</TD></TR>
<TR><TD>3.010e-02</TD><TD>-3.50</TD><TD>N-acetylglucosamine metabolic process</TD><TD>biological process</TD><TD>GO:0006044</TD><TD>19</TD><TD>1</TD><TD>18054</TD><TD>29</TD>
<TD>MGAT3</TD></TR>
<TR><TD>3.010e-02</TD><TD>-3.50</TD><TD>positive regulation of T cell cytokine production</TD><TD>biological process</TD><TD>GO:0002726</TD><TD>19</TD><TD>1</TD><TD>18054</TD><TD>29</TD>
<TD>RSAD2</TD></TR>
<TR><TD>3.010e-02</TD><TD>-3.50</TD><TD>positive regulation of autophagy of mitochondrion</TD><TD>biological process</TD><TD>GO:1903599</TD><TD>19</TD><TD>1</TD><TD>18054</TD><TD>29</TD>
<TD>CAMKK2</TD></TR>
<TR><TD>3.010e-02</TD><TD>-3.50</TD><TD>interferon-gamma production</TD><TD>biological process</TD><TD>GO:0032609</TD><TD>19</TD><TD>1</TD><TD>18054</TD><TD>29</TD>
<TD>ISG15</TD></TR>
<TR><TD>3.010e-02</TD><TD>-3.50</TD><TD>maintenance of gastrointestinal epithelium</TD><TD>biological process</TD><TD>GO:0030277</TD><TD>19</TD><TD>1</TD><TD>18054</TD><TD>29</TD>
<TD>KIAA1211</TD></TR>
<TR><TD>3.019e-02</TD><TD>-3.50</TD><TD>GTP_binding_domain</TD><TD>interpro domains</TD><TD>IPR006073</TD><TD>19</TD><TD>1</TD><TD>18616</TD><TD>30</TD>
<TD>IFI44L</TD></TR>
<TR><TD>3.019e-02</TD><TD>-3.50</TD><TD>Tubulin/FtsZ_C_sf</TD><TD>interpro domains</TD><TD>IPR037103</TD><TD>19</TD><TD>1</TD><TD>18616</TD><TD>30</TD>
<TD>TUBA1A</TD></TR>
<TR><TD>3.036e-02</TD><TD>-3.49</TD><TD>POLY (polyprotein;protein F)</TD><TD>protein interactions</TD><TD>951475</TD><TD>159</TD><TD>2</TD><TD>17456</TD><TD>30</TD>
<TD>OAS1,IFI27</TD></TR>
<TR><TD>3.041e-02</TD><TD>-3.49</TD><TD>GSE6092_IFNG_VS_IFNG_AND_B_BURGDORFERI_INF_ENDOTHELIAL_CELL_DN</TD><TD>MSigDB lists</TD><TD>GSE6092_IFNG_VS_IFNG_AND_B_BURGDORFERI_INF_ENDOTHELIAL_CELL_DN</TD><TD>163</TD><TD>2</TD><TD>17275</TD><TD>29</TD>
<TD>IFIT2,RSAD2</TD></TR>
<TR><TD>3.050e-02</TD><TD>-3.49</TD><TD>ARL3 (ADP ribosylation factor like GTPase 3)</TD><TD>protein interactions</TD><TD>403</TD><TD>18</TD><TD>1</TD><TD>17456</TD><TD>30</TD>
<TD>TUBA1A</TD></TR>
<TR><TD>3.050e-02</TD><TD>-3.49</TD><TD>RUSC2 (RUN and SH3 domain containing 2)</TD><TD>protein interactions</TD><TD>9853</TD><TD>18</TD><TD>1</TD><TD>17456</TD><TD>30</TD>
<TD>KIFAP3</TD></TR>
<TR><TD>3.050e-02</TD><TD>-3.49</TD><TD>BRINP3 (BMP/retinoic acid inducible neural specific 3)</TD><TD>protein interactions</TD><TD>339479</TD><TD>18</TD><TD>1</TD><TD>17456</TD><TD>30</TD>
<TD>TUBA1A</TD></TR>
<TR><TD>3.050e-02</TD><TD>-3.49</TD><TD>GLDC (glycine decarboxylase)</TD><TD>protein interactions</TD><TD>2731</TD><TD>18</TD><TD>1</TD><TD>17456</TD><TD>30</TD>
<TD>CAPN6</TD></TR>
<TR><TD>3.050e-02</TD><TD>-3.49</TD><TD>IFRD2 (interferon related developmental regulator 2)</TD><TD>protein interactions</TD><TD>7866</TD><TD>18</TD><TD>1</TD><TD>17456</TD><TD>30</TD>
<TD>OAS3</TD></TR>
<TR><TD>3.051e-02</TD><TD>-3.49</TD><TD>Ig_V-set</TD><TD>interpro domains</TD><TD>IPR013106</TD><TD>170</TD><TD>2</TD><TD>18616</TD><TD>30</TD>
<TD>MCAM,CADM4</TD></TR>
<TR><TD>3.076e-02</TD><TD>-3.48</TD><TD>GSE25677_MPL_VS_R848_STIM_BCELL_DN</TD><TD>MSigDB lists</TD><TD>GSE25677_MPL_VS_R848_STIM_BCELL_DN</TD><TD>164</TD><TD>2</TD><TD>17275</TD><TD>29</TD>
<TD>ISG15,TUBA1A</TD></TR>
<TR><TD>3.076e-02</TD><TD>-3.48</TD><TD>SASAKI_ADULT_T_CELL_LEUKEMIA</TD><TD>MSigDB lists</TD><TD>SASAKI_ADULT_T_CELL_LEUKEMIA</TD><TD>164</TD><TD>2</TD><TD>17275</TD><TD>29</TD>
<TD>ISG15,OAS2</TD></TR>
<TR><TD>3.091e-02</TD><TD>-3.48</TD><TD>cysteine-type peptidase activity</TD><TD>molecular function</TD><TD>GO:0008234</TD><TD>184</TD><TD>2</TD><TD>17306</TD><TD>26</TD>
<TD>CTSV,CAPN6</TD></TR>
<TR><TD>3.110e-02</TD><TD>-3.47</TD><TD>calcium-release channel activity</TD><TD>molecular function</TD><TD>GO:0015278</TD><TD>21</TD><TD>1</TD><TD>17306</TD><TD>26</TD>
<TD>RYR1</TD></TR>
<TR><TD>3.110e-02</TD><TD>-3.47</TD><TD>GSE29617_DAY3_VS_DAY7_TIV_FLU_VACCINE_PBMC_2008_UP</TD><TD>MSigDB lists</TD><TD>GSE29617_DAY3_VS_DAY7_TIV_FLU_VACCINE_PBMC_2008_UP</TD><TD>165</TD><TD>2</TD><TD>17275</TD><TD>29</TD>
<TD>FAM102B,IFIT2</TD></TR>
<TR><TD>3.110e-02</TD><TD>-3.47</TD><TD>GSE13547_2H_VS_12_H_ANTI_IGM_STIM_BCELL_UP</TD><TD>MSigDB lists</TD><TD>GSE13547_2H_VS_12_H_ANTI_IGM_STIM_BCELL_UP</TD><TD>165</TD><TD>2</TD><TD>17275</TD><TD>29</TD>
<TD>IFI44,RSAD2</TD></TR>
<TR><TD>3.119e-02</TD><TD>-3.47</TD><TD>mouth</TD><TD>COSMIC cancer mutations</TD><TD>mouth</TD><TD>9176</TD><TD>19</TD><TD>17255</TD><TD>26</TD>
<TD>CAMKK2,MCAM,RSAD2,KIAA1211,CADM4,RYR1,KIFAP3,OASL,MGAT3,IFI44,OAS3,BCL6B,IFIT2,ZNF518B,LGR4,CAPN6,IFI44L,ISG15,DIRAS1</TD></TR>
<TR><TD>3.122e-02</TD><TD>-3.47</TD><TD>TUBULIN</TD><TD>prints domains</TD><TD>PR01161</TD><TD>21</TD><TD>1</TD><TD>4648</TD><TD>7</TD>
<TD>TUBA1A</TD></TR>
<TR><TD>3.122e-02</TD><TD>-3.47</TD><TD>phosphatase binding</TD><TD>molecular function</TD><TD>GO:0019902</TD><TD>185</TD><TD>2</TD><TD>17306</TD><TD>26</TD>
<TD>KIFAP3,CADM4</TD></TR>
<TR><TD>3.129e-02</TD><TD>-3.46</TD><TD>cytoskeleton-dependent intracellular transport</TD><TD>biological process</TD><TD>GO:0030705</TD><TD>173</TD><TD>2</TD><TD>18054</TD><TD>29</TD>
<TD>KIFAP3,TUBA1A</TD></TR>
<TR><TD>3.143e-02</TD><TD>-3.46</TD><TD>upper_aerodigestive_tract-mouth-carcinoma</TD><TD>COSMIC cancer mutations</TD><TD>upper_aerodigestive_tract-mouth-carcinoma</TD><TD>6531</TD><TD>15</TD><TD>17255</TD><TD>26</TD>
<TD>IFI44,OAS3,BCL6B,DIRAS1,MGAT3,ISG15,RYR1,KIFAP3,RSAD2,CADM4,KIAA1211,LGR4,IFIT2,MCAM,ZNF518B</TD></TR>
<TR><TD>3.143e-02</TD><TD>-3.46</TD><TD>CROONQUIST_IL6_DEPRIVATION_UP</TD><TD>MSigDB lists</TD><TD>CROONQUIST_IL6_DEPRIVATION_UP</TD><TD>19</TD><TD>1</TD><TD>17275</TD><TD>29</TD>
<TD>IFIT2</TD></TR>
<TR><TD>3.143e-02</TD><TD>-3.46</TD><TD>GO_CALCIUM_DEPENDENT_CYSTEINE_TYPE_ENDOPEPTIDASE_ACTIVITY</TD><TD>MSigDB lists</TD><TD>GO_CALCIUM_DEPENDENT_CYSTEINE_TYPE_ENDOPEPTIDASE_ACTIVITY</TD><TD>19</TD><TD>1</TD><TD>17275</TD><TD>29</TD>
<TD>CAPN6</TD></TR>
<TR><TD>3.143e-02</TD><TD>-3.46</TD><TD>OUYANG_PROSTATE_CANCER_PROGRESSION_DN</TD><TD>MSigDB lists</TD><TD>OUYANG_PROSTATE_CANCER_PROGRESSION_DN</TD><TD>19</TD><TD>1</TD><TD>17275</TD><TD>29</TD>
<TD>DIRAS1</TD></TR>
<TR><TD>3.143e-02</TD><TD>-3.46</TD><TD>GO_POSITIVE_REGULATION_OF_TOLL_LIKE_RECEPTOR_SIGNALING_PATHWAY</TD><TD>MSigDB lists</TD><TD>GO_POSITIVE_REGULATION_OF_TOLL_LIKE_RECEPTOR_SIGNALING_PATHWAY</TD><TD>19</TD><TD>1</TD><TD>17275</TD><TD>29</TD>
<TD>RSAD2</TD></TR>
<TR><TD>3.143e-02</TD><TD>-3.46</TD><TD>SARTIPY_BLUNTED_BY_INSULIN_RESISTANCE_UP</TD><TD>MSigDB lists</TD><TD>SARTIPY_BLUNTED_BY_INSULIN_RESISTANCE_UP</TD><TD>19</TD><TD>1</TD><TD>17275</TD><TD>29</TD>
<TD>RSAD2</TD></TR>
<TR><TD>3.143e-02</TD><TD>-3.46</TD><TD>ZHAN_MULTIPLE_MYELOMA_SPIKED</TD><TD>MSigDB lists</TD><TD>ZHAN_MULTIPLE_MYELOMA_SPIKED</TD><TD>19</TD><TD>1</TD><TD>17275</TD><TD>29</TD>
<TD>IFI27</TD></TR>
<TR><TD>3.166e-02</TD><TD>-3.45</TD><TD>metanephric nephron morphogenesis</TD><TD>biological process</TD><TD>GO:0072273</TD><TD>20</TD><TD>1</TD><TD>18054</TD><TD>29</TD>
<TD>LGR4</TD></TR>
<TR><TD>3.166e-02</TD><TD>-3.45</TD><TD>Sertoli cell differentiation</TD><TD>biological process</TD><TD>GO:0060008</TD><TD>20</TD><TD>1</TD><TD>18054</TD><TD>29</TD>
<TD>CTSV</TD></TR>
<TR><TD>3.166e-02</TD><TD>-3.45</TD><TD>positive regulation of protein depolymerization</TD><TD>biological process</TD><TD>GO:1901881</TD><TD>20</TD><TD>1</TD><TD>18054</TD><TD>29</TD>
<TD>KIAA1211</TD></TR>
<TR><TD>3.166e-02</TD><TD>-3.45</TD><TD>amyloid-beta metabolic process</TD><TD>biological process</TD><TD>GO:0050435</TD><TD>20</TD><TD>1</TD><TD>18054</TD><TD>29</TD>
<TD>MGAT3</TD></TR>
<TR><TD>3.174e-02</TD><TD>-3.45</TD><TD>Tubulin_C</TD><TD>pfam domains</TD><TD>PF03953</TD><TD>20</TD><TD>1</TD><TD>17385</TD><TD>28</TD>
<TD>TUBA1A</TD></TR>
<TR><TD>3.176e-02</TD><TD>-3.45</TD><TD>Tubulin/FtsZ_2-layer-sand-dom</TD><TD>interpro domains</TD><TD>IPR018316</TD><TD>20</TD><TD>1</TD><TD>18616</TD><TD>30</TD>
<TD>TUBA1A</TD></TR>
<TR><TD>3.180e-02</TD><TD>-3.45</TD><TD>GSE22886_NAIVE_CD4_TCELL_VS_MEMORY_TCELL_UP</TD><TD>MSigDB lists</TD><TD>GSE22886_NAIVE_CD4_TCELL_VS_MEMORY_TCELL_UP</TD><TD>167</TD><TD>2</TD><TD>17275</TD><TD>29</TD>
<TD>CADM4,PGF</TD></TR>
<TR><TD>3.180e-02</TD><TD>-3.45</TD><TD>GSE18281_SUBCAPSULAR_VS_CENTRAL_CORTICAL_REGION_OF_THYMUS_UP</TD><TD>MSigDB lists</TD><TD>GSE18281_SUBCAPSULAR_VS_CENTRAL_CORTICAL_REGION_OF_THYMUS_UP</TD><TD>167</TD><TD>2</TD><TD>17275</TD><TD>29</TD>
<TD>OASL,OAS1</TD></TR>
<TR><TD>3.180e-02</TD><TD>-3.45</TD><TD>GSE43863_NAIVE_VS_TH1_EFF_CD4_TCELL_D6_LCMV_UP</TD><TD>MSigDB lists</TD><TD>GSE43863_NAIVE_VS_TH1_EFF_CD4_TCELL_D6_LCMV_UP</TD><TD>167</TD><TD>2</TD><TD>17275</TD><TD>29</TD>
<TD>BCL6B,MCAM</TD></TR>
<TR><TD>3.180e-02</TD><TD>-3.45</TD><TD>GSE2706_2H_VS_8H_LPS_STIM_DC_DN</TD><TD>MSigDB lists</TD><TD>GSE2706_2H_VS_8H_LPS_STIM_DC_DN</TD><TD>167</TD><TD>2</TD><TD>17275</TD><TD>29</TD>
<TD>KIAA1211,OAS1</TD></TR>
<TR><TD>3.180e-02</TD><TD>-3.45</TD><TD>GSE17974_IL4_AND_ANTI_IL12_VS_UNTREATED_12H_ACT_CD4_TCELL_DN</TD><TD>MSigDB lists</TD><TD>GSE17974_IL4_AND_ANTI_IL12_VS_UNTREATED_12H_ACT_CD4_TCELL_DN</TD><TD>167</TD><TD>2</TD><TD>17275</TD><TD>29</TD>
<TD>IFI44L,OASL</TD></TR>
<TR><TD>3.196e-02</TD><TD>-3.44</TD><TD>antigen processing and presentation of exogenous peptide antigen</TD><TD>biological process</TD><TD>GO:0002478</TD><TD>175</TD><TD>2</TD><TD>18054</TD><TD>29</TD>
<TD>CTSV,KIFAP3</TD></TR>
<TR><TD>3.213e-02</TD><TD>-3.44</TD><TD>TUBA1B (tubulin alpha 1b)</TD><TD>protein interactions</TD><TD>10376</TD><TD>164</TD><TD>2</TD><TD>17456</TD><TD>30</TD>
<TD>TUBA1A,LGR4</TD></TR>
<TR><TD>3.215e-02</TD><TD>-3.44</TD><TD>GSE2770_IL4_ACT_VS_ACT_CD4_TCELL_6H_UP</TD><TD>MSigDB lists</TD><TD>GSE2770_IL4_ACT_VS_ACT_CD4_TCELL_6H_UP</TD><TD>168</TD><TD>2</TD><TD>17275</TD><TD>29</TD>
<TD>IFI44L,IFI44</TD></TR>
<TR><TD>3.215e-02</TD><TD>-3.44</TD><TD>GSE10856_CTRL_VS_TNFRSF6B_IN_MACROPHAGE_UP</TD><TD>MSigDB lists</TD><TD>GSE10856_CTRL_VS_TNFRSF6B_IN_MACROPHAGE_UP</TD><TD>168</TD><TD>2</TD><TD>17275</TD><TD>29</TD>
<TD>CAMKK2,MCAM</TD></TR>
<TR><TD>3.215e-02</TD><TD>-3.44</TD><TD>GSE1791_CTRL_VS_NEUROMEDINU_IN_T_CELL_LINE_3H_DN</TD><TD>MSigDB lists</TD><TD>GSE1791_CTRL_VS_NEUROMEDINU_IN_T_CELL_LINE_3H_DN</TD><TD>168</TD><TD>2</TD><TD>17275</TD><TD>29</TD>
<TD>OAS1,OAS2</TD></TR>
<TR><TD>3.217e-02</TD><TD>-3.44</TD><TD>CHST10 (carbohydrate sulfotransferase 10)</TD><TD>protein interactions</TD><TD>9486</TD><TD>19</TD><TD>1</TD><TD>17456</TD><TD>30</TD>
<TD>HS6ST2</TD></TR>
<TR><TD>3.217e-02</TD><TD>-3.44</TD><TD>CAMK4 (calcium/calmodulin dependent protein kinase IV)</TD><TD>protein interactions</TD><TD>814</TD><TD>19</TD><TD>1</TD><TD>17456</TD><TD>30</TD>
<TD>CAMKK2</TD></TR>
<TR><TD>3.217e-02</TD><TD>-3.44</TD><TD>Cdc37 (cell division cycle 37)</TD><TD>protein interactions</TD><TD>12539</TD><TD>19</TD><TD>1</TD><TD>17456</TD><TD>30</TD>
<TD>TUBA1A</TD></TR>
<TR><TD>3.217e-02</TD><TD>-3.44</TD><TD>LYPD1 (LY6/PLAUR domain containing 1)</TD><TD>protein interactions</TD><TD>116372</TD><TD>19</TD><TD>1</TD><TD>17456</TD><TD>30</TD>
<TD>TUBA1A</TD></TR>
<TR><TD>3.217e-02</TD><TD>-3.44</TD><TD>MEST (mesoderm specific transcript)</TD><TD>protein interactions</TD><TD>4232</TD><TD>19</TD><TD>1</TD><TD>17456</TD><TD>30</TD>
<TD>KIFAP3</TD></TR>
<TR><TD>3.217e-02</TD><TD>-3.44</TD><TD>CCSER2 (coiled-coil serine rich protein 2)</TD><TD>protein interactions</TD><TD>54462</TD><TD>19</TD><TD>1</TD><TD>17456</TD><TD>30</TD>
<TD>KIFAP3</TD></TR>
<TR><TD>3.217e-02</TD><TD>-3.44</TD><TD>RYR1 (ryanodine receptor 1)</TD><TD>protein interactions</TD><TD>6261</TD><TD>19</TD><TD>1</TD><TD>17456</TD><TD>30</TD>
<TD>RYR1</TD></TR>
<TR><TD>3.250e-02</TD><TD>-3.43</TD><TD>GO_OUTER_MEMBRANE</TD><TD>MSigDB lists</TD><TD>GO_OUTER_MEMBRANE</TD><TD>169</TD><TD>2</TD><TD>17275</TD><TD>29</TD>
<TD>RSAD2,IFI27</TD></TR>
<TR><TD>3.285e-02</TD><TD>-3.42</TD><TD>GSE25088_CTRL_VS_IL4_STIM_MACROPHAGE_UP</TD><TD>MSigDB lists</TD><TD>GSE25088_CTRL_VS_IL4_STIM_MACROPHAGE_UP</TD><TD>170</TD><TD>2</TD><TD>17275</TD><TD>29</TD>
<TD>BCL6B,FAM102B</TD></TR>
<TR><TD>3.306e-02</TD><TD>-3.41</TD><TD>SMID_BREAST_CANCER_RELAPSE_IN_LUNG_UP</TD><TD>MSigDB lists</TD><TD>SMID_BREAST_CANCER_RELAPSE_IN_LUNG_UP</TD><TD>20</TD><TD>1</TD><TD>17275</TD><TD>29</TD>
<TD>RYR1</TD></TR>
<TR><TD>3.306e-02</TD><TD>-3.41</TD><TD>GO_METANEPHRIC_EPITHELIUM_DEVELOPMENT</TD><TD>MSigDB lists</TD><TD>GO_METANEPHRIC_EPITHELIUM_DEVELOPMENT</TD><TD>20</TD><TD>1</TD><TD>17275</TD><TD>29</TD>
<TD>LGR4</TD></TR>
<TR><TD>3.306e-02</TD><TD>-3.41</TD><TD>SESTO_RESPONSE_TO_UV_C4</TD><TD>MSigDB lists</TD><TD>SESTO_RESPONSE_TO_UV_C4</TD><TD>20</TD><TD>1</TD><TD>17275</TD><TD>29</TD>
<TD>ISG15</TD></TR>
<TR><TD>3.306e-02</TD><TD>-3.41</TD><TD>HASLINGER_B_CLL_WITH_17P13_DELETION</TD><TD>MSigDB lists</TD><TD>HASLINGER_B_CLL_WITH_17P13_DELETION</TD><TD>20</TD><TD>1</TD><TD>17275</TD><TD>29</TD>
<TD>RYR1</TD></TR>
<TR><TD>3.321e-02</TD><TD>-3.41</TD><TD>GSE26488_CTRL_VS_PEPTIDE_INJECTION_OT2_THYMOCYTE_DN</TD><TD>MSigDB lists</TD><TD>GSE26488_CTRL_VS_PEPTIDE_INJECTION_OT2_THYMOCYTE_DN</TD><TD>171</TD><TD>2</TD><TD>17275</TD><TD>29</TD>
<TD>ISG15,TUBA1A</TD></TR>
<TR><TD>3.321e-02</TD><TD>-3.41</TD><TD>GSE17974_IL4_AND_ANTI_IL12_VS_UNTREATED_72H_ACT_CD4_TCELL_DN</TD><TD>MSigDB lists</TD><TD>GSE17974_IL4_AND_ANTI_IL12_VS_UNTREATED_72H_ACT_CD4_TCELL_DN</TD><TD>171</TD><TD>2</TD><TD>17275</TD><TD>29</TD>
<TD>IFI27,ISG15</TD></TR>
<TR><TD>3.321e-02</TD><TD>-3.41</TD><TD>GSE12845_IGD_POS_BLOOD_VS_NAIVE_TONSIL_BCELL_UP</TD><TD>MSigDB lists</TD><TD>GSE12845_IGD_POS_BLOOD_VS_NAIVE_TONSIL_BCELL_UP</TD><TD>171</TD><TD>2</TD><TD>17275</TD><TD>29</TD>
<TD>MGAT3,KIFAP3</TD></TR>
<TR><TD>3.321e-02</TD><TD>-3.40</TD><TD>response to interferon-alpha</TD><TD>biological process</TD><TD>GO:0035455</TD><TD>21</TD><TD>1</TD><TD>18054</TD><TD>29</TD>
<TD>IFIT2</TD></TR>
<TR><TD>3.321e-02</TD><TD>-3.40</TD><TD>positive regulation of mesonephros development</TD><TD>biological process</TD><TD>GO:0061213</TD><TD>21</TD><TD>1</TD><TD>18054</TD><TD>29</TD>
<TD>LGR4</TD></TR>
<TR><TD>3.321e-02</TD><TD>-3.40</TD><TD>mitotic cytokinetic process</TD><TD>biological process</TD><TD>GO:1902410</TD><TD>21</TD><TD>1</TD><TD>18054</TD><TD>29</TD>
<TD>KLHDC8B</TD></TR>
<TR><TD>3.321e-02</TD><TD>-3.40</TD><TD>negative regulation of peptidyl-threonine phosphorylation</TD><TD>biological process</TD><TD>GO:0010801</TD><TD>21</TD><TD>1</TD><TD>18054</TD><TD>29</TD>
<TD>CADM4</TD></TR>
<TR><TD>3.321e-02</TD><TD>-3.40</TD><TD>animal organ maturation</TD><TD>biological process</TD><TD>GO:0048799</TD><TD>21</TD><TD>1</TD><TD>18054</TD><TD>29</TD>
<TD>RYR1</TD></TR>
<TR><TD>3.321e-02</TD><TD>-3.40</TD><TD>metanephric epithelium development</TD><TD>biological process</TD><TD>GO:0072207</TD><TD>21</TD><TD>1</TD><TD>18054</TD><TD>29</TD>
<TD>LGR4</TD></TR>
<TR><TD>3.330e-02</TD><TD>-3.40</TD><TD>Tubulin</TD><TD>pfam domains</TD><TD>PF00091</TD><TD>21</TD><TD>1</TD><TD>17385</TD><TD>28</TD>
<TD>TUBA1A</TD></TR>
<TR><TD>3.332e-02</TD><TD>-3.40</TD><TD>Tubulin_C</TD><TD>interpro domains</TD><TD>IPR023123</TD><TD>21</TD><TD>1</TD><TD>18616</TD><TD>30</TD>
<TD>TUBA1A</TD></TR>
<TR><TD>3.332e-02</TD><TD>-3.40</TD><TD>Pept_cys_AS</TD><TD>interpro domains</TD><TD>IPR000169</TD><TD>21</TD><TD>1</TD><TD>18616</TD><TD>30</TD>
<TD>CTSV</TD></TR>
<TR><TD>3.332e-02</TD><TD>-3.40</TD><TD>Tubulin</TD><TD>interpro domains</TD><TD>IPR000217</TD><TD>21</TD><TD>1</TD><TD>18616</TD><TD>30</TD>
<TD>TUBA1A</TD></TR>
<TR><TD>3.332e-02</TD><TD>-3.40</TD><TD>Tub_FtsZ_C</TD><TD>interpro domains</TD><TD>IPR008280</TD><TD>21</TD><TD>1</TD><TD>18616</TD><TD>30</TD>
<TD>TUBA1A</TD></TR>
<TR><TD>3.332e-02</TD><TD>-3.40</TD><TD>Tubulin_CS</TD><TD>interpro domains</TD><TD>IPR017975</TD><TD>21</TD><TD>1</TD><TD>18616</TD><TD>30</TD>
<TD>TUBA1A</TD></TR>
<TR><TD>3.332e-02</TD><TD>-3.40</TD><TD>Tubulin_FtsZ_GTPase</TD><TD>interpro domains</TD><TD>IPR003008</TD><TD>21</TD><TD>1</TD><TD>18616</TD><TD>30</TD>
<TD>TUBA1A</TD></TR>
<TR><TD>3.356e-02</TD><TD>-3.39</TD><TD>GSE11864_CSF1_PAM3CYS_VS_CSF1_IFNG_PAM3CYS_IN_MAC_DN</TD><TD>MSigDB lists</TD><TD>GSE11864_CSF1_PAM3CYS_VS_CSF1_IFNG_PAM3CYS_IN_MAC_DN</TD><TD>172</TD><TD>2</TD><TD>17275</TD><TD>29</TD>
<TD>OASL,IFI27</TD></TR>
<TR><TD>3.383e-02</TD><TD>-3.39</TD><TD>FCGR3B (Fc fragment of IgG receptor IIIb)</TD><TD>protein interactions</TD><TD>2215</TD><TD>20</TD><TD>1</TD><TD>17456</TD><TD>30</TD>
<TD>TUBA1A</TD></TR>
<TR><TD>3.383e-02</TD><TD>-3.39</TD><TD>ERICH5 (glutamate rich 5)</TD><TD>protein interactions</TD><TD>203111</TD><TD>20</TD><TD>1</TD><TD>17456</TD><TD>30</TD>
<TD>KIFAP3</TD></TR>
<TR><TD>3.383e-02</TD><TD>-3.39</TD><TD>RCCD1 (RCC1 domain containing 1)</TD><TD>protein interactions</TD><TD>91433</TD><TD>20</TD><TD>1</TD><TD>17456</TD><TD>30</TD>
<TD>TUBA1A</TD></TR>
<TR><TD>3.383e-02</TD><TD>-3.39</TD><TD>Eea1 (early endosome antigen 1)</TD><TD>protein interactions</TD><TD>216238</TD><TD>20</TD><TD>1</TD><TD>17456</TD><TD>30</TD>
<TD>OAS3</TD></TR>
<TR><TD>3.383e-02</TD><TD>-3.39</TD><TD>LINC01587 (long intergenic non-protein coding RNA 1587)</TD><TD>protein interactions</TD><TD>10141</TD><TD>20</TD><TD>1</TD><TD>17456</TD><TD>30</TD>
<TD>DIRAS1</TD></TR>
<TR><TD>3.383e-02</TD><TD>-3.39</TD><TD>LGMN (legumain)</TD><TD>protein interactions</TD><TD>5641</TD><TD>20</TD><TD>1</TD><TD>17456</TD><TD>30</TD>
<TD>ISG15</TD></TR>
<TR><TD>3.383e-02</TD><TD>-3.39</TD><TD>ARID5B (AT-rich interaction domain 5B)</TD><TD>protein interactions</TD><TD>84159</TD><TD>20</TD><TD>1</TD><TD>17456</TD><TD>30</TD>
<TD>ISG15</TD></TR>
<TR><TD>3.399e-02</TD><TD>-3.38</TD><TD>female pregnancy</TD><TD>biological process</TD><TD>GO:0007565</TD><TD>181</TD><TD>2</TD><TD>18054</TD><TD>29</TD>
<TD>CTSV,PGF</TD></TR>
<TR><TD>3.401e-02</TD><TD>-3.38</TD><TD>polysaccharide binding</TD><TD>molecular function</TD><TD>GO:0030247</TD><TD>23</TD><TD>1</TD><TD>17306</TD><TD>26</TD>
<TD>SBSPON</TD></TR>
<TR><TD>3.401e-02</TD><TD>-3.38</TD><TD>catalytic activity, acting on a glycoprotein</TD><TD>molecular function</TD><TD>GO:0140103</TD><TD>23</TD><TD>1</TD><TD>17306</TD><TD>26</TD>
<TD>MGAT3</TD></TR>
<TR><TD>3.427e-02</TD><TD>-3.37</TD><TD>HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_UP</TD><TD>MSigDB lists</TD><TD>HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_UP</TD><TD>428</TD><TD>3</TD><TD>17275</TD><TD>29</TD>
<TD>IFI27,PGF,TUBA1A</TD></TR>
<TR><TD>3.428e-02</TD><TD>-3.37</TD><TD>GSE9960_GRAM_NEG_VS_GRAM_POS_SEPSIS_PBMC_UP</TD><TD>MSigDB lists</TD><TD>GSE9960_GRAM_NEG_VS_GRAM_POS_SEPSIS_PBMC_UP</TD><TD>174</TD><TD>2</TD><TD>17275</TD><TD>29</TD>
<TD>IFI44,IFI44L</TD></TR>
<TR><TD>3.434e-02</TD><TD>-3.37</TD><TD>antigen processing and presentation of exogenous antigen</TD><TD>biological process</TD><TD>GO:0019884</TD><TD>182</TD><TD>2</TD><TD>18054</TD><TD>29</TD>
<TD>KIFAP3,CTSV</TD></TR>
<TR><TD>3.457e-02</TD><TD>-3.36</TD><TD>endoplasmic reticulum subcompartment</TD><TD>cellular component</TD><TD>GO:0098827</TD><TD>23</TD><TD>1</TD><TD>18985</TD><TD>29</TD>
<TD>RYR1</TD></TR>
<TR><TD>3.464e-02</TD><TD>-3.36</TD><TD>GSE5455_HEALTHY_VS_TUMOR_BEARING_MOUSE_SPLEEN_MONOCYTE_UP</TD><TD>MSigDB lists</TD><TD>GSE5455_HEALTHY_VS_TUMOR_BEARING_MOUSE_SPLEEN_MONOCYTE_UP</TD><TD>175</TD><TD>2</TD><TD>17275</TD><TD>29</TD>
<TD>RYR1,ZNF518B</TD></TR>
<TR><TD>3.464e-02</TD><TD>-3.36</TD><TD>GSE41176_UNSTIM_VS_ANTI_IGM_STIM_TAK1_KO_BCELL_1H_UP</TD><TD>MSigDB lists</TD><TD>GSE41176_UNSTIM_VS_ANTI_IGM_STIM_TAK1_KO_BCELL_1H_UP</TD><TD>175</TD><TD>2</TD><TD>17275</TD><TD>29</TD>
<TD>OAS1,IFI27</TD></TR>
<TR><TD>3.464e-02</TD><TD>-3.36</TD><TD>GSE21927_SPLEEN_VS_TUMOR_MONOCYTE_BALBC_DN</TD><TD>MSigDB lists</TD><TD>GSE21927_SPLEEN_VS_TUMOR_MONOCYTE_BALBC_DN</TD><TD>175</TD><TD>2</TD><TD>17275</TD><TD>29</TD>
<TD>RYR1,CAMKK2</TD></TR>
<TR><TD>3.469e-02</TD><TD>-3.36</TD><TD>GO_MALE_GENITALIA_DEVELOPMENT</TD><TD>MSigDB lists</TD><TD>GO_MALE_GENITALIA_DEVELOPMENT</TD><TD>21</TD><TD>1</TD><TD>17275</TD><TD>29</TD>
<TD>LGR4</TD></TR>
<TR><TD>3.469e-02</TD><TD>-3.36</TD><TD>GO_ENDOPLASMIC_RETICULUM_TO_CYTOSOL_TRANSPORT</TD><TD>MSigDB lists</TD><TD>GO_ENDOPLASMIC_RETICULUM_TO_CYTOSOL_TRANSPORT</TD><TD>21</TD><TD>1</TD><TD>17275</TD><TD>29</TD>
<TD>RYR1</TD></TR>
<TR><TD>3.469e-02</TD><TD>-3.36</TD><TD>HUI_MAPK14_TARGETS_UP</TD><TD>MSigDB lists</TD><TD>HUI_MAPK14_TARGETS_UP</TD><TD>21</TD><TD>1</TD><TD>17275</TD><TD>29</TD>
<TD>ISG15</TD></TR>
<TR><TD>3.469e-02</TD><TD>-3.36</TD><TD>GO_REGULATION_OF_T_CELL_CYTOKINE_PRODUCTION</TD><TD>MSigDB lists</TD><TD>GO_REGULATION_OF_T_CELL_CYTOKINE_PRODUCTION</TD><TD>21</TD><TD>1</TD><TD>17275</TD><TD>29</TD>
<TD>RSAD2</TD></TR>
<TR><TD>3.469e-02</TD><TD>-3.36</TD><TD>SAGIV_CD24_TARGETS_UP</TD><TD>MSigDB lists</TD><TD>SAGIV_CD24_TARGETS_UP</TD><TD>21</TD><TD>1</TD><TD>17275</TD><TD>29</TD>
<TD>MCAM</TD></TR>
<TR><TD>3.469e-02</TD><TD>-3.36</TD><TD>GO_METANEPHRIC_NEPHRON_MORPHOGENESIS</TD><TD>MSigDB lists</TD><TD>GO_METANEPHRIC_NEPHRON_MORPHOGENESIS</TD><TD>21</TD><TD>1</TD><TD>17275</TD><TD>29</TD>
<TD>LGR4</TD></TR>
<TR><TD>3.469e-02</TD><TD>-3.36</TD><TD>REACTOME_FORMATION_OF_TUBULIN_FOLDING_INTERMEDIATES_BY_CCT_TRIC</TD><TD>MSigDB lists</TD><TD>REACTOME_FORMATION_OF_TUBULIN_FOLDING_INTERMEDIATES_BY_CCT_TRIC</TD><TD>21</TD><TD>1</TD><TD>17275</TD><TD>29</TD>
<TD>TUBA1A</TD></TR>
<TR><TD>3.477e-02</TD><TD>-3.36</TD><TD>vascular endothelial growth factor signaling pathway</TD><TD>biological process</TD><TD>GO:0038084</TD><TD>22</TD><TD>1</TD><TD>18054</TD><TD>29</TD>
<TD>PGF</TD></TR>
<TR><TD>3.477e-02</TD><TD>-3.36</TD><TD>calcium-mediated signaling using intracellular calcium source</TD><TD>biological process</TD><TD>GO:0035584</TD><TD>22</TD><TD>1</TD><TD>18054</TD><TD>29</TD>
<TD>ADGRL1</TD></TR>
<TR><TD>3.477e-02</TD><TD>-3.36</TD><TD>regulation of branching involved in ureteric bud morphogenesis</TD><TD>biological process</TD><TD>GO:0090189</TD><TD>22</TD><TD>1</TD><TD>18054</TD><TD>29</TD>
<TD>LGR4</TD></TR>
<TR><TD>3.486e-02</TD><TD>-3.36</TD><TD>HRM</TD><TD>pfam domains</TD><TD>PF02793</TD><TD>22</TD><TD>1</TD><TD>17385</TD><TD>28</TD>
<TD>ADGRL1</TD></TR>
<TR><TD>3.488e-02</TD><TD>-3.36</TD><TD>Tubulin/FtsZ_GTPase_sf</TD><TD>interpro domains</TD><TD>IPR036525</TD><TD>22</TD><TD>1</TD><TD>18616</TD><TD>30</TD>
<TD>TUBA1A</TD></TR>
<TR><TD>3.500e-02</TD><TD>-3.35</TD><TD>GSE40666_NAIVE_VS_EFFECTOR_CD8_TCELL_WITH_IFNA_STIM_90MIN_DN</TD><TD>MSigDB lists</TD><TD>GSE40666_NAIVE_VS_EFFECTOR_CD8_TCELL_WITH_IFNA_STIM_90MIN_DN</TD><TD>176</TD><TD>2</TD><TD>17275</TD><TD>29</TD>
<TD>KLHDC8B,CAMKK2</TD></TR>
<TR><TD>3.500e-02</TD><TD>-3.35</TD><TD>GSE32533_MIR17_KO_VS_MIR17_OVEREXPRESS_ACT_CD4_TCELL_DN</TD><TD>MSigDB lists</TD><TD>GSE32533_MIR17_KO_VS_MIR17_OVEREXPRESS_ACT_CD4_TCELL_DN</TD><TD>176</TD><TD>2</TD><TD>17275</TD><TD>29</TD>
<TD>IFI44L,RYR1</TD></TR>
<TR><TD>3.500e-02</TD><TD>-3.35</TD><TD>GSE37301_LYMPHOID_PRIMED_MPP_VS_GRAN_MONO_PROGENITOR_DN</TD><TD>MSigDB lists</TD><TD>GSE37301_LYMPHOID_PRIMED_MPP_VS_GRAN_MONO_PROGENITOR_DN</TD><TD>176</TD><TD>2</TD><TD>17275</TD><TD>29</TD>
<TD>OAS1,KIFAP3</TD></TR>
<TR><TD>3.500e-02</TD><TD>-3.35</TD><TD>GSE27786_LIN_NEG_VS_BCELL_DN</TD><TD>MSigDB lists</TD><TD>GSE27786_LIN_NEG_VS_BCELL_DN</TD><TD>176</TD><TD>2</TD><TD>17275</TD><TD>29</TD>
<TD>TUBA1A,OAS2</TD></TR>
<TR><TD>3.500e-02</TD><TD>-3.35</TD><TD>GSE26669_CD4_VS_CD8_TCELL_IN_MLR_DN</TD><TD>MSigDB lists</TD><TD>GSE26669_CD4_VS_CD8_TCELL_IN_MLR_DN</TD><TD>176</TD><TD>2</TD><TD>17275</TD><TD>29</TD>
<TD>OAS3,TUBA1A</TD></TR>
<TR><TD>3.500e-02</TD><TD>-3.35</TD><TD>GSE32423_IL7_VS_IL7_IL4_NAIVE_CD8_TCELL_UP</TD><TD>MSigDB lists</TD><TD>GSE32423_IL7_VS_IL7_IL4_NAIVE_CD8_TCELL_UP</TD><TD>176</TD><TD>2</TD><TD>17275</TD><TD>29</TD>
<TD>ZNF518B,CAPN6</TD></TR>
<TR><TD>3.500e-02</TD><TD>-3.35</TD><TD>GSE14000_4H_VS_16H_LPS_DC_TRANSLATED_RNA_DN</TD><TD>MSigDB lists</TD><TD>GSE14000_4H_VS_16H_LPS_DC_TRANSLATED_RNA_DN</TD><TD>176</TD><TD>2</TD><TD>17275</TD><TD>29</TD>
<TD>MCAM,KIAA1211</TD></TR>
<TR><TD>3.517e-02</TD><TD>-3.35</TD><TD>follicular_lymphoma</TD><TD>COSMIC cancer mutations</TD><TD>follicular_lymphoma</TD><TD>1239</TD><TD>5</TD><TD>17255</TD><TD>26</TD>
<TD>BCL6B,KIAA1211,KIFAP3,RYR1,MCAM</TD></TR>
<TR><TD>3.526e-02</TD><TD>-3.34</TD><TD>Ubiquitin-like_domsf</TD><TD>interpro domains</TD><TD>IPR029071</TD><TD>184</TD><TD>2</TD><TD>18616</TD><TD>30</TD>
<TD>ISG15,OASL</TD></TR>
<TR><TD>3.537e-02</TD><TD>-3.34</TD><TD>GSE9037_WT_VS_IRAK4_KO_BMDM_DN</TD><TD>MSigDB lists</TD><TD>GSE9037_WT_VS_IRAK4_KO_BMDM_DN</TD><TD>177</TD><TD>2</TD><TD>17275</TD><TD>29</TD>
<TD>OAS1,OAS3</TD></TR>
<TR><TD>3.537e-02</TD><TD>-3.34</TD><TD>GSE21360_NAIVE_VS_PRIMARY_MEMORY_CD8_TCELL_DN</TD><TD>MSigDB lists</TD><TD>GSE21360_NAIVE_VS_PRIMARY_MEMORY_CD8_TCELL_DN</TD><TD>177</TD><TD>2</TD><TD>17275</TD><TD>29</TD>
<TD>IFIT2,RSAD2</TD></TR>
<TR><TD>3.537e-02</TD><TD>-3.34</TD><TD>GO_CALMODULIN_BINDING</TD><TD>MSigDB lists</TD><TD>GO_CALMODULIN_BINDING</TD><TD>177</TD><TD>2</TD><TD>17275</TD><TD>29</TD>
<TD>RYR1,CAMKK2</TD></TR>
<TR><TD>3.537e-02</TD><TD>-3.34</TD><TD>GSE20152_SPHK1_KO_VS_HTNFA_OVEREXPRESS_ANKLE_UP</TD><TD>MSigDB lists</TD><TD>GSE20152_SPHK1_KO_VS_HTNFA_OVEREXPRESS_ANKLE_UP</TD><TD>177</TD><TD>2</TD><TD>17275</TD><TD>29</TD>
<TD>RYR1,PGF</TD></TR>
<TR><TD>3.537e-02</TD><TD>-3.34</TD><TD>GSE2770_TGFB_AND_IL4_ACT_VS_ACT_CD4_TCELL_48H_DN</TD><TD>MSigDB lists</TD><TD>GSE2770_TGFB_AND_IL4_ACT_VS_ACT_CD4_TCELL_48H_DN</TD><TD>177</TD><TD>2</TD><TD>17275</TD><TD>29</TD>
<TD>IFI44L,IFI44</TD></TR>
<TR><TD>3.550e-02</TD><TD>-3.34</TD><TD>SHANK1 (SH3 and multiple ankyrin repeat domains 1)</TD><TD>protein interactions</TD><TD>50944</TD><TD>21</TD><TD>1</TD><TD>17456</TD><TD>30</TD>
<TD>ADGRL1</TD></TR>
<TR><TD>3.550e-02</TD><TD>-3.34</TD><TD>FNBP4 (formin binding protein 4)</TD><TD>protein interactions</TD><TD>23360</TD><TD>21</TD><TD>1</TD><TD>17456</TD><TD>30</TD>
<TD>LGR4</TD></TR>
<TR><TD>3.550e-02</TD><TD>-3.34</TD><TD>OSBPL1A (oxysterol binding protein like 1A)</TD><TD>protein interactions</TD><TD>114876</TD><TD>21</TD><TD>1</TD><TD>17456</TD><TD>30</TD>
<TD>KIFAP3</TD></TR>
<TR><TD>3.550e-02</TD><TD>-3.34</TD><TD>S100A13 (S100 calcium binding protein A13)</TD><TD>protein interactions</TD><TD>6284</TD><TD>21</TD><TD>1</TD><TD>17456</TD><TD>30</TD>
<TD>KIFAP3</TD></TR>
<TR><TD>3.550e-02</TD><TD>-3.34</TD><TD>FOPNL (FGFR1OP N-terminal like)</TD><TD>protein interactions</TD><TD>123811</TD><TD>21</TD><TD>1</TD><TD>17456</TD><TD>30</TD>
<TD>TUBA1A</TD></TR>
<TR><TD>3.550e-02</TD><TD>-3.34</TD><TD>KRT75 (keratin 75)</TD><TD>protein interactions</TD><TD>9119</TD><TD>21</TD><TD>1</TD><TD>17456</TD><TD>30</TD>
<TD>LGR4</TD></TR>
<TR><TD>3.550e-02</TD><TD>-3.34</TD><TD>ARL4C (ADP ribosylation factor like GTPase 4C)</TD><TD>protein interactions</TD><TD>10123</TD><TD>21</TD><TD>1</TD><TD>17456</TD><TD>30</TD>
<TD>DIRAS1</TD></TR>
<TR><TD>3.550e-02</TD><TD>-3.34</TD><TD>CCNY (cyclin Y)</TD><TD>protein interactions</TD><TD>219771</TD><TD>21</TD><TD>1</TD><TD>17456</TD><TD>30</TD>
<TD>KIFAP3</TD></TR>
<TR><TD>3.550e-02</TD><TD>-3.34</TD><TD>CCDC103 (coiled-coil domain containing 103)</TD><TD>protein interactions</TD><TD>388389</TD><TD>21</TD><TD>1</TD><TD>17456</TD><TD>30</TD>
<TD>CTSV</TD></TR>
<TR><TD>3.550e-02</TD><TD>-3.34</TD><TD>ATP1A2 (ATPase Na+/K+ transporting subunit alpha 2)</TD><TD>protein interactions</TD><TD>477</TD><TD>21</TD><TD>1</TD><TD>17456</TD><TD>30</TD>
<TD>LGR4</TD></TR>
<TR><TD>3.550e-02</TD><TD>-3.34</TD><TD>IL12RB1 (interleukin 12 receptor subunit beta 1)</TD><TD>protein interactions</TD><TD>3594</TD><TD>21</TD><TD>1</TD><TD>17456</TD><TD>30</TD>
<TD>TUBA1A</TD></TR>
<TR><TD>3.562e-02</TD><TD>-3.33</TD><TD>Stabilization and expansion of the E-cadherin adherens junction</TD><TD>Pathway Interaction DB</TD><TD>ecadherin_stabilization_pathway</TD><TD>40</TD><TD>1</TD><TD>2226</TD><TD>2</TD>
<TD>MGAT3</TD></TR>
<TR><TD>3.573e-02</TD><TD>-3.33</TD><TD>GSE17721_CTRL_VS_PAM3CSK4_4H_BMDC_UP</TD><TD>MSigDB lists</TD><TD>GSE17721_CTRL_VS_PAM3CSK4_4H_BMDC_UP</TD><TD>178</TD><TD>2</TD><TD>17275</TD><TD>29</TD>
<TD>IFIT2,TUBA1A</TD></TR>
<TR><TD>3.573e-02</TD><TD>-3.33</TD><TD>GSE21670_TGFB_VS_IL6_TREATED_STAT3_KO_CD4_TCELL_UP</TD><TD>MSigDB lists</TD><TD>GSE21670_TGFB_VS_IL6_TREATED_STAT3_KO_CD4_TCELL_UP</TD><TD>178</TD><TD>2</TD><TD>17275</TD><TD>29</TD>
<TD>BCL6B,OAS2</TD></TR>
<TR><TD>3.573e-02</TD><TD>-3.33</TD><TD>TGFB_UP.V1_DN</TD><TD>MSigDB lists</TD><TD>TGFB_UP.V1_DN</TD><TD>178</TD><TD>2</TD><TD>17275</TD><TD>29</TD>
<TD>LGR4,IFIT2</TD></TR>
<TR><TD>3.573e-02</TD><TD>-3.33</TD><TD>LEF1_UP.V1_DN</TD><TD>MSigDB lists</TD><TD>LEF1_UP.V1_DN</TD><TD>178</TD><TD>2</TD><TD>17275</TD><TD>29</TD>
<TD>OAS1,OAS3</TD></TR>
<TR><TD>3.585e-02</TD><TD>-3.33</TD><TD>regulation of biological process</TD><TD>biological process</TD><TD>GO:0050789</TD><TD>11862</TD><TD>24</TD><TD>18054</TD><TD>29</TD>
<TD>RSAD2,CAMKK2,IFIT2,RYR1,DIRAS1,OAS1,OAS3,LGR4,BCL6B,OASL,CAPN6,MGAT3,CADM4,ADGRL1,MCAM,IFI27,CTSV,PGF,OAS2,KIAA1211,TUBA1A,ZNF518B,KIFAP3,ISG15</TD></TR>
<TR><TD>3.601e-02</TD><TD>-3.32</TD><TD>calmodulin binding</TD><TD>molecular function</TD><TD>GO:0005516</TD><TD>200</TD><TD>2</TD><TD>17306</TD><TD>26</TD>
<TD>CAMKK2,RYR1</TD></TR>
<TR><TD>3.610e-02</TD><TD>-3.32</TD><TD>GSE3982_EOSINOPHIL_VS_MAC_UP</TD><TD>MSigDB lists</TD><TD>GSE3982_EOSINOPHIL_VS_MAC_UP</TD><TD>179</TD><TD>2</TD><TD>17275</TD><TD>29</TD>
<TD>CAMKK2,ISG15</TD></TR>
<TR><TD>3.610e-02</TD><TD>-3.32</TD><TD>GSE17721_CTRL_VS_GARDIQUIMOD_2H_BMDC_UP</TD><TD>MSigDB lists</TD><TD>GSE17721_CTRL_VS_GARDIQUIMOD_2H_BMDC_UP</TD><TD>179</TD><TD>2</TD><TD>17275</TD><TD>29</TD>
<TD>IFIT2,OASL</TD></TR>
<TR><TD>3.610e-02</TD><TD>-3.32</TD><TD>GSE27786_CD4_TCELL_VS_ERYTHTROBLAST_DN</TD><TD>MSigDB lists</TD><TD>GSE27786_CD4_TCELL_VS_ERYTHTROBLAST_DN</TD><TD>179</TD><TD>2</TD><TD>17275</TD><TD>29</TD>
<TD>DIRAS1,RSAD2</TD></TR>
<TR><TD>3.610e-02</TD><TD>-3.32</TD><TD>GSE2128_C57BL6_VS_NOD_CD4CD8_DP_THYMOCYTE_DN</TD><TD>MSigDB lists</TD><TD>GSE2128_C57BL6_VS_NOD_CD4CD8_DP_THYMOCYTE_DN</TD><TD>179</TD><TD>2</TD><TD>17275</TD><TD>29</TD>
<TD>RSAD2,OAS1</TD></TR>
<TR><TD>3.610e-02</TD><TD>-3.32</TD><TD>GSE17721_CTRL_VS_LPS_0.5H_BMDC_UP</TD><TD>MSigDB lists</TD><TD>GSE17721_CTRL_VS_LPS_0.5H_BMDC_UP</TD><TD>179</TD><TD>2</TD><TD>17275</TD><TD>29</TD>
<TD>ISG15,MCAM</TD></TR>
<TR><TD>3.610e-02</TD><TD>-3.32</TD><TD>GSE13306_TREG_RA_VS_TCONV_RA_DN</TD><TD>MSigDB lists</TD><TD>GSE13306_TREG_RA_VS_TCONV_RA_DN</TD><TD>179</TD><TD>2</TD><TD>17275</TD><TD>29</TD>
<TD>RSAD2,MGAT3</TD></TR>
<TR><TD>3.610e-02</TD><TD>-3.32</TD><TD>GSE22229_RENAL_TRANSPLANT_IMMUNOSUPP_THERAPY_VS_HEALTHY_PBMC_DN</TD><TD>MSigDB lists</TD><TD>GSE22229_RENAL_TRANSPLANT_IMMUNOSUPP_THERAPY_VS_HEALTHY_PBMC_DN</TD><TD>179</TD><TD>2</TD><TD>17275</TD><TD>29</TD>
<TD>ZNF518B,RYR1</TD></TR>
<TR><TD>3.610e-02</TD><TD>-3.32</TD><TD>GSE369_PRE_VS_POST_IL6_INJECTION_IFNG_WT_LIVER_UP</TD><TD>MSigDB lists</TD><TD>GSE369_PRE_VS_POST_IL6_INJECTION_IFNG_WT_LIVER_UP</TD><TD>179</TD><TD>2</TD><TD>17275</TD><TD>29</TD>
<TD>OAS1,IFI27</TD></TR>
<TR><TD>3.610e-02</TD><TD>-3.32</TD><TD>GSE21379_TFH_VS_NON_TFH_CD4_TCELL_UP</TD><TD>MSigDB lists</TD><TD>GSE21379_TFH_VS_NON_TFH_CD4_TCELL_UP</TD><TD>179</TD><TD>2</TD><TD>17275</TD><TD>29</TD>
<TD>OASL,KLHDC8B</TD></TR>
<TR><TD>3.610e-02</TD><TD>-3.32</TD><TD>GSE13229_IMM_VS_INTMATURE_NKCELL_DN</TD><TD>MSigDB lists</TD><TD>GSE13229_IMM_VS_INTMATURE_NKCELL_DN</TD><TD>179</TD><TD>2</TD><TD>17275</TD><TD>29</TD>
<TD>IFIT2,MCAM</TD></TR>
<TR><TD>3.610e-02</TD><TD>-3.32</TD><TD>GSE3982_DC_VS_CENT_MEMORY_CD4_TCELL_DN</TD><TD>MSigDB lists</TD><TD>GSE3982_DC_VS_CENT_MEMORY_CD4_TCELL_DN</TD><TD>179</TD><TD>2</TD><TD>17275</TD><TD>29</TD>
<TD>IFI44L,OAS2</TD></TR>
<TR><TD>3.610e-02</TD><TD>-3.32</TD><TD>GSE41867_DAY6_VS_DAY8_LCMV_CLONE13_EFFECTOR_CD8_TCELL_UP</TD><TD>MSigDB lists</TD><TD>GSE41867_DAY6_VS_DAY8_LCMV_CLONE13_EFFECTOR_CD8_TCELL_UP</TD><TD>179</TD><TD>2</TD><TD>17275</TD><TD>29</TD>
<TD>OAS3,OAS2</TD></TR>
<TR><TD>3.631e-02</TD><TD>-3.32</TD><TD>GO_POSITIVE_REGULATION_OF_MESONEPHROS_DEVELOPMENT</TD><TD>MSigDB lists</TD><TD>GO_POSITIVE_REGULATION_OF_MESONEPHROS_DEVELOPMENT</TD><TD>22</TD><TD>1</TD><TD>17275</TD><TD>29</TD>
<TD>LGR4</TD></TR>
<TR><TD>3.631e-02</TD><TD>-3.32</TD><TD>CGCTGCT_MIR503</TD><TD>MSigDB lists</TD><TD>CGCTGCT_MIR503</TD><TD>22</TD><TD>1</TD><TD>17275</TD><TD>29</TD>
<TD>HS6ST2</TD></TR>
<TR><TD>3.632e-02</TD><TD>-3.32</TD><TD>regulation of vascular endothelial growth factor signaling pathway</TD><TD>biological process</TD><TD>GO:1900746</TD><TD>23</TD><TD>1</TD><TD>18054</TD><TD>29</TD>
<TD>CADM4</TD></TR>
<TR><TD>3.632e-02</TD><TD>-3.32</TD><TD>positive regulation of toll-like receptor signaling pathway</TD><TD>biological process</TD><TD>GO:0034123</TD><TD>23</TD><TD>1</TD><TD>18054</TD><TD>29</TD>
<TD>RSAD2</TD></TR>
<TR><TD>3.632e-02</TD><TD>-3.32</TD><TD>male genitalia development</TD><TD>biological process</TD><TD>GO:0030539</TD><TD>23</TD><TD>1</TD><TD>18054</TD><TD>29</TD>
<TD>LGR4</TD></TR>
<TR><TD>3.643e-02</TD><TD>-3.31</TD><TD>antigen processing and presentation of peptide antigen</TD><TD>biological process</TD><TD>GO:0048002</TD><TD>188</TD><TD>2</TD><TD>18054</TD><TD>29</TD>
<TD>KIFAP3,CTSV</TD></TR>
<TR><TD>3.647e-02</TD><TD>-3.31</TD><TD>GSE36888_STAT5_AB_KNOCKIN_VS_WT_TCELL_IL2_TREATED_6H_UP</TD><TD>MSigDB lists</TD><TD>GSE36888_STAT5_AB_KNOCKIN_VS_WT_TCELL_IL2_TREATED_6H_UP</TD><TD>180</TD><TD>2</TD><TD>17275</TD><TD>29</TD>
<TD>ISG15,IFIT2</TD></TR>
<TR><TD>3.647e-02</TD><TD>-3.31</TD><TD>GSE27786_LSK_VS_CD8_TCELL_UP</TD><TD>MSigDB lists</TD><TD>GSE27786_LSK_VS_CD8_TCELL_UP</TD><TD>180</TD><TD>2</TD><TD>17275</TD><TD>29</TD>
<TD>KIFAP3,OAS1</TD></TR>
<TR><TD>3.647e-02</TD><TD>-3.31</TD><TD>GSE29618_LAIV_VS_TIV_FLU_VACCINE_DAY7_MONOCYTE_UP</TD><TD>MSigDB lists</TD><TD>GSE29618_LAIV_VS_TIV_FLU_VACCINE_DAY7_MONOCYTE_UP</TD><TD>180</TD><TD>2</TD><TD>17275</TD><TD>29</TD>
<TD>CAPN6,CAMKK2</TD></TR>
<TR><TD>3.647e-02</TD><TD>-3.31</TD><TD>GSE15930_STIM_VS_STIM_AND_IL12_72H_CD8_T_CELL_UP</TD><TD>MSigDB lists</TD><TD>GSE15930_STIM_VS_STIM_AND_IL12_72H_CD8_T_CELL_UP</TD><TD>180</TD><TD>2</TD><TD>17275</TD><TD>29</TD>
<TD>ISG15,IFIT2</TD></TR>
<TR><TD>3.647e-02</TD><TD>-3.31</TD><TD>GSE31082_CD4_VS_CD8_SP_THYMOCYTE_UP</TD><TD>MSigDB lists</TD><TD>GSE31082_CD4_VS_CD8_SP_THYMOCYTE_UP</TD><TD>180</TD><TD>2</TD><TD>17275</TD><TD>29</TD>
<TD>CAMKK2,IFI44</TD></TR>
<TR><TD>3.647e-02</TD><TD>-3.31</TD><TD>GSE33424_CD161_HIGH_VS_INT_CD8_TCELL_DN</TD><TD>MSigDB lists</TD><TD>GSE33424_CD161_HIGH_VS_INT_CD8_TCELL_DN</TD><TD>180</TD><TD>2</TD><TD>17275</TD><TD>29</TD>
<TD>TUBA1A,IFI27</TD></TR>
<TR><TD>3.647e-02</TD><TD>-3.31</TD><TD>GSE17721_POLYIC_VS_GARDIQUIMOD_2H_BMDC_UP</TD><TD>MSigDB lists</TD><TD>GSE17721_POLYIC_VS_GARDIQUIMOD_2H_BMDC_UP</TD><TD>180</TD><TD>2</TD><TD>17275</TD><TD>29</TD>
<TD>ISG15,OAS2</TD></TR>
<TR><TD>3.647e-02</TD><TD>-3.31</TD><TD>GSE22886_NEUTROPHIL_VS_DC_UP</TD><TD>MSigDB lists</TD><TD>GSE22886_NEUTROPHIL_VS_DC_UP</TD><TD>180</TD><TD>2</TD><TD>17275</TD><TD>29</TD>
<TD>RSAD2,OASL</TD></TR>
<TR><TD>3.647e-02</TD><TD>-3.31</TD><TD>GSE41176_UNSTIM_VS_ANTI_IGM_STIM_BCELL_3H_DN</TD><TD>MSigDB lists</TD><TD>GSE41176_UNSTIM_VS_ANTI_IGM_STIM_BCELL_3H_DN</TD><TD>180</TD><TD>2</TD><TD>17275</TD><TD>29</TD>
<TD>IFIT2,OAS1</TD></TR>
<TR><TD>3.647e-02</TD><TD>-3.31</TD><TD>GSE12845_PRE_GC_VS_DARKZONE_GC_TONSIL_BCELL_UP</TD><TD>MSigDB lists</TD><TD>GSE12845_PRE_GC_VS_DARKZONE_GC_TONSIL_BCELL_UP</TD><TD>180</TD><TD>2</TD><TD>17275</TD><TD>29</TD>
<TD>IFI44,OAS2</TD></TR>
<TR><TD>3.647e-02</TD><TD>-3.31</TD><TD>GSE9037_WT_VS_IRAK4_KO_LPS_1H_STIM_BMDM_DN</TD><TD>MSigDB lists</TD><TD>GSE9037_WT_VS_IRAK4_KO_LPS_1H_STIM_BMDM_DN</TD><TD>180</TD><TD>2</TD><TD>17275</TD><TD>29</TD>
<TD>RSAD2,IFI44</TD></TR>
<TR><TD>3.647e-02</TD><TD>-3.31</TD><TD>GSE1432_1H_VS_24H_IFNG_MICROGLIA_DN</TD><TD>MSigDB lists</TD><TD>GSE1432_1H_VS_24H_IFNG_MICROGLIA_DN</TD><TD>180</TD><TD>2</TD><TD>17275</TD><TD>29</TD>
<TD>IFI44,IFI44L</TD></TR>
<TR><TD>3.647e-02</TD><TD>-3.31</TD><TD>GSE17580_TREG_VS_TEFF_S_MANSONI_INF_DN</TD><TD>MSigDB lists</TD><TD>GSE17580_TREG_VS_TEFF_S_MANSONI_INF_DN</TD><TD>180</TD><TD>2</TD><TD>17275</TD><TD>29</TD>
<TD>OAS2,IFIT2</TD></TR>
<TR><TD>3.647e-02</TD><TD>-3.31</TD><TD>KRIEG_KDM3A_TARGETS_NOT_HYPOXIA</TD><TD>MSigDB lists</TD><TD>KRIEG_KDM3A_TARGETS_NOT_HYPOXIA</TD><TD>180</TD><TD>2</TD><TD>17275</TD><TD>29</TD>
<TD>OAS1,IFI44</TD></TR>
<TR><TD>3.647e-02</TD><TD>-3.31</TD><TD>GSE2128_CTRL_VS_MIMETOPE_NEGATIVE_SELECTION_DP_THYMOCYTE_NOD_UP</TD><TD>MSigDB lists</TD><TD>GSE2128_CTRL_VS_MIMETOPE_NEGATIVE_SELECTION_DP_THYMOCYTE_NOD_UP</TD><TD>180</TD><TD>2</TD><TD>17275</TD><TD>29</TD>
<TD>OAS1,IFI27</TD></TR>
<TR><TD>3.684e-02</TD><TD>-3.30</TD><TD>GO_SKIN_DEVELOPMENT</TD><TD>MSigDB lists</TD><TD>GO_SKIN_DEVELOPMENT</TD><TD>181</TD><TD>2</TD><TD>17275</TD><TD>29</TD>
<TD>LGR4,RYR1</TD></TR>
<TR><TD>3.684e-02</TD><TD>-3.30</TD><TD>GSE16755_CTRL_VS_IFNA_TREATED_MAC_UP</TD><TD>MSigDB lists</TD><TD>GSE16755_CTRL_VS_IFNA_TREATED_MAC_UP</TD><TD>181</TD><TD>2</TD><TD>17275</TD><TD>29</TD>
<TD>KIFAP3,ZNF518B</TD></TR>
<TR><TD>3.684e-02</TD><TD>-3.30</TD><TD>GSE19198_1H_VS_24H_IL21_TREATED_TCELL_DN</TD><TD>MSigDB lists</TD><TD>GSE19198_1H_VS_24H_IL21_TREATED_TCELL_DN</TD><TD>181</TD><TD>2</TD><TD>17275</TD><TD>29</TD>
<TD>TUBA1A,OAS2</TD></TR>
<TR><TD>3.684e-02</TD><TD>-3.30</TD><TD>GSE40274_FOXP3_VS_FOXP3_AND_GATA1_TRANSDUCED_ACTIVATED_CD4_TCELL_DN</TD><TD>MSigDB lists</TD><TD>GSE40274_FOXP3_VS_FOXP3_AND_GATA1_TRANSDUCED_ACTIVATED_CD4_TCELL_DN</TD><TD>181</TD><TD>2</TD><TD>17275</TD><TD>29</TD>
<TD>IFI44,OASL</TD></TR>
<TR><TD>3.684e-02</TD><TD>-3.30</TD><TD>GSE5589_IL6_KO_VS_IL10_KO_LPS_STIM_MACROPHAGE_180MIN_UP</TD><TD>MSigDB lists</TD><TD>GSE5589_IL6_KO_VS_IL10_KO_LPS_STIM_MACROPHAGE_180MIN_UP</TD><TD>181</TD><TD>2</TD><TD>17275</TD><TD>29</TD>
<TD>RYR1,MCAM</TD></TR>
<TR><TD>3.684e-02</TD><TD>-3.30</TD><TD>GSE5589_WT_VS_IL10_KO_LPS_AND_IL10_STIM_MACROPHAGE_45MIN_UP</TD><TD>MSigDB lists</TD><TD>GSE5589_WT_VS_IL10_KO_LPS_AND_IL10_STIM_MACROPHAGE_45MIN_UP</TD><TD>181</TD><TD>2</TD><TD>17275</TD><TD>29</TD>
<TD>OAS3,FAM102B</TD></TR>
<TR><TD>3.710e-02</TD><TD>-3.29</TD><TD>GO_ENDOPLASMIC_RETICULUM</TD><TD>MSigDB lists</TD><TD>GO_ENDOPLASMIC_RETICULUM</TD><TD>1515</TD><TD>6</TD><TD>17275</TD><TD>29</TD>
<TD>OAS1,OAS2,IFIT2,KIFAP3,RYR1,RSAD2</TD></TR>
<TR><TD>3.716e-02</TD><TD>-3.29</TD><TD>GBP1 (guanylate binding protein 1)</TD><TD>protein interactions</TD><TD>2633</TD><TD>22</TD><TD>1</TD><TD>17456</TD><TD>30</TD>
<TD>ISG15</TD></TR>
<TR><TD>3.716e-02</TD><TD>-3.29</TD><TD>NFIX (nuclear factor I X)</TD><TD>protein interactions</TD><TD>4784</TD><TD>22</TD><TD>1</TD><TD>17456</TD><TD>30</TD>
<TD>ISG15</TD></TR>
<TR><TD>3.716e-02</TD><TD>-3.29</TD><TD>NRN1 (neuritin 1)</TD><TD>protein interactions</TD><TD>51299</TD><TD>22</TD><TD>1</TD><TD>17456</TD><TD>30</TD>
<TD>ADGRL1</TD></TR>
<TR><TD>3.716e-02</TD><TD>-3.29</TD><TD>POTEKP (POTE ankyrin domain family member K, pseudogene)</TD><TD>protein interactions</TD><TD>440915</TD><TD>22</TD><TD>1</TD><TD>17456</TD><TD>30</TD>
<TD>LGR4</TD></TR>
<TR><TD>3.716e-02</TD><TD>-3.29</TD><TD>CPEB2 (cytoplasmic polyadenylation element binding protein 2)</TD><TD>protein interactions</TD><TD>132864</TD><TD>22</TD><TD>1</TD><TD>17456</TD><TD>30</TD>
<TD>TUBA1A</TD></TR>
<TR><TD>3.716e-02</TD><TD>-3.29</TD><TD>BUD23 (BUD23 rRNA methyltransferase and ribosome maturation factor)</TD><TD>protein interactions</TD><TD>114049</TD><TD>22</TD><TD>1</TD><TD>17456</TD><TD>30</TD>
<TD>OAS1</TD></TR>
<TR><TD>3.717e-02</TD><TD>-3.29</TD><TD>human chr14q32.12</TD><TD>chromosome location</TD><TD>human chr14q32.12</TD><TD>33</TD><TD>1</TD><TD>26169</TD><TD>30</TD>
<TD>IFI27</TD></TR>
<TR><TD>3.721e-02</TD><TD>-3.29</TD><TD>GSE2585_CTEC_VS_THYMIC_MACROPHAGE_UP</TD><TD>MSigDB lists</TD><TD>GSE2585_CTEC_VS_THYMIC_MACROPHAGE_UP</TD><TD>182</TD><TD>2</TD><TD>17275</TD><TD>29</TD>
<TD>HS6ST2,ISG15</TD></TR>
<TR><TD>3.721e-02</TD><TD>-3.29</TD><TD>GSE15324_NAIVE_VS_ACTIVATED_ELF4_KO_CD8_TCELL_UP</TD><TD>MSigDB lists</TD><TD>GSE15324_NAIVE_VS_ACTIVATED_ELF4_KO_CD8_TCELL_UP</TD><TD>182</TD><TD>2</TD><TD>17275</TD><TD>29</TD>
<TD>IFIT2,DIRAS1</TD></TR>
<TR><TD>3.721e-02</TD><TD>-3.29</TD><TD>GSE7460_CTRL_VS_FOXP3_OVEREXPR_TCONV_UP</TD><TD>MSigDB lists</TD><TD>GSE7460_CTRL_VS_FOXP3_OVEREXPR_TCONV_UP</TD><TD>182</TD><TD>2</TD><TD>17275</TD><TD>29</TD>
<TD>IFI44L,DIRAS1</TD></TR>
<TR><TD>3.721e-02</TD><TD>-3.29</TD><TD>GSE13306_RA_VS_UNTREATED_TCONV_DN</TD><TD>MSigDB lists</TD><TD>GSE13306_RA_VS_UNTREATED_TCONV_DN</TD><TD>182</TD><TD>2</TD><TD>17275</TD><TD>29</TD>
<TD>RYR1,OAS3</TD></TR>
<TR><TD>3.721e-02</TD><TD>-3.29</TD><TD>GSE19198_CTRL_VS_IL21_TREATED_TCELL_6H_UP</TD><TD>MSigDB lists</TD><TD>GSE19198_CTRL_VS_IL21_TREATED_TCELL_6H_UP</TD><TD>182</TD><TD>2</TD><TD>17275</TD><TD>29</TD>
<TD>OAS2,TUBA1A</TD></TR>
<TR><TD>3.721e-02</TD><TD>-3.29</TD><TD>GSE30083_SP1_VS_SP3_THYMOCYTE_UP</TD><TD>MSigDB lists</TD><TD>GSE30083_SP1_VS_SP3_THYMOCYTE_UP</TD><TD>182</TD><TD>2</TD><TD>17275</TD><TD>29</TD>
<TD>TUBA1A,IFI27</TD></TR>
<TR><TD>3.721e-02</TD><TD>-3.29</TD><TD>GSE27786_CD8_TCELL_VS_NKCELL_DN</TD><TD>MSigDB lists</TD><TD>GSE27786_CD8_TCELL_VS_NKCELL_DN</TD><TD>182</TD><TD>2</TD><TD>17275</TD><TD>29</TD>
<TD>OASL,CAMKK2</TD></TR>
<TR><TD>3.721e-02</TD><TD>-3.29</TD><TD>GSE9006_HEALTHY_VS_TYPE_1_DIABETES_PBMC_AT_DX_UP</TD><TD>MSigDB lists</TD><TD>GSE9006_HEALTHY_VS_TYPE_1_DIABETES_PBMC_AT_DX_UP</TD><TD>182</TD><TD>2</TD><TD>17275</TD><TD>29</TD>
<TD>IFI44L,IFI27</TD></TR>
<TR><TD>3.721e-02</TD><TD>-3.29</TD><TD>GSE14308_TH17_VS_INDUCED_TREG_DN</TD><TD>MSigDB lists</TD><TD>GSE14308_TH17_VS_INDUCED_TREG_DN</TD><TD>182</TD><TD>2</TD><TD>17275</TD><TD>29</TD>
<TD>OAS1,BCL6B</TD></TR>
<TR><TD>3.721e-02</TD><TD>-3.29</TD><TD>GSE20727_H2O2_VS_ROS_INHIBITOR_TREATED_DC_UP</TD><TD>MSigDB lists</TD><TD>GSE20727_H2O2_VS_ROS_INHIBITOR_TREATED_DC_UP</TD><TD>182</TD><TD>2</TD><TD>17275</TD><TD>29</TD>
<TD>FAM102B,IFIT2</TD></TR>
<TR><TD>3.727e-02</TD><TD>-3.29</TD><TD>-</TD><TD>gene3d domains</TD><TD>3.30.1330.20</TD><TD>19</TD><TD>1</TD><TD>8522</TD><TD>17</TD>
<TD>TUBA1A</TD></TR>
<TR><TD>3.732e-02</TD><TD>-3.29</TD><TD>PABPC4 (poly(A) binding protein cytoplasmic 4)</TD><TD>protein interactions</TD><TD>8761</TD><TD>178</TD><TD>2</TD><TD>17456</TD><TD>30</TD>
<TD>OAS3,IFIT2</TD></TR>
<TR><TD>3.755e-02</TD><TD>-3.28</TD><TD>organelle outer membrane</TD><TD>cellular component</TD><TD>GO:0031968</TD><TD>201</TD><TD>2</TD><TD>18985</TD><TD>29</TD>
<TD>IFI27,RSAD2</TD></TR>
<TR><TD>3.758e-02</TD><TD>-3.28</TD><TD>GSE6674_CPG_VS_CPG_AND_ANTI_IGM_STIM_BCELL_UP</TD><TD>MSigDB lists</TD><TD>GSE6674_CPG_VS_CPG_AND_ANTI_IGM_STIM_BCELL_UP</TD><TD>183</TD><TD>2</TD><TD>17275</TD><TD>29</TD>
<TD>IFIT2,TUBA1A</TD></TR>
<TR><TD>3.758e-02</TD><TD>-3.28</TD><TD>GSE17721_POLYIC_VS_GARDIQUIMOD_4H_BMDC_UP</TD><TD>MSigDB lists</TD><TD>GSE17721_POLYIC_VS_GARDIQUIMOD_4H_BMDC_UP</TD><TD>183</TD><TD>2</TD><TD>17275</TD><TD>29</TD>
<TD>RSAD2,OAS2</TD></TR>
<TR><TD>3.758e-02</TD><TD>-3.28</TD><TD>GSE14308_TH17_VS_NAIVE_CD4_TCELL_UP</TD><TD>MSigDB lists</TD><TD>GSE14308_TH17_VS_NAIVE_CD4_TCELL_UP</TD><TD>183</TD><TD>2</TD><TD>17275</TD><TD>29</TD>
<TD>MCAM,KIFAP3</TD></TR>
<TR><TD>3.758e-02</TD><TD>-3.28</TD><TD>GSE12198_NK_VS_NK_ACT_EXPANSION_SYSTEM_DERIVED_NK_CELL_UP</TD><TD>MSigDB lists</TD><TD>GSE12198_NK_VS_NK_ACT_EXPANSION_SYSTEM_DERIVED_NK_CELL_UP</TD><TD>183</TD><TD>2</TD><TD>17275</TD><TD>29</TD>
<TD>ZNF518B,BCL6B</TD></TR>
<TR><TD>3.758e-02</TD><TD>-3.28</TD><TD>GSE34205_HEALTHY_VS_RSV_INF_INFANT_PBMC_DN</TD><TD>MSigDB lists</TD><TD>GSE34205_HEALTHY_VS_RSV_INF_INFANT_PBMC_DN</TD><TD>183</TD><TD>2</TD><TD>17275</TD><TD>29</TD>
<TD>IFI27,TUBA1A</TD></TR>
<TR><TD>3.758e-02</TD><TD>-3.28</TD><TD>GSE14000_UNSTIM_VS_16H_LPS_DC_DN</TD><TD>MSigDB lists</TD><TD>GSE14000_UNSTIM_VS_16H_LPS_DC_DN</TD><TD>183</TD><TD>2</TD><TD>17275</TD><TD>29</TD>
<TD>IFI44,OAS1</TD></TR>
<TR><TD>3.758e-02</TD><TD>-3.28</TD><TD>GSE22033_UNTREATED_VS_ROSIGLITAZONE_TREATED_MEF_DN</TD><TD>MSigDB lists</TD><TD>GSE22033_UNTREATED_VS_ROSIGLITAZONE_TREATED_MEF_DN</TD><TD>183</TD><TD>2</TD><TD>17275</TD><TD>29</TD>
<TD>IFIT2,IFI44</TD></TR>
<TR><TD>3.758e-02</TD><TD>-3.28</TD><TD>GSE16385_ROSIGLITAZONE_IL4_VS_IL4_ALONE_STIM_MACROPHAGE_12H_UP</TD><TD>MSigDB lists</TD><TD>GSE16385_ROSIGLITAZONE_IL4_VS_IL4_ALONE_STIM_MACROPHAGE_12H_UP</TD><TD>183</TD><TD>2</TD><TD>17275</TD><TD>29</TD>
<TD>IFI44L,OAS1</TD></TR>
<TR><TD>3.758e-02</TD><TD>-3.28</TD><TD>GSE27786_LSK_VS_LIN_NEG_CELL_UP</TD><TD>MSigDB lists</TD><TD>GSE27786_LSK_VS_LIN_NEG_CELL_UP</TD><TD>183</TD><TD>2</TD><TD>17275</TD><TD>29</TD>
<TD>OAS3,RSAD2</TD></TR>
<TR><TD>3.758e-02</TD><TD>-3.28</TD><TD>GSE14908_RESTING_VS_HDM_STIM_CD4_TCELL_ATOPIC_PATIENT_DN</TD><TD>MSigDB lists</TD><TD>GSE14908_RESTING_VS_HDM_STIM_CD4_TCELL_ATOPIC_PATIENT_DN</TD><TD>183</TD><TD>2</TD><TD>17275</TD><TD>29</TD>
<TD>ISG15,MCAM</TD></TR>
<TR><TD>3.758e-02</TD><TD>-3.28</TD><TD>GSE27241_CTRL_VS_DIGOXIN_TREATED_CD4_TCELL_IN_TH17_POLARIZING_CONDITIONS_DN</TD><TD>MSigDB lists</TD><TD>GSE27241_CTRL_VS_DIGOXIN_TREATED_CD4_TCELL_IN_TH17_POLARIZING_CONDITIONS_DN</TD><TD>183</TD><TD>2</TD><TD>17275</TD><TD>29</TD>
<TD>OAS1,RSAD2</TD></TR>
<TR><TD>3.758e-02</TD><TD>-3.28</TD><TD>GSE5455_HEALTHY_VS_TUMOR_BEARING_MOUSE_SPLEEN_MONOCYTE_24H_INCUBATION_DN</TD><TD>MSigDB lists</TD><TD>GSE5455_HEALTHY_VS_TUMOR_BEARING_MOUSE_SPLEEN_MONOCYTE_24H_INCUBATION_DN</TD><TD>183</TD><TD>2</TD><TD>17275</TD><TD>29</TD>
<TD>ZNF518B,OAS1</TD></TR>
<TR><TD>3.758e-02</TD><TD>-3.28</TD><TD>GSE30083_SP2_VS_SP4_THYMOCYTE_DN</TD><TD>MSigDB lists</TD><TD>GSE30083_SP2_VS_SP4_THYMOCYTE_DN</TD><TD>183</TD><TD>2</TD><TD>17275</TD><TD>29</TD>
<TD>OAS1,IFI44</TD></TR>
<TR><TD>3.758e-02</TD><TD>-3.28</TD><TD>GSE43955_TH0_VS_TGFB_IL6_TH17_ACT_CD4_TCELL_42H_UP</TD><TD>MSigDB lists</TD><TD>GSE43955_TH0_VS_TGFB_IL6_TH17_ACT_CD4_TCELL_42H_UP</TD><TD>183</TD><TD>2</TD><TD>17275</TD><TD>29</TD>
<TD>RSAD2,ISG15</TD></TR>
<TR><TD>3.758e-02</TD><TD>-3.28</TD><TD>GSE2405_HEAT_KILLED_VS_LIVE_A_PHAGOCYTOPHILUM_STIM_NEUTROPHIL_9H_UP</TD><TD>MSigDB lists</TD><TD>GSE2405_HEAT_KILLED_VS_LIVE_A_PHAGOCYTOPHILUM_STIM_NEUTROPHIL_9H_UP</TD><TD>183</TD><TD>2</TD><TD>17275</TD><TD>29</TD>
<TD>TUBA1A,IFI27</TD></TR>
<TR><TD>3.758e-02</TD><TD>-3.28</TD><TD>GSE22589_SIV_VS_HIV_AND_SIV_INFECTED_DC_UP</TD><TD>MSigDB lists</TD><TD>GSE22589_SIV_VS_HIV_AND_SIV_INFECTED_DC_UP</TD><TD>183</TD><TD>2</TD><TD>17275</TD><TD>29</TD>
<TD>IFIT2,OASL</TD></TR>
<TR><TD>3.765e-02</TD><TD>-3.28</TD><TD>adrenal_gland</TD><TD>COSMIC cancer mutations</TD><TD>adrenal_gland</TD><TD>2669</TD><TD>8</TD><TD>17255</TD><TD>26</TD>
<TD>BCL6B,OASL,RYR1,KIAA1211,CAPN6,OAS2,MCAM,CAMKK2</TD></TR>
<TR><TD>3.783e-02</TD><TD>-3.27</TD><TD>Regulation of FZD by ubiquitination</TD><TD>REACTOME pathways</TD><TD>R-HSA-4641263</TD><TD>22</TD><TD>1</TD><TD>10287</TD><TD>18</TD>
<TD>LGR4</TD></TR>
<TR><TD>3.787e-02</TD><TD>-3.27</TD><TD>decidualization</TD><TD>biological process</TD><TD>GO:0046697</TD><TD>24</TD><TD>1</TD><TD>18054</TD><TD>29</TD>
<TD>CTSV</TD></TR>
<TR><TD>3.787e-02</TD><TD>-3.27</TD><TD>regulation of cellular response to vascular endothelial growth factor stimulus</TD><TD>biological process</TD><TD>GO:1902547</TD><TD>24</TD><TD>1</TD><TD>18054</TD><TD>29</TD>
<TD>CADM4</TD></TR>
<TR><TD>3.787e-02</TD><TD>-3.27</TD><TD>skeletal muscle fiber development</TD><TD>biological process</TD><TD>GO:0048741</TD><TD>24</TD><TD>1</TD><TD>18054</TD><TD>29</TD>
<TD>RYR1</TD></TR>
<TR><TD>3.793e-02</TD><TD>-3.27</TD><TD>ALONSO_METASTASIS_DN</TD><TD>MSigDB lists</TD><TD>ALONSO_METASTASIS_DN</TD><TD>23</TD><TD>1</TD><TD>17275</TD><TD>29</TD>
<TD>IFI44L</TD></TR>
<TR><TD>3.793e-02</TD><TD>-3.27</TD><TD>GNF2_TTN</TD><TD>MSigDB lists</TD><TD>GNF2_TTN</TD><TD>23</TD><TD>1</TD><TD>17275</TD><TD>29</TD>
<TD>RYR1</TD></TR>
<TR><TD>3.793e-02</TD><TD>-3.27</TD><TD>chr11p14</TD><TD>MSigDB lists</TD><TD>chr11p14</TD><TD>23</TD><TD>1</TD><TD>17275</TD><TD>29</TD>
<TD>LGR4</TD></TR>
<TR><TD>3.793e-02</TD><TD>-3.27</TD><TD>WANG_RESPONSE_TO_FORSKOLIN_UP</TD><TD>MSigDB lists</TD><TD>WANG_RESPONSE_TO_FORSKOLIN_UP</TD><TD>23</TD><TD>1</TD><TD>17275</TD><TD>29</TD>
<TD>CAMKK2</TD></TR>
<TR><TD>3.793e-02</TD><TD>-3.27</TD><TD>GO_HEPARAN_SULFATE_PROTEOGLYCAN_BIOSYNTHETIC_PROCESS</TD><TD>MSigDB lists</TD><TD>GO_HEPARAN_SULFATE_PROTEOGLYCAN_BIOSYNTHETIC_PROCESS</TD><TD>23</TD><TD>1</TD><TD>17275</TD><TD>29</TD>
<TD>HS6ST2</TD></TR>
<TR><TD>3.793e-02</TD><TD>-3.27</TD><TD>GO_MYOTUBE_CELL_DEVELOPMENT</TD><TD>MSigDB lists</TD><TD>GO_MYOTUBE_CELL_DEVELOPMENT</TD><TD>23</TD><TD>1</TD><TD>17275</TD><TD>29</TD>
<TD>RYR1</TD></TR>
<TR><TD>3.793e-02</TD><TD>-3.27</TD><TD>LA_MEN1_TARGETS</TD><TD>MSigDB lists</TD><TD>LA_MEN1_TARGETS</TD><TD>23</TD><TD>1</TD><TD>17275</TD><TD>29</TD>
<TD>BCL6B</TD></TR>
<TR><TD>3.793e-02</TD><TD>-3.27</TD><TD>GO_POSITIVE_REGULATION_OF_ERYTHROCYTE_DIFFERENTIATION</TD><TD>MSigDB lists</TD><TD>GO_POSITIVE_REGULATION_OF_ERYTHROCYTE_DIFFERENTIATION</TD><TD>23</TD><TD>1</TD><TD>17275</TD><TD>29</TD>
<TD>ISG15</TD></TR>
<TR><TD>3.795e-02</TD><TD>-3.27</TD><TD>GSE10240_CTRL_VS_IL22_STIM_PRIMARY_BRONCHIAL_EPITHELIAL_CELLS_UP</TD><TD>MSigDB lists</TD><TD>GSE10240_CTRL_VS_IL22_STIM_PRIMARY_BRONCHIAL_EPITHELIAL_CELLS_UP</TD><TD>184</TD><TD>2</TD><TD>17275</TD><TD>29</TD>
<TD>CAMKK2,RSAD2</TD></TR>
<TR><TD>3.795e-02</TD><TD>-3.27</TD><TD>GSE18893_CTRL_VS_TNF_TREATED_TREG_2H_DN</TD><TD>MSigDB lists</TD><TD>GSE18893_CTRL_VS_TNF_TREATED_TREG_2H_DN</TD><TD>184</TD><TD>2</TD><TD>17275</TD><TD>29</TD>
<TD>KLHDC8B,RSAD2</TD></TR>
<TR><TD>3.795e-02</TD><TD>-3.27</TD><TD>GSE24634_IL4_VS_CTRL_TREATED_NAIVE_CD4_TCELL_DAY3_DN</TD><TD>MSigDB lists</TD><TD>GSE24634_IL4_VS_CTRL_TREATED_NAIVE_CD4_TCELL_DAY3_DN</TD><TD>184</TD><TD>2</TD><TD>17275</TD><TD>29</TD>
<TD>IFI44L,ISG15</TD></TR>
<TR><TD>3.795e-02</TD><TD>-3.27</TD><TD>GSE5589_LPS_VS_LPS_AND_IL10_STIM_IL6_KO_MACROPHAGE_180MIN_UP</TD><TD>MSigDB lists</TD><TD>GSE5589_LPS_VS_LPS_AND_IL10_STIM_IL6_KO_MACROPHAGE_180MIN_UP</TD><TD>184</TD><TD>2</TD><TD>17275</TD><TD>29</TD>
<TD>KIFAP3,IFI27</TD></TR>
<TR><TD>3.795e-02</TD><TD>-3.27</TD><TD>GSE44732_UNSTIM_VS_IL27_STIM_IMATURE_DC_UP</TD><TD>MSigDB lists</TD><TD>GSE44732_UNSTIM_VS_IL27_STIM_IMATURE_DC_UP</TD><TD>184</TD><TD>2</TD><TD>17275</TD><TD>29</TD>
<TD>CAMKK2,RYR1</TD></TR>
<TR><TD>3.795e-02</TD><TD>-3.27</TD><TD>GSE360_T_GONDII_VS_B_MALAYI_LOW_DOSE_DC_UP</TD><TD>MSigDB lists</TD><TD>GSE360_T_GONDII_VS_B_MALAYI_LOW_DOSE_DC_UP</TD><TD>184</TD><TD>2</TD><TD>17275</TD><TD>29</TD>
<TD>RSAD2,IFI44L</TD></TR>
<TR><TD>3.795e-02</TD><TD>-3.27</TD><TD>RAF_UP.V1_UP</TD><TD>MSigDB lists</TD><TD>RAF_UP.V1_UP</TD><TD>184</TD><TD>2</TD><TD>17275</TD><TD>29</TD>
<TD>CAPN6,RSAD2</TD></TR>
<TR><TD>3.795e-02</TD><TD>-3.27</TD><TD>GSE36476_YOUNG_VS_OLD_DONOR_MEMORY_CD4_TCELL_40H_TSST_ACT_UP</TD><TD>MSigDB lists</TD><TD>GSE36476_YOUNG_VS_OLD_DONOR_MEMORY_CD4_TCELL_40H_TSST_ACT_UP</TD><TD>184</TD><TD>2</TD><TD>17275</TD><TD>29</TD>
<TD>OAS2,RSAD2</TD></TR>
<TR><TD>3.795e-02</TD><TD>-3.27</TD><TD>GSE22935_24H_VS_48H_MBOVIS_BCG_STIM_MACROPHAGE_UP</TD><TD>MSigDB lists</TD><TD>GSE22935_24H_VS_48H_MBOVIS_BCG_STIM_MACROPHAGE_UP</TD><TD>184</TD><TD>2</TD><TD>17275</TD><TD>29</TD>
<TD>IFIT2,BCL6B</TD></TR>
<TR><TD>3.795e-02</TD><TD>-3.27</TD><TD>GSE3982_EOSINOPHIL_VS_NKCELL_UP</TD><TD>MSigDB lists</TD><TD>GSE3982_EOSINOPHIL_VS_NKCELL_UP</TD><TD>184</TD><TD>2</TD><TD>17275</TD><TD>29</TD>
<TD>LGR4,RSAD2</TD></TR>
<TR><TD>3.795e-02</TD><TD>-3.27</TD><TD>GSE13411_NAIVE_VS_IGM_MEMORY_BCELL_DN</TD><TD>MSigDB lists</TD><TD>GSE13411_NAIVE_VS_IGM_MEMORY_BCELL_DN</TD><TD>184</TD><TD>2</TD><TD>17275</TD><TD>29</TD>
<TD>ISG15,CAMKK2</TD></TR>
<TR><TD>3.795e-02</TD><TD>-3.27</TD><TD>GSE20198_IL12_VS_IFNA_TREATED_ACT_CD4_TCELL_DN</TD><TD>MSigDB lists</TD><TD>GSE20198_IL12_VS_IFNA_TREATED_ACT_CD4_TCELL_DN</TD><TD>184</TD><TD>2</TD><TD>17275</TD><TD>29</TD>
<TD>RSAD2,KIFAP3</TD></TR>
<TR><TD>3.795e-02</TD><TD>-3.27</TD><TD>GSE22886_NAIVE_CD4_TCELL_VS_NEUTROPHIL_DN</TD><TD>MSigDB lists</TD><TD>GSE22886_NAIVE_CD4_TCELL_VS_NEUTROPHIL_DN</TD><TD>184</TD><TD>2</TD><TD>17275</TD><TD>29</TD>
<TD>RSAD2,TUBA1A</TD></TR>
<TR><TD>3.795e-02</TD><TD>-3.27</TD><TD>GSE557_WT_VS_CIITA_KO_DC_UP</TD><TD>MSigDB lists</TD><TD>GSE557_WT_VS_CIITA_KO_DC_UP</TD><TD>184</TD><TD>2</TD><TD>17275</TD><TD>29</TD>
<TD>IFI27,OAS2</TD></TR>
<TR><TD>3.823e-02</TD><TD>-3.26</TD><TD>LIU_PROSTATE_CANCER_DN</TD><TD>MSigDB lists</TD><TD>LIU_PROSTATE_CANCER_DN</TD><TD>447</TD><TD>3</TD><TD>17275</TD><TD>29</TD>
<TD>TUBA1A,PGF,MCAM</TD></TR>
<TR><TD>3.823e-02</TD><TD>-3.26</TD><TD>outer membrane</TD><TD>cellular component</TD><TD>GO:0019867</TD><TD>203</TD><TD>2</TD><TD>18985</TD><TD>29</TD>
<TD>IFI27,RSAD2</TD></TR>
<TR><TD>3.833e-02</TD><TD>-3.26</TD><TD>GSE30083_SP3_VS_SP4_THYMOCYTE_DN</TD><TD>MSigDB lists</TD><TD>GSE30083_SP3_VS_SP4_THYMOCYTE_DN</TD><TD>185</TD><TD>2</TD><TD>17275</TD><TD>29</TD>
<TD>OAS1,IFI44</TD></TR>
<TR><TD>3.833e-02</TD><TD>-3.26</TD><TD>GSE27786_CD4_TCELL_VS_NKCELL_DN</TD><TD>MSigDB lists</TD><TD>GSE27786_CD4_TCELL_VS_NKCELL_DN</TD><TD>185</TD><TD>2</TD><TD>17275</TD><TD>29</TD>
<TD>OASL,CAMKK2</TD></TR>
<TR><TD>3.833e-02</TD><TD>-3.26</TD><TD>GSE17721_CTRL_VS_LPS_1H_BMDC_DN</TD><TD>MSigDB lists</TD><TD>GSE17721_CTRL_VS_LPS_1H_BMDC_DN</TD><TD>185</TD><TD>2</TD><TD>17275</TD><TD>29</TD>
<TD>PGF,OASL</TD></TR>
<TR><TD>3.833e-02</TD><TD>-3.26</TD><TD>GSE29164_DAY3_VS_DAY7_CD8_TCELL_AND_IL12_TREATED_MELANOMA_UP</TD><TD>MSigDB lists</TD><TD>GSE29164_DAY3_VS_DAY7_CD8_TCELL_AND_IL12_TREATED_MELANOMA_UP</TD><TD>185</TD><TD>2</TD><TD>17275</TD><TD>29</TD>
<TD>OASL,CAMKK2</TD></TR>
<TR><TD>3.833e-02</TD><TD>-3.26</TD><TD>GSE3982_DC_VS_NEUTROPHIL_LPS_STIM_UP</TD><TD>MSigDB lists</TD><TD>GSE3982_DC_VS_NEUTROPHIL_LPS_STIM_UP</TD><TD>185</TD><TD>2</TD><TD>17275</TD><TD>29</TD>
<TD>IFI27,OAS1</TD></TR>
<TR><TD>3.833e-02</TD><TD>-3.26</TD><TD>GSE17721_CTRL_VS_GARDIQUIMOD_12H_BMDC_DN</TD><TD>MSigDB lists</TD><TD>GSE17721_CTRL_VS_GARDIQUIMOD_12H_BMDC_DN</TD><TD>185</TD><TD>2</TD><TD>17275</TD><TD>29</TD>
<TD>OAS2,IFIT2</TD></TR>
<TR><TD>3.833e-02</TD><TD>-3.26</TD><TD>GSE32034_LY6C_HIGH_VS_LOW_MONOCYTE_DN</TD><TD>MSigDB lists</TD><TD>GSE32034_LY6C_HIGH_VS_LOW_MONOCYTE_DN</TD><TD>185</TD><TD>2</TD><TD>17275</TD><TD>29</TD>
<TD>IFIT2,OAS1</TD></TR>
<TR><TD>3.833e-02</TD><TD>-3.26</TD><TD>GSE40666_UNTREATED_VS_IFNA_STIM_STAT4_KO_EFFECTOR_CD8_TCELL_90MIN_UP</TD><TD>MSigDB lists</TD><TD>GSE40666_UNTREATED_VS_IFNA_STIM_STAT4_KO_EFFECTOR_CD8_TCELL_90MIN_UP</TD><TD>185</TD><TD>2</TD><TD>17275</TD><TD>29</TD>
<TD>CAMKK2,OAS1</TD></TR>
<TR><TD>3.833e-02</TD><TD>-3.26</TD><TD>GSE3039_NKT_CELL_VS_ALPHAALPHA_CD8_TCELL_UP</TD><TD>MSigDB lists</TD><TD>GSE3039_NKT_CELL_VS_ALPHAALPHA_CD8_TCELL_UP</TD><TD>185</TD><TD>2</TD><TD>17275</TD><TD>29</TD>
<TD>IFI44L,PGF</TD></TR>
<TR><TD>3.833e-02</TD><TD>-3.26</TD><TD>GSE34179_THPOK_KO_VS_WT_VA14I_NKTCELL_UP</TD><TD>MSigDB lists</TD><TD>GSE34179_THPOK_KO_VS_WT_VA14I_NKTCELL_UP</TD><TD>185</TD><TD>2</TD><TD>17275</TD><TD>29</TD>
<TD>LGR4,IFI44</TD></TR>
<TR><TD>3.833e-02</TD><TD>-3.26</TD><TD>BILD_MYC_ONCOGENIC_SIGNATURE</TD><TD>MSigDB lists</TD><TD>BILD_MYC_ONCOGENIC_SIGNATURE</TD><TD>185</TD><TD>2</TD><TD>17275</TD><TD>29</TD>
<TD>TUBA1A,HS6ST2</TD></TR>
<TR><TD>3.833e-02</TD><TD>-3.26</TD><TD>GSE2770_IL12_VS_TGFB_AND_IL12_TREATED_ACT_CD4_TCELL_6H_DN</TD><TD>MSigDB lists</TD><TD>GSE2770_IL12_VS_TGFB_AND_IL12_TREATED_ACT_CD4_TCELL_6H_DN</TD><TD>185</TD><TD>2</TD><TD>17275</TD><TD>29</TD>
<TD>OASL,OAS1</TD></TR>
<TR><TD>3.833e-02</TD><TD>-3.26</TD><TD>GSE3982_EOSINOPHIL_VS_EFF_MEMORY_CD4_TCELL_UP</TD><TD>MSigDB lists</TD><TD>GSE3982_EOSINOPHIL_VS_EFF_MEMORY_CD4_TCELL_UP</TD><TD>185</TD><TD>2</TD><TD>17275</TD><TD>29</TD>
<TD>ISG15,CAMKK2</TD></TR>
<TR><TD>3.833e-02</TD><TD>-3.26</TD><TD>GSE46606_IRF4HIGH_VS_IRF4MID_CD40L_IL2_IL5_DAY1_STIMULATED_BCELL_DN</TD><TD>MSigDB lists</TD><TD>GSE46606_IRF4HIGH_VS_IRF4MID_CD40L_IL2_IL5_DAY1_STIMULATED_BCELL_DN</TD><TD>185</TD><TD>2</TD><TD>17275</TD><TD>29</TD>
<TD>ISG15,OAS1</TD></TR>
<TR><TD>3.833e-02</TD><TD>-3.26</TD><TD>GSE41867_MEMORY_VS_EXHAUSTED_CD8_TCELL_DAY30_LCMV_UP</TD><TD>MSigDB lists</TD><TD>GSE41867_MEMORY_VS_EXHAUSTED_CD8_TCELL_DAY30_LCMV_UP</TD><TD>185</TD><TD>2</TD><TD>17275</TD><TD>29</TD>
<TD>OAS3,IFIT2</TD></TR>
<TR><TD>3.833e-02</TD><TD>-3.26</TD><TD>GSE33162_HDAC3_KO_VS_HDAC3_KO_MACROPHAGE_UP</TD><TD>MSigDB lists</TD><TD>GSE33162_HDAC3_KO_VS_HDAC3_KO_MACROPHAGE_UP</TD><TD>185</TD><TD>2</TD><TD>17275</TD><TD>29</TD>
<TD>OAS1,OAS3</TD></TR>
<TR><TD>3.833e-02</TD><TD>-3.26</TD><TD>GSE19888_ADENOSINE_A3R_ACT_VS_A3R_ACT_WITH_A3R_INH_PRETREATMENT_IN_MAST_CELL_DN</TD><TD>MSigDB lists</TD><TD>GSE19888_ADENOSINE_A3R_ACT_VS_A3R_ACT_WITH_A3R_INH_PRETREATMENT_IN_MAST_CELL_DN</TD><TD>185</TD><TD>2</TD><TD>17275</TD><TD>29</TD>
<TD>ISG15,RSAD2</TD></TR>
<TR><TD>3.833e-02</TD><TD>-3.26</TD><TD>GSE11961_MARGINAL_ZONE_BCELL_VS_MEMORY_BCELL_DAY40_UP</TD><TD>MSigDB lists</TD><TD>GSE11961_MARGINAL_ZONE_BCELL_VS_MEMORY_BCELL_DAY40_UP</TD><TD>185</TD><TD>2</TD><TD>17275</TD><TD>29</TD>
<TD>KIFAP3,RSAD2</TD></TR>
<TR><TD>3.833e-02</TD><TD>-3.26</TD><TD>GSE19941_UNSTIM_VS_LPS_STIM_IL10_KO_MACROPHAGE_DN</TD><TD>MSigDB lists</TD><TD>GSE19941_UNSTIM_VS_LPS_STIM_IL10_KO_MACROPHAGE_DN</TD><TD>185</TD><TD>2</TD><TD>17275</TD><TD>29</TD>
<TD>IFI44L,IFIT2</TD></TR>
<TR><TD>3.833e-02</TD><TD>-3.26</TD><TD>GSE17721_LPS_VS_GARDIQUIMOD_12H_BMDC_UP</TD><TD>MSigDB lists</TD><TD>GSE17721_LPS_VS_GARDIQUIMOD_12H_BMDC_UP</TD><TD>185</TD><TD>2</TD><TD>17275</TD><TD>29</TD>
<TD>OAS1,IFIT2</TD></TR>
<TR><TD>3.833e-02</TD><TD>-3.26</TD><TD>GSE30083_SP3_VS_SP4_THYMOCYTE_UP</TD><TD>MSigDB lists</TD><TD>GSE30083_SP3_VS_SP4_THYMOCYTE_UP</TD><TD>185</TD><TD>2</TD><TD>17275</TD><TD>29</TD>
<TD>TUBA1A,MCAM</TD></TR>
<TR><TD>3.833e-02</TD><TD>-3.26</TD><TD>GSE21380_NON_TFH_VS_TFH_CD4_TCELL_UP</TD><TD>MSigDB lists</TD><TD>GSE21380_NON_TFH_VS_TFH_CD4_TCELL_UP</TD><TD>185</TD><TD>2</TD><TD>17275</TD><TD>29</TD>
<TD>OAS1,IFI44</TD></TR>
<TR><TD>3.833e-02</TD><TD>-3.26</TD><TD>GSE4535_BM_DERIVED_DC_VS_FOLLICULAR_DC_UP</TD><TD>MSigDB lists</TD><TD>GSE4535_BM_DERIVED_DC_VS_FOLLICULAR_DC_UP</TD><TD>185</TD><TD>2</TD><TD>17275</TD><TD>29</TD>
<TD>OAS1,ZNF518B</TD></TR>
<TR><TD>3.833e-02</TD><TD>-3.26</TD><TD>GSE21546_WT_VS_ELK1_KO_DP_THYMOCYTES_UP</TD><TD>MSigDB lists</TD><TD>GSE21546_WT_VS_ELK1_KO_DP_THYMOCYTES_UP</TD><TD>185</TD><TD>2</TD><TD>17275</TD><TD>29</TD>
<TD>RSAD2,OAS2</TD></TR>
<TR><TD>3.857e-02</TD><TD>-3.26</TD><TD>negative regulation of protein transport</TD><TD>biological process</TD><TD>GO:0051224</TD><TD>194</TD><TD>2</TD><TD>18054</TD><TD>29</TD>
<TD>RSAD2,LGR4</TD></TR>
<TR><TD>3.871e-02</TD><TD>-3.25</TD><TD>GSE26156_DOUBLE_POSITIVE_VS_CD4_SINGLE_POSITIVE_THYMOCYTE_UP</TD><TD>MSigDB lists</TD><TD>GSE26156_DOUBLE_POSITIVE_VS_CD4_SINGLE_POSITIVE_THYMOCYTE_UP</TD><TD>186</TD><TD>2</TD><TD>17275</TD><TD>29</TD>
<TD>TUBA1A,IFI44</TD></TR>
<TR><TD>3.871e-02</TD><TD>-3.25</TD><TD>GSE9960_GRAM_POS_VS_GRAM_NEG_AND_POS_SEPSIS_PBMC_UP</TD><TD>MSigDB lists</TD><TD>GSE9960_GRAM_POS_VS_GRAM_NEG_AND_POS_SEPSIS_PBMC_UP</TD><TD>186</TD><TD>2</TD><TD>17275</TD><TD>29</TD>
<TD>IFIT2,IFI27</TD></TR>
<TR><TD>3.871e-02</TD><TD>-3.25</TD><TD>GSE30083_SP1_VS_SP4_THYMOCYTE_UP</TD><TD>MSigDB lists</TD><TD>GSE30083_SP1_VS_SP4_THYMOCYTE_UP</TD><TD>186</TD><TD>2</TD><TD>17275</TD><TD>29</TD>
<TD>TUBA1A,MCAM</TD></TR>
<TR><TD>3.871e-02</TD><TD>-3.25</TD><TD>GSE40184_HEALTHY_VS_HCV_INFECTED_DONOR_PBMC_UP</TD><TD>MSigDB lists</TD><TD>GSE40184_HEALTHY_VS_HCV_INFECTED_DONOR_PBMC_UP</TD><TD>186</TD><TD>2</TD><TD>17275</TD><TD>29</TD>
<TD>ZNF518B,CAPN6</TD></TR>
<TR><TD>3.871e-02</TD><TD>-3.25</TD><TD>GSE5542_IFNG_VS_IFNA_AND_IFNG_TREATED_EPITHELIAL_CELLS_24H_DN</TD><TD>MSigDB lists</TD><TD>GSE5542_IFNG_VS_IFNA_AND_IFNG_TREATED_EPITHELIAL_CELLS_24H_DN</TD><TD>186</TD><TD>2</TD><TD>17275</TD><TD>29</TD>
<TD>PGF,KIFAP3</TD></TR>
<TR><TD>3.871e-02</TD><TD>-3.25</TD><TD>GSE46606_UNSTIM_VS_CD40L_IL2_IL5_3DAY_STIMULATED_IRF4MID_SORTED_BCELL_DN</TD><TD>MSigDB lists</TD><TD>GSE46606_UNSTIM_VS_CD40L_IL2_IL5_3DAY_STIMULATED_IRF4MID_SORTED_BCELL_DN</TD><TD>186</TD><TD>2</TD><TD>17275</TD><TD>29</TD>
<TD>OAS1,ISG15</TD></TR>
<TR><TD>3.871e-02</TD><TD>-3.25</TD><TD>GSE46606_IRF4HIGH_VS_IRF4MID_CD40L_IL2_IL5_DAY3_STIMULATED_BCELL_DN</TD><TD>MSigDB lists</TD><TD>GSE46606_IRF4HIGH_VS_IRF4MID_CD40L_IL2_IL5_DAY3_STIMULATED_BCELL_DN</TD><TD>186</TD><TD>2</TD><TD>17275</TD><TD>29</TD>
<TD>MGAT3,OAS1</TD></TR>
<TR><TD>3.871e-02</TD><TD>-3.25</TD><TD>GSE23505_UNTREATED_VS_4DAY_IL6_IL1_TGFB_TREATED_CD4_TCELL_DN</TD><TD>MSigDB lists</TD><TD>GSE23505_UNTREATED_VS_4DAY_IL6_IL1_TGFB_TREATED_CD4_TCELL_DN</TD><TD>186</TD><TD>2</TD><TD>17275</TD><TD>29</TD>
<TD>RSAD2,OAS1</TD></TR>
<TR><TD>3.871e-02</TD><TD>-3.25</TD><TD>GSE17721_0.5H_VS_4H_POLYIC_BMDC_DN</TD><TD>MSigDB lists</TD><TD>GSE17721_0.5H_VS_4H_POLYIC_BMDC_DN</TD><TD>186</TD><TD>2</TD><TD>17275</TD><TD>29</TD>
<TD>RSAD2,OAS2</TD></TR>
<TR><TD>3.871e-02</TD><TD>-3.25</TD><TD>GSE9037_CTRL_VS_LPS_1H_STIM_IRAK4_KO_BMDM_DN</TD><TD>MSigDB lists</TD><TD>GSE9037_CTRL_VS_LPS_1H_STIM_IRAK4_KO_BMDM_DN</TD><TD>186</TD><TD>2</TD><TD>17275</TD><TD>29</TD>
<TD>OAS3,IFI44L</TD></TR>
<TR><TD>3.871e-02</TD><TD>-3.25</TD><TD>GSE25123_WT_VS_PPARG_KO_MACROPHAGE_ROSIGLITAZONE_STIM_UP</TD><TD>MSigDB lists</TD><TD>GSE25123_WT_VS_PPARG_KO_MACROPHAGE_ROSIGLITAZONE_STIM_UP</TD><TD>186</TD><TD>2</TD><TD>17275</TD><TD>29</TD>
<TD>KIFAP3,RYR1</TD></TR>
<TR><TD>3.871e-02</TD><TD>-3.25</TD><TD>GSE3203_INFLUENZA_INF_VS_IFNB_TREATED_LN_BCELL_UP</TD><TD>MSigDB lists</TD><TD>GSE3203_INFLUENZA_INF_VS_IFNB_TREATED_LN_BCELL_UP</TD><TD>186</TD><TD>2</TD><TD>17275</TD><TD>29</TD>
<TD>KIAA1211,KIFAP3</TD></TR>
<TR><TD>3.871e-02</TD><TD>-3.25</TD><TD>GSE19401_NAIVE_VS_IMMUNIZED_MOUSE_PLN_FOLLICULAR_DC_UP</TD><TD>MSigDB lists</TD><TD>GSE19401_NAIVE_VS_IMMUNIZED_MOUSE_PLN_FOLLICULAR_DC_UP</TD><TD>186</TD><TD>2</TD><TD>17275</TD><TD>29</TD>
<TD>IFI44,OASL</TD></TR>
<TR><TD>3.871e-02</TD><TD>-3.25</TD><TD>GSE2405_S_AUREUS_VS_A_PHAGOCYTOPHILUM_NEUTROPHIL_UP</TD><TD>MSigDB lists</TD><TD>GSE2405_S_AUREUS_VS_A_PHAGOCYTOPHILUM_NEUTROPHIL_UP</TD><TD>186</TD><TD>2</TD><TD>17275</TD><TD>29</TD>
<TD>OASL,RSAD2</TD></TR>
<TR><TD>3.881e-02</TD><TD>-3.25</TD><TD>OTUD7B (OTU deubiquitinase 7B)</TD><TD>protein interactions</TD><TD>56957</TD><TD>23</TD><TD>1</TD><TD>17456</TD><TD>30</TD>
<TD>LGR4</TD></TR>
<TR><TD>3.881e-02</TD><TD>-3.25</TD><TD>IQGAP2 (IQ motif containing GTPase activating protein 2)</TD><TD>protein interactions</TD><TD>10788</TD><TD>23</TD><TD>1</TD><TD>17456</TD><TD>30</TD>
<TD>CAMKK2</TD></TR>
<TR><TD>3.881e-02</TD><TD>-3.25</TD><TD>LAMA4 (laminin subunit alpha 4)</TD><TD>protein interactions</TD><TD>3910</TD><TD>23</TD><TD>1</TD><TD>17456</TD><TD>30</TD>
<TD>MCAM</TD></TR>
<TR><TD>3.881e-02</TD><TD>-3.25</TD><TD>SDC3 (syndecan 3)</TD><TD>protein interactions</TD><TD>9672</TD><TD>23</TD><TD>1</TD><TD>17456</TD><TD>30</TD>
<TD>TUBA1A</TD></TR>
<TR><TD>3.881e-02</TD><TD>-3.25</TD><TD>GAP43 (growth associated protein 43)</TD><TD>protein interactions</TD><TD>2596</TD><TD>23</TD><TD>1</TD><TD>17456</TD><TD>30</TD>
<TD>KIFAP3</TD></TR>
<TR><TD>3.881e-02</TD><TD>-3.25</TD><TD>drug binding</TD><TD>molecular function</TD><TD>GO:0008144</TD><TD>1721</TD><TD>6</TD><TD>17306</TD><TD>26</TD>
<TD>RYR1,CAMKK2,OAS3,OAS1,OASL,OAS2</TD></TR>
<TR><TD>3.908e-02</TD><TD>-3.24</TD><TD>GSE32986_CURDLAN_LOWDOSE_VS_CURDLAN_HIGHDOSE_STIM_DC_DN</TD><TD>MSigDB lists</TD><TD>GSE32986_CURDLAN_LOWDOSE_VS_CURDLAN_HIGHDOSE_STIM_DC_DN</TD><TD>187</TD><TD>2</TD><TD>17275</TD><TD>29</TD>
<TD>RSAD2,IFIT2</TD></TR>
<TR><TD>3.908e-02</TD><TD>-3.24</TD><TD>GSE29949_MICROGLIA_BRAIN_VS_MONOCYTE_BONE_MARROW_DN</TD><TD>MSigDB lists</TD><TD>GSE29949_MICROGLIA_BRAIN_VS_MONOCYTE_BONE_MARROW_DN</TD><TD>187</TD><TD>2</TD><TD>17275</TD><TD>29</TD>
<TD>ISG15,IFI44</TD></TR>
<TR><TD>3.908e-02</TD><TD>-3.24</TD><TD>GSE1460_CD4_THYMOCYTE_VS_NAIVE_CD4_TCELL_ADULT_BLOOD_UP</TD><TD>MSigDB lists</TD><TD>GSE1460_CD4_THYMOCYTE_VS_NAIVE_CD4_TCELL_ADULT_BLOOD_UP</TD><TD>187</TD><TD>2</TD><TD>17275</TD><TD>29</TD>
<TD>IFI44L,RSAD2</TD></TR>
<TR><TD>3.908e-02</TD><TD>-3.24</TD><TD>GSE360_L_DONOVANI_VS_T_GONDII_DC_DN</TD><TD>MSigDB lists</TD><TD>GSE360_L_DONOVANI_VS_T_GONDII_DC_DN</TD><TD>187</TD><TD>2</TD><TD>17275</TD><TD>29</TD>
<TD>OASL,IFI44</TD></TR>
<TR><TD>3.908e-02</TD><TD>-3.24</TD><TD>GSE360_DC_VS_MAC_M_TUBERCULOSIS_UP</TD><TD>MSigDB lists</TD><TD>GSE360_DC_VS_MAC_M_TUBERCULOSIS_UP</TD><TD>187</TD><TD>2</TD><TD>17275</TD><TD>29</TD>
<TD>OASL,OAS2</TD></TR>
<TR><TD>3.908e-02</TD><TD>-3.24</TD><TD>GSE17721_PAM3CSK4_VS_GADIQUIMOD_4H_BMDC_DN</TD><TD>MSigDB lists</TD><TD>GSE17721_PAM3CSK4_VS_GADIQUIMOD_4H_BMDC_DN</TD><TD>187</TD><TD>2</TD><TD>17275</TD><TD>29</TD>
<TD>ISG15,OAS3</TD></TR>
<TR><TD>3.908e-02</TD><TD>-3.24</TD><TD>GSE36078_UNTREATED_VS_AD5_INF_MOUSE_LUNG_DC_UP</TD><TD>MSigDB lists</TD><TD>GSE36078_UNTREATED_VS_AD5_INF_MOUSE_LUNG_DC_UP</TD><TD>187</TD><TD>2</TD><TD>17275</TD><TD>29</TD>
<TD>DIRAS1,RYR1</TD></TR>
<TR><TD>3.908e-02</TD><TD>-3.24</TD><TD>GSE17721_LPS_VS_POLYIC_8H_BMDC_DN</TD><TD>MSigDB lists</TD><TD>GSE17721_LPS_VS_POLYIC_8H_BMDC_DN</TD><TD>187</TD><TD>2</TD><TD>17275</TD><TD>29</TD>
<TD>ISG15,OAS2</TD></TR>
<TR><TD>3.908e-02</TD><TD>-3.24</TD><TD>GSE10239_NAIVE_VS_MEMORY_CD8_TCELL_UP</TD><TD>MSigDB lists</TD><TD>GSE10239_NAIVE_VS_MEMORY_CD8_TCELL_UP</TD><TD>187</TD><TD>2</TD><TD>17275</TD><TD>29</TD>
<TD>CAMKK2,RSAD2</TD></TR>
<TR><TD>3.908e-02</TD><TD>-3.24</TD><TD>GSE24814_STAT5_KO_VS_WT_PRE_BCELL_UP</TD><TD>MSigDB lists</TD><TD>GSE24814_STAT5_KO_VS_WT_PRE_BCELL_UP</TD><TD>187</TD><TD>2</TD><TD>17275</TD><TD>29</TD>
<TD>CADM4,MCAM</TD></TR>
<TR><TD>3.908e-02</TD><TD>-3.24</TD><TD>GSE5589_IL6_KO_VS_IL10_KO_LPS_AND_IL10_STIM_MACROPHAGE_45MIN_UP</TD><TD>MSigDB lists</TD><TD>GSE5589_IL6_KO_VS_IL10_KO_LPS_AND_IL10_STIM_MACROPHAGE_45MIN_UP</TD><TD>187</TD><TD>2</TD><TD>17275</TD><TD>29</TD>
<TD>CAPN6,RYR1</TD></TR>
<TR><TD>3.908e-02</TD><TD>-3.24</TD><TD>GSE7852_LN_VS_THYMUS_TCONV_UP</TD><TD>MSigDB lists</TD><TD>GSE7852_LN_VS_THYMUS_TCONV_UP</TD><TD>187</TD><TD>2</TD><TD>17275</TD><TD>29</TD>
<TD>LGR4,OAS1</TD></TR>
<TR><TD>3.908e-02</TD><TD>-3.24</TD><TD>GSE10240_IL17_VS_IL17_AND_IL22_STIM_PRIMARY_BRONCHIAL_EPITHELIAL_CELLS_DN</TD><TD>MSigDB lists</TD><TD>GSE10240_IL17_VS_IL17_AND_IL22_STIM_PRIMARY_BRONCHIAL_EPITHELIAL_CELLS_DN</TD><TD>187</TD><TD>2</TD><TD>17275</TD><TD>29</TD>
<TD>RYR1,RSAD2</TD></TR>
<TR><TD>3.908e-02</TD><TD>-3.24</TD><TD>GSE22886_DAY1_VS_DAY7_MONOCYTE_IN_CULTURE_UP</TD><TD>MSigDB lists</TD><TD>GSE22886_DAY1_VS_DAY7_MONOCYTE_IN_CULTURE_UP</TD><TD>187</TD><TD>2</TD><TD>17275</TD><TD>29</TD>
<TD>OASL,RSAD2</TD></TR>
<TR><TD>3.908e-02</TD><TD>-3.24</TD><TD>GSE45382_UNTREATED_VS_TGFB_TREATED_MACROPHAGES_UP</TD><TD>MSigDB lists</TD><TD>GSE45382_UNTREATED_VS_TGFB_TREATED_MACROPHAGES_UP</TD><TD>187</TD><TD>2</TD><TD>17275</TD><TD>29</TD>
<TD>OAS2,IFI44</TD></TR>
<TR><TD>3.908e-02</TD><TD>-3.24</TD><TD>GSE40225_WT_VS_RIP_B7X_DIABETIC_MOUSE_PANCREATIC_CD8_TCELL_DN</TD><TD>MSigDB lists</TD><TD>GSE40225_WT_VS_RIP_B7X_DIABETIC_MOUSE_PANCREATIC_CD8_TCELL_DN</TD><TD>187</TD><TD>2</TD><TD>17275</TD><TD>29</TD>
<TD>CAMKK2,OAS1</TD></TR>
<TR><TD>3.908e-02</TD><TD>-3.24</TD><TD>GSE5589_WT_VS_IL6_KO_LPS_AND_IL6_STIM_MACROPHAGE_45MIN_UP</TD><TD>MSigDB lists</TD><TD>GSE5589_WT_VS_IL6_KO_LPS_AND_IL6_STIM_MACROPHAGE_45MIN_UP</TD><TD>187</TD><TD>2</TD><TD>17275</TD><TD>29</TD>
<TD>BCL6B,RYR1</TD></TR>
<TR><TD>3.908e-02</TD><TD>-3.24</TD><TD>GSE23568_CTRL_TRANSDUCED_VS_WT_CD8_TCELL_DN</TD><TD>MSigDB lists</TD><TD>GSE23568_CTRL_TRANSDUCED_VS_WT_CD8_TCELL_DN</TD><TD>187</TD><TD>2</TD><TD>17275</TD><TD>29</TD>
<TD>ISG15,TUBA1A</TD></TR>
<TR><TD>3.908e-02</TD><TD>-3.24</TD><TD>GSE17721_POLYIC_VS_PAM3CSK4_1H_BMDC_UP</TD><TD>MSigDB lists</TD><TD>GSE17721_POLYIC_VS_PAM3CSK4_1H_BMDC_UP</TD><TD>187</TD><TD>2</TD><TD>17275</TD><TD>29</TD>
<TD>CAPN6,OAS2</TD></TR>
<TR><TD>3.939e-02</TD><TD>-3.23</TD><TD>Tubulin_C</TD><TD>smart domains</TD><TD>SM00865</TD><TD>20</TD><TD>1</TD><TD>9476</TD><TD>19</TD>
<TD>TUBA1A</TD></TR>
<TR><TD>3.942e-02</TD><TD>-3.23</TD><TD>regulation of mesonephros development</TD><TD>biological process</TD><TD>GO:0061217</TD><TD>25</TD><TD>1</TD><TD>18054</TD><TD>29</TD>
<TD>LGR4</TD></TR>
<TR><TD>3.942e-02</TD><TD>-3.23</TD><TD>glucosamine-containing compound metabolic process</TD><TD>biological process</TD><TD>GO:1901071</TD><TD>25</TD><TD>1</TD><TD>18054</TD><TD>29</TD>
<TD>MGAT3</TD></TR>
<TR><TD>3.942e-02</TD><TD>-3.23</TD><TD>positive regulation of positive chemotaxis</TD><TD>biological process</TD><TD>GO:0050927</TD><TD>25</TD><TD>1</TD><TD>18054</TD><TD>29</TD>
<TD>PGF</TD></TR>
<TR><TD>3.946e-02</TD><TD>-3.23</TD><TD>GSE40274_FOXP3_VS_FOXP3_AND_PBX1_TRANSDUCED_ACTIVATED_CD4_TCELL_DN</TD><TD>MSigDB lists</TD><TD>GSE40274_FOXP3_VS_FOXP3_AND_PBX1_TRANSDUCED_ACTIVATED_CD4_TCELL_DN</TD><TD>188</TD><TD>2</TD><TD>17275</TD><TD>29</TD>
<TD>IFI44L,IFI44</TD></TR>
<TR><TD>3.946e-02</TD><TD>-3.23</TD><TD>GSE28726_ACT_CD4_TCELL_VS_ACT_VA24NEG_NKTCELL_DN</TD><TD>MSigDB lists</TD><TD>GSE28726_ACT_CD4_TCELL_VS_ACT_VA24NEG_NKTCELL_DN</TD><TD>188</TD><TD>2</TD><TD>17275</TD><TD>29</TD>
<TD>TUBA1A,IFI44</TD></TR>
<TR><TD>3.946e-02</TD><TD>-3.23</TD><TD>GSE41176_UNSTIM_VS_ANTI_IGM_STIM_BCELL_1H_DN</TD><TD>MSigDB lists</TD><TD>GSE41176_UNSTIM_VS_ANTI_IGM_STIM_BCELL_1H_DN</TD><TD>188</TD><TD>2</TD><TD>17275</TD><TD>29</TD>
<TD>OAS1,IFIT2</TD></TR>
<TR><TD>3.946e-02</TD><TD>-3.23</TD><TD>GSE5455_EX_VIVO_VS_POST_24H_INCUBATION_MONOCYTES_FROM_TUMOR_BEARING_MOUSE_DN</TD><TD>MSigDB lists</TD><TD>GSE5455_EX_VIVO_VS_POST_24H_INCUBATION_MONOCYTES_FROM_TUMOR_BEARING_MOUSE_DN</TD><TD>188</TD><TD>2</TD><TD>17275</TD><TD>29</TD>
<TD>OAS2,RYR1</TD></TR>
<TR><TD>3.946e-02</TD><TD>-3.23</TD><TD>GSE39110_UNTREATED_VS_IL2_TREATED_CD8_TCELL_DAY6_POST_IMMUNIZATION_DN</TD><TD>MSigDB lists</TD><TD>GSE39110_UNTREATED_VS_IL2_TREATED_CD8_TCELL_DAY6_POST_IMMUNIZATION_DN</TD><TD>188</TD><TD>2</TD><TD>17275</TD><TD>29</TD>
<TD>TUBA1A,ZNF518B</TD></TR>
<TR><TD>3.946e-02</TD><TD>-3.23</TD><TD>GSE2405_0H_VS_12H_A_PHAGOCYTOPHILUM_STIM_NEUTROPHIL_UP</TD><TD>MSigDB lists</TD><TD>GSE2405_0H_VS_12H_A_PHAGOCYTOPHILUM_STIM_NEUTROPHIL_UP</TD><TD>188</TD><TD>2</TD><TD>17275</TD><TD>29</TD>
<TD>OASL,RSAD2</TD></TR>
<TR><TD>3.946e-02</TD><TD>-3.23</TD><TD>GSE31082_DP_VS_CD8_SP_THYMOCYTE_DN</TD><TD>MSigDB lists</TD><TD>GSE31082_DP_VS_CD8_SP_THYMOCYTE_DN</TD><TD>188</TD><TD>2</TD><TD>17275</TD><TD>29</TD>
<TD>OAS2,IFI27</TD></TR>
<TR><TD>3.946e-02</TD><TD>-3.23</TD><TD>GSE31082_DN_VS_CD4_SP_THYMOCYTE_DN</TD><TD>MSigDB lists</TD><TD>GSE31082_DN_VS_CD4_SP_THYMOCYTE_DN</TD><TD>188</TD><TD>2</TD><TD>17275</TD><TD>29</TD>
<TD>OAS3,KLHDC8B</TD></TR>
<TR><TD>3.946e-02</TD><TD>-3.23</TD><TD>GSE17301_ACD3_ACD28_VS_ACD3_ACD28_AND_IFNA5_STIM_CD8_TCELL_DN</TD><TD>MSigDB lists</TD><TD>GSE17301_ACD3_ACD28_VS_ACD3_ACD28_AND_IFNA5_STIM_CD8_TCELL_DN</TD><TD>188</TD><TD>2</TD><TD>17275</TD><TD>29</TD>
<TD>IFI27,IFI44L</TD></TR>
<TR><TD>3.946e-02</TD><TD>-3.23</TD><TD>GSE29618_PDC_VS_MDC_DAY7_FLU_VACCINE_DN</TD><TD>MSigDB lists</TD><TD>GSE29618_PDC_VS_MDC_DAY7_FLU_VACCINE_DN</TD><TD>188</TD><TD>2</TD><TD>17275</TD><TD>29</TD>
<TD>OAS3,TUBA1A</TD></TR>
<TR><TD>3.946e-02</TD><TD>-3.23</TD><TD>GSE15139_GMCSF_TREATED_VS_UNTREATED_NEUTROPHILS_DN</TD><TD>MSigDB lists</TD><TD>GSE15139_GMCSF_TREATED_VS_UNTREATED_NEUTROPHILS_DN</TD><TD>188</TD><TD>2</TD><TD>17275</TD><TD>29</TD>
<TD>OAS1,KIFAP3</TD></TR>
<TR><TD>3.946e-02</TD><TD>-3.23</TD><TD>GSE39556_CD8A_DC_VS_NK_CELL_MOUSE_3H_POST_POLYIC_INJ_DN</TD><TD>MSigDB lists</TD><TD>GSE39556_CD8A_DC_VS_NK_CELL_MOUSE_3H_POST_POLYIC_INJ_DN</TD><TD>188</TD><TD>2</TD><TD>17275</TD><TD>29</TD>
<TD>OAS1,OAS2</TD></TR>
<TR><TD>3.946e-02</TD><TD>-3.23</TD><TD>GSE44732_UNSTIM_VS_IL27_STIM_IMATURE_DC_DN</TD><TD>MSigDB lists</TD><TD>GSE44732_UNSTIM_VS_IL27_STIM_IMATURE_DC_DN</TD><TD>188</TD><TD>2</TD><TD>17275</TD><TD>29</TD>
<TD>OAS1,IFIT2</TD></TR>
<TR><TD>3.946e-02</TD><TD>-3.23</TD><TD>GSE21774_CD62L_POS_CD56_DIM_VS_CD62L_NEG_CD56_DIM_NK_CELL_UP</TD><TD>MSigDB lists</TD><TD>GSE21774_CD62L_POS_CD56_DIM_VS_CD62L_NEG_CD56_DIM_NK_CELL_UP</TD><TD>188</TD><TD>2</TD><TD>17275</TD><TD>29</TD>
<TD>OAS1,IFI44</TD></TR>
<TR><TD>3.951e-02</TD><TD>-3.23</TD><TD>Glycosaminoglycan biosynthesis - heparan sulfate / heparin</TD><TD>KEGG pathways</TD><TD>ko00534</TD><TD>24</TD><TD>1</TD><TD>7161</TD><TD>12</TD>
<TD>HS6ST2</TD></TR>
<TR><TD>3.951e-02</TD><TD>-3.23</TD><TD>Glycosaminoglycan biosynthesis - heparan sulfate / heparin</TD><TD>KEGG pathways</TD><TD>hsa00534</TD><TD>24</TD><TD>1</TD><TD>7161</TD><TD>12</TD>
<TD>HS6ST2</TD></TR>
<TR><TD>3.952e-02</TD><TD>-3.23</TD><TD>Post-chaperonin tubulin folding pathway</TD><TD>REACTOME pathways</TD><TD>R-HSA-389977</TD><TD>23</TD><TD>1</TD><TD>10287</TD><TD>18</TD>
<TD>TUBA1A</TD></TR>
<TR><TD>3.952e-02</TD><TD>-3.23</TD><TD>LRRNT</TD><TD>pfam domains</TD><TD>PF01462</TD><TD>25</TD><TD>1</TD><TD>17385</TD><TD>28</TD>
<TD>LGR4</TD></TR>
<TR><TD>3.955e-02</TD><TD>-3.23</TD><TD>GO_MITOGEN_ACTIVATED_PROTEIN_KINASE_BINDING</TD><TD>MSigDB lists</TD><TD>GO_MITOGEN_ACTIVATED_PROTEIN_KINASE_BINDING</TD><TD>24</TD><TD>1</TD><TD>17275</TD><TD>29</TD>
<TD>DIRAS1</TD></TR>
<TR><TD>3.955e-02</TD><TD>-3.23</TD><TD>YAN_ESCAPE_FROM_ANOIKIS</TD><TD>MSigDB lists</TD><TD>YAN_ESCAPE_FROM_ANOIKIS</TD><TD>24</TD><TD>1</TD><TD>17275</TD><TD>29</TD>
<TD>RSAD2</TD></TR>
<TR><TD>3.955e-02</TD><TD>-3.23</TD><TD>REACTOME_KINESINS</TD><TD>MSigDB lists</TD><TD>REACTOME_KINESINS</TD><TD>24</TD><TD>1</TD><TD>17275</TD><TD>29</TD>
<TD>KIFAP3</TD></TR>
<TR><TD>3.955e-02</TD><TD>-3.23</TD><TD>NOJIMA_SFRP2_TARGETS_DN</TD><TD>MSigDB lists</TD><TD>NOJIMA_SFRP2_TARGETS_DN</TD><TD>24</TD><TD>1</TD><TD>17275</TD><TD>29</TD>
<TD>IFI44</TD></TR>
<TR><TD>3.955e-02</TD><TD>-3.23</TD><TD>STEGER_ADIPOGENESIS_DN</TD><TD>MSigDB lists</TD><TD>STEGER_ADIPOGENESIS_DN</TD><TD>24</TD><TD>1</TD><TD>17275</TD><TD>29</TD>
<TD>CAPN6</TD></TR>
<TR><TD>3.981e-02</TD><TD>-3.22</TD><TD>ligand-gated calcium channel activity</TD><TD>molecular function</TD><TD>GO:0099604</TD><TD>27</TD><TD>1</TD><TD>17306</TD><TD>26</TD>
<TD>RYR1</TD></TR>
<TR><TD>3.981e-02</TD><TD>-3.22</TD><TD>mitogen-activated protein kinase binding</TD><TD>molecular function</TD><TD>GO:0051019</TD><TD>27</TD><TD>1</TD><TD>17306</TD><TD>26</TD>
<TD>DIRAS1</TD></TR>
<TR><TD>3.984e-02</TD><TD>-3.22</TD><TD>GSE17721_POLYIC_VS_GARDIQUIMOD_8H_BMDC_UP</TD><TD>MSigDB lists</TD><TD>GSE17721_POLYIC_VS_GARDIQUIMOD_8H_BMDC_UP</TD><TD>189</TD><TD>2</TD><TD>17275</TD><TD>29</TD>
<TD>ISG15,OAS2</TD></TR>
<TR><TD>3.984e-02</TD><TD>-3.22</TD><TD>GSE22935_WT_VS_MYD88_KO_MACROPHAGE_12H_MBOVIS_BCG_STIM_DN</TD><TD>MSigDB lists</TD><TD>GSE22935_WT_VS_MYD88_KO_MACROPHAGE_12H_MBOVIS_BCG_STIM_DN</TD><TD>189</TD><TD>2</TD><TD>17275</TD><TD>29</TD>
<TD>RSAD2,ISG15</TD></TR>
<TR><TD>3.984e-02</TD><TD>-3.22</TD><TD>GSE31082_DN_VS_CD8_SP_THYMOCYTE_DN</TD><TD>MSigDB lists</TD><TD>GSE31082_DN_VS_CD8_SP_THYMOCYTE_DN</TD><TD>189</TD><TD>2</TD><TD>17275</TD><TD>29</TD>
<TD>OAS2,IFI27</TD></TR>
<TR><TD>3.984e-02</TD><TD>-3.22</TD><TD>GSE360_L_MAJOR_VS_M_TUBERCULOSIS_DC_DN</TD><TD>MSigDB lists</TD><TD>GSE360_L_MAJOR_VS_M_TUBERCULOSIS_DC_DN</TD><TD>189</TD><TD>2</TD><TD>17275</TD><TD>29</TD>
<TD>ISG15,RSAD2</TD></TR>
<TR><TD>3.984e-02</TD><TD>-3.22</TD><TD>GSE36078_WT_VS_IL1R_KO_LUNG_DC_UP</TD><TD>MSigDB lists</TD><TD>GSE36078_WT_VS_IL1R_KO_LUNG_DC_UP</TD><TD>189</TD><TD>2</TD><TD>17275</TD><TD>29</TD>
<TD>OAS2,IFIT2</TD></TR>
<TR><TD>3.984e-02</TD><TD>-3.22</TD><TD>GSE9037_WT_VS_IRAK4_KO_LPS_4H_STIM_BMDM_DN</TD><TD>MSigDB lists</TD><TD>GSE9037_WT_VS_IRAK4_KO_LPS_4H_STIM_BMDM_DN</TD><TD>189</TD><TD>2</TD><TD>17275</TD><TD>29</TD>
<TD>MCAM,TUBA1A</TD></TR>
<TR><TD>3.984e-02</TD><TD>-3.22</TD><TD>GSE29164_UNTREATED_VS_CD8_TCELL_TREATED_MELANOMA_DAY3_DN</TD><TD>MSigDB lists</TD><TD>GSE29164_UNTREATED_VS_CD8_TCELL_TREATED_MELANOMA_DAY3_DN</TD><TD>189</TD><TD>2</TD><TD>17275</TD><TD>29</TD>
<TD>RSAD2,OAS1</TD></TR>
<TR><TD>3.984e-02</TD><TD>-3.22</TD><TD>GSE29949_CD8_NEG_DC_SPLEEN_VS_CD8_POS_DC_SPLEEN_UP</TD><TD>MSigDB lists</TD><TD>GSE29949_CD8_NEG_DC_SPLEEN_VS_CD8_POS_DC_SPLEEN_UP</TD><TD>189</TD><TD>2</TD><TD>17275</TD><TD>29</TD>
<TD>RYR1,RSAD2</TD></TR>
<TR><TD>3.984e-02</TD><TD>-3.22</TD><TD>GSE26669_CTRL_VS_COSTIM_BLOCK_MLR_CD8_TCELL_UP</TD><TD>MSigDB lists</TD><TD>GSE26669_CTRL_VS_COSTIM_BLOCK_MLR_CD8_TCELL_UP</TD><TD>189</TD><TD>2</TD><TD>17275</TD><TD>29</TD>
<TD>IFI44L,RSAD2</TD></TR>
<TR><TD>3.984e-02</TD><TD>-3.22</TD><TD>GSE30083_SP1_VS_SP2_THYMOCYTE_DN</TD><TD>MSigDB lists</TD><TD>GSE30083_SP1_VS_SP2_THYMOCYTE_DN</TD><TD>189</TD><TD>2</TD><TD>17275</TD><TD>29</TD>
<TD>OAS2,IFI44</TD></TR>
<TR><TD>3.984e-02</TD><TD>-3.22</TD><TD>GSE22935_UNSTIM_VS_12H_MBOVIS_BCG_STIM_MYD88_KO_MACROPHAGE_UP</TD><TD>MSigDB lists</TD><TD>GSE22935_UNSTIM_VS_12H_MBOVIS_BCG_STIM_MYD88_KO_MACROPHAGE_UP</TD><TD>189</TD><TD>2</TD><TD>17275</TD><TD>29</TD>
<TD>CAMKK2,RYR1</TD></TR>
<TR><TD>3.984e-02</TD><TD>-3.22</TD><TD>GSE11961_MARGINAL_ZONE_BCELL_VS_MEMORY_BCELL_DAY7_UP</TD><TD>MSigDB lists</TD><TD>GSE11961_MARGINAL_ZONE_BCELL_VS_MEMORY_BCELL_DAY7_UP</TD><TD>189</TD><TD>2</TD><TD>17275</TD><TD>29</TD>
<TD>RSAD2,IFIT2</TD></TR>
<TR><TD>3.984e-02</TD><TD>-3.22</TD><TD>MORF_IFNA1</TD><TD>MSigDB lists</TD><TD>MORF_IFNA1</TD><TD>189</TD><TD>2</TD><TD>17275</TD><TD>29</TD>
<TD>RYR1,CADM4</TD></TR>
<TR><TD>3.984e-02</TD><TD>-3.22</TD><TD>GSE27670_CTRL_VS_LMP1_TRANSDUCED_GC_BCELL_DN</TD><TD>MSigDB lists</TD><TD>GSE27670_CTRL_VS_LMP1_TRANSDUCED_GC_BCELL_DN</TD><TD>189</TD><TD>2</TD><TD>17275</TD><TD>29</TD>
<TD>IFI27,MCAM</TD></TR>
<TR><TD>3.984e-02</TD><TD>-3.22</TD><TD>GSE3720_VD1_VS_VD2_GAMMADELTA_TCELL_DN</TD><TD>MSigDB lists</TD><TD>GSE3720_VD1_VS_VD2_GAMMADELTA_TCELL_DN</TD><TD>189</TD><TD>2</TD><TD>17275</TD><TD>29</TD>
<TD>BCL6B,ZNF518B</TD></TR>
<TR><TD>3.984e-02</TD><TD>-3.22</TD><TD>GSE39556_UNTREATED_VS_3H_POLYIC_INJ_MOUSE_CD8A_DC_DN</TD><TD>MSigDB lists</TD><TD>GSE39556_UNTREATED_VS_3H_POLYIC_INJ_MOUSE_CD8A_DC_DN</TD><TD>189</TD><TD>2</TD><TD>17275</TD><TD>29</TD>
<TD>IFI44,RSAD2</TD></TR>
<TR><TD>3.984e-02</TD><TD>-3.22</TD><TD>GSE28726_NAIVE_VS_ACTIVATED_VA24NEG_NKTCELL_UP</TD><TD>MSigDB lists</TD><TD>GSE28726_NAIVE_VS_ACTIVATED_VA24NEG_NKTCELL_UP</TD><TD>189</TD><TD>2</TD><TD>17275</TD><TD>29</TD>
<TD>RSAD2,CAMKK2</TD></TR>
<TR><TD>3.984e-02</TD><TD>-3.22</TD><TD>GSE39110_DAY3_VS_DAY6_POST_IMMUNIZATION_CD8_TCELL_WITH_IL2_TREATMENT_UP</TD><TD>MSigDB lists</TD><TD>GSE39110_DAY3_VS_DAY6_POST_IMMUNIZATION_CD8_TCELL_WITH_IL2_TREATMENT_UP</TD><TD>189</TD><TD>2</TD><TD>17275</TD><TD>29</TD>
<TD>OAS1,ISG15</TD></TR>
<TR><TD>4.002e-02</TD><TD>-3.22</TD><TD>negative regulation of establishment of protein localization</TD><TD>biological process</TD><TD>GO:1904950</TD><TD>198</TD><TD>2</TD><TD>18054</TD><TD>29</TD>
<TD>RSAD2,LGR4</TD></TR>
<TR><TD>4.023e-02</TD><TD>-3.21</TD><TD>GSE2405_0H_VS_24H_A_PHAGOCYTOPHILUM_STIM_NEUTROPHIL_UP</TD><TD>MSigDB lists</TD><TD>GSE2405_0H_VS_24H_A_PHAGOCYTOPHILUM_STIM_NEUTROPHIL_UP</TD><TD>190</TD><TD>2</TD><TD>17275</TD><TD>29</TD>
<TD>ISG15,OAS2</TD></TR>
<TR><TD>4.023e-02</TD><TD>-3.21</TD><TD>GSE16522_MEMORY_VS_NAIVE_ANTI_CD3CD28_STIM_CD8_TCELL_DN</TD><TD>MSigDB lists</TD><TD>GSE16522_MEMORY_VS_NAIVE_ANTI_CD3CD28_STIM_CD8_TCELL_DN</TD><TD>190</TD><TD>2</TD><TD>17275</TD><TD>29</TD>
<TD>IFI27,OAS1</TD></TR>
<TR><TD>4.023e-02</TD><TD>-3.21</TD><TD>GSE40277_GATA1_AND_SATB1_TRANSDUCED_VS_CTRL_CD4_TCELL_DN</TD><TD>MSigDB lists</TD><TD>GSE40277_GATA1_AND_SATB1_TRANSDUCED_VS_CTRL_CD4_TCELL_DN</TD><TD>190</TD><TD>2</TD><TD>17275</TD><TD>29</TD>
<TD>OASL,IFI44</TD></TR>
<TR><TD>4.023e-02</TD><TD>-3.21</TD><TD>GSE33424_CD161_HIGH_VS_INT_CD8_TCELL_UP</TD><TD>MSigDB lists</TD><TD>GSE33424_CD161_HIGH_VS_INT_CD8_TCELL_UP</TD><TD>190</TD><TD>2</TD><TD>17275</TD><TD>29</TD>
<TD>RYR1,TUBA1A</TD></TR>
<TR><TD>4.023e-02</TD><TD>-3.21</TD><TD>GO_NEGATIVE_REGULATION_OF_SECRETION</TD><TD>MSigDB lists</TD><TD>GO_NEGATIVE_REGULATION_OF_SECRETION</TD><TD>190</TD><TD>2</TD><TD>17275</TD><TD>29</TD>
<TD>RSAD2,LGR4</TD></TR>
<TR><TD>4.023e-02</TD><TD>-3.21</TD><TD>GSE2405_0H_VS_3H_A_PHAGOCYTOPHILUM_STIM_NEUTROPHIL_UP</TD><TD>MSigDB lists</TD><TD>GSE2405_0H_VS_3H_A_PHAGOCYTOPHILUM_STIM_NEUTROPHIL_UP</TD><TD>190</TD><TD>2</TD><TD>17275</TD><TD>29</TD>
<TD>LGR4,CADM4</TD></TR>
<TR><TD>4.023e-02</TD><TD>-3.21</TD><TD>GSE29618_PDC_VS_MDC_DN</TD><TD>MSigDB lists</TD><TD>GSE29618_PDC_VS_MDC_DN</TD><TD>190</TD><TD>2</TD><TD>17275</TD><TD>29</TD>
<TD>OAS3,TUBA1A</TD></TR>
<TR><TD>4.023e-02</TD><TD>-3.21</TD><TD>GSE7852_TREG_VS_TCONV_FAT_UP</TD><TD>MSigDB lists</TD><TD>GSE7852_TREG_VS_TCONV_FAT_UP</TD><TD>190</TD><TD>2</TD><TD>17275</TD><TD>29</TD>
<TD>KIFAP3,HS6ST2</TD></TR>
<TR><TD>4.023e-02</TD><TD>-3.21</TD><TD>GSE7852_LN_VS_FAT_TREG_DN</TD><TD>MSigDB lists</TD><TD>GSE7852_LN_VS_FAT_TREG_DN</TD><TD>190</TD><TD>2</TD><TD>17275</TD><TD>29</TD>
<TD>KIFAP3,HS6ST2</TD></TR>
<TR><TD>4.023e-02</TD><TD>-3.21</TD><TD>GSE26030_UNSTIM_VS_RESTIM_TH17_DAY15_POST_POLARIZATION_DN</TD><TD>MSigDB lists</TD><TD>GSE26030_UNSTIM_VS_RESTIM_TH17_DAY15_POST_POLARIZATION_DN</TD><TD>190</TD><TD>2</TD><TD>17275</TD><TD>29</TD>
<TD>TUBA1A,FAM102B</TD></TR>
<TR><TD>4.023e-02</TD><TD>-3.21</TD><TD>GSE12392_WT_VS_IFNB_KO_CD8A_NEG_SPLEEN_DC_DN</TD><TD>MSigDB lists</TD><TD>GSE12392_WT_VS_IFNB_KO_CD8A_NEG_SPLEEN_DC_DN</TD><TD>190</TD><TD>2</TD><TD>17275</TD><TD>29</TD>
<TD>OAS2,RSAD2</TD></TR>
<TR><TD>4.023e-02</TD><TD>-3.21</TD><TD>GSE23505_IL6_IL1_IL23_VS_IL6_IL1_TGFB_TREATED_CD4_TCELL_UP</TD><TD>MSigDB lists</TD><TD>GSE23505_IL6_IL1_IL23_VS_IL6_IL1_TGFB_TREATED_CD4_TCELL_UP</TD><TD>190</TD><TD>2</TD><TD>17275</TD><TD>29</TD>
<TD>OAS2,IFIT2</TD></TR>
<TR><TD>4.023e-02</TD><TD>-3.21</TD><TD>GSE5679_CTRL_VS_PPARG_LIGAND_ROSIGLITAZONE_AND_RARA_AGONIST_AM580_TREATED_DC_UP</TD><TD>MSigDB lists</TD><TD>GSE5679_CTRL_VS_PPARG_LIGAND_ROSIGLITAZONE_AND_RARA_AGONIST_AM580_TREATED_DC_UP</TD><TD>190</TD><TD>2</TD><TD>17275</TD><TD>29</TD>
<TD>RSAD2,ISG15</TD></TR>
<TR><TD>4.023e-02</TD><TD>-3.21</TD><TD>GSE9601_NFKB_INHIBITOR_VS_PI3K_INHIBITOR_TREATED_HCMV_INF_MONOCYTE_DN</TD><TD>MSigDB lists</TD><TD>GSE9601_NFKB_INHIBITOR_VS_PI3K_INHIBITOR_TREATED_HCMV_INF_MONOCYTE_DN</TD><TD>190</TD><TD>2</TD><TD>17275</TD><TD>29</TD>
<TD>IFIT2,OAS2</TD></TR>
<TR><TD>4.023e-02</TD><TD>-3.21</TD><TD>GSE21360_PRIMARY_VS_TERTIARY_MEMORY_CD8_TCELL_DN</TD><TD>MSigDB lists</TD><TD>GSE21360_PRIMARY_VS_TERTIARY_MEMORY_CD8_TCELL_DN</TD><TD>190</TD><TD>2</TD><TD>17275</TD><TD>29</TD>
<TD>IFI27,OAS2</TD></TR>
<TR><TD>4.023e-02</TD><TD>-3.21</TD><TD>GSE37534_UNTREATED_VS_GW1929_TREATED_CD4_TCELL_PPARG1_AND_FOXP3_TRASDUCED_UP</TD><TD>MSigDB lists</TD><TD>GSE37534_UNTREATED_VS_GW1929_TREATED_CD4_TCELL_PPARG1_AND_FOXP3_TRASDUCED_UP</TD><TD>190</TD><TD>2</TD><TD>17275</TD><TD>29</TD>
<TD>IFIT2,IFI27</TD></TR>
<TR><TD>4.023e-02</TD><TD>-3.21</TD><TD>GSE40277_EOS_AND_LEF1_TRANSDUCED_VS_CTRL_CD4_TCELL_DN</TD><TD>MSigDB lists</TD><TD>GSE40277_EOS_AND_LEF1_TRANSDUCED_VS_CTRL_CD4_TCELL_DN</TD><TD>190</TD><TD>2</TD><TD>17275</TD><TD>29</TD>
<TD>OAS2,OAS3</TD></TR>
<TR><TD>4.023e-02</TD><TD>-3.21</TD><TD>GSE33374_CD8_ALPHAALPHA_VS_ALPHABETA_CD161_HIGH_TCELL_DN</TD><TD>MSigDB lists</TD><TD>GSE33374_CD8_ALPHAALPHA_VS_ALPHABETA_CD161_HIGH_TCELL_DN</TD><TD>190</TD><TD>2</TD><TD>17275</TD><TD>29</TD>
<TD>ISG15,IFIT2</TD></TR>
<TR><TD>4.047e-02</TD><TD>-3.21</TD><TD>GML (glycosylphosphatidylinositol anchored molecule like)</TD><TD>protein interactions</TD><TD>2765</TD><TD>24</TD><TD>1</TD><TD>17456</TD><TD>30</TD>
<TD>TUBA1A</TD></TR>
<TR><TD>4.047e-02</TD><TD>-3.21</TD><TD>KRT77 (keratin 77)</TD><TD>protein interactions</TD><TD>374454</TD><TD>24</TD><TD>1</TD><TD>17456</TD><TD>30</TD>
<TD>LGR4</TD></TR>
<TR><TD>4.047e-02</TD><TD>-3.21</TD><TD>CPD (carboxypeptidase D)</TD><TD>protein interactions</TD><TD>1362</TD><TD>24</TD><TD>1</TD><TD>17456</TD><TD>30</TD>
<TD>LGR4</TD></TR>
<TR><TD>4.047e-02</TD><TD>-3.21</TD><TD>KIR3DS1 (killer cell immunoglobulin like receptor, three Ig domains and short cytoplasmic tail 1)</TD><TD>protein interactions</TD><TD>3813</TD><TD>24</TD><TD>1</TD><TD>17456</TD><TD>30</TD>
<TD>CTSV</TD></TR>
<TR><TD>4.047e-02</TD><TD>-3.21</TD><TD>KRT79 (keratin 79)</TD><TD>protein interactions</TD><TD>338785</TD><TD>24</TD><TD>1</TD><TD>17456</TD><TD>30</TD>
<TD>LGR4</TD></TR>
<TR><TD>4.047e-02</TD><TD>-3.21</TD><TD>NUTM1 (NUT midline carcinoma family member 1)</TD><TD>protein interactions</TD><TD>256646</TD><TD>24</TD><TD>1</TD><TD>17456</TD><TD>30</TD>
<TD>IFIT2</TD></TR>
<TR><TD>4.047e-02</TD><TD>-3.21</TD><TD>PACRG (parkin coregulated)</TD><TD>protein interactions</TD><TD>135138</TD><TD>24</TD><TD>1</TD><TD>17456</TD><TD>30</TD>
<TD>TUBA1A</TD></TR>
<TR><TD>4.047e-02</TD><TD>-3.21</TD><TD>ZNF609 (zinc finger protein 609)</TD><TD>protein interactions</TD><TD>23060</TD><TD>24</TD><TD>1</TD><TD>17456</TD><TD>30</TD>
<TD>SBSPON</TD></TR>
<TR><TD>4.061e-02</TD><TD>-3.20</TD><TD>GSE15735_2H_VS_12H_HDAC_INHIBITOR_TREATED_CD4_TCELL_DN</TD><TD>MSigDB lists</TD><TD>GSE15735_2H_VS_12H_HDAC_INHIBITOR_TREATED_CD4_TCELL_DN</TD><TD>191</TD><TD>2</TD><TD>17275</TD><TD>29</TD>
<TD>KIFAP3,OAS2</TD></TR>
<TR><TD>4.061e-02</TD><TD>-3.20</TD><TD>GSE15330_HSC_VS_LYMPHOID_PRIMED_MULTIPOTENT_PROGENITOR_UP</TD><TD>MSigDB lists</TD><TD>GSE15330_HSC_VS_LYMPHOID_PRIMED_MULTIPOTENT_PROGENITOR_UP</TD><TD>191</TD><TD>2</TD><TD>17275</TD><TD>29</TD>
<TD>ISG15,OAS2</TD></TR>
<TR><TD>4.061e-02</TD><TD>-3.20</TD><TD>GSE1925_3H_VS_24H_IFNG_STIM_IFNG_PRIMED_MACROPHAGE_UP</TD><TD>MSigDB lists</TD><TD>GSE1925_3H_VS_24H_IFNG_STIM_IFNG_PRIMED_MACROPHAGE_UP</TD><TD>191</TD><TD>2</TD><TD>17275</TD><TD>29</TD>
<TD>KIFAP3,MCAM</TD></TR>
<TR><TD>4.061e-02</TD><TD>-3.20</TD><TD>GSE35685_CD34POS_CD38NEG_VS_CD34POS_CD10POS_BONE_MARROW_DN</TD><TD>MSigDB lists</TD><TD>GSE35685_CD34POS_CD38NEG_VS_CD34POS_CD10POS_BONE_MARROW_DN</TD><TD>191</TD><TD>2</TD><TD>17275</TD><TD>29</TD>
<TD>ISG15,IFIT2</TD></TR>
<TR><TD>4.061e-02</TD><TD>-3.20</TD><TD>GSE32034_LY6C_HIGH_VS_LOW_ROSIGLIZATONE_TREATED_MONOCYTE_UP</TD><TD>MSigDB lists</TD><TD>GSE32034_LY6C_HIGH_VS_LOW_ROSIGLIZATONE_TREATED_MONOCYTE_UP</TD><TD>191</TD><TD>2</TD><TD>17275</TD><TD>29</TD>
<TD>ISG15,IFIT2</TD></TR>
<TR><TD>4.061e-02</TD><TD>-3.20</TD><TD>GSE17721_CPG_VS_GARDIQUIMOD_0.5H_BMDC_DN</TD><TD>MSigDB lists</TD><TD>GSE17721_CPG_VS_GARDIQUIMOD_0.5H_BMDC_DN</TD><TD>191</TD><TD>2</TD><TD>17275</TD><TD>29</TD>
<TD>OAS3,ZNF518B</TD></TR>
<TR><TD>4.061e-02</TD><TD>-3.20</TD><TD>GSE43955_TH0_VS_TGFB_IL6_TH17_ACT_CD4_TCELL_4H_DN</TD><TD>MSigDB lists</TD><TD>GSE43955_TH0_VS_TGFB_IL6_TH17_ACT_CD4_TCELL_4H_DN</TD><TD>191</TD><TD>2</TD><TD>17275</TD><TD>29</TD>
<TD>IFIT2,RSAD2</TD></TR>
<TR><TD>4.061e-02</TD><TD>-3.20</TD><TD>GSE19923_E2A_KO_VS_E2A_AND_HEB_KO_DP_THYMOCYTE_DN</TD><TD>MSigDB lists</TD><TD>GSE19923_E2A_KO_VS_E2A_AND_HEB_KO_DP_THYMOCYTE_DN</TD><TD>191</TD><TD>2</TD><TD>17275</TD><TD>29</TD>
<TD>RSAD2,ISG15</TD></TR>
<TR><TD>4.061e-02</TD><TD>-3.20</TD><TD>GSE17721_LPS_VS_PAM3CSK4_1H_BMDC_DN</TD><TD>MSigDB lists</TD><TD>GSE17721_LPS_VS_PAM3CSK4_1H_BMDC_DN</TD><TD>191</TD><TD>2</TD><TD>17275</TD><TD>29</TD>
<TD>MCAM,RYR1</TD></TR>
<TR><TD>4.061e-02</TD><TD>-3.20</TD><TD>GSE32164_RESTING_DIFFERENTIATED_VS_CMYC_INHIBITED_MACROPHAGE_DN</TD><TD>MSigDB lists</TD><TD>GSE32164_RESTING_DIFFERENTIATED_VS_CMYC_INHIBITED_MACROPHAGE_DN</TD><TD>191</TD><TD>2</TD><TD>17275</TD><TD>29</TD>
<TD>IFIT2,IFI27</TD></TR>
<TR><TD>4.061e-02</TD><TD>-3.20</TD><TD>PICCALUGA_ANGIOIMMUNOBLASTIC_LYMPHOMA_UP</TD><TD>MSigDB lists</TD><TD>PICCALUGA_ANGIOIMMUNOBLASTIC_LYMPHOMA_UP</TD><TD>191</TD><TD>2</TD><TD>17275</TD><TD>29</TD>
<TD>PGF,IFI27</TD></TR>
<TR><TD>4.061e-02</TD><TD>-3.20</TD><TD>GSE43955_10H_VS_30H_ACT_CD4_TCELL_UP</TD><TD>MSigDB lists</TD><TD>GSE43955_10H_VS_30H_ACT_CD4_TCELL_UP</TD><TD>191</TD><TD>2</TD><TD>17275</TD><TD>29</TD>
<TD>RSAD2,IFIT2</TD></TR>
<TR><TD>4.061e-02</TD><TD>-3.20</TD><TD>GSE9316_IL6_KO_VS_IFNG_KO_INVIVO_EXPANDED_CD4_TCELL_DN</TD><TD>MSigDB lists</TD><TD>GSE9316_IL6_KO_VS_IFNG_KO_INVIVO_EXPANDED_CD4_TCELL_DN</TD><TD>191</TD><TD>2</TD><TD>17275</TD><TD>29</TD>
<TD>OAS1,OASL</TD></TR>
<TR><TD>4.085e-02</TD><TD>-3.20</TD><TD>SENESE_HDAC3_TARGETS_UP</TD><TD>MSigDB lists</TD><TD>SENESE_HDAC3_TARGETS_UP</TD><TD>459</TD><TD>3</TD><TD>17275</TD><TD>29</TD>
<TD>IFIT2,OASL,TUBA1A</TD></TR>
<TR><TD>4.094e-02</TD><TD>-3.20</TD><TD>THIOL_PROTEASE_CYS</TD><TD>prosite domains</TD><TD>PS00139</TD><TD>21</TD><TD>1</TD><TD>12079</TD><TD>24</TD>
<TD>CTSV</TD></TR>
<TR><TD>4.094e-02</TD><TD>-3.20</TD><TD>TUBULIN</TD><TD>prosite domains</TD><TD>PS00227</TD><TD>21</TD><TD>1</TD><TD>12079</TD><TD>24</TD>
<TD>TUBA1A</TD></TR>
<TR><TD>4.096e-02</TD><TD>-3.20</TD><TD>regulation of positive chemotaxis</TD><TD>biological process</TD><TD>GO:0050926</TD><TD>26</TD><TD>1</TD><TD>18054</TD><TD>29</TD>
<TD>PGF</TD></TR>
<TR><TD>4.100e-02</TD><TD>-3.19</TD><TD>GSE26669_CD4_VS_CD8_TCELL_IN_MLR_UP</TD><TD>MSigDB lists</TD><TD>GSE26669_CD4_VS_CD8_TCELL_IN_MLR_UP</TD><TD>192</TD><TD>2</TD><TD>17275</TD><TD>29</TD>
<TD>IFIT2,OAS2</TD></TR>
<TR><TD>4.111e-02</TD><TD>-3.19</TD><TD>-</TD><TD>gene3d domains</TD><TD>1.10.287.600</TD><TD>21</TD><TD>1</TD><TD>8522</TD><TD>17</TD>
<TD>TUBA1A</TD></TR>
<TR><TD>4.111e-02</TD><TD>-3.19</TD><TD>-</TD><TD>gene3d domains</TD><TD>3.40.50.1440</TD><TD>21</TD><TD>1</TD><TD>8522</TD><TD>17</TD>
<TD>TUBA1A</TD></TR>
<TR><TD>4.116e-02</TD><TD>-3.19</TD><TD>GLI1_UP.V1_DN</TD><TD>MSigDB lists</TD><TD>GLI1_UP.V1_DN</TD><TD>25</TD><TD>1</TD><TD>17275</TD><TD>29</TD>
<TD>RSAD2</TD></TR>
<TR><TD>4.116e-02</TD><TD>-3.19</TD><TD>GO_NEGATIVE_REGULATION_OF_TOLL_LIKE_RECEPTOR_SIGNALING_PATHWAY</TD><TD>MSigDB lists</TD><TD>GO_NEGATIVE_REGULATION_OF_TOLL_LIKE_RECEPTOR_SIGNALING_PATHWAY</TD><TD>25</TD><TD>1</TD><TD>17275</TD><TD>29</TD>
<TD>LGR4</TD></TR>
<TR><TD>4.116e-02</TD><TD>-3.19</TD><TD>GO_REGULATION_OF_TYPE_2_IMMUNE_RESPONSE</TD><TD>MSigDB lists</TD><TD>GO_REGULATION_OF_TYPE_2_IMMUNE_RESPONSE</TD><TD>25</TD><TD>1</TD><TD>17275</TD><TD>29</TD>
<TD>RSAD2</TD></TR>
<TR><TD>4.116e-02</TD><TD>-3.19</TD><TD>TAXCREB_02</TD><TD>MSigDB lists</TD><TD>TAXCREB_02</TD><TD>25</TD><TD>1</TD><TD>17275</TD><TD>29</TD>
<TD>CAPN6</TD></TR>
<TR><TD>4.116e-02</TD><TD>-3.19</TD><TD>GENTILE_UV_HIGH_DOSE_UP</TD><TD>MSigDB lists</TD><TD>GENTILE_UV_HIGH_DOSE_UP</TD><TD>25</TD><TD>1</TD><TD>17275</TD><TD>29</TD>
<TD>ISG15</TD></TR>
<TR><TD>4.116e-02</TD><TD>-3.19</TD><TD>GNF2_CDKN1C</TD><TD>MSigDB lists</TD><TD>GNF2_CDKN1C</TD><TD>25</TD><TD>1</TD><TD>17275</TD><TD>29</TD>
<TD>CAPN6</TD></TR>
<TR><TD>4.120e-02</TD><TD>-3.19</TD><TD>DDX17 (DEAD-box helicase 17)</TD><TD>protein interactions</TD><TD>10521</TD><TD>188</TD><TD>2</TD><TD>17456</TD><TD>30</TD>
<TD>ISG15,LGR4</TD></TR>
<TR><TD>4.126e-02</TD><TD>-3.19</TD><TD>calmodulin-dependent protein kinase activity</TD><TD>molecular function</TD><TD>GO:0004683</TD><TD>28</TD><TD>1</TD><TD>17306</TD><TD>26</TD>
<TD>CAMKK2</TD></TR>
<TR><TD>4.132e-02</TD><TD>-3.19</TD><TD>Tubulin</TD><TD>smart domains</TD><TD>SM00864</TD><TD>21</TD><TD>1</TD><TD>9476</TD><TD>19</TD>
<TD>TUBA1A</TD></TR>
<TR><TD>4.138e-02</TD><TD>-3.18</TD><TD>GSE11961_GERMINAL_CENTER_BCELL_DAY7_VS_PLASMA_CELL_DAY7_UP</TD><TD>MSigDB lists</TD><TD>GSE11961_GERMINAL_CENTER_BCELL_DAY7_VS_PLASMA_CELL_DAY7_UP</TD><TD>193</TD><TD>2</TD><TD>17275</TD><TD>29</TD>
<TD>OASL,IFI44</TD></TR>
<TR><TD>4.138e-02</TD><TD>-3.18</TD><TD>GSE17721_LPS_VS_PAM3CSK4_0.5H_BMDC_DN</TD><TD>MSigDB lists</TD><TD>GSE17721_LPS_VS_PAM3CSK4_0.5H_BMDC_DN</TD><TD>193</TD><TD>2</TD><TD>17275</TD><TD>29</TD>
<TD>OAS2,CAPN6</TD></TR>
<TR><TD>4.138e-02</TD><TD>-3.18</TD><TD>GSE2770_UNTREATED_VS_IL4_TREATED_ACT_CD4_TCELL_6H_DN</TD><TD>MSigDB lists</TD><TD>GSE2770_UNTREATED_VS_IL4_TREATED_ACT_CD4_TCELL_6H_DN</TD><TD>193</TD><TD>2</TD><TD>17275</TD><TD>29</TD>
<TD>IFIT2,OAS1</TD></TR>
<TR><TD>4.138e-02</TD><TD>-3.18</TD><TD>GSE26488_WT_VS_HDAC7_DELTAP_TG_OT2_THYMOCYTE_WITH_PEPTIDE_INJECTION_DN</TD><TD>MSigDB lists</TD><TD>GSE26488_WT_VS_HDAC7_DELTAP_TG_OT2_THYMOCYTE_WITH_PEPTIDE_INJECTION_DN</TD><TD>193</TD><TD>2</TD><TD>17275</TD><TD>29</TD>
<TD>ISG15,IFI27</TD></TR>
<TR><TD>4.158e-02</TD><TD>-3.18</TD><TD>human chr9q22.33</TD><TD>chromosome location</TD><TD>human chr9q22.33</TD><TD>37</TD><TD>1</TD><TD>26169</TD><TD>30</TD>
<TD>CTSV</TD></TR>
<TR><TD>4.177e-02</TD><TD>-3.18</TD><TD>GSE14769_UNSTIM_VS_120MIN_LPS_BMDM_DN</TD><TD>MSigDB lists</TD><TD>GSE14769_UNSTIM_VS_120MIN_LPS_BMDM_DN</TD><TD>194</TD><TD>2</TD><TD>17275</TD><TD>29</TD>
<TD>ISG15,RSAD2</TD></TR>
<TR><TD>4.177e-02</TD><TD>-3.18</TD><TD>GSE39820_TGFBETA1_IL6_VS_TGFBETA1_IL6_IL23A_TREATED_CD4_TCELL_UP</TD><TD>MSigDB lists</TD><TD>GSE39820_TGFBETA1_IL6_VS_TGFBETA1_IL6_IL23A_TREATED_CD4_TCELL_UP</TD><TD>194</TD><TD>2</TD><TD>17275</TD><TD>29</TD>
<TD>PGF,FAM102B</TD></TR>
<TR><TD>4.177e-02</TD><TD>-3.18</TD><TD>GSE32164_RESTING_DIFFERENTIATED_VS_CMYC_INHIBITED_MACROPHAGE_UP</TD><TD>MSigDB lists</TD><TD>GSE32164_RESTING_DIFFERENTIATED_VS_CMYC_INHIBITED_MACROPHAGE_UP</TD><TD>194</TD><TD>2</TD><TD>17275</TD><TD>29</TD>
<TD>CAPN6,RYR1</TD></TR>
<TR><TD>4.212e-02</TD><TD>-3.17</TD><TD>PRSS1 (serine protease 1)</TD><TD>protein interactions</TD><TD>5644</TD><TD>25</TD><TD>1</TD><TD>17456</TD><TD>30</TD>
<TD>LGR4</TD></TR>
<TR><TD>4.212e-02</TD><TD>-3.17</TD><TD>BTG1 (BTG anti-proliferation factor 1)</TD><TD>protein interactions</TD><TD>694</TD><TD>25</TD><TD>1</TD><TD>17456</TD><TD>30</TD>
<TD>TUBA1A</TD></TR>
<TR><TD>4.212e-02</TD><TD>-3.17</TD><TD>TUBA3E (tubulin alpha 3e)</TD><TD>protein interactions</TD><TD>112714</TD><TD>25</TD><TD>1</TD><TD>17456</TD><TD>30</TD>
<TD>LGR4</TD></TR>
<TR><TD>4.212e-02</TD><TD>-3.17</TD><TD>Cenph (centromere protein H)</TD><TD>protein interactions</TD><TD>26886</TD><TD>25</TD><TD>1</TD><TD>17456</TD><TD>30</TD>
<TD>FAM102B</TD></TR>
<TR><TD>4.212e-02</TD><TD>-3.17</TD><TD>PARD6G (par-6 family cell polarity regulator gamma)</TD><TD>protein interactions</TD><TD>84552</TD><TD>25</TD><TD>1</TD><TD>17456</TD><TD>30</TD>
<TD>KIFAP3</TD></TR>
<TR><TD>4.212e-02</TD><TD>-3.17</TD><TD>NCF2 (neutrophil cytosolic factor 2)</TD><TD>protein interactions</TD><TD>4688</TD><TD>25</TD><TD>1</TD><TD>17456</TD><TD>30</TD>
<TD>KIFAP3</TD></TR>
<TR><TD>4.216e-02</TD><TD>-3.17</TD><TD>GSE39864_WT_VS_GATA3_KO_TREG_UP</TD><TD>MSigDB lists</TD><TD>GSE39864_WT_VS_GATA3_KO_TREG_UP</TD><TD>195</TD><TD>2</TD><TD>17275</TD><TD>29</TD>
<TD>IFIT2,RSAD2</TD></TR>
<TR><TD>4.251e-02</TD><TD>-3.16</TD><TD>metanephros morphogenesis</TD><TD>biological process</TD><TD>GO:0003338</TD><TD>27</TD><TD>1</TD><TD>18054</TD><TD>29</TD>
<TD>LGR4</TD></TR>
<TR><TD>4.251e-02</TD><TD>-3.16</TD><TD>myotube cell development</TD><TD>biological process</TD><TD>GO:0014904</TD><TD>27</TD><TD>1</TD><TD>18054</TD><TD>29</TD>
<TD>RYR1</TD></TR>
<TR><TD>4.251e-02</TD><TD>-3.16</TD><TD>epithelial structure maintenance</TD><TD>biological process</TD><TD>GO:0010669</TD><TD>27</TD><TD>1</TD><TD>18054</TD><TD>29</TD>
<TD>KIAA1211</TD></TR>
<TR><TD>4.255e-02</TD><TD>-3.16</TD><TD>STAT5A_04</TD><TD>MSigDB lists</TD><TD>STAT5A_04</TD><TD>196</TD><TD>2</TD><TD>17275</TD><TD>29</TD>
<TD>BCL6B,CAPN6</TD></TR>
<TR><TD>4.255e-02</TD><TD>-3.16</TD><TD>RSRFC4_Q2</TD><TD>MSigDB lists</TD><TD>RSRFC4_Q2</TD><TD>196</TD><TD>2</TD><TD>17275</TD><TD>29</TD>
<TD>DIRAS1,KLHDC8B</TD></TR>
<TR><TD>4.264e-02</TD><TD>-3.15</TD><TD>GPCR_2_extracell_dom_sf</TD><TD>interpro domains</TD><TD>IPR036445</TD><TD>27</TD><TD>1</TD><TD>18616</TD><TD>30</TD>
<TD>ADGRL1</TD></TR>
<TR><TD>4.264e-02</TD><TD>-3.15</TD><TD>GPCR_2_extracellular_dom</TD><TD>interpro domains</TD><TD>IPR001879</TD><TD>27</TD><TD>1</TD><TD>18616</TD><TD>30</TD>
<TD>ADGRL1</TD></TR>
<TR><TD>4.268e-02</TD><TD>-3.15</TD><TD>human chr10q23.31</TD><TD>chromosome location</TD><TD>human chr10q23.31</TD><TD>38</TD><TD>1</TD><TD>26169</TD><TD>30</TD>
<TD>IFIT2</TD></TR>
<TR><TD>4.270e-02</TD><TD>-3.15</TD><TD>thyroid hormone receptor binding</TD><TD>molecular function</TD><TD>GO:0046966</TD><TD>29</TD><TD>1</TD><TD>17306</TD><TD>26</TD>
<TD>OASL</TD></TR>
<TR><TD>4.272e-02</TD><TD>-3.15</TD><TD>skin-trunk-malignant_melanoma-nodular</TD><TD>COSMIC cancer mutations</TD><TD>skin-trunk-malignant_melanoma-nodular</TD><TD>1306</TD><TD>5</TD><TD>17255</TD><TD>26</TD>
<TD>RYR1,KIFAP3,OAS2,RSAD2,CADM4</TD></TR>
<TR><TD>4.277e-02</TD><TD>-3.15</TD><TD>MODULE_214</TD><TD>MSigDB lists</TD><TD>MODULE_214</TD><TD>26</TD><TD>1</TD><TD>17275</TD><TD>29</TD>
<TD>RYR1</TD></TR>
<TR><TD>4.277e-02</TD><TD>-3.15</TD><TD>DAZARD_UV_RESPONSE_CLUSTER_G24</TD><TD>MSigDB lists</TD><TD>DAZARD_UV_RESPONSE_CLUSTER_G24</TD><TD>26</TD><TD>1</TD><TD>17275</TD><TD>29</TD>
<TD>IFI27</TD></TR>
<TR><TD>4.277e-02</TD><TD>-3.15</TD><TD>BOYAULT_LIVER_CANCER_SUBCLASS_G5_DN</TD><TD>MSigDB lists</TD><TD>BOYAULT_LIVER_CANCER_SUBCLASS_G5_DN</TD><TD>26</TD><TD>1</TD><TD>17275</TD><TD>29</TD>
<TD>IFI44</TD></TR>
<TR><TD>4.277e-02</TD><TD>-3.15</TD><TD>PID_VEGFR1_PATHWAY</TD><TD>MSigDB lists</TD><TD>PID_VEGFR1_PATHWAY</TD><TD>26</TD><TD>1</TD><TD>17275</TD><TD>29</TD>
<TD>PGF</TD></TR>
<TR><TD>4.277e-02</TD><TD>-3.15</TD><TD>KEGG_GLYCOSAMINOGLYCAN_BIOSYNTHESIS_HEPARAN_SULFATE</TD><TD>MSigDB lists</TD><TD>KEGG_GLYCOSAMINOGLYCAN_BIOSYNTHESIS_HEPARAN_SULFATE</TD><TD>26</TD><TD>1</TD><TD>17275</TD><TD>29</TD>
<TD>HS6ST2</TD></TR>
<TR><TD>4.277e-02</TD><TD>-3.15</TD><TD>GO_REGULATION_OF_MESONEPHROS_DEVELOPMENT</TD><TD>MSigDB lists</TD><TD>GO_REGULATION_OF_MESONEPHROS_DEVELOPMENT</TD><TD>26</TD><TD>1</TD><TD>17275</TD><TD>29</TD>
<TD>LGR4</TD></TR>
<TR><TD>4.277e-02</TD><TD>-3.15</TD><TD>FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_OK_VS_DONOR_DN</TD><TD>MSigDB lists</TD><TD>FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_OK_VS_DONOR_DN</TD><TD>26</TD><TD>1</TD><TD>17275</TD><TD>29</TD>
<TD>CADM4</TD></TR>
<TR><TD>4.282e-02</TD><TD>-3.15</TD><TD>central_nervous_system-medulla-glioma-astrocytoma_Grade_III</TD><TD>COSMIC cancer mutations</TD><TD>central_nervous_system-medulla-glioma-astrocytoma_Grade_III</TD><TD>29</TD><TD>1</TD><TD>17255</TD><TD>26</TD>
<TD>IFI44</TD></TR>
<TR><TD>4.295e-02</TD><TD>-3.15</TD><TD>LEE_RECENT_THYMIC_EMIGRANT</TD><TD>MSigDB lists</TD><TD>LEE_RECENT_THYMIC_EMIGRANT</TD><TD>197</TD><TD>2</TD><TD>17275</TD><TD>29</TD>
<TD>ISG15,RSAD2</TD></TR>
<TR><TD>4.295e-02</TD><TD>-3.15</TD><TD>GSE35685_CD34POS_CD10NEG_CD62LPOS_VS_CD34POS_CD10POS_BONE_MARROW_DN</TD><TD>MSigDB lists</TD><TD>GSE35685_CD34POS_CD10NEG_CD62LPOS_VS_CD34POS_CD10POS_BONE_MARROW_DN</TD><TD>197</TD><TD>2</TD><TD>17275</TD><TD>29</TD>
<TD>IFIT2,ISG15</TD></TR>
<TR><TD>4.334e-02</TD><TD>-3.14</TD><TD>GSE26488_CTRL_VS_PEPTIDE_INJECTION_HDAC7_DELTAP_TG_OT2_THYMOCYTE_UP</TD><TD>MSigDB lists</TD><TD>GSE26488_CTRL_VS_PEPTIDE_INJECTION_HDAC7_DELTAP_TG_OT2_THYMOCYTE_UP</TD><TD>198</TD><TD>2</TD><TD>17275</TD><TD>29</TD>
<TD>ISG15,IFI27</TD></TR>
<TR><TD>4.334e-02</TD><TD>-3.14</TD><TD>GO_NEGATIVE_REGULATION_OF_CYTOKINE_PRODUCTION</TD><TD>MSigDB lists</TD><TD>GO_NEGATIVE_REGULATION_OF_CYTOKINE_PRODUCTION</TD><TD>198</TD><TD>2</TD><TD>17275</TD><TD>29</TD>
<TD>LGR4,ISG15</TD></TR>
<TR><TD>4.337e-02</TD><TD>-3.14</TD><TD>adenylate cyclase-modulating G protein-coupled receptor signaling pathway</TD><TD>biological process</TD><TD>GO:0007188</TD><TD>207</TD><TD>2</TD><TD>18054</TD><TD>29</TD>
<TD>LGR4,ADGRL1</TD></TR>
<TR><TD>4.359e-02</TD><TD>-3.13</TD><TD>Cilium Assembly</TD><TD>REACTOME pathways</TD><TD>R-HSA-5617833</TD><TD>192</TD><TD>2</TD><TD>10287</TD><TD>18</TD>
<TD>TUBA1A,KIFAP3</TD></TR>
<TR><TD>4.377e-02</TD><TD>-3.13</TD><TD>CTDSP1 (CTD small phosphatase 1)</TD><TD>protein interactions</TD><TD>58190</TD><TD>26</TD><TD>1</TD><TD>17456</TD><TD>30</TD>
<TD>TUBA1A</TD></TR>
<TR><TD>4.377e-02</TD><TD>-3.13</TD><TD>YTHDF3 (YTH N6-methyladenosine RNA binding protein 3)</TD><TD>protein interactions</TD><TD>253943</TD><TD>26</TD><TD>1</TD><TD>17456</TD><TD>30</TD>
<TD>ISG15</TD></TR>
<TR><TD>4.377e-02</TD><TD>-3.13</TD><TD>CNKSR1 (connector enhancer of kinase suppressor of Ras 1)</TD><TD>protein interactions</TD><TD>10256</TD><TD>26</TD><TD>1</TD><TD>17456</TD><TD>30</TD>
<TD>CADM4</TD></TR>
<TR><TD>4.377e-02</TD><TD>-3.13</TD><TD>ATP2A1 (ATPase sarcoplasmic/endoplasmic reticulum Ca2+ transporting 1)</TD><TD>protein interactions</TD><TD>487</TD><TD>26</TD><TD>1</TD><TD>17456</TD><TD>30</TD>
<TD>LGR4</TD></TR>
<TR><TD>4.377e-02</TD><TD>-3.13</TD><TD>DHX29 (DExH-box helicase 29)</TD><TD>protein interactions</TD><TD>54505</TD><TD>26</TD><TD>1</TD><TD>17456</TD><TD>30</TD>
<TD>IFIT2</TD></TR>
<TR><TD>4.377e-02</TD><TD>-3.13</TD><TD>ATG4B (autophagy related 4B cysteine peptidase)</TD><TD>protein interactions</TD><TD>23192</TD><TD>26</TD><TD>1</TD><TD>17456</TD><TD>30</TD>
<TD>CAMKK2</TD></TR>
<TR><TD>4.377e-02</TD><TD>-3.13</TD><TD>FLT1 (fms related tyrosine kinase 1)</TD><TD>protein interactions</TD><TD>2321</TD><TD>26</TD><TD>1</TD><TD>17456</TD><TD>30</TD>
<TD>PGF</TD></TR>
<TR><TD>4.405e-02</TD><TD>-3.12</TD><TD>response to gonadotropin</TD><TD>biological process</TD><TD>GO:0034698</TD><TD>28</TD><TD>1</TD><TD>18054</TD><TD>29</TD>
<TD>CTSV</TD></TR>
<TR><TD>4.438e-02</TD><TD>-3.11</TD><TD>GILDEA_METASTASIS</TD><TD>MSigDB lists</TD><TD>GILDEA_METASTASIS</TD><TD>27</TD><TD>1</TD><TD>17275</TD><TD>29</TD>
<TD>IFI27</TD></TR>
<TR><TD>4.438e-02</TD><TD>-3.11</TD><TD>ST_MYOCYTE_AD_PATHWAY</TD><TD>MSigDB lists</TD><TD>ST_MYOCYTE_AD_PATHWAY</TD><TD>27</TD><TD>1</TD><TD>17275</TD><TD>29</TD>
<TD>RYR1</TD></TR>
<TR><TD>4.438e-02</TD><TD>-3.11</TD><TD>REACTOME_PREFOLDIN_MEDIATED_TRANSFER_OF_SUBSTRATE_TO_CCT_TRIC</TD><TD>MSigDB lists</TD><TD>REACTOME_PREFOLDIN_MEDIATED_TRANSFER_OF_SUBSTRATE_TO_CCT_TRIC</TD><TD>27</TD><TD>1</TD><TD>17275</TD><TD>29</TD>
<TD>TUBA1A</TD></TR>
<TR><TD>4.438e-02</TD><TD>-3.11</TD><TD>DAIRKEE_CANCER_PRONE_RESPONSE_E2</TD><TD>MSigDB lists</TD><TD>DAIRKEE_CANCER_PRONE_RESPONSE_E2</TD><TD>27</TD><TD>1</TD><TD>17275</TD><TD>29</TD>
<TD>RYR1</TD></TR>
<TR><TD>4.438e-02</TD><TD>-3.11</TD><TD>BOYLAN_MULTIPLE_MYELOMA_D_CLUSTER_UP</TD><TD>MSigDB lists</TD><TD>BOYLAN_MULTIPLE_MYELOMA_D_CLUSTER_UP</TD><TD>27</TD><TD>1</TD><TD>17275</TD><TD>29</TD>
<TD>KIFAP3</TD></TR>
<TR><TD>4.438e-02</TD><TD>-3.11</TD><TD>GENTILE_UV_LOW_DOSE_UP</TD><TD>MSigDB lists</TD><TD>GENTILE_UV_LOW_DOSE_UP</TD><TD>27</TD><TD>1</TD><TD>17275</TD><TD>29</TD>
<TD>ISG15</TD></TR>
<TR><TD>4.438e-02</TD><TD>-3.11</TD><TD>ZHANG_ANTIVIRAL_RESPONSE_TO_RIBAVIRIN_UP</TD><TD>MSigDB lists</TD><TD>ZHANG_ANTIVIRAL_RESPONSE_TO_RIBAVIRIN_UP</TD><TD>27</TD><TD>1</TD><TD>17275</TD><TD>29</TD>
<TD>IFI27</TD></TR>
<TR><TD>4.438e-02</TD><TD>-3.11</TD><TD>MODULE_330</TD><TD>MSigDB lists</TD><TD>MODULE_330</TD><TD>27</TD><TD>1</TD><TD>17275</TD><TD>29</TD>
<TD>RYR1</TD></TR>
<TR><TD>4.442e-02</TD><TD>-3.11</TD><TD>APC (APC regulator of WNT signaling pathway)</TD><TD>protein interactions</TD><TD>324</TD><TD>196</TD><TD>2</TD><TD>17456</TD><TD>30</TD>
<TD>KIFAP3,ADGRL1</TD></TR>
<TR><TD>4.457e-02</TD><TD>-3.11</TD><TD>Formation of tubulin folding intermediates by CCT/TriC</TD><TD>REACTOME pathways</TD><TD>R-HSA-389960</TD><TD>26</TD><TD>1</TD><TD>10287</TD><TD>18</TD>
<TD>TUBA1A</TD></TR>
<TR><TD>4.457e-02</TD><TD>-3.11</TD><TD>N-glycan antennae elongation in the medial/trans-Golgi</TD><TD>REACTOME pathways</TD><TD>R-HSA-975576</TD><TD>26</TD><TD>1</TD><TD>10287</TD><TD>18</TD>
<TD>MGAT3</TD></TR>
<TR><TD>4.489e-02</TD><TD>-3.10</TD><TD>negative regulation of secretion by cell</TD><TD>biological process</TD><TD>GO:1903531</TD><TD>211</TD><TD>2</TD><TD>18054</TD><TD>29</TD>
<TD>RSAD2,LGR4</TD></TR>
<TR><TD>4.489e-02</TD><TD>-3.10</TD><TD>multi-multicellular organism process</TD><TD>biological process</TD><TD>GO:0044706</TD><TD>211</TD><TD>2</TD><TD>18054</TD><TD>29</TD>
<TD>CTSV,PGF</TD></TR>
<TR><TD>4.519e-02</TD><TD>-3.10</TD><TD>GO_MICROTUBULE_BASED_PROCESS</TD><TD>MSigDB lists</TD><TD>GO_MICROTUBULE_BASED_PROCESS</TD><TD>478</TD><TD>3</TD><TD>17275</TD><TD>29</TD>
<TD>TUBA1A,CAPN6,KIFAP3</TD></TR>
<TR><TD>4.540e-02</TD><TD>-3.09</TD><TD>skin-arm-malignant_melanoma</TD><TD>COSMIC cancer mutations</TD><TD>skin-arm-malignant_melanoma</TD><TD>1328</TD><TD>5</TD><TD>17255</TD><TD>26</TD>
<TD>CAPN6,ZNF518B,MCAM,OASL,RYR1</TD></TR>
<TR><TD>4.541e-02</TD><TD>-3.09</TD><TD>AAAS (aladin WD repeat nucleoporin)</TD><TD>protein interactions</TD><TD>8086</TD><TD>27</TD><TD>1</TD><TD>17456</TD><TD>30</TD>
<TD>ISG15</TD></TR>
<TR><TD>4.541e-02</TD><TD>-3.09</TD><TD>BUD13 (BUD13 homolog)</TD><TD>protein interactions</TD><TD>84811</TD><TD>27</TD><TD>1</TD><TD>17456</TD><TD>30</TD>
<TD>KIFAP3</TD></TR>
<TR><TD>4.541e-02</TD><TD>-3.09</TD><TD>MYOF (myoferlin)</TD><TD>protein interactions</TD><TD>26509</TD><TD>27</TD><TD>1</TD><TD>17456</TD><TD>30</TD>
<TD>ISG15</TD></TR>
<TR><TD>4.541e-02</TD><TD>-3.09</TD><TD>DHX40 (DEAH-box helicase 40)</TD><TD>protein interactions</TD><TD>79665</TD><TD>27</TD><TD>1</TD><TD>17456</TD><TD>30</TD>
<TD>IFIT2</TD></TR>
<TR><TD>4.541e-02</TD><TD>-3.09</TD><TD>TAOK2 (TAO kinase 2)</TD><TD>protein interactions</TD><TD>9344</TD><TD>27</TD><TD>1</TD><TD>17456</TD><TD>30</TD>
<TD>TUBA1A</TD></TR>
<TR><TD>4.541e-02</TD><TD>-3.09</TD><TD>SHANK2 (SH3 and multiple ankyrin repeat domains 2)</TD><TD>protein interactions</TD><TD>22941</TD><TD>27</TD><TD>1</TD><TD>17456</TD><TD>30</TD>
<TD>ADGRL1</TD></TR>
<TR><TD>4.541e-02</TD><TD>-3.09</TD><TD>TUSC3 (tumor suppressor candidate 3)</TD><TD>protein interactions</TD><TD>7991</TD><TD>27</TD><TD>1</TD><TD>17456</TD><TD>30</TD>
<TD>TUBA1A</TD></TR>
<TR><TD>4.541e-02</TD><TD>-3.09</TD><TD>USP18 (ubiquitin specific peptidase 18)</TD><TD>protein interactions</TD><TD>11274</TD><TD>27</TD><TD>1</TD><TD>17456</TD><TD>30</TD>
<TD>ISG15</TD></TR>
<TR><TD>4.541e-02</TD><TD>-3.09</TD><TD>KLK11 (kallikrein related peptidase 11)</TD><TD>protein interactions</TD><TD>11012</TD><TD>27</TD><TD>1</TD><TD>17456</TD><TD>30</TD>
<TD>TUBA1A</TD></TR>
<TR><TD>4.541e-02</TD><TD>-3.09</TD><TD>CDC42BPB (CDC42 binding protein kinase beta)</TD><TD>protein interactions</TD><TD>9578</TD><TD>27</TD><TD>1</TD><TD>17456</TD><TD>30</TD>
<TD>LGR4</TD></TR>
<TR><TD>4.553e-02</TD><TD>-3.09</TD><TD>RIOK1 (RIO kinase 1)</TD><TD>protein interactions</TD><TD>83732</TD><TD>468</TD><TD>3</TD><TD>17456</TD><TD>30</TD>
<TD>TUBA1A,IFIT2,FAM102B</TD></TR>
<TR><TD>4.558e-02</TD><TD>-3.09</TD><TD>heparan sulfate proteoglycan biosynthetic process</TD><TD>biological process</TD><TD>GO:0015012</TD><TD>29</TD><TD>1</TD><TD>18054</TD><TD>29</TD>
<TD>HS6ST2</TD></TR>
<TR><TD>4.565e-02</TD><TD>-3.09</TD><TD>SNRNP200 (small nuclear ribonucleoprotein U5 subunit 200)</TD><TD>protein interactions</TD><TD>23020</TD><TD>199</TD><TD>2</TD><TD>17456</TD><TD>30</TD>
<TD>ISG15,LGR4</TD></TR>
<TR><TD>4.573e-02</TD><TD>-3.08</TD><TD>GO_NEGATIVE_REGULATION_OF_ESTABLISHMENT_OF_PROTEIN_LOCALIZATION</TD><TD>MSigDB lists</TD><TD>GO_NEGATIVE_REGULATION_OF_ESTABLISHMENT_OF_PROTEIN_LOCALIZATION</TD><TD>204</TD><TD>2</TD><TD>17275</TD><TD>29</TD>
<TD>RSAD2,LGR4</TD></TR>
<TR><TD>4.574e-02</TD><TD>-3.08</TD><TD>P-loop_NTPase</TD><TD>interpro domains</TD><TD>IPR027417</TD><TD>848</TD><TD>4</TD><TD>18616</TD><TD>30</TD>
<TD>IFI44L,IFI44,DIRAS1,HS6ST2</TD></TR>
<TR><TD>4.597e-02</TD><TD>-3.08</TD><TD>human chrXq23</TD><TD>chromosome location</TD><TD>human chrXq23</TD><TD>41</TD><TD>1</TD><TD>26169</TD><TD>30</TD>
<TD>CAPN6</TD></TR>
<TR><TD>4.599e-02</TD><TD>-3.08</TD><TD>DORN_ADENOVIRUS_INFECTION_12HR_UP</TD><TD>MSigDB lists</TD><TD>DORN_ADENOVIRUS_INFECTION_12HR_UP</TD><TD>28</TD><TD>1</TD><TD>17275</TD><TD>29</TD>
<TD>IFIT2</TD></TR>
<TR><TD>4.599e-02</TD><TD>-3.08</TD><TD>GO_CALMODULIN_DEPENDENT_PROTEIN_KINASE_ACTIVITY</TD><TD>MSigDB lists</TD><TD>GO_CALMODULIN_DEPENDENT_PROTEIN_KINASE_ACTIVITY</TD><TD>28</TD><TD>1</TD><TD>17275</TD><TD>29</TD>
<TD>CAMKK2</TD></TR>
<TR><TD>4.599e-02</TD><TD>-3.08</TD><TD>GO_HEPARAN_SULFATE_PROTEOGLYCAN_METABOLIC_PROCESS</TD><TD>MSigDB lists</TD><TD>GO_HEPARAN_SULFATE_PROTEOGLYCAN_METABOLIC_PROCESS</TD><TD>28</TD><TD>1</TD><TD>17275</TD><TD>29</TD>
<TD>HS6ST2</TD></TR>
<TR><TD>4.599e-02</TD><TD>-3.08</TD><TD>GO_METANEPHROS_MORPHOGENESIS</TD><TD>MSigDB lists</TD><TD>GO_METANEPHROS_MORPHOGENESIS</TD><TD>28</TD><TD>1</TD><TD>17275</TD><TD>29</TD>
<TD>LGR4</TD></TR>
<TR><TD>4.599e-02</TD><TD>-3.08</TD><TD>GO_INTRACELLULAR_LIGAND_GATED_ION_CHANNEL_ACTIVITY</TD><TD>MSigDB lists</TD><TD>GO_INTRACELLULAR_LIGAND_GATED_ION_CHANNEL_ACTIVITY</TD><TD>28</TD><TD>1</TD><TD>17275</TD><TD>29</TD>
<TD>RYR1</TD></TR>
<TR><TD>4.599e-02</TD><TD>-3.08</TD><TD>WANG_RESPONSE_TO_ANDROGEN_UP</TD><TD>MSigDB lists</TD><TD>WANG_RESPONSE_TO_ANDROGEN_UP</TD><TD>28</TD><TD>1</TD><TD>17275</TD><TD>29</TD>
<TD>CAMKK2</TD></TR>
<TR><TD>4.605e-02</TD><TD>-3.08</TD><TD>antigen processing and presentation</TD><TD>biological process</TD><TD>GO:0019882</TD><TD>214</TD><TD>2</TD><TD>18054</TD><TD>29</TD>
<TD>CTSV,KIFAP3</TD></TR>
<TR><TD>4.646e-02</TD><TD>-3.07</TD><TD>transferase activity</TD><TD>molecular function</TD><TD>GO:0016740</TD><TD>2280</TD><TD>7</TD><TD>17306</TD><TD>26</TD>
<TD>OASL,OAS2,OAS1,HS6ST2,OAS3,MGAT3,CAMKK2</TD></TR>
<TR><TD>4.654e-02</TD><TD>-3.07</TD><TD>LBP1_Q6</TD><TD>MSigDB lists</TD><TD>LBP1_Q6</TD><TD>206</TD><TD>2</TD><TD>17275</TD><TD>29</TD>
<TD>MCAM,TUBA1A</TD></TR>
<TR><TD>4.694e-02</TD><TD>-3.06</TD><TD>MEF2_02</TD><TD>MSigDB lists</TD><TD>MEF2_02</TD><TD>207</TD><TD>2</TD><TD>17275</TD><TD>29</TD>
<TD>DIRAS1,KLHDC8B</TD></TR>
<TR><TD>4.706e-02</TD><TD>-3.06</TD><TD>GZMB (granzyme B)</TD><TD>protein interactions</TD><TD>3002</TD><TD>28</TD><TD>1</TD><TD>17456</TD><TD>30</TD>
<TD>TUBA1A</TD></TR>
<TR><TD>4.706e-02</TD><TD>-3.06</TD><TD>NIPSNAP3A (nipsnap homolog 3A)</TD><TD>protein interactions</TD><TD>25934</TD><TD>28</TD><TD>1</TD><TD>17456</TD><TD>30</TD>
<TD>KIFAP3</TD></TR>
<TR><TD>4.706e-02</TD><TD>-3.06</TD><TD>SUN1 (Sad1 and UNC84 domain containing 1)</TD><TD>protein interactions</TD><TD>23353</TD><TD>28</TD><TD>1</TD><TD>17456</TD><TD>30</TD>
<TD>CAPN6</TD></TR>
<TR><TD>4.706e-02</TD><TD>-3.06</TD><TD>KIF3B (kinesin family member 3B)</TD><TD>protein interactions</TD><TD>9371</TD><TD>28</TD><TD>1</TD><TD>17456</TD><TD>30</TD>
<TD>KIFAP3</TD></TR>
<TR><TD>4.706e-02</TD><TD>-3.06</TD><TD>GBE1 (1,4-alpha-glucan branching enzyme 1)</TD><TD>protein interactions</TD><TD>2632</TD><TD>28</TD><TD>1</TD><TD>17456</TD><TD>30</TD>
<TD>KIFAP3</TD></TR>
<TR><TD>4.706e-02</TD><TD>-3.06</TD><TD>CDC42BPA (CDC42 binding protein kinase alpha)</TD><TD>protein interactions</TD><TD>8476</TD><TD>28</TD><TD>1</TD><TD>17456</TD><TD>30</TD>
<TD>LGR4</TD></TR>
<TR><TD>4.706e-02</TD><TD>-3.06</TD><TD>NRP2 (neuropilin 2)</TD><TD>protein interactions</TD><TD>8828</TD><TD>28</TD><TD>1</TD><TD>17456</TD><TD>30</TD>
<TD>PGF</TD></TR>
<TR><TD>4.706e-02</TD><TD>-3.06</TD><TD>LSM14B (LSM family member 14B)</TD><TD>protein interactions</TD><TD>149986</TD><TD>28</TD><TD>1</TD><TD>17456</TD><TD>30</TD>
<TD>LGR4</TD></TR>
<TR><TD>4.706e-02</TD><TD>-3.06</TD><TD>RYR2 (ryanodine receptor 2)</TD><TD>protein interactions</TD><TD>6262</TD><TD>28</TD><TD>1</TD><TD>17456</TD><TD>30</TD>
<TD>RYR1</TD></TR>
<TR><TD>4.706e-02</TD><TD>-3.06</TD><TD>LRRIQ1 (leucine rich repeats and IQ motif containing 1)</TD><TD>protein interactions</TD><TD>84125</TD><TD>28</TD><TD>1</TD><TD>17456</TD><TD>30</TD>
<TD>LGR4</TD></TR>
<TR><TD>4.707e-02</TD><TD>-3.06</TD><TD>human chr1q24.2</TD><TD>chromosome location</TD><TD>human chr1q24.2</TD><TD>42</TD><TD>1</TD><TD>26169</TD><TD>30</TD>
<TD>KIFAP3</TD></TR>
<TR><TD>4.708e-02</TD><TD>-3.06</TD><TD>HormR</TD><TD>smart domains</TD><TD>SM00008</TD><TD>24</TD><TD>1</TD><TD>9476</TD><TD>19</TD>
<TD>ADGRL1</TD></TR>
<TR><TD>4.712e-02</TD><TD>-3.06</TD><TD>regulation of type 2 immune response</TD><TD>biological process</TD><TD>GO:0002828</TD><TD>30</TD><TD>1</TD><TD>18054</TD><TD>29</TD>
<TD>RSAD2</TD></TR>
<TR><TD>4.712e-02</TD><TD>-3.06</TD><TD>modulation by host of viral process</TD><TD>biological process</TD><TD>GO:0044788</TD><TD>30</TD><TD>1</TD><TD>18054</TD><TD>29</TD>
<TD>IFI27</TD></TR>
<TR><TD>4.735e-02</TD><TD>-3.05</TD><TD>BOQUEST_STEM_CELL_DN</TD><TD>MSigDB lists</TD><TD>BOQUEST_STEM_CELL_DN</TD><TD>208</TD><TD>2</TD><TD>17275</TD><TD>29</TD>
<TD>IFI27,IFI44L</TD></TR>
<TR><TD>4.759e-02</TD><TD>-3.05</TD><TD>LU_TUMOR_VASCULATURE_UP</TD><TD>MSigDB lists</TD><TD>LU_TUMOR_VASCULATURE_UP</TD><TD>29</TD><TD>1</TD><TD>17275</TD><TD>29</TD>
<TD>ISG15</TD></TR>
<TR><TD>4.759e-02</TD><TD>-3.05</TD><TD>GO_THYROID_HORMONE_RECEPTOR_BINDING</TD><TD>MSigDB lists</TD><TD>GO_THYROID_HORMONE_RECEPTOR_BINDING</TD><TD>29</TD><TD>1</TD><TD>17275</TD><TD>29</TD>
<TD>OASL</TD></TR>
<TR><TD>4.759e-02</TD><TD>-3.05</TD><TD>ZWANG_EGF_PERSISTENTLY_UP</TD><TD>MSigDB lists</TD><TD>ZWANG_EGF_PERSISTENTLY_UP</TD><TD>29</TD><TD>1</TD><TD>17275</TD><TD>29</TD>
<TD>OASL</TD></TR>
<TR><TD>4.759e-02</TD><TD>-3.05</TD><TD>MUELLER_COMMON_TARGETS_OF_AML_FUSIONS_DN</TD><TD>MSigDB lists</TD><TD>MUELLER_COMMON_TARGETS_OF_AML_FUSIONS_DN</TD><TD>29</TD><TD>1</TD><TD>17275</TD><TD>29</TD>
<TD>IFI44L</TD></TR>
<TR><TD>4.759e-02</TD><TD>-3.05</TD><TD>GO_INTRACILIARY_TRANSPORT_PARTICLE</TD><TD>MSigDB lists</TD><TD>GO_INTRACILIARY_TRANSPORT_PARTICLE</TD><TD>29</TD><TD>1</TD><TD>17275</TD><TD>29</TD>
<TD>KIFAP3</TD></TR>
<TR><TD>4.759e-02</TD><TD>-3.05</TD><TD>GO_PHOTORECEPTOR_CONNECTING_CILIUM</TD><TD>MSigDB lists</TD><TD>GO_PHOTORECEPTOR_CONNECTING_CILIUM</TD><TD>29</TD><TD>1</TD><TD>17275</TD><TD>29</TD>
<TD>KIFAP3</TD></TR>
<TR><TD>4.760e-02</TD><TD>-3.04</TD><TD>regulation of synapse organization</TD><TD>biological process</TD><TD>GO:0050807</TD><TD>218</TD><TD>2</TD><TD>18054</TD><TD>29</TD>
<TD>TUBA1A,ADGRL1</TD></TR>
<TR><TD>4.816e-02</TD><TD>-3.03</TD><TD>adrenal_cortical_carcinoma</TD><TD>COSMIC cancer mutations</TD><TD>adrenal_cortical_carcinoma</TD><TD>2291</TD><TD>7</TD><TD>17255</TD><TD>26</TD>
<TD>KIAA1211,CAPN6,OASL,MCAM,OAS2,CAMKK2,RYR1</TD></TR>
<TR><TD>4.831e-02</TD><TD>-3.03</TD><TD>arm</TD><TD>COSMIC cancer mutations</TD><TD>arm</TD><TD>1351</TD><TD>5</TD><TD>17255</TD><TD>26</TD>
<TD>RYR1,OASL,MCAM,ZNF518B,CAPN6</TD></TR>
<TR><TD>4.845e-02</TD><TD>-3.03</TD><TD>intracellular ligand-gated ion channel activity</TD><TD>molecular function</TD><TD>GO:0005217</TD><TD>33</TD><TD>1</TD><TD>17306</TD><TD>26</TD>
<TD>RYR1</TD></TR>
<TR><TD>4.858e-02</TD><TD>-3.02</TD><TD>ZHANG_TLX_TARGETS_36HR_UP</TD><TD>MSigDB lists</TD><TD>ZHANG_TLX_TARGETS_36HR_UP</TD><TD>211</TD><TD>2</TD><TD>17275</TD><TD>29</TD>
<TD>CADM4,CAMKK2</TD></TR>
<TR><TD>4.865e-02</TD><TD>-3.02</TD><TD>regulation of T cell cytokine production</TD><TD>biological process</TD><TD>GO:0002724</TD><TD>31</TD><TD>1</TD><TD>18054</TD><TD>29</TD>
<TD>RSAD2</TD></TR>
<TR><TD>4.865e-02</TD><TD>-3.02</TD><TD>metanephric nephron development</TD><TD>biological process</TD><TD>GO:0072210</TD><TD>31</TD><TD>1</TD><TD>18054</TD><TD>29</TD>
<TD>LGR4</TD></TR>
<TR><TD>4.870e-02</TD><TD>-3.02</TD><TD>PHACTR4 (phosphatase and actin regulator 4)</TD><TD>protein interactions</TD><TD>65979</TD><TD>29</TD><TD>1</TD><TD>17456</TD><TD>30</TD>
<TD>IFIT2</TD></TR>
<TR><TD>4.870e-02</TD><TD>-3.02</TD><TD>N4BP2L2 (NEDD4 binding protein 2 like 2)</TD><TD>protein interactions</TD><TD>10443</TD><TD>29</TD><TD>1</TD><TD>17456</TD><TD>30</TD>
<TD>LGR4</TD></TR>
<TR><TD>4.870e-02</TD><TD>-3.02</TD><TD>USP50 (ubiquitin specific peptidase 50)</TD><TD>protein interactions</TD><TD>373509</TD><TD>29</TD><TD>1</TD><TD>17456</TD><TD>30</TD>
<TD>TUBA1A</TD></TR>
<TR><TD>4.870e-02</TD><TD>-3.02</TD><TD>HMGXB4 (HMG-box containing 4)</TD><TD>protein interactions</TD><TD>10042</TD><TD>29</TD><TD>1</TD><TD>17456</TD><TD>30</TD>
<TD>KIFAP3</TD></TR>
<TR><TD>4.870e-02</TD><TD>-3.02</TD><TD>WNT7A (Wnt family member 7A)</TD><TD>protein interactions</TD><TD>7476</TD><TD>29</TD><TD>1</TD><TD>17456</TD><TD>30</TD>
<TD>TUBA1A</TD></TR>
<TR><TD>4.870e-02</TD><TD>-3.02</TD><TD>S100A1 (S100 calcium binding protein A1)</TD><TD>protein interactions</TD><TD>6271</TD><TD>29</TD><TD>1</TD><TD>17456</TD><TD>30</TD>
<TD>RYR1</TD></TR>
<TR><TD>4.878e-02</TD><TD>-3.02</TD><TD>GPS</TD><TD>pfam domains</TD><TD>PF01825</TD><TD>31</TD><TD>1</TD><TD>17385</TD><TD>28</TD>
<TD>ADGRL1</TD></TR>
<TR><TD>4.920e-02</TD><TD>-3.01</TD><TD>GO_POSITIVE_REGULATION_OF_CYTOKINE_PRODUCTION_INVOLVED_IN_IMMUNE_RESPONSE</TD><TD>MSigDB lists</TD><TD>GO_POSITIVE_REGULATION_OF_CYTOKINE_PRODUCTION_INVOLVED_IN_IMMUNE_RESPONSE</TD><TD>30</TD><TD>1</TD><TD>17275</TD><TD>29</TD>
<TD>RSAD2</TD></TR>
<TR><TD>4.920e-02</TD><TD>-3.01</TD><TD>HOLLERN_SOLID_NODULAR_BREAST_TUMOR_DN</TD><TD>MSigDB lists</TD><TD>HOLLERN_SOLID_NODULAR_BREAST_TUMOR_DN</TD><TD>30</TD><TD>1</TD><TD>17275</TD><TD>29</TD>
<TD>RYR1</TD></TR>
<TR><TD>4.920e-02</TD><TD>-3.01</TD><TD>GO_KINESIN_BINDING</TD><TD>MSigDB lists</TD><TD>GO_KINESIN_BINDING</TD><TD>30</TD><TD>1</TD><TD>17275</TD><TD>29</TD>
<TD>KIFAP3</TD></TR>
<TR><TD>4.920e-02</TD><TD>-3.01</TD><TD>chr4q12</TD><TD>MSigDB lists</TD><TD>chr4q12</TD><TD>30</TD><TD>1</TD><TD>17275</TD><TD>29</TD>
<TD>KIAA1211</TD></TR>
<TR><TD>4.920e-02</TD><TD>-3.01</TD><TD>GNF2_EGFR</TD><TD>MSigDB lists</TD><TD>GNF2_EGFR</TD><TD>30</TD><TD>1</TD><TD>17275</TD><TD>29</TD>
<TD>CAPN6</TD></TR>
<TR><TD>4.920e-02</TD><TD>-3.01</TD><TD>REACTOME_HS_GAG_BIOSYNTHESIS</TD><TD>MSigDB lists</TD><TD>REACTOME_HS_GAG_BIOSYNTHESIS</TD><TD>30</TD><TD>1</TD><TD>17275</TD><TD>29</TD>
<TD>HS6ST2</TD></TR>
<TR><TD>4.920e-02</TD><TD>-3.01</TD><TD>REACTOME_NEGATIVE_REGULATORS_OF_RIG_I_MDA5_SIGNALING</TD><TD>MSigDB lists</TD><TD>REACTOME_NEGATIVE_REGULATORS_OF_RIG_I_MDA5_SIGNALING</TD><TD>30</TD><TD>1</TD><TD>17275</TD><TD>29</TD>
<TD>ISG15</TD></TR>
<TR><TD>4.920e-02</TD><TD>-3.01</TD><TD>CAFFAREL_RESPONSE_TO_THC_DN</TD><TD>MSigDB lists</TD><TD>CAFFAREL_RESPONSE_TO_THC_DN</TD><TD>30</TD><TD>1</TD><TD>17275</TD><TD>29</TD>
<TD>TUBA1A</TD></TR>
<TR><TD>4.920e-02</TD><TD>-3.01</TD><TD>LIANG_SILENCED_BY_METHYLATION_UP</TD><TD>MSigDB lists</TD><TD>LIANG_SILENCED_BY_METHYLATION_UP</TD><TD>30</TD><TD>1</TD><TD>17275</TD><TD>29</TD>
<TD>IFI27</TD></TR>
<TR><TD>4.941e-02</TD><TD>-3.01</TD><TD>CHYLA_CBFA2T3_TARGETS_DN</TD><TD>MSigDB lists</TD><TD>CHYLA_CBFA2T3_TARGETS_DN</TD><TD>213</TD><TD>2</TD><TD>17275</TD><TD>29</TD>
<TD>OASL,KLHDC8B</TD></TR>
<TR><TD>4.941e-02</TD><TD>-3.01</TD><TD>MODULE_129</TD><TD>MSigDB lists</TD><TD>MODULE_129</TD><TD>213</TD><TD>2</TD><TD>17275</TD><TD>29</TD>
<TD>IFI44L,OAS1</TD></TR>
<TR><TD>4.959e-02</TD><TD>-3.00</TD><TD>Prefoldin mediated transfer of substrate  to CCT/TriC</TD><TD>REACTOME pathways</TD><TD>R-HSA-389957</TD><TD>29</TD><TD>1</TD><TD>10287</TD><TD>18</TD>
<TD>TUBA1A</TD></TR>
</TABLE>
</BODY></HTML>
